<?xml version="1.0" encoding="UTF-8"?>
<ekb complete="true" id="3595493" timestamp="20160614T192405">
  <input>
    <paragraphs>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/0T.xml" id="paragraph0" sec-type="title">&lt;article-title&gt;ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells&lt;/article-title&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/1A_01a_01.xml" id="paragraph1" sec-type="abstract">&lt;p&gt;RAS mutations occur frequently in human cancer and activated RAS signalling contributes to tumour development and progression. Apart from its oncogenic effects on cell growth, active RAS has tumour-suppressive functions via its ability to induce cellular senescence and apoptosis. RAS is known to induce p53-dependent cell cycle arrest, yet its effect on p53-dependent apoptosis remains unclear. We report here that apoptosis-stimulating protein of p53 (ASPP) 1 and 2, two activators of p53, preferentially bind active RAS via their N-terminal RAS-association domains (RAD). Additionally, ASPP2 colocalises with and contributes to RAS cellular membrane localisation and potentiates RAS signalling. In cancer cells, ASPP1 and ASPP2 cooperate with oncogenic RAS to enhance the transcription and apoptotic function of p53. Thus, loss of ASPP1 and ASPP2 in human cancer cells may contribute to the full transforming property of RAS oncogene.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_00b_01.xml" id="paragraph2" sec-type="background">&lt;p&gt;The evolutionarily conserved &lt;italic&gt;RAS&lt;/italic&gt; proto-oncogenes encode 21 kDa guanine nucleotide-binding proteins. RAS–GDP is inactive, whereas RAS–GTP is active and binds effectors to activate RAS/RAF/ERK or RAS/PI3K/AKT signalling cascades that are important in cell growth and death.&lt;sup&gt;&lt;xref&gt;1&lt;/xref&gt;, &lt;xref&gt;2&lt;/xref&gt;&lt;/sup&gt; RAS activation takes place primarily at the plasma membrane. As one of the first oncogene identified in human cancer, activation of mutations at residues 12, 13 or 61 result in a mutant RAS that constitutively binds GTP. Activation of RAS can also be achieved by overexpression or mutation of its upstream activators such as epidermal growth factor receptor (EGFR).&lt;sup&gt;&lt;xref&gt;3&lt;/xref&gt;, &lt;xref&gt;4&lt;/xref&gt;&lt;/sup&gt; Apart from its oncogenic effect, it is emerging that RAS also has tumour-suppressive functions through its ability to induce senescence and apoptosis.&lt;sup&gt;&lt;xref&gt;5&lt;/xref&gt;&lt;/sup&gt; The final outcome of these contradictory signals depends largely on the cell type and context. It is therefore important to identify molecules that dictate cellular response to RAS activation.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_00b_02.xml" id="paragraph3" sec-type="background">&lt;p&gt;Oncogenes, such as &lt;italic&gt;RAS&lt;/italic&gt;, &lt;italic&gt;Myc&lt;/italic&gt; and &lt;italic&gt;E1A&lt;/italic&gt; are also known to activate the tumour-suppressor p53 via their ability to induce the expression of &lt;italic&gt;Arf&lt;/italic&gt; and prevent Mdm2-mediated protein degradation of p53.&lt;sup&gt;&lt;xref&gt;6&lt;/xref&gt;, &lt;xref&gt;7&lt;/xref&gt;, &lt;xref&gt;8&lt;/xref&gt;&lt;/sup&gt; Oncogenic signalling to p53 leads to one of two responses: cell cycle arrest or apoptosis. Oncogenic RAS induces senescence mediated by p53 and its downstream target gene &lt;italic&gt;p21&lt;/italic&gt;.&lt;sup&gt;&lt;xref&gt;9&lt;/xref&gt;, &lt;xref&gt;10&lt;/xref&gt;, &lt;xref&gt;11&lt;/xref&gt;&lt;/sup&gt; However, the tumour-suppressive function of p53 is closely linked to its ability to induce apoptosis. Therefore, it remains unclear whether oncogenic RAS has a role in regulating p53-mediated apoptosis.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_00b_03.xml" id="paragraph4" sec-type="background">&lt;p&gt;Consistent with p53 as an important mediator of oncogenic RAS-induced senescence in primary fibroblasts, mutations of &lt;italic&gt;p53&lt;/italic&gt; and &lt;italic&gt;RAS&lt;/italic&gt; are found at high frequency in colorectal and pancreatic tumours. In colorectal cancer, &lt;italic&gt;RAS&lt;/italic&gt; mutations are an early event, whereas &lt;italic&gt;p53&lt;/italic&gt; mutations occur predominantly in metastatic tumours.&lt;sup&gt;&lt;xref&gt;12&lt;/xref&gt;&lt;/sup&gt; Therefore, there might be a selective advantage in tumours expressing oncogenic RAS to inactivate the tumour-suppression function of p53. Regulators of p53 may thus also have a role in affecting cellular responses to RAS. Among those, apoptosis-stimulating protein of p53 (ASPP)1 and ASPP2 are two such potential candidates.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_00b_04.xml" id="paragraph5" sec-type="background">&lt;p&gt;ASPP1 and ASPP2 belong to the evolutionarily conserved ASPP family of proteins, including ASPP1, ASPP2 and iASPP, which contain signature sequences in their C-termini; ankyrin repeats, a SH3 domain and proline-rich sequences. The evolutionarily conserved RAS-association domains (RAD) of ASPP1 and ASPP2 are located at their N-termini (first 100 amino acids) and this sequence does not exist in iASPP's N-terminus. In mouse primary fibroblasts, ASPP2 is a key mediator of RAS-induced senescence via its ability to inhibit RAS-induced autophagy, and nuclear accumulation of small ubiquitin-like modifier (SUMO) modified cyclin D1.&lt;sup&gt;&lt;xref&gt;13&lt;/xref&gt;, &lt;xref&gt;14&lt;/xref&gt;&lt;/sup&gt; Mechanistically, the N-terminus of ASPP2 binds ATG5 and inhibits RAS-induced autophagy, independently of p53.&lt;sup&gt;&lt;xref&gt;13&lt;/xref&gt;&lt;/sup&gt;&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_00b_05.xml" id="paragraph6" sec-type="background">&lt;p&gt;In addition to inducing cellular senescence in primary cells, RAS activation induces apoptosis in certain cancer cells. Similarly, DNA damage- or oncogene-induced p53 mainly induces senescence in primary cells, but apoptosis in cancer cells. One explanation for this selective action of p53 in different cell types is the expression levels and activities of the ASPP family of proteins. In cancer cells, ASPP1 and ASPP2 stimulate, whereas iASPP inhibits, apoptosis induced by p53 and its family members, p63 and p73.&lt;sup&gt;&lt;xref&gt;15&lt;/xref&gt;, &lt;xref&gt;16&lt;/xref&gt;, &lt;xref&gt;17&lt;/xref&gt;, &lt;xref&gt;18&lt;/xref&gt;&lt;/sup&gt; ASPP1 and ASPP2 are also transcriptional targets of E2F, and elevated E2F activity mainly occurs in cancer cells due to inactivation of the Rb pathway. Moreover, E2F1 binds and cooperates with p53 to induce apoptosis.&lt;sup&gt;&lt;xref&gt;19&lt;/xref&gt;&lt;/sup&gt; Therefore, in cancer cells, enhanced activities of E2F, ASPP1 and ASPP2 may sensitise cancer cells to p53-induced apoptosis.&lt;sup&gt;&lt;xref&gt;19&lt;/xref&gt;, &lt;xref&gt;20&lt;/xref&gt;&lt;/sup&gt; Importantly, the ability of ASPP1 and ASPP2 to stimulate p53-dependent apoptosis in cancer cells also requires their first 120 amino acids, as mutants lacking them are unable to coactivate with p53, even though they interact with p53.&lt;sup&gt;&lt;xref&gt;16&lt;/xref&gt;&lt;/sup&gt;&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_00b_06.xml" id="paragraph7" sec-type="background">&lt;p&gt;Recently, ASPP2 was shown to bind and colocalise with PAR3 via its N-terminus to maintain the integrity of cell polarity and adherence junctions.&lt;sup&gt;&lt;xref&gt;21&lt;/xref&gt;, &lt;xref&gt;22&lt;/xref&gt;&lt;/sup&gt; RAS activation mainly occurs at the cellular membrane, and the RAD-containing N-terminus of ASPP2 is crucial in mediating oncogenic RAS-induced senescence in primary fibroblasts. Therefore, it is possible that ASPP1 and ASPP2 may interact with RAS and regulate RAS signalling. As a result, the status of ASPP1 and ASPP2 may dictate the cellular response to RAS signalling in both primary fibroblasts and cancer cells. Here we show that ASPP1 and ASPP2 bind active RAS. Endogenous ASPP2 contributes to endogenous RAS cellular membrane localisation, and potentiates RAS signalling. Additionally, we demonstrate that ASPP1 and ASPP2 cooperate with oncogenic RAS to enhance the transcription and apoptotic function of p53 in cancer cells.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_01.xml" id="paragraph8" sec-type="results">&lt;p&gt;The evolutionarily conserved N-terminal 100 amino acids of ASPP1 and ASPP2 share high sequence homology with RAD present in c-Raf, PI3K and RasGDL,&lt;sup&gt;&lt;xref&gt;23&lt;/xref&gt;&lt;/sup&gt; suggesting that ASPP1 and ASPP2 may interact with RAS. Purified N-terminal ASPP1 and purified RAS loaded with [&lt;sup&gt;3&lt;/sup&gt;H]-labelled GTP or GDP were used to investigate whether ASPP1 RAD has a binding preference towards either RAS–GTP or RAS–GDP. We observed that purified ASPP1 fragment (1–310), containing the RAD, interacted with purified RAS &lt;italic&gt;in vitro&lt;/italic&gt;. The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity than RAS–GDP (&lt;xref&gt;Figure 1a&lt;/xref&gt;, compare lanes 4 and 5). To illustrate that only the N-terminal region of ASPP1 binds RAS, various truncated ASPP1 mutants were constructed. All truncated ASPP1 mutants containing RAD complexed with endogenous RAS except ASPP1 (310–1090) lacking RAD (&lt;xref&gt;Supplementary Figures 1a and b&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_02.xml" id="paragraph9" sec-type="results">&lt;p&gt;Activated RAS has a higher interaction affinity with the RAS-binding domain (RBD) of Raf1. Agarose beads linked to the Raf1–RBD can be used to pull down proteins associated with RAS–GTP. In this assay, the presence of small but detectable amounts of c-Raf served as a positive control for the assay. We thus used this as an alternative assay to investigate whether ASPP2 also selectively binds RAS–GTP. Under the same conditions, the percentage of ASPP2 pulled down by Raf1–RBD is clearly higher than that of c-Raf, illustrating that endogenous ASPP2 also complexes with active RAS (&lt;xref&gt;Figure 1b&lt;/xref&gt;). Raf1–RBD failed to pull down iASPP, which does not contain RAD at its N-terminus. These results illustrate that ASPP1 and ASPP2 can bind active RAS, and this interaction is likely mediated through their N-termini.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_03.xml" id="paragraph10" sec-type="results">&lt;p&gt;An ASPP2 inducible U2OS cell line that expresses wild-type p53 was first used to test whether endogenous wild-type RAS binds ASPP2 with different efficiency upon EGF stimulation. Endogenous RAS was immunoprecipitated with or without ASPP2 induction in the presence or absence of EGF treatment (&lt;xref&gt;Supplementary Figure 1c&lt;/xref&gt;). We found that there is very little binding between RAS and ASPP2 in starved cells. The RAS–ASPP2 complex was mainly detected in EGF-treated cells that express active RAS (&lt;xref&gt;Supplementary Figure 1c&lt;/xref&gt;, compare lanes 7 and 8). It is important to note that the expression levels of RAS and ASPP2 are similar in cells before or after EGF treatment. Moreover, an interaction was also observed between endogenous ASPP2 and HRASV12 in a human colon cancer cell line HKe3 ER:HRASV12 cells, in which RAS activation is induced upon the addition of 4-hydroxytamoxifen (4-OHT) (&lt;xref&gt;Figure 1c&lt;/xref&gt;).&lt;sup&gt;&lt;xref&gt;24&lt;/xref&gt;, &lt;xref&gt;25&lt;/xref&gt;&lt;/sup&gt; The ability of endogenous ASPP2 to bind with endogenous active RAS was further tested in mouse embryonic fibroblasts (MEFs) derived from ASPP2 wild-type and ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; embryos. Growth factors such as EGF or insulin were used to stimulate serum-starved ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; and ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs to induce RAS activation. Endogenous ASPP2 and RAS were co-immunoprecipitated with an anti-RAS antibody in ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; MEFs. However, no co-immunoprecipitation was detected in ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs, which occasionally express reduced amounts of N-terminal-truncated ASPP2 (&lt;xref&gt;Figure 1d&lt;/xref&gt;). These data demonstrate that ASPP2 preferentially binds RAS when it is activated.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_04.xml" id="paragraph11" sec-type="results">&lt;p&gt;To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP, a p53-null osteosarcoma cell line Saos2 was starved for 20 h and then stimulated with 20% foetal calf serum (FCS) and EGF. More RAS was detected in the ASPP1 and ASPP2 immunoprecipitates derived from serum- and EGF-stimulated cell lysates than in non-stimulated ones (&lt;xref&gt;Figure 1e&lt;/xref&gt;, compare lanes 1–2 for ASPP2 and 3–4 for ASPP1). All these suggest that N-termini of ASPP1 and ASPP2 selectively bind active RAS. This new property of ASPP1 and ASPP2 is independent of p53 because p53 binds the C-termini of the ASPPs and Saos2 cells are p53-null.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_05.xml" id="paragraph12" sec-type="results">&lt;p&gt;Activated RAS is mainly located at cellular membranes. To test the biological importance of the observed RAS–ASPP interactions, we first examined the cellular localisation of exogenously coexpressed HRASV12 and ASPP2, and observed that they colocalise to the cell membrane in U2OS cells (&lt;xref&gt;Figure 2a&lt;/xref&gt;). In HK-e3ER:HRASV12 cells, ASPP2 is normally expressed at cell/cell junctions.&lt;sup&gt;&lt;xref&gt;22&lt;/xref&gt;&lt;/sup&gt; One hour after RAS induction, endogenous ASPP2 colocalised with induced HRASV12 at the cell membrane in HKe3 cells (&lt;xref&gt;Figure 2b&lt;/xref&gt;). Importantly, ASPP2 depletion by RNA interference (RNAi) largely abolished the membrane localisation of HRASV12 after RAS induction in these cells (&lt;xref&gt;Supplementary Figure 2&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_06.xml" id="paragraph13" sec-type="results">&lt;p&gt;The ability of endogenous ASPP2 to bind and colocalise with endogenous active RAS was tested in a physiological setting. In ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; MEFs, insulin-induced active RAS and ASPP2 colocalised at the cell membrane. The majority of the cells expressing membrane-associated ASPP2 also had membrane-localised RAS and &lt;italic&gt;vice versa&lt;/italic&gt; (&lt;xref&gt;Figure 2c&lt;/xref&gt;, left panel with arrows). RAS was not detected at the cell membrane in ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs (&lt;xref&gt;Figure 2c&lt;/xref&gt;) under the same conditions, consistent with the results in HKe3 cells (&lt;xref&gt;Supplementary Figure 2&lt;/xref&gt;). Similar results were observed in HRASV12-expressing ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; and ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs (&lt;xref&gt;Figure 2c&lt;/xref&gt;, right panel). Together, these data suggest that ASPP2 colocalises with RAS and facilitates the membrane localisation of RAS in human cancer cells and MEFs.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_07.xml" id="paragraph14" sec-type="results">&lt;p&gt;The biological implications of ASPP2–RAS binding and colocalisation were investigated by examining the RAS signalling cascade in ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; and ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs. The basal phosphorylation level of ERK in ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; MEFs was higher than that in ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs (&lt;xref&gt;Figure 3a&lt;/xref&gt;; &lt;xref&gt;Supplementary Figure 3a&lt;/xref&gt;). This difference was more notable in HRASV12-expressing ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; than in ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs (&lt;xref&gt;Figure 3b&lt;/xref&gt;; &lt;xref&gt;Supplementary Figure 3b&lt;/xref&gt;). Upon insulin treatment, a stronger response was observed in ASPP2&lt;sup&gt;(+/+)&lt;/sup&gt; compared with ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs, reflected by the phosphorylation level of both ERK and AKT (&lt;xref&gt;Figures 3a and b&lt;/xref&gt;; &lt;xref&gt;Supplementary Figures 3a and b&lt;/xref&gt;). These data suggest that by binding to and colocalising with active RAS at the cell membrane, ASPP2 potentiates RAS signalling.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_08.xml" id="paragraph15" sec-type="results">&lt;p&gt;The effects of ASPP2 on RAS signalling were further confirmed with human phospho-MAPK arrays. As expected, phosphorylation levels of several downstream effectors of RAS were increased to various extents following RAS activation in HKe3 ER:HRASV12 cells. ASPP2 knockdown dampened the RAS-induced activation of some effectors such as MSK2, p38s and JNKs (&lt;xref&gt;Supplementary Figure 3d&lt;/xref&gt;). Consistent with this, RAS-induced phosphorylation of ERK and AKT is compromised in these cells upon ASPP2 depletion (&lt;xref&gt;Figure 3c&lt;/xref&gt;; &lt;xref&gt;Supplementary Figure 3c&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_09.xml" id="paragraph16" sec-type="results">&lt;p&gt;Finally, to confirm whether the RAD in the N-terminus of ASPP2 is critical for its potentiation of RAS signalling, two ASPP2 mutants were generated: ASPP2 (1–360) and ASPP2 (123–1128), representing a naturally occurring ASPP2 splice variant.&lt;sup&gt;&lt;xref&gt;26&lt;/xref&gt;&lt;/sup&gt; Retroviruses expressing full-length or truncated ASPP2 were infected into HRASV12-expressing ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs. The impaired RAS–ERK and RAS–AKT signalling in HRASV12-expressing ASPP2&lt;sup&gt;(Δ3/Δ3)&lt;/sup&gt; MEFs was largely rescued by the expression of full-length ASPP2 (&lt;xref&gt;Figure 3d&lt;/xref&gt;, lower panel, lanes 7–9). The expression of ASPP2 (1–360) also partially restored the activities of ERK and AKT (&lt;xref&gt;Figure 3d&lt;/xref&gt;, lower panel, lanes 10–12). This may be explained by the reduced expression of ASPP2 (1–360) relative to full-length ASPP2 (&lt;xref&gt;Figure 3e&lt;/xref&gt;). The expression of ASPP2 (123–1128) failed to stimulate ERK and AKT pathways, although the amount of protein was similar to that of ASPP2 (1–1128) (&lt;xref&gt;Figure 3d&lt;/xref&gt; (lower panel, lanes 13–15) and &lt;xref&gt;Figure 3e&lt;/xref&gt;). This result illustrates that the N-terminus of ASPP2 (1–123) is sufficient to potentiate RAS signalling.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_10.xml" id="paragraph17" sec-type="results">&lt;p&gt;We showed previously that the N-termini of ASPP1 and ASPP2 are required for full enhancement of p53 activity.&lt;sup&gt;&lt;xref&gt;16&lt;/xref&gt;&lt;/sup&gt; We thus tested whether ASPP1 and ASPP2 cooperate with RAS to stimulate the apoptotic function of p53. HRASV12 or KRASV12 was co-transfected with ASPP1, ASPP2 and p53 into Saos2 cells. The results shown in &lt;xref&gt;Figure 4a&lt;/xref&gt; illustrate that HRASV12 or KRASV12 alone had a small stimulatory effect on p53 transactivity. As expected, coexpression of ASPP1 or ASPP2 with p53 enhanced the transcriptional activity of p53 on the Bax promoter–luciferase reporter by 3 and 10 times, respectively. In the presence of ASPP1, expression of HRASV12 or KRASV12 stimulated the transactivation function of p53 by ∼10-fold (&lt;xref&gt;Figure 4a&lt;/xref&gt;). Similarly, the coexpression of ASPP2 and HRASV12 or KRASV12 stimulated the transcriptional activity of p53 by around 30–35-fold. When the transcriptional activities of p53+ASPP1 and p53+ASPP2 were set as 1, we observed that both HRASV12 and KRASV12 were able to further enhance the transcriptional activity of p53 by around three-folds (&lt;xref&gt;Figure 4b&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_11.xml" id="paragraph18" sec-type="results">&lt;p&gt;To demonstrate further that RAS activation is required to enhance the transcriptional activity of p53 via ASPP1 or ASPP2, a wild-type RAS or a dominant negative form of HRAS–HRASN17 was co-transfected with ASPP2 and p53 into Saos2 cells. The results shown in &lt;xref&gt;Figure 4c&lt;/xref&gt; illustrate that HRASV12 alone had a small stimulatory effect on the transactivation function of p53. In the presence of ASPP2, however, HRASV12 stimulated the transactivation function of p53 by approximately 3-fold. When HRASN17 was co-transfected with ASPP2 and p53, the transactivation activity of p53 was inhibited. This inhibition was via ASPP2, as HRASN17 transfected only with p53 did not have such a strong inhibitory effect: HRASN17 inhibited p53 and ASPP2 activity more than 4-fold, whereas it inhibited p53 via endogenous ASPP about 1.5-fold. In contrast, wild-type RAS had very little effect on the transactivation function of p53. This may be explained by the fact that increased RAS expression does not necessarily lead to increased levels of RAS–GTP in cells.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_12.xml" id="paragraph19" sec-type="results">&lt;p&gt;We tested whether the observed ability of &lt;italic&gt;RAS&lt;/italic&gt; oncogene to cooperate with ASPP2 to enhance p53 transcriptional activity is promoter-specific. Three p53 target gene promoter-containing reporters, PIG3-, Bax- and Mdm2-luciferases, were used. We observed that HRASV12 had the most profound effect on the transcriptional activity of p53 on PIG3 and BAX promoters. Under the same conditions, a reduced stimulatory effect was seen on Mdm2 promoter (&lt;xref&gt;Figure 4d&lt;/xref&gt;). This agrees with our previous finding that ASPP2 has minimal impact on the transcriptional activity of p53 on the promoters of Mdm2 and p21&lt;sup&gt;waf1&lt;/sup&gt;.&lt;sup&gt;&lt;xref&gt;16&lt;/xref&gt;&lt;/sup&gt; Consistent with this, we also observed that p21&lt;sup&gt;waf1&lt;/sup&gt; mRNA expression induced by activated RAS in HKe3 cells is independent of ASPP2 status, as ASPP2 knockdown in these cells did not alter p21&lt;sup&gt;waf1&lt;/sup&gt; expression (&lt;xref&gt;Supplementary Figure 4a&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_13.xml" id="paragraph20" sec-type="results">&lt;p&gt;The requirement of endogenous RAS to stimulate the transcriptional activity of p53 via ASPP2 was tested using shRNA against HRAS or KRAS. Their ability to specifically reduce the expression level of HRAS or KRAS was confirmed (&lt;xref&gt;Supplementary Figure 4b&lt;/xref&gt;). We found that RNAi against HRAS or KRAS dampened the ability of ASPP2 to stimulate the transactivation function of p53 on the promoters of the pro-apoptotic gene &lt;italic&gt;Bax&lt;/italic&gt; (&lt;xref&gt;Figure 4e&lt;/xref&gt;) and &lt;italic&gt;PIG3&lt;/italic&gt; (&lt;xref&gt;Supplementary Figure 4c&lt;/xref&gt;). All these support the notion that ASPP1 and ASPP2 cooperate with RAS to enhance the transcriptional activity of p53 for apoptotic genes. This cooperation is likely to be mediated by the identified interaction between active RAS and RAD of the ASPPs, which also explains why the RAD of the ASPPs is required for their full potential to enhance the transcriptional activity of p53.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_14.xml" id="paragraph21" sec-type="results">&lt;p&gt;The requirement of RAS activation to potentiate the pro-apoptotic function of ASPP1 and ASPP2 was tested in two human cancer cell lines with wild-type p53: MCF7 and U2OS. As published previously, increased expression of ASPP1 or ASPP2 induces p53-mediated apoptosis in both cell lines.&lt;sup&gt;&lt;xref&gt;16&lt;/xref&gt;&lt;/sup&gt; Using shRNAs to reduce the expression of endogenous HRAS or KRAS, we observed a reduction in the percentage of apoptosis in cells induced by ASPP1 or ASPP2 overexpression (&lt;xref&gt;Figure 5a&lt;/xref&gt;). These findings suggest that endogenous HRAS and KRAS are required for the full activities of ASPP1 and ASPP2.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_15.xml" id="paragraph22" sec-type="results">&lt;p&gt;To further confirm this, we used HKe3 ER:HRASV12 cells, in which RAS activation is induced upon the addition of 4-OHT. Importantly, oncogenic RAS activation induced apoptosis in these cells indicated by the presence of cleaved-PARP (&lt;xref&gt;Figure 5c&lt;/xref&gt;). To test whether p53 has a role in mediating the observed RAS-induced apoptosis in HKe3 cells, RNAi against p53 was used. Depletion of p53 abolished RAS-induced apoptosis in these cells. This is evident from a lack of PARP cleavage in these cells (&lt;xref&gt;Figure 5d&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_01r_16.xml" id="paragraph23" sec-type="results">&lt;p&gt;To understand how ASPP2 cooperates with p53 to induce apoptosis in cancer cells, we examined the cellular localisation of ASPP2 in HKe3 ER:HRASV12 cells upon RAS induction. We observed that endogenous ASPP2 translocates from cell/cell junctions to the cytosol/nucleus following RAS activation (&lt;xref&gt;Figure 6a&lt;/xref&gt;). This is also confirmed by the detection of an increase in the expression levels of ASPP2 in the nuclear and cytoplasmic fractions in these cells upon RAS activation, with around two–three-folds increase in the level of nuclear and cytoplasmic ASPP2, respectively (&lt;xref&gt;Figure 6b&lt;/xref&gt;). Moreover, we also detected an increase in the amount of p53–ASPP2 complex in these cells following RAS activation (&lt;xref&gt;Figure 6c&lt;/xref&gt;). To test whether endogenous ASPP2 mediates the observed RAS-induced apoptosis in HKe3 cells, ASPP2 RNAi was used. ASPP2 knockdown abolished RAS-induced apoptosis indicated by a lack of PARP cleavage (&lt;xref&gt;Figure 6d&lt;/xref&gt;). These data identify ASPP2 as an important mediator of oncogenic RAS-induced apoptosis. This may be achieved via the ability of the active RAS to induce the cellular translocation of ASPP2, and enhance the ability of ASPP2 to bind p53 and to enhance its activity.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_02d_01.xml" id="paragraph24" sec-type="discussion">&lt;p&gt;In addition to its well-established oncogenic properties, it is emerging that RAS also has growth-suppressive functions by its ability to induce senescence in primary fibroblasts and apoptosis in cancer cells. Recently, we showed that ASPP2 is a potent mediator of RAS-induced senescence. This property is p53-independent, and is achieved partly through the ability of the N-terminus of ASPP2 to bind ATG5 and to inhibit RAS-induced autophagy, as elevated autophagy activity bypasses oncogenic RAS-induced senescence in fibroblasts.&lt;sup&gt;&lt;xref&gt;13&lt;/xref&gt;&lt;/sup&gt;&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_02d_02.xml" id="paragraph25" sec-type="discussion">&lt;p&gt;We show here that ASPP1 and ASPP2 bind active RAS via their N-termini. ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane. Moreover, the observed RAS–ASPP interactions enhance the transcription and apoptotic function of p53 in cancer cells. In primary fibroblasts, ASPP2 mediates RAS-induced senescence independent of p53, whereas in cancer cells, ASPP1 and ASPP2 mediate RAS-induced p53-dependent apoptosis. Therefore, ASPP1 and ASPP2 are the key mediators of RAS signalling in both primary and cancer cells. The status of ASPP1 and ASPP2 may therefore dictate the cellular response to RAS signalling. Therefore, the ability of ASPP2 to be located at cell junctions to bind and colocalise with RAS on the one hand, and located in the cytoplasm and bind p53 upon RAS activation on the other, places ASPP2 in an ideal position to survey the intensity of RAS signalling and to coordinate appropriate cellular responses accordingly. One possible explanation for this property of ASPP2 is that, when RAS is activated, it binds active RAS and controls the intensity of the RAS signal. When RAS signalling is elevated to a certain level, high enough to disrupt cell/cell junctions for example, it may then displace ASPP2 from cell/cell junctions. This redistribution of ASPP2 would thus enable the interaction with ATG5 to inhibit autophagy and to mediate RAS-induced senescence or to bind p53 to promote apoptosis (&lt;xref&gt;Figure 6e&lt;/xref&gt;). As the levels of RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions is lower than that in cancer cells caused by mutation or amplifications of &lt;italic&gt;RAS&lt;/italic&gt; or &lt;italic&gt;EGFR&lt;/italic&gt; genes, this cellular localisation of ASPP2 and its binding partners may differ between primary cells and cancer cells. Future studies are needed to test whether cellular localisation of ASPP1 and ASPP2, and their ability to interact with ATG5 or p53 may be an underline reason for why RAS or p53 activation predominately induces senescence in primary cells but apoptosis in cancer cells.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_02d_03.xml" id="paragraph26" sec-type="discussion">&lt;p&gt;Although ASPP1 and ASPP2 share sequence similarity and have many overlapping functions &lt;italic&gt;in vitro&lt;/italic&gt;, including the interaction with active RAS, they have distinct biological functions &lt;italic&gt;in vivo&lt;/italic&gt;. ASPP2 binds PAR3 and locates at cell/cell junctions,&lt;sup&gt;&lt;xref&gt;21&lt;/xref&gt;, &lt;xref&gt;22&lt;/xref&gt;&lt;/sup&gt; whereas ASPP1 binds YAP and locates in cytosol.&lt;sup&gt;&lt;xref&gt;27&lt;/xref&gt;, &lt;xref&gt;28&lt;/xref&gt;&lt;/sup&gt; ASPP1 deficiency in mice is predominantly tolerated in mouse development, although lymphatic vessel leakage occurs.&lt;sup&gt;&lt;xref&gt;29&lt;/xref&gt;&lt;/sup&gt; This differs from ASPP2-deficient mice, where a loss of cell polarity and excessive proliferation of neural progenitors are common features. Importantly, ASPP2 heterozygosity is sufficient to predispose mice to develop tumours,&lt;sup&gt;&lt;xref&gt;30&lt;/xref&gt;, &lt;xref&gt;31&lt;/xref&gt;&lt;/sup&gt; establishing ASPP2's tumour-suppressive function. These differences may explain why ASPP2 depletion alone is sufficient to affect RAS signalling. Future studies are therefore needed to elucidate which of the &lt;italic&gt;in vivo&lt;/italic&gt; functions of ASPP1 are influenced by the identified ASPP1–RAS interaction.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_02d_04.xml" id="paragraph27" sec-type="discussion">&lt;p&gt;There have been many reports demonstrating that RAS activation inhibits apoptosis and promotes survival. Paradoxically, increasing numbers of studies have also shown that RAS activation induces apoptosis. The effect of RAS on survival &lt;italic&gt;versus&lt;/italic&gt; apoptosis depends largely on cell types and concurrent activation of other signalling pathways. The most prominent pathway involved in RAS-mediated apoptosis is the Raf–ERK pathway.&lt;sup&gt;&lt;xref&gt;32&lt;/xref&gt;, &lt;xref&gt;33&lt;/xref&gt;, &lt;xref&gt;34&lt;/xref&gt;&lt;/sup&gt; p53 is also thought to be involved in RAS-mediated apoptosis, as RAS is no longer able to induce apoptosis following p53 loss.&lt;sup&gt;&lt;xref&gt;34&lt;/xref&gt;, &lt;xref&gt;35&lt;/xref&gt;, &lt;xref&gt;36&lt;/xref&gt;&lt;/sup&gt; RAS is known to stimulate p53 activity through the induction of Arf and PML.&lt;sup&gt;&lt;xref&gt;37&lt;/xref&gt;, &lt;xref&gt;38&lt;/xref&gt;, &lt;xref&gt;39&lt;/xref&gt;&lt;/sup&gt; However, under the conditions used in these studies, RAS is likely to enhance the apoptotic function of p53 independently of Arf, as UO2S and MCF7 cells do not express Arf.&lt;sup&gt;&lt;xref&gt;40&lt;/xref&gt;&lt;/sup&gt; The overall effect of RAS on p53 activity may be dependent on a balance between the different pathways linking the two proteins.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/3595493/2B_02d_05.xml" id="paragraph28" sec-type="discussion">&lt;p&gt;The ability of oncogenes to stimulate cell cycle arrest or apoptosis allows the cell to have a fail-proof system: oncogene activation would, instead of inducing the cell to proliferate in an uncontrolled manner, activate tumour-suppressor proteins, thereby preventing the cell from replicating its damage. Although cell cycle arrest and apoptosis are both efficient ways for cells to prevent propagation of their damage, apoptosis is irreversible and therefore more effective. The identification of ASPP1 and ASPP2 as mediators of RAS and p53 in regulating apoptosis suggests that oncogenic RAS would put pressure on p53 to induce apoptosis. Therefore, the discovery that ASPP1 and ASPP2 cooperate with RAS to enhance p53-induced apoptosis suggests that loss of ASPP1 or ASPP2 expression may be a frequent event in human cancers with mutant RAS. This finding may provide a novel molecular explanation for why RAS and p53 mutations are so tightly associated in human cancer.&lt;/p&gt;
</paragraph>
    </paragraphs>
    <sentences>
      <sentence id="1" pid="paragraph0">ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells</sentence>
      <sentence id="2" pid="paragraph1">RAS mutations occur frequently in human cancer and activated RAS signalling contributes to tumour development and progression.</sentence>
      <sentence id="3" pid="paragraph1">Apart from its oncogenic effects on cell growth, active RAS has tumour-suppressive functions via its ability to induce cellular senescence and apoptosis.</sentence>
      <sentence id="4" pid="paragraph1">RAS is known to induce p53-dependent cell cycle arrest, yet its effect on p53-dependent apoptosis remains unclear.</sentence>
      <sentence id="5" pid="paragraph1">We report here that apoptosis-stimulating protein of p53 (ASPP) 1 and 2, two activators of p53, preferentially bind active RAS via their N-terminal RAS-association domains (RAD).</sentence>
      <sentence id="6" pid="paragraph1">Additionally, ASPP2 colocalises with and contributes to RAS cellular membrane localisation and potentiates RAS signalling.</sentence>
      <sentence id="7" pid="paragraph1">In cancer cells, ASPP1 and ASPP2 cooperate with oncogenic RAS to enhance the transcription and apoptotic function of p53.</sentence>
      <sentence id="8" pid="paragraph1">Thus, loss of ASPP1 and ASPP2 in human cancer cells may contribute to the full transforming property of RAS oncogene.</sentence>
      <sentence id="9" pid="paragraph2">The evolutionarily conserved RAS proto-oncogenes encode 21 kDa guanine nucleotide-binding proteins.</sentence>
      <sentence id="10" pid="paragraph2">RAS–GDP is inactive, whereas RAS–GTP is active and binds effectors to activate RAS/RAF/ERK or RAS/PI3K/AKT signalling cascades that are important in cell growth and death. 1 , 2 RAS activation takes place primarily at the plasma membrane.</sentence>
      <sentence id="11" pid="paragraph2">As one of the first oncogene identified in human cancer, activation of mutations at residues 12, 13 or 61 result in a mutant RAS that constitutively binds GTP.</sentence>
      <sentence id="12" pid="paragraph2">Activation of RAS can also be achieved by overexpression or mutation of its upstream activators such as epidermal growth factor receptor (EGFR). 3 , 4 Apart from its oncogenic effect, it is emerging that RAS also has tumour-suppressive functions through its ability to induce senescence and apoptosis. 5 The final outcome of these contradictory signals depends largely on the cell type and context.</sentence>
      <sentence id="13" pid="paragraph2">It is therefore important to identify molecules that dictate cellular response to RAS activation.</sentence>
      <sentence id="14" pid="paragraph3">Oncogenes, such as RAS , Myc and E1A are also known to activate the tumour-suppressor p53 via their ability to induce the expression of Arf and prevent Mdm2-mediated protein degradation of p53. 6 , 7 , 8 Oncogenic signalling to p53 leads to one of two responses: cell cycle arrest or apoptosis.</sentence>
      <sentence id="15" pid="paragraph3">Oncogenic RAS induces senescence mediated by p53 and its downstream target gene p21 . 9 , 10 , 11 However, the tumour-suppressive function of p53 is closely linked to its ability to induce apoptosis.</sentence>
      <sentence id="16" pid="paragraph3">Therefore, it remains unclear whether oncogenic RAS has a role in regulating p53-mediated apoptosis.</sentence>
      <sentence id="17" pid="paragraph4">Consistent with p53 as an important mediator of oncogenic RAS-induced senescence in primary fibroblasts, mutations of p53 and RAS are found at high frequency in colorectal and pancreatic tumours.</sentence>
      <sentence id="18" pid="paragraph4">In colorectal cancer, RAS mutations are an early event, whereas p53 mutations occur predominantly in metastatic tumours. 12 Therefore, there might be a selective advantage in tumours expressing oncogenic RAS to inactivate the tumour-suppression function of p53.</sentence>
      <sentence id="19" pid="paragraph4">Regulators of p53 may thus also have a role in affecting cellular responses to RAS.</sentence>
      <sentence id="20" pid="paragraph4">Among those, apoptosis-stimulating protein of p53 (ASPP)1 and ASPP2 are two such potential candidates.</sentence>
      <sentence id="21" pid="paragraph5">ASPP1 and ASPP2 belong to the evolutionarily conserved ASPP family of proteins, including ASPP1, ASPP2 and iASPP, which contain signature sequences in their C-termini; ankyrin repeats, a SH3 domain and proline-rich sequences.</sentence>
      <sentence id="22" pid="paragraph5">The evolutionarily conserved RAS-association domains (RAD) of ASPP1 and ASPP2 are located at their N-termini (first 100 amino acids) and this sequence does not exist in iASPP's N-terminus.</sentence>
      <sentence id="23" pid="paragraph5">In mouse primary fibroblasts, ASPP2 is a key mediator of RAS-induced senescence via its ability to inhibit RAS-induced autophagy, and nuclear accumulation of small ubiquitin-like modifier (SUMO) modified cyclin D1. 13 , 14 Mechanistically, the N-terminus of ASPP2 binds ATG5 and inhibits RAS-induced autophagy, independently of p53. 13</sentence>
      <sentence id="24" pid="paragraph6">In addition to inducing cellular senescence in primary cells, RAS activation induces apoptosis in certain cancer cells.</sentence>
      <sentence id="25" pid="paragraph6">Similarly, DNA damage- or oncogene-induced p53 mainly induces senescence in primary cells, but apoptosis in cancer cells.</sentence>
      <sentence id="26" pid="paragraph6">One explanation for this selective action of p53 in different cell types is the expression levels and activities of the ASPP family of proteins.</sentence>
      <sentence id="27" pid="paragraph6">In cancer cells, ASPP1 and ASPP2 stimulate, whereas iASPP inhibits, apoptosis induced by p53 and its family members, p63 and p73. 15 , 16 , 17 , 18 ASPP1 and ASPP2 are also transcriptional targets of E2F, and elevated E2F activity mainly occurs in cancer cells due to inactivation of the Rb pathway.</sentence>
      <sentence id="28" pid="paragraph6">Moreover, E2F1 binds and cooperates with p53 to induce apoptosis. 19 Therefore, in cancer cells, enhanced activities of E2F, ASPP1 and ASPP2 may sensitise cancer cells to p53-induced apoptosis. 19 , 20 Importantly, the ability of ASPP1 and ASPP2 to stimulate p53-dependent apoptosis in cancer cells also requires their first 120 amino acids, as mutants lacking them are unable to coactivate with p53, even though they interact with p53. 16</sentence>
      <sentence id="29" pid="paragraph7">Recently, ASPP2 was shown to bind and colocalise with PAR3 via its N-terminus to maintain the integrity of cell polarity and adherence junctions. 21 , 22 RAS activation mainly occurs at the cellular membrane, and the RAD-containing N-terminus of ASPP2 is crucial in mediating oncogenic RAS-induced senescence in primary fibroblasts.</sentence>
      <sentence id="30" pid="paragraph7">Therefore, it is possible that ASPP1 and ASPP2 may interact with RAS and regulate RAS signalling.</sentence>
      <sentence id="31" pid="paragraph7">As a result, the status of ASPP1 and ASPP2 may dictate the cellular response to RAS signalling in both primary fibroblasts and cancer cells.</sentence>
      <sentence id="32" pid="paragraph7">Here we show that ASPP1 and ASPP2 bind active RAS.</sentence>
      <sentence id="33" pid="paragraph7">Endogenous ASPP2 contributes to endogenous RAS cellular membrane localisation, and potentiates RAS signalling.</sentence>
      <sentence id="34" pid="paragraph7">Additionally, we demonstrate that ASPP1 and ASPP2 cooperate with oncogenic RAS to enhance the transcription and apoptotic function of p53 in cancer cells.</sentence>
      <sentence id="35" pid="paragraph8">The evolutionarily conserved N-terminal 100 amino acids of ASPP1 and ASPP2 share high sequence homology with RAD present in c-Raf, PI3K and RasGDL, 23 suggesting that ASPP1 and ASPP2 may interact with RAS.</sentence>
      <sentence id="36" pid="paragraph8">Purified N-terminal ASPP1 and purified RAS loaded with [ 3 H]-labelled GTP or GDP were used to investigate whether ASPP1 RAD has a binding preference towards either RAS–GTP or RAS–GDP.</sentence>
      <sentence id="37" pid="paragraph8">We observed that purified ASPP1 fragment (1–310), containing the RAD, interacted with purified RAS in vitro .</sentence>
      <sentence id="38" pid="paragraph8">The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity than RAS–GDP ( Figure 1a , compare lanes 4 and 5).</sentence>
      <sentence id="39" pid="paragraph8">To illustrate that only the N-terminal region of ASPP1 binds RAS, various truncated ASPP1 mutants were constructed.</sentence>
      <sentence id="40" pid="paragraph8">All truncated ASPP1 mutants containing RAD complexed with endogenous RAS except ASPP1 (310–1090) lacking RAD ( Supplementary Figures 1a and b ).</sentence>
      <sentence id="41" pid="paragraph9">Activated RAS has a higher interaction affinity with the RAS-binding domain (RBD) of Raf1.</sentence>
      <sentence id="42" pid="paragraph9">Agarose beads linked to the Raf1–RBD can be used to pull down proteins associated with RAS–GTP.</sentence>
      <sentence id="43" pid="paragraph9">In this assay, the presence of small but detectable amounts of c-Raf served as a positive control for the assay.</sentence>
      <sentence id="44" pid="paragraph9">We thus used this as an alternative assay to investigate whether ASPP2 also selectively binds RAS–GTP.</sentence>
      <sentence id="45" pid="paragraph9">Under the same conditions, the percentage of ASPP2 pulled down by Raf1–RBD is clearly higher than that of c-Raf, illustrating that endogenous ASPP2 also complexes with active RAS ( Figure 1b ).</sentence>
      <sentence id="46" pid="paragraph9">Raf1–RBD failed to pull down iASPP, which does not contain RAD at its N-terminus.</sentence>
      <sentence id="47" pid="paragraph9">These results illustrate that ASPP1 and ASPP2 can bind active RAS, and this interaction is likely mediated through their N-termini.</sentence>
      <sentence id="48" pid="paragraph10">An ASPP2 inducible U2OS cell line that expresses wild-type p53 was first used to test whether endogenous wild-type RAS binds ASPP2 with different efficiency upon EGF stimulation.</sentence>
      <sentence id="49" pid="paragraph10">Endogenous RAS was immunoprecipitated with or without ASPP2 induction in the presence or absence of EGF treatment ( Supplementary Figure 1c ).</sentence>
      <sentence id="50" pid="paragraph10">We found that there is very little binding between RAS and ASPP2 in starved cells.</sentence>
      <sentence id="51" pid="paragraph10">The RAS–ASPP2 complex was mainly detected in EGF-treated cells that express active RAS ( Supplementary Figure 1c , compare lanes 7 and 8).</sentence>
      <sentence id="52" pid="paragraph10">It is important to note that the expression levels of RAS and ASPP2 are similar in cells before or after EGF treatment.</sentence>
      <sentence id="53" pid="paragraph10">Moreover, an interaction was also observed between endogenous ASPP2 and HRASV12 in a human colon cancer cell line HKe3 ER:HRASV12 cells, in which RAS activation is induced upon the addition of 4-hydroxytamoxifen (4-OHT) ( Figure 1c ) . 24 , 25 The ability of endogenous ASPP2 to bind with endogenous active RAS was further tested in mouse embryonic fibroblasts (MEFs) derived from ASPP2 wild-type and ASPP2 (Δ3/Δ3) embryos.</sentence>
      <sentence id="54" pid="paragraph10">Growth factors such as EGF or insulin were used to stimulate serum-starved ASPP2 (+/+) and ASPP2 (Δ3/Δ3) MEFs to induce RAS activation.</sentence>
      <sentence id="55" pid="paragraph10">Endogenous ASPP2 and RAS were co-immunoprecipitated with an anti-RAS antibody in ASPP2 (+/+) MEFs.</sentence>
      <sentence id="56" pid="paragraph10">However, no co-immunoprecipitation was detected in ASPP2 (Δ3/Δ3) MEFs, which occasionally express reduced amounts of N-terminal-truncated ASPP2 ( Figure 1d ).</sentence>
      <sentence id="57" pid="paragraph10">These data demonstrate that ASPP2 preferentially binds RAS when it is activated.</sentence>
      <sentence id="58" pid="paragraph11">To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP, a p53-null osteosarcoma cell line Saos2 was starved for 20 h and then stimulated with 20% foetal calf serum (FCS) and EGF.</sentence>
      <sentence id="59" pid="paragraph11">More RAS was detected in the ASPP1 and ASPP2 immunoprecipitates derived from serum- and EGF-stimulated cell lysates than in non-stimulated ones ( Figure 1e , compare lanes 1–2 for ASPP2 and 3–4 for ASPP1).</sentence>
      <sentence id="60" pid="paragraph11">All these suggest that N-termini of ASPP1 and ASPP2 selectively bind active RAS.</sentence>
      <sentence id="61" pid="paragraph11">This new property of ASPP1 and ASPP2 is independent of p53 because p53 binds the C-termini of the ASPPs and Saos2 cells are p53-null.</sentence>
      <sentence id="62" pid="paragraph12">Activated RAS is mainly located at cellular membranes.</sentence>
      <sentence id="63" pid="paragraph12">To test the biological importance of the observed RAS–ASPP interactions, we first examined the cellular localisation of exogenously coexpressed HRASV12 and ASPP2, and observed that they colocalise to the cell membrane in U2OS cells ( Figure 2a ).</sentence>
      <sentence id="64" pid="paragraph12">In HK-e3ER:HRASV12 cells, ASPP2 is normally expressed at cell/cell junctions. 22 One hour after RAS induction, endogenous ASPP2 colocalised with induced HRASV12 at the cell membrane in HKe3 cells ( Figure 2b ).</sentence>
      <sentence id="65" pid="paragraph12">Importantly, ASPP2 depletion by RNA interference (RNAi) largely abolished the membrane localisation of HRASV12 after RAS induction in these cells ( Supplementary Figure 2 ).</sentence>
      <sentence id="66" pid="paragraph13">The ability of endogenous ASPP2 to bind and colocalise with endogenous active RAS was tested in a physiological setting.</sentence>
      <sentence id="67" pid="paragraph13">In ASPP2 (+/+) MEFs, insulin-induced active RAS and ASPP2 colocalised at the cell membrane.</sentence>
      <sentence id="68" pid="paragraph13">The majority of the cells expressing membrane-associated ASPP2 also had membrane-localised RAS and vice versa ( Figure 2c , left panel with arrows).</sentence>
      <sentence id="69" pid="paragraph13">RAS was not detected at the cell membrane in ASPP2 (Δ3/Δ3) MEFs ( Figure 2c ) under the same conditions, consistent with the results in HKe3 cells ( Supplementary Figure 2 ).</sentence>
      <sentence id="70" pid="paragraph13">Similar results were observed in HRASV12-expressing ASPP2 (+/+) and ASPP2 (Δ3/Δ3) MEFs ( Figure 2c , right panel).</sentence>
      <sentence id="71" pid="paragraph13">Together, these data suggest that ASPP2 colocalises with RAS and facilitates the membrane localisation of RAS in human cancer cells and MEFs.</sentence>
      <sentence id="72" pid="paragraph14">The biological implications of ASPP2–RAS binding and colocalisation were investigated by examining the RAS signalling cascade in ASPP2 (+/+) and ASPP2 (Δ3/Δ3) MEFs.</sentence>
      <sentence id="73" pid="paragraph14">The basal phosphorylation level of ERK in ASPP2 (+/+) MEFs was higher than that in ASPP2 (Δ3/Δ3) MEFs ( Figure 3a ; Supplementary Figure 3a ).</sentence>
      <sentence id="74" pid="paragraph14">This difference was more notable in HRASV12-expressing ASPP2 (+/+) than in ASPP2 (Δ3/Δ3) MEFs ( Figure 3b ; Supplementary Figure 3b ).</sentence>
      <sentence id="75" pid="paragraph14">Upon insulin treatment, a stronger response was observed in ASPP2 (+/+) compared with ASPP2 (Δ3/Δ3) MEFs, reflected by the phosphorylation level of both ERK and AKT ( Figures 3a and b ; Supplementary Figures 3a and b ).</sentence>
      <sentence id="76" pid="paragraph14">These data suggest that by binding to and colocalising with active RAS at the cell membrane, ASPP2 potentiates RAS signalling.</sentence>
      <sentence id="77" pid="paragraph15">The effects of ASPP2 on RAS signalling were further confirmed with human phospho-MAPK arrays.</sentence>
      <sentence id="78" pid="paragraph15">As expected, phosphorylation levels of several downstream effectors of RAS were increased to various extents following RAS activation in HKe3 ER:HRASV12 cells.</sentence>
      <sentence id="79" pid="paragraph15">ASPP2 knockdown dampened the RAS-induced activation of some effectors such as MSK2, p38s and JNKs ( Supplementary Figure 3d ).</sentence>
      <sentence id="80" pid="paragraph15">Consistent with this, RAS-induced phosphorylation of ERK and AKT is compromised in these cells upon ASPP2 depletion ( Figure 3c ; Supplementary Figure 3c ).</sentence>
      <sentence id="81" pid="paragraph16">Finally, to confirm whether the RAD in the N-terminus of ASPP2 is critical for its potentiation of RAS signalling, two ASPP2 mutants were generated: ASPP2 (1–360) and ASPP2 (123–1128), representing a naturally occurring ASPP2 splice variant. 26 Retroviruses expressing full-length or truncated ASPP2 were infected into HRASV12-expressing ASPP2 (Δ3/Δ3) MEFs.</sentence>
      <sentence id="82" pid="paragraph16">The impaired RAS–ERK and RAS–AKT signalling in HRASV12-expressing ASPP2 (Δ3/Δ3) MEFs was largely rescued by the expression of full-length ASPP2 ( Figure 3d , lower panel, lanes 7–9).</sentence>
      <sentence id="83" pid="paragraph16">The expression of ASPP2 (1–360) also partially restored the activities of ERK and AKT ( Figure 3d , lower panel, lanes 10–12).</sentence>
      <sentence id="84" pid="paragraph16">This may be explained by the reduced expression of ASPP2 (1–360) relative to full-length ASPP2 ( Figure 3e ).</sentence>
      <sentence id="85" pid="paragraph16">The expression of ASPP2 (123–1128) failed to stimulate ERK and AKT pathways, although the amount of protein was similar to that of ASPP2 (1–1128) ( Figure 3d (lower panel, lanes 13–15) and Figure 3e ).</sentence>
      <sentence id="86" pid="paragraph16">This result illustrates that the N-terminus of ASPP2 (1–123) is sufficient to potentiate RAS signalling.</sentence>
      <sentence id="87" pid="paragraph17">We showed previously that the N-termini of ASPP1 and ASPP2 are required for full enhancement of p53 activity. 16 We thus tested whether ASPP1 and ASPP2 cooperate with RAS to stimulate the apoptotic function of p53.</sentence>
      <sentence id="88" pid="paragraph17">HRASV12 or KRASV12 was co-transfected with ASPP1, ASPP2 and p53 into Saos2 cells.</sentence>
      <sentence id="89" pid="paragraph17">The results shown in Figure 4a illustrate that HRASV12 or KRASV12 alone had a small stimulatory effect on p53 transactivity.</sentence>
      <sentence id="90" pid="paragraph17">As expected, coexpression of ASPP1 or ASPP2 with p53 enhanced the transcriptional activity of p53 on the Bax promoter–luciferase reporter by 3 and 10 times, respectively.</sentence>
      <sentence id="91" pid="paragraph17">In the presence of ASPP1, expression of HRASV12 or KRASV12 stimulated the transactivation function of p53 by ∼10-fold ( Figure 4a ).</sentence>
      <sentence id="92" pid="paragraph17">Similarly, the coexpression of ASPP2 and HRASV12 or KRASV12 stimulated the transcriptional activity of p53 by around 30–35-fold.</sentence>
      <sentence id="93" pid="paragraph17">When the transcriptional activities of p53+ASPP1 and p53+ASPP2 were set as 1, we observed that both HRASV12 and KRASV12 were able to further enhance the transcriptional activity of p53 by around three-folds ( Figure 4b ).</sentence>
      <sentence id="94" pid="paragraph18">To demonstrate further that RAS activation is required to enhance the transcriptional activity of p53 via ASPP1 or ASPP2, a wild-type RAS or a dominant negative form of HRAS–HRASN17 was co-transfected with ASPP2 and p53 into Saos2 cells.</sentence>
      <sentence id="95" pid="paragraph18">The results shown in Figure 4c illustrate that HRASV12 alone had a small stimulatory effect on the transactivation function of p53.</sentence>
      <sentence id="96" pid="paragraph18">In the presence of ASPP2, however, HRASV12 stimulated the transactivation function of p53 by approximately 3-fold.</sentence>
      <sentence id="97" pid="paragraph18">When HRASN17 was co-transfected with ASPP2 and p53, the transactivation activity of p53 was inhibited.</sentence>
      <sentence id="98" pid="paragraph18">This inhibition was via ASPP2, as HRASN17 transfected only with p53 did not have such a strong inhibitory effect: HRASN17 inhibited p53 and ASPP2 activity more than 4-fold, whereas it inhibited p53 via endogenous ASPP about 1.5-fold.</sentence>
      <sentence id="99" pid="paragraph18">In contrast, wild-type RAS had very little effect on the transactivation function of p53.</sentence>
      <sentence id="100" pid="paragraph18">This may be explained by the fact that increased RAS expression does not necessarily lead to increased levels of RAS–GTP in cells.</sentence>
      <sentence id="101" pid="paragraph19">We tested whether the observed ability of RAS oncogene to cooperate with ASPP2 to enhance p53 transcriptional activity is promoter-specific.</sentence>
      <sentence id="102" pid="paragraph19">Three p53 target gene promoter-containing reporters, PIG3-, Bax- and Mdm2-luciferases, were used.</sentence>
      <sentence id="103" pid="paragraph19">We observed that HRASV12 had the most profound effect on the transcriptional activity of p53 on PIG3 and BAX promoters.</sentence>
      <sentence id="104" pid="paragraph19">Under the same conditions, a reduced stimulatory effect was seen on Mdm2 promoter ( Figure 4d ).</sentence>
      <sentence id="105" pid="paragraph19">This agrees with our previous finding that ASPP2 has minimal impact on the transcriptional activity of p53 on the promoters of Mdm2 and p21 waf1 . 16 Consistent with this, we also observed that p21 waf1 mRNA expression induced by activated RAS in HKe3 cells is independent of ASPP2 status, as ASPP2 knockdown in these cells did not alter p21 waf1 expression ( Supplementary Figure 4a ).</sentence>
      <sentence id="106" pid="paragraph20">The requirement of endogenous RAS to stimulate the transcriptional activity of p53 via ASPP2 was tested using shRNA against HRAS or KRAS.</sentence>
      <sentence id="107" pid="paragraph20">Their ability to specifically reduce the expression level of HRAS or KRAS was confirmed ( Supplementary Figure 4b ).</sentence>
      <sentence id="108" pid="paragraph20">We found that RNAi against HRAS or KRAS dampened the ability of ASPP2 to stimulate the transactivation function of p53 on the promoters of the pro-apoptotic gene Bax ( Figure 4e ) and PIG3 ( Supplementary Figure 4c ).</sentence>
      <sentence id="109" pid="paragraph20">All these support the notion that ASPP1 and ASPP2 cooperate with RAS to enhance the transcriptional activity of p53 for apoptotic genes.</sentence>
      <sentence id="110" pid="paragraph20">This cooperation is likely to be mediated by the identified interaction between active RAS and RAD of the ASPPs, which also explains why the RAD of the ASPPs is required for their full potential to enhance the transcriptional activity of p53.</sentence>
      <sentence id="111" pid="paragraph21">The requirement of RAS activation to potentiate the pro-apoptotic function of ASPP1 and ASPP2 was tested in two human cancer cell lines with wild-type p53: MCF7 and U2OS.</sentence>
      <sentence id="112" pid="paragraph21">As published previously, increased expression of ASPP1 or ASPP2 induces p53-mediated apoptosis in both cell lines. 16 Using shRNAs to reduce the expression of endogenous HRAS or KRAS, we observed a reduction in the percentage of apoptosis in cells induced by ASPP1 or ASPP2 overexpression ( Figure 5a ).</sentence>
      <sentence id="113" pid="paragraph21">These findings suggest that endogenous HRAS and KRAS are required for the full activities of ASPP1 and ASPP2.</sentence>
      <sentence id="114" pid="paragraph22">To further confirm this, we used HKe3 ER:HRASV12 cells, in which RAS activation is induced upon the addition of 4-OHT.</sentence>
      <sentence id="115" pid="paragraph22">Importantly, oncogenic RAS activation induced apoptosis in these cells indicated by the presence of cleaved-PARP ( Figure 5c ).</sentence>
      <sentence id="116" pid="paragraph22">To test whether p53 has a role in mediating the observed RAS-induced apoptosis in HKe3 cells, RNAi against p53 was used.</sentence>
      <sentence id="117" pid="paragraph22">Depletion of p53 abolished RAS-induced apoptosis in these cells.</sentence>
      <sentence id="118" pid="paragraph22">This is evident from a lack of PARP cleavage in these cells ( Figure 5d ).</sentence>
      <sentence id="119" pid="paragraph23">To understand how ASPP2 cooperates with p53 to induce apoptosis in cancer cells, we examined the cellular localisation of ASPP2 in HKe3 ER:HRASV12 cells upon RAS induction.</sentence>
      <sentence id="120" pid="paragraph23">We observed that endogenous ASPP2 translocates from cell/cell junctions to the cytosol/nucleus following RAS activation ( Figure 6a ).</sentence>
      <sentence id="121" pid="paragraph23">This is also confirmed by the detection of an increase in the expression levels of ASPP2 in the nuclear and cytoplasmic fractions in these cells upon RAS activation, with around two–three-folds increase in the level of nuclear and cytoplasmic ASPP2, respectively ( Figure 6b ).</sentence>
      <sentence id="122" pid="paragraph23">Moreover, we also detected an increase in the amount of p53–ASPP2 complex in these cells following RAS activation ( Figure 6c ).</sentence>
      <sentence id="123" pid="paragraph23">To test whether endogenous ASPP2 mediates the observed RAS-induced apoptosis in HKe3 cells, ASPP2 RNAi was used.</sentence>
      <sentence id="124" pid="paragraph23">ASPP2 knockdown abolished RAS-induced apoptosis indicated by a lack of PARP cleavage ( Figure 6d ).</sentence>
      <sentence id="125" pid="paragraph23">These data identify ASPP2 as an important mediator of oncogenic RAS-induced apoptosis.</sentence>
      <sentence id="126" pid="paragraph23">This may be achieved via the ability of the active RAS to induce the cellular translocation of ASPP2, and enhance the ability of ASPP2 to bind p53 and to enhance its activity.</sentence>
      <sentence id="127" pid="paragraph24">In addition to its well-established oncogenic properties, it is emerging that RAS also has growth-suppressive functions by its ability to induce senescence in primary fibroblasts and apoptosis in cancer cells.</sentence>
      <sentence id="128" pid="paragraph24">Recently, we showed that ASPP2 is a potent mediator of RAS-induced senescence.</sentence>
      <sentence id="129" pid="paragraph24">This property is p53-independent, and is achieved partly through the ability of the N-terminus of ASPP2 to bind ATG5 and to inhibit RAS-induced autophagy, as elevated autophagy activity bypasses oncogenic RAS-induced senescence in fibroblasts. 13</sentence>
      <sentence id="130" pid="paragraph25">We show here that ASPP1 and ASPP2 bind active RAS via their N-termini.</sentence>
      <sentence id="131" pid="paragraph25">ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane.</sentence>
      <sentence id="132" pid="paragraph25">Moreover, the observed RAS–ASPP interactions enhance the transcription and apoptotic function of p53 in cancer cells.</sentence>
      <sentence id="133" pid="paragraph25">In primary fibroblasts, ASPP2 mediates RAS-induced senescence independent of p53, whereas in cancer cells, ASPP1 and ASPP2 mediate RAS-induced p53-dependent apoptosis.</sentence>
      <sentence id="134" pid="paragraph25">Therefore, ASPP1 and ASPP2 are the key mediators of RAS signalling in both primary and cancer cells.</sentence>
      <sentence id="135" pid="paragraph25">The status of ASPP1 and ASPP2 may therefore dictate the cellular response to RAS signalling.</sentence>
      <sentence id="136" pid="paragraph25">Therefore, the ability of ASPP2 to be located at cell junctions to bind and colocalise with RAS on the one hand, and located in the cytoplasm and bind p53 upon RAS activation on the other, places ASPP2 in an ideal position to survey the intensity of RAS signalling and to coordinate appropriate cellular responses accordingly.</sentence>
      <sentence id="137" pid="paragraph25">One possible explanation for this property of ASPP2 is that, when RAS is activated, it binds active RAS and controls the intensity of the RAS signal.</sentence>
      <sentence id="138" pid="paragraph25">When RAS signalling is elevated to a certain level, high enough to disrupt cell/cell junctions for example, it may then displace ASPP2 from cell/cell junctions.</sentence>
      <sentence id="139" pid="paragraph25">This redistribution of ASPP2 would thus enable the interaction with ATG5 to inhibit autophagy and to mediate RAS-induced senescence or to bind p53 to promote apoptosis ( Figure 6e ).</sentence>
      <sentence id="140" pid="paragraph25">As the levels of RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions is lower than that in cancer cells caused by mutation or amplifications of RAS or EGFR genes, this cellular localisation of ASPP2 and its binding partners may differ between primary cells and cancer cells.</sentence>
      <sentence id="141" pid="paragraph25">Future studies are needed to test whether cellular localisation of ASPP1 and ASPP2, and their ability to interact with ATG5 or p53 may be an underline reason for why RAS or p53 activation predominately induces senescence in primary cells but apoptosis in cancer cells.</sentence>
      <sentence id="142" pid="paragraph26">Although ASPP1 and ASPP2 share sequence similarity and have many overlapping functions in vitro , including the interaction with active RAS, they have distinct biological functions in vivo .</sentence>
      <sentence id="143" pid="paragraph26">ASPP2 binds PAR3 and locates at cell/cell junctions, 21 , 22 whereas ASPP1 binds YAP and locates in cytosol. 27 , 28 ASPP1 deficiency in mice is predominantly tolerated in mouse development, although lymphatic vessel leakage occurs. 29 This differs from ASPP2-deficient mice, where a loss of cell polarity and excessive proliferation of neural progenitors are common features.</sentence>
      <sentence id="144" pid="paragraph26">Importantly, ASPP2 heterozygosity is sufficient to predispose mice to develop tumours, 30 , 31 establishing ASPP2's tumour-suppressive function.</sentence>
      <sentence id="145" pid="paragraph26">These differences may explain why ASPP2 depletion alone is sufficient to affect RAS signalling.</sentence>
      <sentence id="146" pid="paragraph26">Future studies are therefore needed to elucidate which of the in vivo functions of ASPP1 are influenced by the identified ASPP1–RAS interaction.</sentence>
      <sentence id="147" pid="paragraph27">There have been many reports demonstrating that RAS activation inhibits apoptosis and promotes survival.</sentence>
      <sentence id="148" pid="paragraph27">Paradoxically, increasing numbers of studies have also shown that RAS activation induces apoptosis.</sentence>
      <sentence id="149" pid="paragraph27">The effect of RAS on survival versus apoptosis depends largely on cell types and concurrent activation of other signalling pathways.</sentence>
      <sentence id="150" pid="paragraph27">The most prominent pathway involved in RAS-mediated apoptosis is the Raf–ERK pathway. 32 , 33 , 34 p53 is also thought to be involved in RAS-mediated apoptosis, as RAS is no longer able to induce apoptosis following p53 loss. 34 , 35 , 36 RAS is known to stimulate p53 activity through the induction of Arf and PML. 37 , 38 , 39 However, under the conditions used in these studies, RAS is likely to enhance the apoptotic function of p53 independently of Arf, as UO2S and MCF7 cells do not express Arf. 40 The overall effect of RAS on p53 activity may be dependent on a balance between the different pathways linking the two proteins.</sentence>
      <sentence id="151" pid="paragraph28">The ability of oncogenes to stimulate cell cycle arrest or apoptosis allows the cell to have a fail-proof system: oncogene activation would, instead of inducing the cell to proliferate in an uncontrolled manner, activate tumour-suppressor proteins, thereby preventing the cell from replicating its damage.</sentence>
      <sentence id="152" pid="paragraph28">Although cell cycle arrest and apoptosis are both efficient ways for cells to prevent propagation of their damage, apoptosis is irreversible and therefore more effective.</sentence>
      <sentence id="153" pid="paragraph28">The identification of ASPP1 and ASPP2 as mediators of RAS and p53 in regulating apoptosis suggests that oncogenic RAS would put pressure on p53 to induce apoptosis.</sentence>
      <sentence id="154" pid="paragraph28">Therefore, the discovery that ASPP1 and ASPP2 cooperate with RAS to enhance p53-induced apoptosis suggests that loss of ASPP1 or ASPP2 expression may be a frequent event in human cancers with mutant RAS.</sentence>
      <sentence id="155" pid="paragraph28">This finding may provide a novel molecular explanation for why RAS and p53 mutations are so tightly associated in human cancer.</sentence>
    </sentences>
  </input>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="21" id="V31991" paragraph="paragraph0" rule="-SIMPLE-REF" start="15" uttnum="1">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="31" id="V32011" paragraph="paragraph0" rule="-SIMPLE-REF" start="25" uttnum="1">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="46" id="V32016" paragraph="paragraph0" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="31" uttnum="1">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="46" id="V32016" start="31">
      <type>ONT::BIND</type>
      <text>bind active RAS</text>
    </predicate>
    <arg2 id="V32031" role=":AFFECTED"/>
    <text>bind active RAS</text>
  </EVENT>
  <EVENT end="74" id="V32038" paragraph="paragraph0" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="48" uttnum="1">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="74" id="V32038" start="48">
      <type>ONT::INCREASE</type>
      <text>potentiate RAS signalling</text>
    </predicate>
    <arg2 id="V32057" role=":AFFECTED"/>
    <text>potentiate RAS signalling</text>
  </EVENT>
  <EVENT end="114" id="V32072" paragraph="paragraph0" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="78" uttnum="1">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="114" id="V32072" start="78">
      <type>ONT::STIMULATE</type>
      <text>enhance p53 activity in cancer cells</text>
    </predicate>
    <arg2 id="V32106" role=":AFFECTED"/>
    <text>enhance p53 activity in cancer cells</text>
  </EVENT>
  <TERM end="46" id="V32031" paragraph="paragraph0" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="36" uttnum="1">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM dbid="GO:0023052" end="74" id="V32057" paragraph="paragraph0" rule="-SIMPLE-REF" start="59" uttnum="1">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="74" id="V32052" paragraph="paragraph0" rule="-SIMPLE-REF" start="59" uttnum="1">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <EVENT end="99" id="V32106" paragraph="paragraph0" rule="-ACTIVITY1" start="86" uttnum="1">
    <type>ONT::ACTIVITY</type>
    <predicate end="99" id="V32106" start="86">
      <type>ONT::ACTIVITY</type>
      <text>p53 activity</text>
    </predicate>
    <arg1 id="V32103" role=":AGENT"/>
    <text>p53 activity</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="90" id="V32103" paragraph="paragraph0" rule="-SIMPLE-REF" start="86" uttnum="1">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="114" id="V32175" paragraph="paragraph0" rule="-SIMPLE-REF" start="102" uttnum="1">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="17" id="V45873" paragraph="paragraph1" rule="-SIMPLE-REF" start="3" uttnum="2">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS mutations</text>
  </TERM>
  <TERM dbid="GO:0023052" end="79" id="V45981" paragraph="paragraph1" rule="-SIMPLE-REF" start="54" uttnum="2">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>activated RAS signalling</text>
  </TERM>
  <TERM end="79" id="V45976" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="54" uttnum="2">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">activated RAS signalling</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="79" id="V45969" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="54" uttnum="2">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="79" id="V45969" start="54">
      <type>ONT::ACTIVATE</type>
      <text>activated RAS signalling</text>
    </predicate>
    <arg2 id="V45976" role=":RESULT"/>
    <arg id="R000036" role=":AFFECTED"/>
    <text>activated RAS signalling</text>
  </EVENT>
  <TERM end="190" id="V59674" paragraph="paragraph1" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="179" uttnum="3">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM dbid="GO:0016049" end="177" id="V59660" paragraph="paragraph1" rule="-SIMPLE-REF" start="166" uttnum="3">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-GROWTH</name>
    <text>cell growth</text>
  </TERM>
  <TERM end="242" id="V59735" paragraph="paragraph1" rule="-SIMPLE-REF" start="227" uttnum="3">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>its ability to</text>
  </TERM>
  <TERM end="242" id="V59723" paragraph="paragraph1" rule="-SIMPLE-REF" start="227" uttnum="3">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>its ability to</text>
  </TERM>
  <TERM end="282" id="V59794" paragraph="paragraph1" rule="-LOGICALOP-REF" start="249" uttnum="3">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <aggregate operator="AND">
      <member id="V59790"/>
      <member id="V59805"/>
    </aggregate>
    <text normalization="">cellular senescence and apoptosis</text>
  </TERM>
  <TERM dbid="GO:0090398" end="269" id="V59790" paragraph="paragraph1" rule="-SIMPLE-REF" start="249" uttnum="3">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELLULAR-SENESCENCE</name>
    <text>cellular senescence</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="282" id="V59805" paragraph="paragraph1" rule="-SIMPLE-REF" start="273" uttnum="3">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <EPI end="338" id="V75757" paragraph="paragraph1" rule="-RULE50_0_EXPERIENCER_NEUTRAL-NONE" start="284" uttnum="4">
    <type>ONT::KNOW</type>
    <force>ONT::TRUE</force>
    <arg2 id="V75800" role=":FORMAL"/>
    <text>RAS is known to induce p53-dependent cell cycle arrest</text>
  </EPI>
  <TERM end="288" id="V75731" paragraph="paragraph1" rule="-SIMPLE-REF" start="284" uttnum="4">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <CC end="338" id="V75800" paragraph="paragraph1" rule="-RULE5B_AGENT_AFFECTED" start="284" uttnum="4">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V75731" role=":FACTOR"/>
    <arg id="V75915" role=":OUTCOME"/>
    <text>RAS is known to induce p53-dependent cell cycle arrest</text>
  </CC>
  <TERM dbid="GO:0007050" end="338" id="V75915" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="307" uttnum="4">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V75838"/>
      </inevent>
    </features>
    <name>CELL-CYCLE-ARREST</name>
    <text>p53-dependent cell cycle arrest</text>
  </TERM>
  <CC end="338" id="V75838" paragraph="paragraph1" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="307" uttnum="4">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V75832" role=":FACTOR"/>
    <arg id="V75915" role=":OUTCOME"/>
    <text>p53-dependent cell cycle arrest</text>
  </CC>
  <TERM dbid="UP:P04637" end="321" id="V75832" paragraph="paragraph1" rule="-SIMPLE-REF" start="307" uttnum="4">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-dependent</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="382" id="V76548" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="355" uttnum="4">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V76526"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>on p53-dependent apoptosis</text>
  </TERM>
  <CC end="382" id="V76526" paragraph="paragraph1" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="355" uttnum="4">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V76520" role=":FACTOR"/>
    <arg id="V76548" role=":OUTCOME"/>
    <text>on p53-dependent apoptosis</text>
  </CC>
  <TERM dbid="UP:P04637" end="372" id="V76520" paragraph="paragraph1" rule="-SIMPLE-REF" start="358" uttnum="4">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-dependent</text>
  </TERM>
  <TERM end="402" id="V77717" paragraph="paragraph1" rule="-ROBUSTPRO" start="399" uttnum="5">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="UP:P04637" end="463" id="V77830" paragraph="paragraph1" rule="-SIMPLE-REF" start="452" uttnum="5">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53 (ASPP)</text>
  </TERM>
  <TERM dbid="FA:00278" end="461" id="V77838" paragraph="paragraph1" rule="-SIMPLE-REF" start="457" uttnum="5">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPP</name>
    <text normalization="">ASPP</text>
  </TERM>
  <TERM end="495" id="V77868" paragraph="paragraph1" rule="-SIMPLE-REF" start="472" uttnum="5">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATORS</name>
    <text>two activators of p53,</text>
  </TERM>
  <TERM end="526" id="V77937" paragraph="paragraph1" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="515" uttnum="5">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="493" id="V77906" paragraph="paragraph1" rule="-SIMPLE-REF" start="490" uttnum="5">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="563" id="V77991" paragraph="paragraph1" rule="-SIMPLE-REF" start="530" uttnum="5">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">their N-terminal RAS-association</text>
  </TERM>
  <TERM end="563" id="V77947" paragraph="paragraph1" rule="-SIMPLE-REF" start="530" uttnum="5">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATORS</name>
    <text>their N-terminal RAS-association</text>
  </TERM>
  <TERM end="547" id="V77953" paragraph="paragraph1" rule="-SIMPLE-REF" start="536" uttnum="5">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINAL</name>
    <text>N-terminal</text>
  </TERM>
  <TERM end="576" id="V78009" paragraph="paragraph1" rule="-SIMPLE-REF" start="563" uttnum="5">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>domains (RAD)</text>
  </TERM>
  <EVENT end="699" id="V91687" paragraph="paragraph1" rule="-RULE20_AGENT_AFFECTED" start="592" uttnum="6">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="699" id="V91687" start="592">
      <type>ONT::INCREASE</type>
      <text>ASPP2 colocalises with and contributes to RAS cellular membrane localisation and potentiates RAS signalling</text>
    </predicate>
    <arg1 id="V91577" role=":AGENT"/>
    <arg2 id="V91706" role=":AFFECTED"/>
    <text>ASPP2 colocalises with and contributes to RAS cellular membrane localisation and potentiates RAS signalling</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="598" id="V91577" paragraph="paragraph1" rule="-SIMPLE-REF" start="592" uttnum="6">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="656" id="V91661" paragraph="paragraph1" rule="-SIMPLE-REF" start="634" uttnum="6">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>RAS cellular membrane</text>
  </TERM>
  <TERM end="638" id="V91651" paragraph="paragraph1" rule="-SIMPLE-REF" start="634" uttnum="6">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="GO:0023052" end="699" id="V91706" paragraph="paragraph1" rule="-SIMPLE-REF" start="685" uttnum="6">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="699" id="V91701" paragraph="paragraph1" rule="-SIMPLE-REF" start="685" uttnum="6">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM end="734" id="V105269" paragraph="paragraph1" rule="-LOGICALOP-REF" start="718" uttnum="7">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V105265"/>
      <member id="V105285"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="763" id="V105311" paragraph="paragraph1" rule="-SIMPLE-REF" start="744" uttnum="7">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with oncogenic RAS</text>
  </TERM>
  <TERM end="716" id="V105252" paragraph="paragraph1" rule="-SIMPLE-REF" start="704" uttnum="7">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="724" id="V105265" paragraph="paragraph1" rule="-SIMPLE-REF" start="718" uttnum="7">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="734" id="V105285" paragraph="paragraph1" rule="-SIMPLE-REF" start="728" uttnum="7">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="821" id="V105421" paragraph="paragraph1" rule="-SIMPLE-REF" start="818" uttnum="7">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="875" id="V121190" paragraph="paragraph1" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="847" uttnum="8">
    <type>ONT::GENE</type>
    <features>
      <location id="V121264"/>
    </features>
    <name>ASPP-2</name>
    <text>ASPP2 in human cancer cells</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="843" id="V121170" paragraph="paragraph1" rule="-SIMPLE-REF" start="834" uttnum="8">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <TERM end="875" id="V121264" paragraph="paragraph1" rule="-SIMPLE-REF" start="856" uttnum="8">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>human cancer cells</text>
  </TERM>
  <TERM end="939" id="V121367" paragraph="paragraph1" rule="-SIMPLE-REF" start="924" uttnum="8">
    <type>ONT::GENE</type>
    <name>ONCOGENE</name>
    <text>of RAS oncogene</text>
  </TERM>
  <TERM end="931" id="V121363" paragraph="paragraph1" rule="-SIMPLE-REF" start="927" uttnum="8">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <EVENT end="118" id="V134724" paragraph="paragraph2" rule="-RULE10_AGENT_AFFECTED" start="3" uttnum="9">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="118" id="V134724" start="3">
      <type>ONT::MODULATE</type>
      <text>The evolutionarily conserved RAS proto-oncogenes encode 21 kDa guanine nucleotide-binding proteins</text>
    </predicate>
    <arg1 id="V134720" role=":AGENT"/>
    <arg2 id="V134758" role=":AFFECTED"/>
    <text>The evolutionarily conserved RAS proto-oncogenes encode 21 kDa guanine nucleotide-binding proteins</text>
  </EVENT>
  <TERM end="69" id="V134720" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="3" uttnum="9">
    <type>ONT::GENE</type>
    <features>
      <inevent>
        <event id="V134699"/>
      </inevent>
    </features>
    <name>PROTO-ONCOGENES</name>
    <text>The evolutionarily conserved RAS proto-oncogenes</text>
  </TERM>
  <TERM dbid="CHEBI:16235" end="118" id="V134758" paragraph="paragraph2" rule="-SIMPLE-REF" start="76" uttnum="9">
    <type>ONT::MOLECULE</type>
    <name>GUANINE</name>
    <text>21 kDa guanine nucleotide-binding proteins</text>
  </TERM>
  <EVENT end="69" id="V134699" paragraph="paragraph2" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="3" uttnum="9">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="69" id="V134699" start="3">
      <type>ONT::NO-CHANGE</type>
      <text>The evolutionarily conserved RAS proto-oncogenes</text>
    </predicate>
    <arg2 id="V134720" role=":AFFECTED"/>
    <text>The evolutionarily conserved RAS proto-oncogenes</text>
  </EVENT>
  <TERM end="53" id="V134704" paragraph="paragraph2" rule="-SIMPLE-REF" start="40" uttnum="9">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="118" id="V135275" paragraph="paragraph2" rule="-EXPLICIT-REF-SEQ0B" start="91" uttnum="9">
    <type>ONT::MOLECULAR-PART</type>
    <components>
      <component id="V134763"/>
      <component id="V134793"/>
    </components>
    <text normalization="">nucleotide-binding proteins</text>
  </TERM>
  <TERM end="83" id="V134829" paragraph="paragraph2" rule="-SIMPLE-REF" start="76" uttnum="9">
    <type>ONT::PROFESSIONAL</type>
    <name>DA</name>
    <text>21 kDa</text>
  </TERM>
  <TERM dbid="CHEBI:36976" end="118" id="V134763" paragraph="paragraph2" rule="-EXPLICIT-REF-SEQ0B-TERM" start="91" uttnum="9">
    <type>ONT::MOLECULE</type>
    <name>NUCLEOTIDE</name>
    <text>nucleotide-binding proteins</text>
  </TERM>
  <TERM end="118" id="V134793" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="102" uttnum="9">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V134777"/>
      </inevent>
    </features>
    <name>PROTEIN</name>
    <text>binding proteins</text>
  </TERM>
  <EVENT end="118" id="V134777" paragraph="paragraph2" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="102" uttnum="9">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="118" id="V134777" start="102">
      <type>ONT::BIND</type>
      <text>binding proteins</text>
    </predicate>
    <arg1 id="V134793" role=":AGENT"/>
    <text>binding proteins</text>
  </EVENT>
  <TERM end="167" id="V151338" paragraph="paragraph2" rule="-ACTIVE4,-SIMPLE-REF" start="120" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>FALSE</active>
    </features>
    <name>RAS-GDP</name>
    <text normalization="">RAS–GDP is inactive, whereas RAS–GTP is active</text>
  </TERM>
  <TERM end="167" id="V151386" paragraph="paragraph2" rule="-ACTIVE3,-SIMPLE-REF" start="149" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS-GTP</name>
    <text normalization="">RAS–GTP is active</text>
  </TERM>
  <TERM end="187" id="V151439" paragraph="paragraph2" rule="-SIMPLE-REF" start="177" uttnum="10">
    <type>ONT::PERSON</type>
    <name>EFFECTORS</name>
    <text>effectors</text>
  </TERM>
  <TERM dbid="GO:0023052" end="238" id="V151484" paragraph="paragraph2" rule="-SIMPLE-REF" start="214" uttnum="10">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS/PI3K/AKT signalling</text>
  </TERM>
  <TERM end="211" id="V151801" paragraph="paragraph2" rule="-EXPLICIT-REF-SEQ0B" start="199" uttnum="10">
    <type>ONT::GENE-PROTEIN</type>
    <components>
      <component id="V151260"/>
      <component id="V151244"/>
      <component id="V151252"/>
    </components>
    <text normalization="">RAS/RAF/ERK</text>
  </TERM>
  <TERM end="238" id="V151796" paragraph="paragraph2" rule="-SIMPLE-REF" start="214" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>RAS/PI-3-K/AKT</name>
    <text normalization="">RAS/PI3K/AKT signalling</text>
  </TERM>
  <TERM end="202" id="V151244" paragraph="paragraph2" rule="-SIMPLE-REF" start="199" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="206" id="V151252" paragraph="paragraph2" rule="-SIMPLE-REF" start="203" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10398" type="ONT::PROTEIN"/>
      <member dbid="UP:P04049" type="ONT::PROTEIN"/>
      <member dbid="UP:P15056" type="ONT::PROTEIN"/>
    </members>
    <name>RAF</name>
    <text normalization="">RAF</text>
  </TERM>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="211" id="V151260" paragraph="paragraph2" rule="-EXPLICIT-REF-SEQ0B-TERM" start="199" uttnum="10">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>RAS/RAF/ERK</text>
  </TERM>
  <TERM end="247" id="V151492" paragraph="paragraph2" rule="-SIMPLE-REF" start="238" uttnum="10">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>CASCADE</name>
    <text>cascades</text>
  </TERM>
  <TERM end="252" id="V151512" paragraph="paragraph2" rule="-SIMPLE-REF" start="247" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GDP</name>
    <text normalization="">that</text>
  </TERM>
  <TERM dbid="GO:0016049" end="281" id="V151617" paragraph="paragraph2" rule="-SIMPLE-REF" start="269" uttnum="10">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-GROWTH</name>
    <text>cell growth</text>
  </TERM>
  <EVENT end="348" id="V151651" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="333" uttnum="10">
    <type>ONT::ACTIVATE</type>
    <predicate end="348" id="V151651" start="333">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V151648" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000187"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="337" id="V151648" paragraph="paragraph2" rule="-SIMPLE-REF" start="333" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="360" id="V151705" paragraph="paragraph2" rule="-SIMPLE-REF" start="354" uttnum="10">
    <type>ONT::PLACE</type>
    <name>PLACE</name>
    <text>place</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="392" id="V151786" paragraph="paragraph2" rule="-SIMPLE-REF" start="373" uttnum="10">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM end="401" id="V167630" paragraph="paragraph2" rule="-ROBUSTPRO" start="397" uttnum="11">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>one</text>
  </TERM>
  <TERM end="487" id="V167663" paragraph="paragraph2" rule="-SIMPLE-REF-2" start="404" uttnum="11">
    <type>ONT::GENE</type>
    <name>ONCOGENE</name>
    <text>the first oncogene identified in human cancer, activation of mutations at residues</text>
  </TERM>
  <TERM end="487" id="V167756" paragraph="paragraph2" rule="-SIMPLE-REF-MUTATION8" start="462" uttnum="11">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>of mutations at residues</text>
  </TERM>
  <TERM end="487" id="V167778" paragraph="paragraph2" rule="-SIMPLE-REF" start="478" uttnum="11">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>residues</text>
  </TERM>
  <TERM end="519" id="V167910" paragraph="paragraph2" rule="-SIMPLE-REF-MUTATION8" start="507" uttnum="11">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>in a mutant</text>
  </TERM>
  <TERM end="552" id="V167917" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="519" uttnum="11">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS that constitutively binds GTP</text>
    <features>
      <bound-to event="V167943" id="R000010"/>
    </features>
  </TERM>
  <EVENT end="552" id="V167943" paragraph="paragraph2" rule="-RULE20C_AGENT_AFFECTED" start="519" uttnum="11">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="552" id="V167943" start="519">
      <type>ONT::BIND</type>
      <text>RAS that constitutively binds GTP</text>
    </predicate>
    <arg1 id="R000009" role=":AGENT"/>
    <arg2 id="V167952" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000011"/>
    <text>RAS that constitutively binds GTP</text>
  </EVENT>
  <TERM dbid="CHEBI:15996|CHEBI:37565" end="552" id="V167952" paragraph="paragraph2" rule="-SIMPLE-REF" start="549" uttnum="11">
    <type>ONT::MOLECULE</type>
    <name>GTP</name>
    <text>GTP</text>
    <not-features>
      <bound-to event="V167943" id="R000009"/>
    </not-features>
  </TERM>
  <EVENT end="623" id="V179472" paragraph="paragraph2" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="554" uttnum="12">
    <type>ONT::TRANSFORM</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::CAN</modality>
    <predicate end="623" id="V179472" start="554">
      <type>ONT::TRANSFORM</type>
      <text>Activation of RAS can also be achieved by overexpression or mutation</text>
    </predicate>
    <arg2 id="V179420" role=":FORMAL"/>
    <text>Activation of RAS can also be achieved by overexpression or mutation</text>
  </EVENT>
  <EVENT end="572" id="V179420" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="554" uttnum="12">
    <type>ONT::ACTIVATE</type>
    <predicate end="572" id="V179420" start="554">
      <type>ONT::ACTIVATE</type>
      <text>Activation of RAS</text>
    </predicate>
    <arg2 id="V179434" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000192"/>
    <text>Activation of RAS</text>
  </EVENT>
  <TERM end="572" id="V179434" paragraph="paragraph2" rule="-SIMPLE-REF" start="565" uttnum="12">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">of RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <MODALITY end="623" id="X195944" paragraph="paragraph2" rule="-MODALITY" start="554" uttnum="12">
    <type>ONT::ABILITY</type>
    <arg2 id="V179472" role=":EVENT"/>
    <text>Activation of RAS can also be achieved by overexpression or mutation</text>
  </MODALITY>
  <TERM dbid="UP:P01133" end="682" id="V179622" paragraph="paragraph2" rule="-SIMPLE-REF" start="626" uttnum="12">
    <type>ONT::PROTEIN</type>
    <name>EPIDERMAL-GROWTH-FACTOR</name>
    <text>its upstream activators such as epidermal growth factor</text>
  </TERM>
  <TERM dbid="UP:P01133" end="682" id="V179541" paragraph="paragraph2" rule="-SIMPLE-REF" start="626" uttnum="12">
    <type>ONT::PROTEIN</type>
    <name>EPIDERMAL-GROWTH-FACTOR</name>
    <text>its upstream activators such as epidermal growth factor</text>
  </TERM>
  <TERM end="658" id="V179552" paragraph="paragraph2" rule="-SIMPLE-REF" start="639" uttnum="12">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATORS</name>
    <text>activators such as</text>
  </TERM>
  <TERM dbid="GO:0004872" end="697" id="V179627" paragraph="paragraph2" rule="-SIMPLE-REF" start="682" uttnum="12">
    <type>ONT::PROTEIN</type>
    <name>RECEPTOR</name>
    <text>receptor (EGFR)</text>
  </TERM>
  <TERM dbid="UP:P00533" end="696" id="V179649" paragraph="paragraph2" rule="-SIMPLE-REF" start="692" uttnum="12">
    <type>ONT::PROTEIN</type>
    <name>EGFR</name>
    <text>EGFR</text>
  </TERM>
  <TERM end="797" id="V194322" paragraph="paragraph2" rule="-SIMPLE-REF" start="788" uttnum="12">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">that RAS</text>
  </TERM>
  <TERM end="855" id="V194382" paragraph="paragraph2" rule="-SIMPLE-REF" start="843" uttnum="12">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">its ability</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="876" id="V194439" paragraph="paragraph2" rule="-SIMPLE-REF" start="865" uttnum="12">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SENESCENCE</name>
    <text normalization="">senescence</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="889" id="V194454" paragraph="paragraph2" rule="-SIMPLE-REF" start="880" uttnum="12">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="965" id="V194474" paragraph="paragraph2" rule="-SIMPLE-REF" start="916" uttnum="12">
    <type>ONT::OUTCOME</type>
    <name>OUTCOME</name>
    <text>The final outcome of these contradictory signals</text>
  </TERM>
  <TERM dbid="EFO:0000324" end="998" id="V194586" paragraph="paragraph2" rule="-SIMPLE-REF" start="984" uttnum="12">
    <type>ONT::CELL</type>
    <name>CELL-TYPE</name>
    <text>the cell type</text>
  </TERM>
  <TERM end="1009" id="V194603" paragraph="paragraph2" rule="-SIMPLE-REF" start="1002" uttnum="12">
    <type>ONT::LINGUISTIC-OBJECT</type>
    <name>CONTEXT</name>
    <text>context</text>
  </TERM>
  <TERM end="1107" id="V207985" paragraph="paragraph2" rule="-SIMPLE-REF" start="1049" uttnum="13">
    <type>ONT::MOLECULE</type>
    <name>MOLECULE</name>
    <text>molecules that dictate cellular response to RAS activation</text>
  </TERM>
  <EVENT end="1107" id="V208047" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1093" uttnum="13">
    <type>ONT::ACTIVATE</type>
    <predicate end="1107" id="V208047" start="1093">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V208043" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000197"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="1097" id="V208043" paragraph="paragraph2" rule="-SIMPLE-REF" start="1093" uttnum="13">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="12" id="V222141" paragraph="paragraph3" rule="-SIMPLE-REF" start="3" uttnum="14">
    <type>ONT::GENE</type>
    <name>ONCOGENES</name>
    <text>Oncogenes</text>
  </TERM>
  <TERM end="42" id="V222194" paragraph="paragraph3" rule="-SIMPLE-REF" start="30" uttnum="14">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:P01106" end="65" id="V222202" paragraph="paragraph3" rule="-SIMPLE-REF" start="52" uttnum="14">
    <type>ONT::PROTEIN</type>
    <name>MYC</name>
    <text>Myc</text>
  </TERM>
  <TERM dbid="CVCL:V078" end="90" id="V222274" paragraph="paragraph3" rule="-SIMPLE-REF" start="77" uttnum="14">
    <type>ONT::CELL-LINE</type>
    <name>E-1-A</name>
    <text>E1A</text>
  </TERM>
  <TERM dbid="UP:P04637" end="143" id="V222386" paragraph="paragraph3" rule="-SIMPLE-REF" start="139" uttnum="14">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="161" id="V222396" paragraph="paragraph3" rule="-ROBUSTPRO" start="147" uttnum="14">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>their ability</text>
  </TERM>
  <EVENT end="262" id="V222501" paragraph="paragraph3" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="161" uttnum="14">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="262" id="V222501" start="161">
      <type>ONT::INHIBIT</type>
      <text>to induce the expression of Arf and prevent Mdm2-mediated protein degradation of p53</text>
    </predicate>
    <arg2 id="V222539" role=":AFFECTED"/>
    <text>to induce the expression of Arf and prevent Mdm2-mediated protein degradation of p53</text>
  </EVENT>
  <EVENT end="262" id="V222539" paragraph="paragraph3" rule="-INEVENT2B,-RULE40_AGENT_AFFECTED" start="222" uttnum="14">
    <type>ONT::CONSUME</type>
    <predicate end="262" id="V222539" start="222">
      <type>ONT::CONSUME</type>
      <text>Mdm2-mediated protein degradation of p53</text>
    </predicate>
    <arg1 id="V222534" role=":AGENT"/>
    <arg2 id="V222587" role=":AFFECTED"/>
    <text>Mdm2-mediated protein degradation of p53</text>
  </EVENT>
  <EVENT end="262" id="V222521" paragraph="paragraph3" rule="-RULE10_AGENT_AFFECTED" start="222" uttnum="14">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="262" id="V222521" start="222">
      <type>ONT::MODULATE</type>
      <text>Mdm2-mediated protein degradation of p53</text>
    </predicate>
    <arg1 id="V222513" role=":AGENT"/>
    <arg2 id="V222539" role=":AFFECTED"/>
    <text>Mdm2-mediated protein degradation of p53</text>
  </EVENT>
  <TERM end="244" id="V222534" paragraph="paragraph3" rule="-SIMPLE-REF" start="236" uttnum="14">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>protein</text>
  </TERM>
  <TERM dbid="UP:P04637" end="262" id="V222587" paragraph="paragraph3" rule="-SIMPLE-REF" start="256" uttnum="14">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM dbid="UP:Q00987|HGNC:6973" end="236" id="V222513" paragraph="paragraph3" rule="-SIMPLE-REF" start="222" uttnum="14">
    <type>ONT::GENE</type>
    <name>MDM-2</name>
    <text>Mdm2-mediated</text>
  </TERM>
  <EVENT end="210" id="V222461" paragraph="paragraph3" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="171" uttnum="14">
    <type>ONT::EXPRESS</type>
    <predicate end="210" id="V222461" start="171">
      <type>ONT::EXPRESS</type>
      <text>the expression of Arf</text>
    </predicate>
    <arg2 id="V222478" role=":AFFECTED-RESULT"/>
    <text>the expression of Arf</text>
  </EVENT>
  <TERM dbid="UP:Q8N726|XFAM:PF07392|FA:03659|UP:P42771|UP:Q64364|HGNC:1787" end="210" id="V222478" paragraph="paragraph3" rule="-SIMPLE-REF" start="186" uttnum="14">
    <type>ONT::GENE-PROTEIN</type>
    <name>ARF</name>
    <text>of Arf</text>
  </TERM>
  <TERM dbid="GO:0023052" end="349" id="V222620" paragraph="paragraph3" rule="-SIMPLE-REF" start="331" uttnum="14">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>signalling to p53</text>
  </TERM>
  <TERM end="410" id="V223539" paragraph="paragraph3" rule="-SIMPLE-REF" start="355" uttnum="14">
    <type>ONT::INFORMATION</type>
    <name>RESPONSE</name>
    <text>to one of two responses: cell cycle arrest or apoptosis</text>
  </TERM>
  <TERM dbid="UP:P04637" end="349" id="V222675" paragraph="paragraph3" rule="-SIMPLE-REF" start="345" uttnum="14">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="410" id="V222734" paragraph="paragraph3" rule="-SIMPLE-REF" start="362" uttnum="14">
    <type>ONT::INFORMATION</type>
    <name>RESPONSE</name>
    <text>of two responses: cell cycle arrest or apoptosis</text>
  </TERM>
  <TERM end="410" id="V222802" paragraph="paragraph3" rule="-LOGICALOP-REF" start="380" uttnum="14">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <aggregate operator="OR">
      <member id="V222799"/>
      <member id="V222811"/>
    </aggregate>
    <text normalization="">cell cycle arrest or apoptosis</text>
  </TERM>
  <TERM dbid="GO:0007050" end="398" id="V222799" paragraph="paragraph3" rule="-SIMPLE-REF" start="380" uttnum="14">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-CYCLE-ARREST</name>
    <text>cell cycle arrest</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="410" id="V222811" paragraph="paragraph3" rule="-SIMPLE-REF" start="401" uttnum="14">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <EVENT end="532" id="V236950" paragraph="paragraph3" rule="-RULE40A_AGENT_AFFECTED" start="412" uttnum="15">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="532" id="V236950" start="412">
      <type>ONT::PRODUCE</type>
      <text>Oncogenic RAS induces senescence mediated by p53 and its downstream target gene p21.9</text>
    </predicate>
    <arg1 id="V236945" role=":AGENT"/>
    <arg2 id="V236956" role=":AFFECTED"/>
    <text>Oncogenic RAS induces senescence mediated by p53 and its downstream target gene p21.9</text>
  </EVENT>
  <TERM end="426" id="V236945" paragraph="paragraph3" rule="-SIMPLE-REF" start="412" uttnum="15">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">Oncogenic RAS</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="512" id="V236956" paragraph="paragraph3" rule="-INEVENT2B,-SIMPLE-REF" start="434" uttnum="15">
    <type>ONT::PROTEIN-FAMILY</type>
    <features>
      <inevent>
        <event id="V236961"/>
      </inevent>
    </features>
    <name>SENESCENCE</name>
    <text normalization="">senescence mediated by p53 and its downstream target gene p21</text>
  </TERM>
  <EVENT end="512" id="V236961" paragraph="paragraph3" rule="-RULE10_AGENT_AFFECTED" start="434" uttnum="15">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="512" id="V236961" start="434">
      <type>ONT::MODULATE</type>
      <text>senescence mediated by p53 and its downstream target gene p21</text>
    </predicate>
    <arg1 id="V237020" role=":AGENT"/>
    <arg2 id="V236956" role=":AFFECTED"/>
    <text>senescence mediated by p53 and its downstream target gene p21</text>
  </EVENT>
  <TERM end="512" id="V237020" paragraph="paragraph3" rule="-LOGICALOP-REF" start="454" uttnum="15">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V237016"/>
      <member id="V237080"/>
    </aggregate>
    <text normalization="">by p53 and its downstream target gene p21</text>
  </TERM>
  <TERM dbid="UP:P04637" end="461" id="V237016" paragraph="paragraph3" rule="-SIMPLE-REF" start="457" uttnum="15">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="UP:Q15170|XFAM:PF02234|UP:Q62092|HGNC:11616|UP:P38936|XFAM:PF06387|UP:P63028|HGNC:1784|UP:P39689|XFAM:PF00838" end="512" id="V237080" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV" start="465" uttnum="15">
    <type>ONT::GENE</type>
    <name>P-21</name>
    <assoc-with id="X252901"/>
    <text>its downstream target gene p21</text>
  </TERM>
  <TERM end="512" id="V237042" paragraph="paragraph3" rule="-SIMPLE-REF" start="465" uttnum="15">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>its downstream target gene p21</text>
  </TERM>
  <TERM end="512" id="V237029" paragraph="paragraph3" rule="-LOGICALOP-REF" start="465" uttnum="15">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V237016"/>
      <member id="V237080"/>
    </aggregate>
    <text normalization="">its downstream target gene p21</text>
  </TERM>
  <TERM dbid="UP:Q15170|XFAM:PF02234|UP:Q62092|HGNC:11616|UP:P38936|XFAM:PF06387|UP:P63028|HGNC:1784|UP:P39689|XFAM:PF00838" end="512" id="X252901" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV-BASE" start="465" uttnum="15">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-21</name>
    <text>its downstream target gene p21</text>
  </TERM>
  <TERM dbid="UP:P04637" end="621" id="V252939" paragraph="paragraph3" rule="-SIMPLE-REF" start="614" uttnum="15">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="654" id="V253008" paragraph="paragraph3" rule="-SIMPLE-REF" start="642" uttnum="15">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>its ability</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="673" id="V253054" paragraph="paragraph3" rule="-SIMPLE-REF" start="664" uttnum="15">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="727" id="V256580" paragraph="paragraph3" rule="-SIMPLE-REF" start="713" uttnum="16">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">oncogenic RAS</text>
  </TERM>
  <EVENT end="774" id="V256696" paragraph="paragraph3" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="741" uttnum="16">
    <type>ONT::MODULATE</type>
    <predicate end="774" id="V256696" start="741">
      <type>ONT::MODULATE</type>
      <text>regulating p53-mediated apoptosis</text>
    </predicate>
    <arg2 id="V256756" role=":AFFECTED"/>
    <text>regulating p53-mediated apoptosis</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="774" id="V256756" paragraph="paragraph3" rule="-INEVENT2B,-SIMPLE-REF" start="752" uttnum="16">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V256735"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>p53-mediated apoptosis</text>
  </TERM>
  <EVENT end="774" id="V256735" paragraph="paragraph3" rule="-RULE10_AGENT_AFFECTED" start="752" uttnum="16">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="774" id="V256735" start="752">
      <type>ONT::MODULATE</type>
      <text>p53-mediated apoptosis</text>
    </predicate>
    <arg1 id="V256727" role=":AGENT"/>
    <arg2 id="V256756" role=":AFFECTED"/>
    <text>p53-mediated apoptosis</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="765" id="V256727" paragraph="paragraph3" rule="-SIMPLE-REF" start="752" uttnum="16">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-mediated</text>
  </TERM>
  <TERM dbid="UP:P04637" end="84" id="V263311" paragraph="paragraph4" rule="-SIMPLE-REF" start="14" uttnum="17">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>with p53 as an important mediator of oncogenic RAS-induced senescence</text>
  </TERM>
  <TERM end="48" id="V263352" paragraph="paragraph4" rule="-SIMPLE-REF" start="26" uttnum="17">
    <type>ONT::COMMUNICATION-PARTY</type>
    <name>MEDIATOR</name>
    <text>an important mediator</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="84" id="V263393" paragraph="paragraph4" rule="-INEVENT2B,-SIMPLE-REF" start="51" uttnum="17">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SENESCENCE</name>
    <text normalization="">oncogenic RAS-induced senescence</text>
  </TERM>
  <CC end="73" id="V263378" paragraph="paragraph4" rule="-RULE5B_AGENT_RESULT-AGENT" start="51" uttnum="17">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V263370" role=":FACTOR"/>
    <text>oncogenic RAS-induced</text>
  </CC>
  <TERM end="73" id="V263370" paragraph="paragraph4" rule="-SIMPLE-REF" start="51" uttnum="17">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">oncogenic RAS-induced</text>
  </TERM>
  <EPI end="231" id="V263551" paragraph="paragraph4" rule="-RULE50_0_AGENT_FORMAL-NONE" start="84" uttnum="17">
    <type>ONT::LEARN</type>
    <force>ONT::TRUE</force>
    <arg2 id="V263470" role=":NEUTRAL"/>
    <text>in primary fibroblasts, mutations of p53 and RAS are found at high frequency in colorectal and pancreatic tumours</text>
  </EPI>
  <TERM end="167" id="V263470" paragraph="paragraph4" rule="-SIMPLE-REF-MUTATION8" start="108" uttnum="17">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>mutations of p53 and RAS</text>
  </TERM>
  <TERM dbid="CO:0000057" end="106" id="V263461" paragraph="paragraph4" rule="-SIMPLE-REF" start="87" uttnum="17">
    <type>ONT::CELL</type>
    <name>FIBROBLASTS</name>
    <text>primary fibroblasts</text>
  </TERM>
  <TERM end="167" id="V263513" paragraph="paragraph4" rule="-LOGICALOP-REF" start="129" uttnum="17">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V263509"/>
      <member id="V263524"/>
    </aggregate>
    <text normalization="">p53 and RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="142" id="V263509" paragraph="paragraph4" rule="-SIMPLE-REF" start="129" uttnum="17">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="167" id="V263524" paragraph="paragraph4" rule="-SIMPLE-REF" start="154" uttnum="17">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="286" id="V280546" paragraph="paragraph4" rule="-SIMPLE-REF-MUTATION8" start="263" uttnum="18">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>RAS mutations</text>
  </TERM>
  <TERM end="276" id="V280540" paragraph="paragraph4" rule="-SIMPLE-REF" start="263" uttnum="18">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="345" id="V281083" paragraph="paragraph4" rule="-SIMPLE-REF" start="322" uttnum="18">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53 mutations</text>
  </TERM>
  <EVENT end="550" id="V281334" paragraph="paragraph4" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="462" uttnum="18">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="550" id="V281334" start="462">
      <type>ONT::EXPRESS</type>
      <text>in tumours expressing oncogenic RAS to inactivate the tumour-suppression function of p53</text>
    </predicate>
    <arg2 id="V281348" role=":AFFECTED-RESULT"/>
    <text>in tumours expressing oncogenic RAS to inactivate the tumour-suppression function of p53</text>
  </EVENT>
  <TERM end="498" id="V281348" paragraph="paragraph4" rule="-SIMPLE-REF" start="484" uttnum="18">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">oncogenic RAS</text>
  </TERM>
  <EVENT end="550" id="V281378" paragraph="paragraph4" rule="-RULE30_AGENT_FORMAL-NONE" start="501" uttnum="18">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="550" id="V281378" start="501">
      <type>ONT::INHIBIT</type>
      <text>inactivate the tumour-suppression function of p53</text>
    </predicate>
    <text>inactivate the tumour-suppression function of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="550" id="V281431" paragraph="paragraph4" rule="-SIMPLE-REF" start="544" uttnum="18">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="535" id="V280977" paragraph="paragraph4" rule="-SIMPLE-REF" start="523" uttnum="18">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SUPPRESSION</name>
    <text>suppression</text>
  </TERM>
  <CC end="550" id="X304071" paragraph="paragraph4" rule="-PURPOSE" start="462" uttnum="18">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V281334" role=":FACTOR"/>
    <arg id="V281378" role=":OUTCOME"/>
    <text>in tumours expressing oncogenic RAS to inactivate the tumour-suppression function of p53</text>
  </CC>
  <TERM end="570" id="V296000" paragraph="paragraph4" rule="-SIMPLE-REF" start="552" uttnum="19">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>REGULATORS</name>
    <text>Regulators of p53</text>
  </TERM>
  <TERM dbid="UP:P04637" end="570" id="V296039" paragraph="paragraph4" rule="-SIMPLE-REF" start="566" uttnum="19">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="634" id="V296219" paragraph="paragraph4" rule="-SIMPLE-REF" start="631" uttnum="19">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="737" id="V312662" paragraph="paragraph4" rule="-SIMPLE-REF" start="708" uttnum="20">
    <type>ONT::PROFESSIONAL</type>
    <name>CANDIDATE</name>
    <text>two such potential candidates</text>
  </TERM>
  <TERM end="647" id="V312520" paragraph="paragraph4" rule="-SIMPLE-REF" start="642" uttnum="20">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>REGULATORS</name>
    <text>those</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="704" id="V312628" paragraph="paragraph4" rule="-SIMPLE-REF" start="698" uttnum="20">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="692" id="V312594" paragraph="paragraph4" rule="-SIMPLE-REF" start="682" uttnum="20">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53 (ASPP)</text>
  </TERM>
  <TERM end="19" id="V327390" paragraph="paragraph5" rule="-LOGICALOP-REF" start="3" uttnum="21">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V327386"/>
      <member id="V327406"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="9" id="V327386" paragraph="paragraph5" rule="-SIMPLE-REF" start="3" uttnum="21">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="19" id="V327406" paragraph="paragraph5" rule="-SIMPLE-REF" start="13" uttnum="21">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="FA:00278" end="116" id="V327481" paragraph="paragraph5" rule="-INEVENT2B,-SIMPLE-REF" start="29" uttnum="21">
    <type>ONT::PROTEIN-FAMILY</type>
    <features>
      <inevent>
        <event id="V327468"/>
      </inevent>
    </features>
    <name>ASPP-FAMILY</name>
    <text normalization="">the evolutionarily conserved ASPP family of proteins, including ASPP1, ASPP2 and iASPP,</text>
  </TERM>
  <EVENT end="116" id="V327468" paragraph="paragraph5" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="29" uttnum="21">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="116" id="V327468" start="29">
      <type>ONT::NO-CHANGE</type>
      <text>the evolutionarily conserved ASPP family of proteins, including ASPP1, ASPP2 and iASPP,</text>
    </predicate>
    <arg2 id="V327481" role=":AFFECTED"/>
    <text>the evolutionarily conserved ASPP family of proteins, including ASPP1, ASPP2 and iASPP,</text>
  </EVENT>
  <TERM end="81" id="V327491" paragraph="paragraph5" rule="-SIMPLE-REF" start="73" uttnum="21">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>proteins</text>
  </TERM>
  <TERM end="115" id="V327527" paragraph="paragraph5" rule="-LOGICALOP-REF" start="93" uttnum="21">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V327568"/>
      <member id="V327510"/>
      <member id="V327523"/>
    </aggregate>
    <text normalization="">ASPP1, ASPP2 and iASPP</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="98" id="V327510" paragraph="paragraph5" rule="-SIMPLE-REF" start="93" uttnum="21">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="106" id="V327523" paragraph="paragraph5" rule="-SIMPLE-REF" start="100" uttnum="21">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:18838|UP:Q8WUF5" end="115" id="V327568" paragraph="paragraph5" rule="-SIMPLE-REF" start="110" uttnum="21">
    <type>ONT::GENE</type>
    <name>IASPP</name>
    <text>iASPP</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="227" id="V335109" paragraph="paragraph5" rule="-SIMPLE-REF" start="117" uttnum="21">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>which contain signature sequences in their C-termini; ankyrin repeats, a SH3 domain and proline-rich sequences</text>
  </TERM>
  <TERM end="161" id="V335120" paragraph="paragraph5" rule="-SIMPLE-REF" start="131" uttnum="21">
    <type>ONT::SIGNATURE</type>
    <name>SIGNATURE</name>
    <text>signature sequences in their C</text>
  </TERM>
  <TERM end="201" id="V335326" paragraph="paragraph5" rule="-SIMPLE-REF" start="188" uttnum="21">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>a SH3 domain</text>
  </TERM>
  <TERM dbid="CVCL:7701|CVCL:M383" end="194" id="V335323" paragraph="paragraph5" rule="-SIMPLE-REF" start="190" uttnum="21">
    <type>ONT::CELL-LINE</type>
    <name>SH-3</name>
    <text>SH3</text>
  </TERM>
  <TERM end="212" id="V335346" paragraph="paragraph5" rule="-SIMPLE-REF" start="205" uttnum="21">
    <type>ONT::AMINO-ACID</type>
    <name>PROLINE</name>
    <text>proline</text>
  </TERM>
  <TERM end="288" id="V347241" paragraph="paragraph5" rule="-SIMPLE-REF" start="229" uttnum="22">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>The evolutionarily conserved RAS-association domains (RAD)</text>
  </TERM>
  <EVENT end="288" id="V347229" paragraph="paragraph5" rule="-INEVENT2B,-RULE20C_AGENT_AFFECTED-AFFECTED" start="229" uttnum="22">
    <type>ONT::BIND</type>
    <predicate end="288" id="V347229" start="229">
      <type>ONT::BIND</type>
      <text>The evolutionarily conserved RAS-association domains (RAD)</text>
    </predicate>
    <arg2 id="V347223" role=":AFFECTED"/>
    <text>The evolutionarily conserved RAS-association domains (RAD)</text>
  </EVENT>
  <EVENT end="288" id="V347218" paragraph="paragraph5" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="229" uttnum="22">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="288" id="V347218" start="229">
      <type>ONT::NO-CHANGE</type>
      <text>The evolutionarily conserved RAS-association domains (RAD)</text>
    </predicate>
    <arg2 id="V347229" role=":AFFECTED"/>
    <text>The evolutionarily conserved RAS-association domains (RAD)</text>
  </EVENT>
  <TERM end="261" id="V347223" paragraph="paragraph5" rule="-SIMPLE-REF" start="258" uttnum="22">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="307" id="V347281" paragraph="paragraph5" rule="-LOGICALOP-REF" start="291" uttnum="22">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V347277"/>
      <member id="V347297"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="297" id="V347277" paragraph="paragraph5" rule="-SIMPLE-REF" start="291" uttnum="22">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="307" id="V347297" paragraph="paragraph5" rule="-SIMPLE-REF" start="301" uttnum="22">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="361" id="V347359" paragraph="paragraph5" rule="-SIMPLE-REF" start="322" uttnum="22">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>N</name>
    <text>their N-termini (first 100 amino acids)</text>
  </TERM>
  <TERM end="361" id="V347345" paragraph="paragraph5" rule="-SIMPLE-REF" start="322" uttnum="22">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>their N-termini (first 100 amino acids)</text>
  </TERM>
  <TERM end="360" id="V347411" paragraph="paragraph5" rule="-SIMPLE-REF" start="345" uttnum="22">
    <type>ONT::AMINO-ACID</type>
    <name>AMINO-ACIDS</name>
    <text>100 amino acids</text>
  </TERM>
  <TERM end="416" id="V362186" paragraph="paragraph5" rule="-SIMPLE-REF" start="398" uttnum="22">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>iASPP's N-terminus</text>
  </TERM>
  <TERM dbid="HGNC:18838|UP:Q8WUF5" end="403" id="V362132" paragraph="paragraph5" rule="-SIMPLE-REF" start="398" uttnum="22">
    <type>ONT::GENE</type>
    <name>IASPP</name>
    <text>iASPP</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="454" id="V363290" paragraph="paragraph5" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="427" uttnum="23">
    <type>ONT::GENE</type>
    <features>
      <location id="V363277"/>
    </features>
    <name>ASPP-2</name>
    <text>primary fibroblasts, ASPP2</text>
  </TERM>
  <TERM end="463" id="V363354" paragraph="paragraph5" rule="-SIMPLE-REF" start="457" uttnum="23">
    <type>ONT::DEVICE</type>
    <name>KEY</name>
    <text>a key</text>
  </TERM>
  <TERM end="427" id="V363259" paragraph="paragraph5" rule="-SIMPLE-REF" start="421" uttnum="23">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>MOUSE</name>
    <text>mouse</text>
  </TERM>
  <TERM dbid="CO:0000057" end="454" id="V363277" paragraph="paragraph5" rule="-SIMPLE-REF" start="427" uttnum="23">
    <type>ONT::CELL</type>
    <name>FIBROBLASTS</name>
    <text>primary fibroblasts, ASPP2</text>
  </TERM>
  <TERM end="475" id="V363362" paragraph="paragraph5" rule="-SIMPLE-REF" start="463" uttnum="23">
    <type>ONT::COMMUNICATION-PARTY</type>
    <name>MEDIATOR</name>
    <text>mediator of</text>
  </TERM>
  <EVENT end="547" id="V363385" paragraph="paragraph5" rule="-RULE40A_AGENT_AFFECTED" start="475" uttnum="23">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="547" id="V363385" start="475">
      <type>ONT::PRODUCE</type>
      <text>RAS-induced senescence via its ability to inhibit RAS-induced autophagy,</text>
    </predicate>
    <arg1 id="V363376" role=":AGENT"/>
    <arg2 id="V363399" role=":AFFECTED"/>
    <text>RAS-induced senescence via its ability to inhibit RAS-induced autophagy,</text>
  </EVENT>
  <TERM end="478" id="V363376" paragraph="paragraph5" rule="-SIMPLE-REF" start="475" uttnum="23">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="498" id="V363399" paragraph="paragraph5" rule="-SIMPLE-REF" start="487" uttnum="23">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SENESCENCE</name>
    <text normalization="">senescence</text>
  </TERM>
  <TERM dbid="GO:0006914" end="547" id="V363489" paragraph="paragraph5" rule="-SIMPLE-REF" start="502" uttnum="23">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>AUTOPHAGY</name>
    <text>its ability to inhibit RAS-induced autophagy,</text>
  </TERM>
  <TERM end="547" id="V363409" paragraph="paragraph5" rule="-SIMPLE-REF" start="502" uttnum="23">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">its ability to inhibit RAS-induced autophagy,</text>
  </TERM>
  <EVENT end="537" id="V363475" paragraph="paragraph5" rule="-RULE40_AGENT_AFFECTED-RESULT-NONE" start="514" uttnum="23">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="537" id="V363475" start="514">
      <type>ONT::PRODUCE</type>
      <text>to inhibit RAS-induced</text>
    </predicate>
    <text>to inhibit RAS-induced</text>
  </EVENT>
  <EVENT end="528" id="V363459" paragraph="paragraph5" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="517" uttnum="23">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="528" id="V363459" start="517">
      <type>ONT::INHIBIT</type>
      <text>inhibit RAS</text>
    </predicate>
    <arg2 id="V363466" role=":AFFECTED"/>
    <text>inhibit RAS</text>
  </EVENT>
  <TERM end="528" id="V363466" paragraph="paragraph5" rule="-SIMPLE-REF" start="525" uttnum="23">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <CC end="537" id="X378764" paragraph="paragraph5" rule="-PURPOSE" start="514" uttnum="23">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V363475" role=":FACTOR"/>
    <arg id="V363459" role=":OUTCOME"/>
    <text>to inhibit RAS-induced</text>
  </CC>
  <EVENT end="631" id="V377070" paragraph="paragraph5" rule="-RULE10_AGENT_AFFECTED" start="552" uttnum="23">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="631" id="V377070" start="552">
      <type>ONT::MODULATE</type>
      <text>nuclear accumulation of small ubiquitin-like modifier (SUMO) modified cyclin D1</text>
    </predicate>
    <arg2 id="V377125" role=":AFFECTED"/>
    <text>nuclear accumulation of small ubiquitin-like modifier (SUMO) modified cyclin D1</text>
  </EVENT>
  <TERM dbid="UP:P24385|HGNC:1582" end="631" id="V377125" paragraph="paragraph5" rule="-SIMPLE-REF" start="622" uttnum="23">
    <type>ONT::GENE</type>
    <name>CYCLIN-D-1</name>
    <text>cyclin D1</text>
  </TERM>
  <TERM dbid="FA:04277" end="611" id="V377062" paragraph="paragraph5" rule="-SIMPLE-REF" start="607" uttnum="23">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SUMO</name>
    <text normalization="">SUMO</text>
  </TERM>
  <EVENT end="728" id="V386909" paragraph="paragraph5" rule="-RULE20C_AGENT_AFFECTED" start="693" uttnum="23">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="728" id="V386909" start="693">
      <type>ONT::BIND</type>
      <text>the N-terminus of ASPP2 binds ATG5</text>
    </predicate>
    <arg1 id="V386862" role=":AGENT"/>
    <arg2 id="V386923" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000058"/>
    <text>the N-terminus of ASPP2 binds ATG5</text>
  </EVENT>
  <EVENT end="762" id="V386937" paragraph="paragraph5" rule="-RULE30_AGENT_AFFECTED" start="693" uttnum="23">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="762" id="V386937" start="693">
      <type>ONT::INHIBIT</type>
      <text>the N-terminus of ASPP2 binds ATG5 and inhibits RAS-induced autophagy</text>
    </predicate>
    <arg1 id="V386862" role=":AGENT"/>
    <arg2 id="V386967" role=":AFFECTED"/>
    <text>the N-terminus of ASPP2 binds ATG5 and inhibits RAS-induced autophagy</text>
  </EVENT>
  <TERM end="717" id="V386862" paragraph="paragraph5" rule="-SIMPLE-REF" start="693" uttnum="23">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>the N-terminus of ASPP2</text>
    <not-features>
      <bound-to id="V386923" event="V386909"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:589|FA:00292|UP:Q9H1Y0" end="728" id="V386923" paragraph="paragraph5" rule="-SIMPLE-REF" start="723" uttnum="23">
    <type>ONT::GENE-PROTEIN</type>
    <name>ATG-5</name>
    <text>ATG5</text>
    <not-features>
      <bound-to event="V386909" id="V386862"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="717" id="V386905" paragraph="paragraph5" rule="-SIMPLE-REF" start="711" uttnum="23">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0006914" end="762" id="V386967" paragraph="paragraph5" rule="-INEVENT2B,-SIMPLE-REF" start="741" uttnum="23">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V386953"/>
      </inevent>
    </features>
    <name>AUTOPHAGY</name>
    <text>RAS-induced autophagy</text>
  </TERM>
  <CC end="762" id="V386953" paragraph="paragraph5" rule="-RULE5B_AGENT_AFFECTED" start="741" uttnum="23">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V386944" role=":FACTOR"/>
    <arg id="V386967" role=":OUTCOME"/>
    <text>RAS-induced autophagy</text>
  </CC>
  <TERM end="753" id="V386944" paragraph="paragraph5" rule="-SIMPLE-REF" start="741" uttnum="23">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="UP:P04637" end="784" id="V388851" paragraph="paragraph5" rule="-SIMPLE-REF" start="781" uttnum="23">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="GO:0090398" end="47" id="V389209" paragraph="paragraph6" rule="-SIMPLE-REF" start="27" uttnum="24">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELLULAR-SENESCENCE</name>
    <text>cellular senescence</text>
  </TERM>
  <TERM dbid="BTO:0001413" end="63" id="V389332" paragraph="paragraph6" rule="-SIMPLE-REF" start="50" uttnum="24">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>PRIMARY-CELLS</name>
    <text>primary cells</text>
  </TERM>
  <CC end="121" id="V398397" paragraph="paragraph6" rule="-RULE5B_AGENT_AFFECTED" start="65" uttnum="24">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V398390" role=":FACTOR"/>
    <arg id="V398403" role=":OUTCOME"/>
    <text>RAS activation induces apoptosis in certain cancer cells</text>
  </CC>
  <EVENT end="80" id="V398390" paragraph="paragraph6" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="65" uttnum="24">
    <type>ONT::ACTIVATE</type>
    <predicate end="80" id="V398390" start="65">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V398387" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000202"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="98" id="V398403" paragraph="paragraph6" rule="-SIMPLE-REF" start="88" uttnum="24">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="69" id="V398387" paragraph="paragraph6" rule="-SIMPLE-REF" start="65" uttnum="24">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="121" id="V398479" paragraph="paragraph6" rule="-SIMPLE-REF" start="101" uttnum="24">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>certain cancer cells</text>
  </TERM>
  <TERM dbid="CHEBI:16991" end="144" id="V399185" paragraph="paragraph6" rule="-SIMPLE-REF" start="134" uttnum="25">
    <type>ONT::CELL-PART</type>
    <name>DNA</name>
    <text>DNA damage</text>
  </TERM>
  <EVENT end="214" id="V399284" paragraph="paragraph6" rule="-RULE40A_AGENT_AFFECTED" start="149" uttnum="25">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="214" id="V399284" start="149">
      <type>ONT::PRODUCE</type>
      <text>oncogene-induced p53 mainly induces senescence in primary cells,</text>
    </predicate>
    <arg1 id="V399274" role=":AGENT"/>
    <arg2 id="V399290" role=":AFFECTED"/>
    <text>oncogene-induced p53 mainly induces senescence in primary cells,</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="170" id="V399274" paragraph="paragraph6" rule="-INEVENT2B,-SIMPLE-REF" start="149" uttnum="25">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>oncogene-induced p53</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="214" id="V399290" paragraph="paragraph6" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="185" uttnum="25">
    <type>ONT::PROTEIN-FAMILY</type>
    <features>
      <location id="V399413"/>
    </features>
    <name>SENESCENCE</name>
    <text normalization="">senescence in primary cells,</text>
  </TERM>
  <CC end="166" id="V399233" paragraph="paragraph6" rule="-RULE5B_AGENT_RESULT-AGENT" start="149" uttnum="25">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V399225" role=":FACTOR"/>
    <text>oncogene-induced</text>
  </CC>
  <TERM end="166" id="V399225" paragraph="paragraph6" rule="-SIMPLE-REF" start="149" uttnum="25">
    <type>ONT::GENE</type>
    <name>ONCOGENE</name>
    <text>oncogene-induced</text>
  </TERM>
  <TERM dbid="BTO:0001413" end="212" id="V399413" paragraph="paragraph6" rule="-SIMPLE-REF" start="199" uttnum="25">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>PRIMARY-CELLS</name>
    <text>primary cells</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="243" id="V399430" paragraph="paragraph6" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="218" uttnum="25">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <location id="V399497"/>
    </features>
    <name>APOPTOSIS</name>
    <text>apoptosis in cancer cells</text>
  </TERM>
  <TERM end="243" id="V399497" paragraph="paragraph6" rule="-SIMPLE-REF" start="231" uttnum="25">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM dbid="UP:P04637" end="318" id="V416182" paragraph="paragraph6" rule="-SIMPLE-REF" start="287" uttnum="26">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53 in different cell types</text>
  </TERM>
  <TERM dbid="EFO:0000324" end="318" id="V416275" paragraph="paragraph6" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="297" uttnum="26">
    <type>ONT::CELL</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>DIFFERENT</value>
      </mod>
    </mods>
    <name>CELL-TYPES</name>
    <text>different cell types</text>
  </TERM>
  <EVENT end="388" id="V416308" paragraph="paragraph6" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="321" uttnum="26">
    <type>ONT::EXPRESS</type>
    <predicate end="388" id="V416308" start="321">
      <type>ONT::EXPRESS</type>
      <text>the expression levels and activities of the ASPP family of proteins</text>
    </predicate>
    <site end="388" id="V416375" start="358">
      <type>ONT::PROTEIN-FAMILY</type>
      <text normalization="">of the ASPP family of proteins</text>
    </site>
    <text>the expression levels and activities of the ASPP family of proteins</text>
  </EVENT>
  <TERM dbid="FA:00278" end="388" id="V416375" paragraph="paragraph6" rule="-SIMPLE-REF" start="358" uttnum="26">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPP-FAMILY</name>
    <text normalization="">of the ASPP family of proteins</text>
  </TERM>
  <TERM end="388" id="V416385" paragraph="paragraph6" rule="-SIMPLE-REF" start="380" uttnum="26">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>proteins</text>
  </TERM>
  <TERM end="405" id="V431018" paragraph="paragraph6" rule="-SIMPLE-REF" start="393" uttnum="27">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="413" id="V431031" paragraph="paragraph6" rule="-SIMPLE-REF" start="407" uttnum="27">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="423" id="V431051" paragraph="paragraph6" rule="-SIMPLE-REF" start="417" uttnum="27">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="468" id="V439541" paragraph="paragraph6" rule="-RULE30_AGENT_AFFECTED" start="442" uttnum="27">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="468" id="V439541" start="442">
      <type>ONT::INHIBIT</type>
      <text>iASPP inhibits, apoptosis</text>
    </predicate>
    <arg1 id="V439537" role=":AGENT"/>
    <arg2 id="V439551" role=":AFFECTED"/>
    <text>iASPP inhibits, apoptosis</text>
  </EVENT>
  <TERM dbid="HGNC:18838|UP:Q8WUF5" end="448" id="V439537" paragraph="paragraph6" rule="-SIMPLE-REF" start="442" uttnum="27">
    <type>ONT::GENE</type>
    <name>IASPP</name>
    <text>iASPP</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="468" id="V439551" paragraph="paragraph6" rule="-SIMPLE-REF" start="458" uttnum="27">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM dbid="UP:P04637" end="483" id="V439613" paragraph="paragraph6" rule="-SIMPLE-REF" start="479" uttnum="27">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="518" id="V454644" paragraph="paragraph6" rule="-LOGICALOP-REF" start="507" uttnum="27">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V454640"/>
      <member id="V454681"/>
    </aggregate>
    <text normalization="">p63 and p73</text>
  </TERM>
  <TERM dbid="UP:Q9H3D4" end="511" id="V454640" paragraph="paragraph6" rule="-SIMPLE-REF" start="507" uttnum="27">
    <type>ONT::PROTEIN</type>
    <name>P-63</name>
    <text>p63</text>
  </TERM>
  <TERM dbid="UP:O15350|HGNC:12003" end="518" id="V454681" paragraph="paragraph6" rule="-SIMPLE-REF" start="515" uttnum="27">
    <type>ONT::GENE</type>
    <name>P-73</name>
    <text>p73</text>
  </TERM>
  <TERM end="613" id="V454720" paragraph="paragraph6" rule="-LOGICALOP-REF" start="597" uttnum="27">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V454716"/>
      <member id="V454736"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="652" id="V454769" paragraph="paragraph6" rule="-SIMPLE-REF" start="622" uttnum="27">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>transcriptional targets of E2F</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="603" id="V454716" paragraph="paragraph6" rule="-SIMPLE-REF" start="597" uttnum="27">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="613" id="V454736" paragraph="paragraph6" rule="-SIMPLE-REF" start="607" uttnum="27">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="652" id="V454809" paragraph="paragraph6" rule="-SIMPLE-REF" start="649" uttnum="27">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E2F</text>
  </TERM>
  <TERM end="671" id="V461236" paragraph="paragraph6" rule="-SIMPLE-REF" start="667" uttnum="27">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E2F</text>
  </TERM>
  <TERM end="710" id="V461317" paragraph="paragraph6" rule="-SIMPLE-REF" start="697" uttnum="27">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <EVENT end="740" id="V461356" paragraph="paragraph6" rule="-RULE40_AGENT_AFFECTED-AFFECTED" start="717" uttnum="27">
    <type>ONT::DEACTIVATE</type>
    <predicate end="740" id="V461356" start="717">
      <type>ONT::DEACTIVATE</type>
      <text>inactivation of the Rb</text>
    </predicate>
    <arg2 id="V461376" role=":AFFECTED"/>
    <arg id="R000297" role=":RESULT"/>
    <text>inactivation of the Rb</text>
  </EVENT>
  <TERM dbid="XFAM:PF08934|HGNC:9884|UP:P13405|XFAM:PF01857|UP:P06400|XFAM:PF11934|XFAM:PF01858" end="740" id="V461376" paragraph="paragraph6" rule="-SIMPLE-REF" start="730" uttnum="27">
    <type>ONT::PROTEIN</type>
    <name>RB</name>
    <text>of the Rb</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <TERM end="747" id="V461379" paragraph="paragraph6" rule="-SIMPLE-REF" start="740" uttnum="27">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>pathway</text>
  </TERM>
  <EVENT end="813" id="V476692" paragraph="paragraph6" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="759" uttnum="28">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="813" id="V476692" start="759">
      <type>ONT::BIND</type>
      <text>E2F1 binds and cooperates with p53 to induce apoptosis</text>
    </predicate>
    <arg1 id="V476686" role=":AGENT"/>
    <text>E2F1 binds and cooperates with p53 to induce apoptosis</text>
  </EVENT>
  <TERM dbid="HGNC:3113|UP:Q61501|XFAM:PF16421|XFAM:PF02319|UP:Q01094" end="764" id="V476686" paragraph="paragraph6" rule="-SIMPLE-REF" start="759" uttnum="28">
    <type>ONT::GENE-PROTEIN</type>
    <name>E-2-F-1</name>
    <text>E2F1</text>
  </TERM>
  <TERM dbid="UP:P04637" end="794" id="V476750" paragraph="paragraph6" rule="-SIMPLE-REF" start="785" uttnum="28">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>with p53</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="813" id="V476786" paragraph="paragraph6" rule="-SIMPLE-REF" start="804" uttnum="28">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="869" id="V476871" paragraph="paragraph6" rule="-SIMPLE-REF" start="855" uttnum="28">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells,</text>
  </TERM>
  <TERM end="897" id="V476930" paragraph="paragraph6" rule="-SIMPLE-REF" start="892" uttnum="28">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E2F,</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="903" id="V476943" paragraph="paragraph6" rule="-SIMPLE-REF" start="897" uttnum="28">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <EVENT end="964" id="V476979" paragraph="paragraph6" rule="-RULE10_AGENT_AFFECTED" start="907" uttnum="28">
    <type>ONT::MODULATE</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::MAY</modality>
    <predicate end="964" id="V476979" start="907">
      <type>ONT::MODULATE</type>
      <text>ASPP2 may sensitise cancer cells to p53-induced apoptosis</text>
    </predicate>
    <arg1 id="V476963" role=":AGENT"/>
    <arg2 id="V477000" role=":AFFECTED"/>
    <text>ASPP2 may sensitise cancer cells to p53-induced apoptosis</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="913" id="V476963" paragraph="paragraph6" rule="-SIMPLE-REF" start="907" uttnum="28">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="940" id="V477000" paragraph="paragraph6" rule="-SIMPLE-REF" start="927" uttnum="28">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="964" id="V477086" paragraph="paragraph6" rule="-INEVENT2B,-SIMPLE-REF" start="940" uttnum="28">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V477064"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>to p53-induced apoptosis</text>
  </TERM>
  <CC end="964" id="V477064" paragraph="paragraph6" rule="-RULE5B_AGENT_AFFECTED" start="940" uttnum="28">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V477055" role=":FACTOR"/>
    <arg id="V477086" role=":OUTCOME"/>
    <text>to p53-induced apoptosis</text>
  </CC>
  <TERM dbid="UP:P04637" end="955" id="V477055" paragraph="paragraph6" rule="-SIMPLE-REF" start="943" uttnum="28">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-induced</text>
  </TERM>
  <MODALITY end="964" id="X498510" paragraph="paragraph6" rule="-MODALITY" start="903" uttnum="28">
    <type>ONT::POSSIBILITY</type>
    <arg2 id="V476979" role=":EVENT"/>
    <text>and ASPP2 may sensitise cancer cells to p53-induced apoptosis</text>
  </MODALITY>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="1043" id="V477153" paragraph="paragraph6" rule="-SIMPLE-REF" start="1034" uttnum="28">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1053" id="V477173" paragraph="paragraph6" rule="-SIMPLE-REF" start="1047" uttnum="28">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="1106" id="V477203" paragraph="paragraph6" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="1053" uttnum="28">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1106" id="V477203" start="1053">
      <type>ONT::STIMULATE</type>
      <text>to stimulate p53-dependent apoptosis in cancer cells</text>
    </predicate>
    <arg2 id="V477263" role=":AFFECTED"/>
    <text>to stimulate p53-dependent apoptosis in cancer cells</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="1090" id="V477263" paragraph="paragraph6" rule="-INEVENT2B,-SIMPLE-REF" start="1066" uttnum="28">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V477241"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>p53-dependent apoptosis</text>
  </TERM>
  <CC end="1090" id="V477241" paragraph="paragraph6" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="1066" uttnum="28">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V477235" role=":FACTOR"/>
    <arg id="V477263" role=":OUTCOME"/>
    <text>p53-dependent apoptosis</text>
  </CC>
  <TERM dbid="UP:P04637" end="1080" id="V477235" paragraph="paragraph6" rule="-SIMPLE-REF" start="1066" uttnum="28">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-dependent</text>
  </TERM>
  <TERM end="1106" id="V477330" paragraph="paragraph6" rule="-SIMPLE-REF" start="1093" uttnum="28">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="1147" id="V477366" paragraph="paragraph6" rule="-SIMPLE-REF" start="1132" uttnum="28">
    <type>ONT::AMINO-ACID</type>
    <name>AMINO-ACIDS</name>
    <text>120 amino acids</text>
  </TERM>
  <TERM end="1173" id="V491140" paragraph="paragraph6" rule="-SIMPLE-REF-MUTATION8" start="1152" uttnum="28">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutants lacking them</text>
  </TERM>
  <TERM end="1173" id="V491147" paragraph="paragraph6" rule="-SIMPLE-REF-MUTATION8" start="1168" uttnum="28">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>them</text>
  </TERM>
  <TERM dbid="UP:P04637" end="1206" id="V491252" paragraph="paragraph6" rule="-SIMPLE-REF" start="1203" uttnum="28">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EVENT end="1256" id="V503939" paragraph="paragraph6" rule="-RULE20C_AGENT_AFFECTED" start="1220" uttnum="28">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1256" id="V503939" start="1220">
      <type>ONT::BIND</type>
      <text>they interact with p53.16</text>
    </predicate>
    <arg1 id="V503931" role=":AGENT"/>
    <arg2 id="V503985" role=":AFFECTED"/>
    <text>they interact with p53.16</text>
  </EVENT>
  <TERM end="1225" id="V503931" paragraph="paragraph6" rule="-SIMPLE-REF-MUTATION8" start="1220" uttnum="28">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>they</text>
  </TERM>
  <TERM dbid="UP:P04637" end="1242" id="V503985" paragraph="paragraph6" rule="-SIMPLE-REF" start="1234" uttnum="28">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>with p53</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="19" id="V507005" paragraph="paragraph7" rule="-SIMPLE-REF" start="13" uttnum="29">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:O08675|UP:Q99NH2|XFAM:PF00001|XFAM:PF00595|UP:Q8TEW0|HGNC:16051|HGNC:3539|UP:O00254|FA:02653|XFAM:PF12053" end="62" id="V507127" paragraph="paragraph7" rule="-SIMPLE-REF" start="52" uttnum="29">
    <type>ONT::GENE-PROTEIN</type>
    <name>PAR-3</name>
    <text>with PAR3</text>
  </TERM>
  <TERM end="81" id="V507141" paragraph="paragraph7" rule="-SIMPLE-REF" start="66" uttnum="29">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>its N-terminus</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="81" id="V507137" paragraph="paragraph7" rule="-SIMPLE-REF" start="66" uttnum="29">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>its N-terminus</text>
  </TERM>
  <TERM end="124" id="V507225" paragraph="paragraph7" rule="-SIMPLE-REF" start="110" uttnum="29">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell polarity</text>
  </TERM>
  <TERM end="147" id="V507259" paragraph="paragraph7" rule="-SIMPLE-REF" start="138" uttnum="29">
    <type>ONT::DEVICE-COMPONENT</type>
    <name>JUNCTION</name>
    <text>junctions</text>
  </TERM>
  <TERM end="196" id="V507277" paragraph="paragraph7" rule="-SIMPLE-REF" start="159" uttnum="29">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">21, 22 RAS</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="246" id="V507326" paragraph="paragraph7" rule="-SIMPLE-REF" start="224" uttnum="29">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the cellular membrane,</text>
  </TERM>
  <TERM end="290" id="V522819" paragraph="paragraph7" rule="-SIMPLE-REF" start="251" uttnum="29">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>the RAD-containing N-terminus of ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="290" id="V522862" paragraph="paragraph7" rule="-SIMPLE-REF" start="284" uttnum="29">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="369" id="V522959" paragraph="paragraph7" rule="-RULE40A_AGENT_AFFECTED" start="301" uttnum="29">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="369" id="V522959" start="301">
      <type>ONT::PRODUCE</type>
      <text>in mediating oncogenic RAS-induced senescence in primary fibroblasts</text>
    </predicate>
    <arg1 id="V522950" role=":AGENT"/>
    <arg2 id="V522973" role=":AFFECTED"/>
    <text>in mediating oncogenic RAS-induced senescence in primary fibroblasts</text>
  </EVENT>
  <TERM end="327" id="V522950" paragraph="paragraph7" rule="-SIMPLE-REF" start="324" uttnum="29">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="347" id="V522973" paragraph="paragraph7" rule="-SIMPLE-REF" start="336" uttnum="29">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SENESCENCE</name>
    <text normalization="">senescence</text>
  </TERM>
  <TERM dbid="CO:0000057" end="369" id="V523041" paragraph="paragraph7" rule="-SIMPLE-REF" start="350" uttnum="29">
    <type>ONT::CELL</type>
    <name>FIBROBLASTS</name>
    <text>primary fibroblasts</text>
  </TERM>
  <EVENT end="467" id="V534554" paragraph="paragraph7" rule="-RULE10_AGENT_AFFECTED" start="397" uttnum="30">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="467" id="V534554" start="397">
      <type>ONT::MODULATE</type>
      <text>that ASPP1 and ASPP2 may interact with RAS and regulate RAS signalling</text>
    </predicate>
    <arg1 id="V534484" role=":AGENT"/>
    <arg2 id="V534564" role=":AFFECTED"/>
    <text>that ASPP1 and ASPP2 may interact with RAS and regulate RAS signalling</text>
  </EVENT>
  <EVENT end="467" id="V534520" paragraph="paragraph7" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="397" uttnum="30">
    <type>ONT::BIND</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::MAY</modality>
    <predicate end="467" id="V534520" start="397">
      <type>ONT::BIND</type>
      <text>that ASPP1 and ASPP2 may interact with RAS and regulate RAS signalling</text>
    </predicate>
    <arg1 id="V534484" role=":AGENT"/>
    <text>that ASPP1 and ASPP2 may interact with RAS and regulate RAS signalling</text>
  </EVENT>
  <TERM end="418" id="V534484" paragraph="paragraph7" rule="-LOGICALOP-REF" start="402" uttnum="30">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V534480"/>
      <member id="V534500"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="GO:0023052" end="467" id="V534564" paragraph="paragraph7" rule="-SIMPLE-REF" start="453" uttnum="30">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="408" id="V534480" paragraph="paragraph7" rule="-SIMPLE-REF" start="402" uttnum="30">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="418" id="V534500" paragraph="paragraph7" rule="-SIMPLE-REF" start="412" uttnum="30">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="467" id="V534559" paragraph="paragraph7" rule="-SIMPLE-REF" start="453" uttnum="30">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM end="440" id="V534539" paragraph="paragraph7" rule="-SIMPLE-REF" start="436" uttnum="30">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <MODALITY end="468" id="X545014" paragraph="paragraph7" rule="-MODALITY" start="371" uttnum="30">
    <type>ONT::POSSIBILITY</type>
    <arg2 id="V534520" role=":EVENT"/>
    <text>Therefore, it is possible that ASPP1 and ASPP2 may interact with RAS and regulate RAS signalling.</text>
  </MODALITY>
  <TERM end="546" id="V541914" paragraph="paragraph7" rule="-SIMPLE-REF" start="524" uttnum="31">
    <type>ONT::INFORMATION</type>
    <name>RESPONSE</name>
    <text>the cellular response</text>
  </TERM>
  <TERM end="480" id="V541822" paragraph="paragraph7" rule="-SIMPLE-REF" start="472" uttnum="31">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>a result</text>
  </TERM>
  <TERM end="512" id="V541867" paragraph="paragraph7" rule="-LOGICALOP-REF" start="493" uttnum="31">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V541863"/>
      <member id="V541883"/>
    </aggregate>
    <text normalization="">of ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="502" id="V541863" paragraph="paragraph7" rule="-SIMPLE-REF" start="496" uttnum="31">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="512" id="V541883" paragraph="paragraph7" rule="-SIMPLE-REF" start="506" uttnum="31">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0023052" end="608" id="V541950" paragraph="paragraph7" rule="-SIMPLE-REF" start="549" uttnum="31">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling in both primary fibroblasts and cancer cells</text>
  </TERM>
  <TERM end="608" id="V541945" paragraph="paragraph7" rule="-SIMPLE-REF" start="549" uttnum="31">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling in both primary fibroblasts and cancer cells</text>
  </TERM>
  <TERM end="608" id="V542006" paragraph="paragraph7" rule="-LOGICALOP-REF" start="567" uttnum="31">
    <type>ONT::CELL</type>
    <aggregate operator="BOTH">
      <member id="V542025"/>
      <member id="V542050"/>
    </aggregate>
    <text normalization="">both primary fibroblasts and cancer cells</text>
  </TERM>
  <TERM dbid="CO:0000057" end="592" id="V542025" paragraph="paragraph7" rule="-SIMPLE-REF" start="572" uttnum="31">
    <type>ONT::CELL</type>
    <name>FIBROBLASTS</name>
    <text>primary fibroblasts</text>
  </TERM>
  <TERM end="608" id="V542050" paragraph="paragraph7" rule="-SIMPLE-REF" start="596" uttnum="31">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="615" id="V556301" paragraph="paragraph7" rule="-ROBUSTPRO" start="610" uttnum="32">
    <type>ONT::PLACE</type>
    <text>Here</text>
  </TERM>
  <EPI end="659" id="V556316" paragraph="paragraph7" rule="-RULE50_0_AGENT_FORMAL" start="615" uttnum="32">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V556306" role=":AGENT"/>
    <arg2 id="V556375" role=":FORMAL"/>
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
  </EPI>
  <TERM end="618" id="V556306" paragraph="paragraph7" rule="-ROBUSTPRO" start="615" uttnum="32">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="659" id="V556375" paragraph="paragraph7" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE20C_AGENT_AFFECTED" start="615" uttnum="32">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V556316"/>
    <predicate end="659" id="V556375" start="615">
      <type>ONT::BIND</type>
      <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    </predicate>
    <arg1 id="V556354" role=":AGENT"/>
    <arg2 id="V556390" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000067"/>
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
  </EVENT>
  <TERM end="644" id="V556354" paragraph="paragraph7" rule="-LOGICALOP-REF" start="628" uttnum="32">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V556350"/>
      <member id="V556370"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <not-features>
      <bound-to event="V556375" id="V556390"/>
    </not-features>
  </TERM>
  <TERM end="659" id="V556390" paragraph="paragraph7" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="649" uttnum="32">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
    <not-features>
      <bound-to id="V556354" event="V556375"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="634" id="V556350" paragraph="paragraph7" rule="-SIMPLE-REF" start="628" uttnum="32">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="644" id="V556370" paragraph="paragraph7" rule="-SIMPLE-REF" start="638" uttnum="32">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="678" id="V564258" paragraph="paragraph7" rule="-SIMPLE-REF" start="661" uttnum="33">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>Endogenous ASPP2</text>
  </TERM>
  <TERM end="738" id="V564296" paragraph="paragraph7" rule="-SIMPLE-REF" start="693" uttnum="33">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">endogenous RAS cellular membrane localisation</text>
  </TERM>
  <TERM dbid="GO:0005886" end="726" id="V564311" paragraph="paragraph7" rule="-SIMPLE-REF" start="708" uttnum="33">
    <type>ONT::CELL-PART</type>
    <name>CELLULAR-MEMBRANE</name>
    <text>cellular membrane</text>
  </TERM>
  <EVENT end="770" id="V564335" paragraph="paragraph7" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="744" uttnum="33">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="770" id="V564335" start="744">
      <type>ONT::INCREASE</type>
      <text>potentiates RAS signalling</text>
    </predicate>
    <arg2 id="V564354" role=":AFFECTED"/>
    <text>potentiates RAS signalling</text>
  </EVENT>
  <TERM dbid="GO:0023052" end="770" id="V564354" paragraph="paragraph7" rule="-SIMPLE-REF" start="756" uttnum="33">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="770" id="V564349" paragraph="paragraph7" rule="-SIMPLE-REF" start="756" uttnum="33">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM end="789" id="V576998" paragraph="paragraph7" rule="-ROBUSTPRO" start="786" uttnum="34">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="822" id="V577041" paragraph="paragraph7" rule="-LOGICALOP-REF" start="806" uttnum="34">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V577037"/>
      <member id="V577057"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="851" id="V577083" paragraph="paragraph7" rule="-SIMPLE-REF" start="832" uttnum="34">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with oncogenic RAS</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="812" id="V577037" paragraph="paragraph7" rule="-SIMPLE-REF" start="806" uttnum="34">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="822" id="V577057" paragraph="paragraph7" rule="-SIMPLE-REF" start="816" uttnum="34">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="910" id="V577193" paragraph="paragraph7" rule="-SIMPLE-REF" start="906" uttnum="34">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="925" id="V577260" paragraph="paragraph7" rule="-SIMPLE-REF" start="913" uttnum="34">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="43" id="V591774" paragraph="paragraph8" rule="-INEVENT2B,-SIMPLE-REF" start="3" uttnum="35">
    <type>ONT::TERMINUS</type>
    <features>
      <inevent>
        <event id="V591768"/>
      </inevent>
    </features>
    <name>N-TERMINAL</name>
    <text>The evolutionarily conserved N-terminal</text>
  </TERM>
  <EVENT end="43" id="V591768" paragraph="paragraph8" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="3" uttnum="35">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="43" id="V591768" start="3">
      <type>ONT::NO-CHANGE</type>
      <text>The evolutionarily conserved N-terminal</text>
    </predicate>
    <arg2 id="V591774" role=":AFFECTED"/>
    <text>The evolutionarily conserved N-terminal</text>
  </EVENT>
  <TERM end="78" id="V591822" paragraph="paragraph8" rule="-SIMPLE-REF" start="43" uttnum="35">
    <type>ONT::AMINO-ACID</type>
    <name>AMINO-ACIDS</name>
    <text>100 amino acids of ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="78" id="V591847" paragraph="paragraph8" rule="-LOGICALOP-REF" start="62" uttnum="35">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V591843"/>
      <member id="V591863"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="68" id="V591843" paragraph="paragraph8" rule="-SIMPLE-REF" start="62" uttnum="35">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="78" id="V591863" paragraph="paragraph8" rule="-SIMPLE-REF" start="72" uttnum="35">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="146" id="V592099" paragraph="paragraph8" rule="-LOGICALOP-REF" start="127" uttnum="35">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V592110"/>
      <member id="V592052"/>
      <member id="V592095"/>
    </aggregate>
    <text normalization="">c-Raf, PI3K and Ras</text>
  </TERM>
  <TERM dbid="UP:P04049" end="132" id="V592052" paragraph="paragraph8" rule="-SIMPLE-REF" start="127" uttnum="35">
    <type>ONT::PROTEIN</type>
    <name>C-RAF</name>
    <text>c-Raf</text>
  </TERM>
  <TERM end="139" id="V592095" paragraph="paragraph8" rule="-SIMPLE-REF" start="134" uttnum="35">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <TERM dbid="FA:03663" end="146" id="V592110" paragraph="paragraph8" rule="-SIMPLE-REF" start="143" uttnum="35">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>RAS</name>
    <text normalization="">Ras</text>
  </TERM>
  <EVENT end="230" id="V592218" paragraph="paragraph8" rule="-RULE20C_AGENT_AFFECTED" start="188" uttnum="35">
    <type>ONT::BIND</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::MAY</modality>
    <predicate end="230" id="V592218" start="188">
      <type>ONT::BIND</type>
      <text>that ASPP1 and ASPP2 may interact with RAS</text>
    </predicate>
    <arg1 id="V592183" role=":AGENT"/>
    <arg2 id="V592238" role=":AFFECTED"/>
    <arg id="R000076" role=":RESULT"/>
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
  </EVENT>
  <TERM end="209" id="V592183" paragraph="paragraph8" rule="-LOGICALOP-REF" start="193" uttnum="35">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V592179"/>
      <member id="V592199"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <not-features>
      <bound-to event="V592218" id="V592238"/>
    </not-features>
  </TERM>
  <TERM end="230" id="V592238" paragraph="paragraph8" rule="-SIMPLE-REF" start="222" uttnum="35">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with RAS</text>
    <not-features>
      <bound-to id="V592183" event="V592218"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="199" id="V592179" paragraph="paragraph8" rule="-SIMPLE-REF" start="193" uttnum="35">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="209" id="V592199" paragraph="paragraph8" rule="-SIMPLE-REF" start="203" uttnum="35">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <MODALITY end="231" id="X615688" paragraph="paragraph8" rule="-MODALITY" start="177" uttnum="35">
    <type>ONT::POSSIBILITY</type>
    <arg2 id="V592218" role=":EVENT"/>
    <text>suggesting that ASPP1 and ASPP2 may interact with RAS.</text>
  </MODALITY>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="258" id="V605119" paragraph="paragraph8" rule="-SIMPLE-REF" start="241" uttnum="36">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>N-terminal ASPP1</text>
  </TERM>
  <TERM end="258" id="V605076" paragraph="paragraph8" rule="-SIMPLE-REF" start="241" uttnum="36">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINAL</name>
    <text>N-terminal ASPP1</text>
  </TERM>
  <TERM end="275" id="V605143" paragraph="paragraph8" rule="-SIMPLE-REF" start="271" uttnum="36">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <EVENT end="282" id="V605148" paragraph="paragraph8" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="271" uttnum="36">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="282" id="V605148" start="271">
      <type>ONT::BIND</type>
      <text>RAS loaded</text>
    </predicate>
    <arg2 id="V605143" role=":AFFECTED"/>
    <text>RAS loaded</text>
  </EVENT>
  <TERM end="301" id="V605166" paragraph="paragraph8" rule="-SIMPLE-REF" start="293" uttnum="36">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>3H</text>
  </TERM>
  <TERM end="323" id="V605202" paragraph="paragraph8" rule="-LOGICALOP-REF" start="312" uttnum="36">
    <type>ONT::MOLECULE</type>
    <aggregate operator="OR">
      <member id="V605199"/>
      <member id="V605211"/>
    </aggregate>
    <text normalization="">GTP or GDP</text>
  </TERM>
  <TERM dbid="CHEBI:15996|CHEBI:37565" end="316" id="V605199" paragraph="paragraph8" rule="-SIMPLE-REF" start="312" uttnum="36">
    <type>ONT::MOLECULE</type>
    <name>GTP</name>
    <text>GTP</text>
  </TERM>
  <TERM dbid="CHEBI:17552|CHEBI:58189" end="323" id="V605211" paragraph="paragraph8" rule="-SIMPLE-REF" start="319" uttnum="36">
    <type>ONT::MOLECULE</type>
    <name>GDP</name>
    <text>GDP</text>
  </TERM>
  <TERM dbid="HGNC:10446|UP:P55042" end="366" id="V605304" paragraph="paragraph8" rule="-SIMPLE-REF" start="356" uttnum="36">
    <type>ONT::GENE</type>
    <name>RAD</name>
    <text>ASPP1 RAD</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="362" id="V605293" paragraph="paragraph8" rule="-SIMPLE-REF" start="356" uttnum="36">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM end="424" id="V605390" paragraph="paragraph8" rule="-LOGICALOP-REF" start="399" uttnum="36">
    <type>ONT::PROTEIN-FAMILY</type>
    <aggregate operator="ONE-OF">
      <member id="V605409"/>
      <member id="V605434"/>
    </aggregate>
    <text normalization="">either RAS–GTP or RAS–GDP</text>
  </TERM>
  <TERM end="414" id="V605409" paragraph="paragraph8" rule="-SIMPLE-REF" start="406" uttnum="36">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">RAS–GTP</text>
  </TERM>
  <TERM end="424" id="V605434" paragraph="paragraph8" rule="-SIMPLE-REF" start="417" uttnum="36">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GDP</name>
    <text normalization="">RAS–GDP</text>
  </TERM>
  <EPI end="476" id="V620477" paragraph="paragraph8" rule="-RULE50_0_AGENT_FORMAL" start="426" uttnum="37">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg1 id="V620471" role=":AGENT"/>
    <arg2 id="V620501" role=":FORMAL"/>
    <text>We observed that purified ASPP1 fragment (1–310),</text>
  </EPI>
  <TERM end="429" id="V620471" paragraph="paragraph8" rule="-ROBUSTPRO" start="426" uttnum="37">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="476" id="V620501" paragraph="paragraph8" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE20_AGENT_AFFECTED" start="426" uttnum="37">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V620477"/>
    <predicate end="476" id="V620501" start="426">
      <type>ONT::PPEXPT</type>
      <text>We observed that purified ASPP1 fragment (1–310),</text>
    </predicate>
    <arg1 id="V620491" role=":AGENT"/>
    <arg2 id="V620524" role=":AFFECTED"/>
    <text>We observed that purified ASPP1 fragment (1–310),</text>
  </EVENT>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="443" id="V620491" paragraph="paragraph8" rule="-SIMPLE-REF" start="438" uttnum="37">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>that</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="476" id="V620524" paragraph="paragraph8" rule="-EXPLICIT-REF2" start="452" uttnum="37">
    <type>ONT::GENE</type>
    <name>ASPP-1 FRAGMENT</name>
    <text>ASPP1 fragment (1–310),</text>
  </TERM>
  <TERM end="533" id="V620599" paragraph="paragraph8" rule="-INEVENT2B,-SIMPLE-REF" start="507" uttnum="37">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <inevent>
        <event id="V620590"/>
      </inevent>
    </features>
    <name>RAS</name>
    <text normalization="">with purified RAS</text>
  </TERM>
  <TERM dbid="HGNC:10446|UP:P55042" end="494" id="V620557" paragraph="paragraph8" rule="-SIMPLE-REF" start="487" uttnum="37">
    <type>ONT::GENE</type>
    <name>RAD</name>
    <text>the RAD</text>
  </TERM>
  <EVENT end="533" id="V620590" paragraph="paragraph8" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="507" uttnum="37">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="533" id="V620590" start="507">
      <type>ONT::PPEXPT</type>
      <text>with purified RAS</text>
    </predicate>
    <arg2 id="V620599" role=":AFFECTED"/>
    <text>with purified RAS</text>
  </EVENT>
  <EVENT end="620" id="V635915" paragraph="paragraph8" rule="-RULE20C_AGENT_AFFECTED" start="552" uttnum="38">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="620" id="V635915" start="552">
      <type>ONT::BIND</type>
      <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity</text>
    </predicate>
    <arg1 id="V635876" role=":AGENT"/>
    <arg2 id="V635942" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000085"/>
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity</text>
  </EVENT>
  <TERM end="573" id="V635876" paragraph="paragraph8" rule="-SIMPLE-REF" start="552" uttnum="38">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>The ASPP1 N-terminus</text>
    <not-features>
      <bound-to event="V635915" id="V635942"/>
    </not-features>
  </TERM>
  <TERM end="587" id="V635942" paragraph="paragraph8" rule="-SIMPLE-REF" start="579" uttnum="38">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">RAS–GTP</text>
    <not-features>
      <bound-to event="V635915" id="V635876"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="562" id="V635872" paragraph="paragraph8" rule="-SIMPLE-REF" start="556" uttnum="38">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM end="658" id="V636340" paragraph="paragraph8" rule="-EXPLICIT-REF-SEQ0B" start="625" uttnum="38">
    <type>ONT::MOLECULAR-PART</type>
    <components>
      <component id="V636035"/>
      <component id="V636043"/>
    </components>
    <text normalization="">RAS–GDP (Figure 1a,</text>
  </TERM>
  <TERM end="679" id="V636131" paragraph="paragraph8" rule="-SIMPLE-REF" start="666" uttnum="38">
    <type>ONT::LANE</type>
    <name>LANE</name>
    <text>lanes 4 and 5</text>
  </TERM>
  <TERM end="658" id="V636035" paragraph="paragraph8" rule="-EXPLICIT-REF-SEQ0B-TERM" start="625" uttnum="38">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS–GDP (Figure 1a,</text>
  </TERM>
  <TERM dbid="CHEBI:17552|CHEBI:58189" end="633" id="V636043" paragraph="paragraph8" rule="-SIMPLE-REF" start="629" uttnum="38">
    <type>ONT::MOLECULE</type>
    <name>GDP</name>
    <text>GDP</text>
  </TERM>
  <TERM end="656" id="V636058" paragraph="paragraph8" rule="-SIMPLE-REF" start="640" uttnum="38">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1a</text>
  </TERM>
  <TERM end="737" id="V651926" paragraph="paragraph8" rule="-SIMPLE-REF" start="706" uttnum="39">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>REGION</name>
    <text>the N-terminal region of ASPP1</text>
  </TERM>
  <TERM end="746" id="V651966" paragraph="paragraph8" rule="-SIMPLE-REF" start="743" uttnum="39">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="737" id="V651890" paragraph="paragraph8" rule="-SIMPLE-REF" start="706" uttnum="39">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINAL</name>
    <text>the N-terminal region of ASPP1</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="737" id="V651953" paragraph="paragraph8" rule="-SIMPLE-REF" start="728" uttnum="39">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <EVENT end="796" id="V655623" paragraph="paragraph8" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="748" uttnum="39">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="796" id="V655623" start="748">
      <type>ONT::TRANSFORM</type>
      <text>various truncated ASPP1 mutants were constructed</text>
    </predicate>
    <arg2 id="V655633" role=":FORMAL"/>
    <text>various truncated ASPP1 mutants were constructed</text>
  </EVENT>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="796" id="V655633" paragraph="paragraph8" rule="-INEVENT2B,-SIMPLE-REF" start="766" uttnum="39">
    <type>ONT::GENE</type>
    <features>
      <inevent>
        <event id="V655658"/>
      </inevent>
    </features>
    <name>ASPP-1</name>
    <text>ASPP1 mutants were constructed</text>
  </TERM>
  <EVENT end="796" id="V655658" paragraph="paragraph8" rule="-RULE40_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="766" uttnum="39">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="796" id="V655658" start="766">
      <type>ONT::PRODUCE</type>
      <text>ASPP1 mutants were constructed</text>
    </predicate>
    <arg2 id="V655633" role=":AFFECTED-RESULT"/>
    <text>ASPP1 mutants were constructed</text>
  </EVENT>
  <TERM end="780" id="V655636" paragraph="paragraph8" rule="-SIMPLE-REF-MUTATION8" start="772" uttnum="39">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutants</text>
  </TERM>
  <EVENT end="871" id="V656346" paragraph="paragraph8" rule="-RULE20C_AGENT_AFFECTED" start="798" uttnum="40">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="871" id="V656346" start="798">
      <type>ONT::BIND</type>
      <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS</text>
    </predicate>
    <arg1 id="V656323" role=":AGENT"/>
    <arg2 id="V656368" role=":AFFECTED"/>
    <arg id="R000094" role=":RESULT"/>
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS</text>
  </EVENT>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="841" id="V656323" paragraph="paragraph8" rule="-EXPLICIT-REF4" start="812" uttnum="40">
    <type>ONT::GENE</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>ASPP-1</name>
    <text>ASPP1 mutants containing RAD</text>
    <not-features>
      <bound-to id="V656368" event="V656346"/>
    </not-features>
  </TERM>
  <TERM end="871" id="V656368" paragraph="paragraph8" rule="-SIMPLE-REF" start="851" uttnum="40">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with endogenous RAS</text>
    <not-features>
      <bound-to id="V656323" event="V656346"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="894" id="V656381" paragraph="paragraph8" rule="-SIMPLE-REF" start="878" uttnum="40">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1 (310–1090)</text>
  </TERM>
  <TERM end="951" id="V670609" paragraph="paragraph8" rule="-SIMPLE-REF" start="943" uttnum="40">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>b</text>
  </TERM>
  <TERM end="939" id="V670529" paragraph="paragraph8" rule="-SIMPLE-REF" start="914" uttnum="40">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figures 1a</text>
  </TERM>
  <TERM end="17" id="V671475" paragraph="paragraph9" rule="-INEVENT2B,-SIMPLE-REF" start="3" uttnum="41">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">Activated RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="92" id="V671548" paragraph="paragraph9" rule="-RULE20C_AGENT_AFFECTED-LOC5-GD-AGENT" start="21" uttnum="41">
    <type>ONT::BIND</type>
    <predicate end="92" id="V671548" start="21">
      <type>ONT::BIND</type>
      <text>a higher interaction affinity with the RAS-binding domain (RBD) of Raf1</text>
    </predicate>
    <arg1 id="V671541" role=":AGENT"/>
    <site end="85" id="V671596" start="72">
      <type>ONT::MOLECULAR-DOMAIN</type>
      <text normalization="">domain (RBD)</text>
    </site>
    <text>a higher interaction affinity with the RAS-binding domain (RBD) of Raf1</text>
  </EVENT>
  <EVENT end="17" id="V671469" paragraph="paragraph9" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="3" uttnum="41">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="17" id="V671469" start="3">
      <type>ONT::ACTIVATE</type>
      <text>Activated RAS</text>
    </predicate>
    <arg2 id="V671475" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000041"/>
    <text>Activated RAS</text>
  </EVENT>
  <EVENT end="92" id="V671541" paragraph="paragraph9" rule="-RULE20C_AFFECTED_AFFECTED1-LOC5-GD-NONE" start="21" uttnum="41">
    <type>ONT::BIND</type>
    <predicate end="92" id="V671541" start="21">
      <type>ONT::BIND</type>
      <text>a higher interaction affinity with the RAS-binding domain (RBD) of Raf1</text>
    </predicate>
    <site end="85" id="V671596" start="72">
      <type>ONT::MOLECULAR-DOMAIN</type>
      <text normalization="">domain (RBD)</text>
    </site>
    <text>a higher interaction affinity with the RAS-binding domain (RBD) of Raf1</text>
  </EVENT>
  <TERM end="92" id="V671571" paragraph="paragraph9" rule="-INEVENT2B,-SIMPLE-REF" start="56" uttnum="41">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">the RAS-binding domain (RBD) of Raf1</text>
    <features>
      <bound-to id="R000019" event="V671578"/>
    </features>
  </TERM>
  <EVENT end="92" id="V671578" paragraph="paragraph9" rule="-RULE20C_AGENT_AFFECTED-LOC12" start="56" uttnum="41">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="92" id="V671578" start="56">
      <type>ONT::BIND</type>
      <text>the RAS-binding domain (RBD) of Raf1</text>
    </predicate>
    <arg1 id="R000018" role=":AGENT"/>
    <arg2 id="V671596" role=":AFFECTED"/>
    <arg id="R000020" role=":RESULT"/>
    <site end="83" id="V671609" start="80">
      <type>ONT::MOLECULAR-DOMAIN</type>
      <text normalization="">RBD</text>
    </site>
    <text>the RAS-binding domain (RBD) of Raf1</text>
  </EVENT>
  <TERM end="85" id="V671596" paragraph="paragraph9" rule="-SIMPLE-REF" start="72" uttnum="41">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>domain (RBD)</text>
    <not-features>
      <bound-to event="V671578" id="R000018"/>
    </not-features>
  </TERM>
  <TERM dbid="XFAM:PF02196.12" end="83" id="V671609" paragraph="paragraph9" rule="-SIMPLE-REF" start="80" uttnum="41">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>RBD</name>
    <text>RBD</text>
  </TERM>
  <TERM dbid="UP:P04049" end="92" id="V671629" paragraph="paragraph9" rule="-SIMPLE-REF" start="88" uttnum="41">
    <type>ONT::PROTEIN</type>
    <name>RAF-1</name>
    <text>Raf1</text>
  </TERM>
  <TERM dbid="CHEBI:2511" end="188" id="V687436" paragraph="paragraph9" rule="-INEVENT2B,-SIMPLE-REF" start="94" uttnum="42">
    <type>ONT::MOLECULE</type>
    <name>AGAROSE</name>
    <text>Agarose beads linked to the Raf1–RBD can be used to pull down proteins associated with RAS–GTP</text>
  </TERM>
  <CC end="188" id="V687521" paragraph="paragraph9" rule="-RULE5B_AGENT_RESULT-NONE" start="102" uttnum="42">
    <type>ONT::CAUSE</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::ABILITY</modality>
    <text>beads linked to the Raf1–RBD can be used to pull down proteins associated with RAS–GTP</text>
  </CC>
  <TERM end="188" id="V687636" paragraph="paragraph9" rule="-INEVENT2B,-SIMPLE-REF" start="156" uttnum="42">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>proteins associated with RAS–GTP</text>
    <features>
      <bound-to event="V687641" id="R000028"/>
    </features>
  </TERM>
  <EVENT end="188" id="V687641" paragraph="paragraph9" rule="-RULE20C_AFFECTED_AFFECTED1" start="156" uttnum="42">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="188" id="V687641" start="156">
      <type>ONT::BIND</type>
      <text>proteins associated with RAS–GTP</text>
    </predicate>
    <arg1 id="R000027" role=":AFFECTED"/>
    <arg2 id="V687674" role=":AFFECTED1"/>
    <arg id="R000029" role=":RESULT"/>
    <text>proteins associated with RAS–GTP</text>
  </EVENT>
  <TERM end="188" id="V687674" paragraph="paragraph9" rule="-SIMPLE-REF" start="176" uttnum="42">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">with RAS–GTP</text>
    <not-features>
      <bound-to event="V687641" id="R000027"/>
    </not-features>
  </TERM>
  <TERM end="131" id="V687683" paragraph="paragraph9" rule="-EXPLICIT-REF-SEQ0B" start="122" uttnum="42">
    <type>ONT::MOLECULAR-PART</type>
    <components>
      <component id="V687358"/>
      <component id="V687366"/>
    </components>
    <text normalization="">Raf1–RBD</text>
  </TERM>
  <TERM dbid="UP:P04049" end="131" id="V687358" paragraph="paragraph9" rule="-EXPLICIT-REF-SEQ0B-TERM" start="122" uttnum="42">
    <type>ONT::PROTEIN</type>
    <name>RAF-1</name>
    <text>Raf1–RBD</text>
  </TERM>
  <TERM dbid="XFAM:PF02196.12" end="131" id="V687366" paragraph="paragraph9" rule="-SIMPLE-REF" start="127" uttnum="42">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>RBD</name>
    <text>RBD</text>
  </TERM>
  <TERM end="205" id="V702773" paragraph="paragraph9" rule="-SIMPLE-REF" start="193" uttnum="43">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAY</name>
    <text>this assay,</text>
  </TERM>
  <TERM dbid="UP:P04049" end="301" id="V702900" paragraph="paragraph9" rule="-SIMPLE-REF" start="250" uttnum="43">
    <type>ONT::PROTEIN</type>
    <name>C-RAF</name>
    <text>of c-Raf served as a positive control for the assay</text>
  </TERM>
  <TERM end="301" id="V703034" paragraph="paragraph9" rule="-SIMPLE-REF" start="292" uttnum="43">
    <type>ONT::SUBSTANCE</type>
    <name>ASSAY</name>
    <text>the assay</text>
  </TERM>
  <TERM end="306" id="V720990" paragraph="paragraph9" rule="-ROBUSTPRO" start="303" uttnum="44">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="404" id="V721063" paragraph="paragraph9" rule="-SIMPLE-REF" start="324" uttnum="44">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAY</name>
    <text>an alternative assay to investigate whether ASPP2 also selectively binds RAS–GTP</text>
  </TERM>
  <TERM end="404" id="V721048" paragraph="paragraph9" rule="-SIMPLE-REF" start="324" uttnum="44">
    <type>ONT::OPTION</type>
    <name>ALTERNATIVE</name>
    <text>an alternative assay to investigate whether ASPP2 also selectively binds RAS–GTP</text>
  </TERM>
  <EPI end="404" id="V721100" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-NONE" start="345" uttnum="44">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V721063" role=":NEUTRAL"/>
    <text>to investigate whether ASPP2 also selectively binds RAS–GTP</text>
  </EPI>
  <EVENT end="404" id="V721131" paragraph="paragraph9" rule="-RULE20C_AGENT_AFFECTED" start="368" uttnum="44">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="404" id="V721131" start="368">
      <type>ONT::BIND</type>
      <text>ASPP2 also selectively binds RAS–GTP</text>
    </predicate>
    <arg1 id="V721114" role=":AGENT"/>
    <arg2 id="V721153" role=":AFFECTED"/>
    <arg id="R000103" role=":RESULT"/>
    <text>ASPP2 also selectively binds RAS–GTP</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="374" id="V721114" paragraph="paragraph9" rule="-SIMPLE-REF" start="368" uttnum="44">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <not-features>
      <bound-to event="V721131" id="V721153"/>
    </not-features>
  </TERM>
  <TERM end="404" id="V721153" paragraph="paragraph9" rule="-SIMPLE-REF" start="397" uttnum="44">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">RAS–GTP</text>
    <not-features>
      <bound-to id="V721114" event="V721131"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="457" id="V734969" paragraph="paragraph9" rule="-SIMPLE-REF" start="448" uttnum="45">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2</text>
  </TERM>
  <TERM end="481" id="V735325" paragraph="paragraph9" rule="-EXPLICIT-REF-SEQ0B" start="472" uttnum="45">
    <type>ONT::MOLECULAR-PART</type>
    <components>
      <component id="V734840"/>
      <component id="V734848"/>
    </components>
    <text normalization="">Raf1–RBD</text>
  </TERM>
  <TERM dbid="UP:P04049" end="481" id="V734840" paragraph="paragraph9" rule="-EXPLICIT-REF-SEQ0B-TERM" start="472" uttnum="45">
    <type>ONT::PROTEIN</type>
    <name>RAF-1</name>
    <text>Raf1–RBD</text>
  </TERM>
  <TERM dbid="XFAM:PF02196.12" end="481" id="V734848" paragraph="paragraph9" rule="-SIMPLE-REF" start="477" uttnum="45">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>RBD</name>
    <text>RBD</text>
  </TERM>
  <TERM dbid="UP:P04049" end="519" id="V735188" paragraph="paragraph9" rule="-SIMPLE-REF" start="512" uttnum="45">
    <type>ONT::PROTEIN</type>
    <name>C-RAF</name>
    <text>c-Raf,</text>
  </TERM>
  <EVENT end="585" id="V735245" paragraph="paragraph9" rule="-RULE20C_AGENT_AFFECTED" start="532" uttnum="45">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="585" id="V735245" start="532">
      <type>ONT::BIND</type>
      <text>that endogenous ASPP2 also complexes with active RAS</text>
    </predicate>
    <arg1 id="V735235" role=":AGENT"/>
    <arg2 id="V735272" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000112"/>
    <text>that endogenous ASPP2 also complexes with active RAS</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="554" id="V735235" paragraph="paragraph9" rule="-SIMPLE-REF" start="537" uttnum="45">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>endogenous ASPP2</text>
    <not-features>
      <bound-to id="V735272" event="V735245"/>
    </not-features>
  </TERM>
  <TERM end="585" id="V735272" paragraph="paragraph9" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="569" uttnum="45">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">with active RAS</text>
    <not-features>
      <bound-to event="V735245" id="V735235"/>
    </not-features>
  </TERM>
  <TERM end="599" id="V735282" paragraph="paragraph9" rule="-SIMPLE-REF" start="592" uttnum="45">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="608" id="V735306" paragraph="paragraph9" rule="-SIMPLE-REF" start="599" uttnum="45">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>1b</text>
  </TERM>
  <TERM end="620" id="V752098" paragraph="paragraph9" rule="-EXPLICIT-REF-SEQ0B" start="611" uttnum="46">
    <type>ONT::MOLECULAR-PART</type>
    <components>
      <component id="V751868"/>
      <component id="V751876"/>
    </components>
    <text normalization="">Raf1–RBD</text>
  </TERM>
  <TERM dbid="HGNC:18838|UP:Q8WUF5" end="646" id="V752090" paragraph="paragraph9" rule="-SIMPLE-REF" start="640" uttnum="46">
    <type>ONT::GENE</type>
    <name>IASPP</name>
    <text>iASPP,</text>
  </TERM>
  <TERM dbid="UP:P04049" end="620" id="V751868" paragraph="paragraph9" rule="-EXPLICIT-REF-SEQ0B-TERM" start="611" uttnum="46">
    <type>ONT::PROTEIN</type>
    <name>RAF-1</name>
    <text>Raf1–RBD</text>
  </TERM>
  <TERM dbid="XFAM:PF02196.12" end="620" id="V751876" paragraph="paragraph9" rule="-SIMPLE-REF" start="616" uttnum="46">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>RBD</name>
    <text>RBD</text>
  </TERM>
  <TERM dbid="XFAM:PF02196.12" end="691" id="V752732" paragraph="paragraph9" rule="-SIMPLE-REF" start="647" uttnum="46">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>RBD</name>
    <text>which does not contain RAD at its N-terminus</text>
  </TERM>
  <TERM end="691" id="V752806" paragraph="paragraph9" rule="-SIMPLE-REF" start="677" uttnum="46">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>its N-terminus</text>
  </TERM>
  <TERM end="707" id="V754747" paragraph="paragraph9" rule="-SIMPLE-REF" start="693" uttnum="47">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>These results</text>
  </TERM>
  <EVENT end="758" id="V754827" paragraph="paragraph9" rule="-RULE20C_AGENT_AFFECTED" start="718" uttnum="47">
    <type>ONT::BIND</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::CAN</modality>
    <predicate end="758" id="V754827" start="718">
      <type>ONT::BIND</type>
      <text>that ASPP1 and ASPP2 can bind active RAS</text>
    </predicate>
    <arg1 id="V754793" role=":AGENT"/>
    <arg2 id="V754842" role=":AFFECTED"/>
    <arg id="R000121" role=":RESULT"/>
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
  </EVENT>
  <TERM end="739" id="V754793" paragraph="paragraph9" rule="-LOGICALOP-REF" start="723" uttnum="47">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V754789"/>
      <member id="V754809"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <not-features>
      <bound-to event="V754827" id="V754842"/>
    </not-features>
  </TERM>
  <TERM end="758" id="V754842" paragraph="paragraph9" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="748" uttnum="47">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
    <not-features>
      <bound-to id="V754793" event="V754827"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="729" id="V754789" paragraph="paragraph9" rule="-SIMPLE-REF" start="723" uttnum="47">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="739" id="V754809" paragraph="paragraph9" rule="-SIMPLE-REF" start="733" uttnum="47">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <MODALITY end="759" id="X768633" paragraph="paragraph9" rule="-MODALITY" start="693" uttnum="47">
    <type>ONT::ABILITY</type>
    <arg2 id="V754827" role=":EVENT"/>
    <text>These results illustrate that ASPP1 and ASPP2 can bind active RAS,</text>
  </MODALITY>
  <EVENT end="823" id="V755829" paragraph="paragraph9" rule="-RULE10_AGENT_AFFECTED-MODA1_1-AFFECTED" start="764" uttnum="47">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::VIA</type>
        <value>THROUGH</value>
      </mod>
    </mods>
    <predicate end="823" id="V755829" start="764">
      <type>ONT::MODULATE</type>
      <text>this interaction is likely mediated through their N-termini</text>
    </predicate>
    <arg2 id="V755794" role=":AFFECTED"/>
    <text>this interaction is likely mediated through their N-termini</text>
  </EVENT>
  <EVENT end="781" id="V755794" paragraph="paragraph9" rule="-RULE20C_AFFECTED_AFFECTED1-NONE" start="764" uttnum="47">
    <type>ONT::BIND</type>
    <predicate end="781" id="V755794" start="764">
      <type>ONT::BIND</type>
      <text>this interaction</text>
    </predicate>
    <text>this interaction</text>
  </EVENT>
  <TERM end="823" id="V755859" paragraph="paragraph9" rule="-SIMPLE-REF" start="808" uttnum="47">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>N</name>
    <text>their N-termini</text>
  </TERM>
  <TERM end="823" id="V755845" paragraph="paragraph9" rule="-SIMPLE-REF" start="808" uttnum="47">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>their N-termini</text>
  </TERM>
  <TERM end="66" id="V772499" paragraph="paragraph10" rule="-SIMPLE-REF" start="3" uttnum="48">
    <type>ONT::CELL-LINE</type>
    <name>CELL-LINE</name>
    <text>An ASPP2 inducible U2OS cell line that expresses wild-type p53</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="12" id="V772449" paragraph="paragraph10" rule="-SIMPLE-REF" start="6" uttnum="48">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="EFO:0002869|CVCL:0042" end="27" id="V772494" paragraph="paragraph10" rule="-SIMPLE-REF" start="22" uttnum="48">
    <type>ONT::CELL-LINE</type>
    <name>U-2-OS</name>
    <text>U2OS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="66" id="V772642" paragraph="paragraph10" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="52" uttnum="48">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>P-53</name>
    <text>wild-type p53</text>
  </TERM>
  <EVENT end="160" id="V772813" paragraph="paragraph10" rule="-RULE20C_AGENT_AFFECTED" start="97" uttnum="48">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="160" id="V772813" start="97">
      <type>ONT::BIND</type>
      <text>endogenous wild-type RAS binds ASPP2 with different efficiency</text>
    </predicate>
    <arg1 id="V772809" role=":AGENT"/>
    <arg2 id="V772827" role=":AFFECTED"/>
    <arg id="R000130" role=":RESULT"/>
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency</text>
  </EVENT>
  <TERM end="122" id="V772809" paragraph="paragraph10" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="97" uttnum="48">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>RAS</name>
    <text normalization="">endogenous wild-type RAS</text>
    <not-features>
      <bound-to event="V772813" id="V772827"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="134" id="V772827" paragraph="paragraph10" rule="-SIMPLE-REF" start="128" uttnum="48">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <not-features>
      <bound-to id="V772809" event="V772813"/>
    </not-features>
  </TERM>
  <EVENT end="180" id="V772864" paragraph="paragraph10" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="165" uttnum="48">
    <type>ONT::STIMULATE</type>
    <predicate end="180" id="V772864" start="165">
      <type>ONT::STIMULATE</type>
      <text>EGF stimulation</text>
    </predicate>
    <arg2 id="V772860" role=":AFFECTED"/>
    <text>EGF stimulation</text>
  </EVENT>
  <TERM dbid="UP:P01133" end="169" id="V772860" paragraph="paragraph10" rule="-SIMPLE-REF" start="165" uttnum="48">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <EVENT end="236" id="V787374" paragraph="paragraph10" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="182" uttnum="49">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="236" id="V787374" start="182">
      <type>ONT::PPEXPT</type>
      <text>Endogenous RAS was immunoprecipitated with or without</text>
    </predicate>
    <arg2 id="V787346" role=":AFFECTED"/>
    <text>Endogenous RAS was immunoprecipitated with or without</text>
  </EVENT>
  <TERM end="197" id="V787346" paragraph="paragraph10" rule="-SIMPLE-REF" start="182" uttnum="49">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">Endogenous RAS</text>
  </TERM>
  <EVENT end="334" id="V787424" paragraph="paragraph10" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="236" uttnum="49">
    <type>ONT::PRODUCE</type>
    <predicate end="334" id="V787424" start="236">
      <type>ONT::PRODUCE</type>
      <text>ASPP2 induction in the presence or absence of EGF treatment (Supplementary Figure 1c)</text>
    </predicate>
    <arg2 id="V787419" role=":AFFECTED"/>
    <text>ASPP2 induction in the presence or absence of EGF treatment (Supplementary Figure 1c)</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="242" id="V787419" paragraph="paragraph10" rule="-SIMPLE-REF" start="236" uttnum="49">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="334" id="V787519" paragraph="paragraph10" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="282" uttnum="49">
    <type>ONT::MODULATE</type>
    <predicate end="334" id="V787519" start="282">
      <type>ONT::MODULATE</type>
      <text>EGF treatment (Supplementary Figure 1c)</text>
    </predicate>
    <arg2 id="V787516" role=":AFFECTED"/>
    <text>EGF treatment (Supplementary Figure 1c)</text>
  </EVENT>
  <TERM dbid="UP:P01133" end="286" id="V787516" paragraph="paragraph10" rule="-SIMPLE-REF" start="282" uttnum="49">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM end="333" id="V787538" paragraph="paragraph10" rule="-SIMPLE-REF" start="303" uttnum="49">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure 1c</text>
  </TERM>
  <TERM end="339" id="V796195" paragraph="paragraph10" rule="-ROBUSTPRO" start="336" uttnum="50">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="379" id="V796278" paragraph="paragraph10" rule="-SIMPLE-REF" start="359" uttnum="50">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BINDING</name>
    <text>very little binding</text>
  </TERM>
  <TERM end="417" id="V796301" paragraph="paragraph10" rule="-LOGICALOP-REF" start="387" uttnum="50">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V796297"/>
      <member id="V796317"/>
    </aggregate>
    <text normalization="">RAS and ASPP2 in starved cells</text>
  </TERM>
  <TERM end="391" id="V796297" paragraph="paragraph10" rule="-SIMPLE-REF" start="387" uttnum="50">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="417" id="V796317" paragraph="paragraph10" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="395" uttnum="50">
    <type>ONT::GENE</type>
    <features>
      <location id="V796384"/>
    </features>
    <name>ASPP-2</name>
    <text>ASPP2 in starved cells</text>
  </TERM>
  <TERM end="417" id="V796384" paragraph="paragraph10" rule="-SIMPLE-REF" start="404" uttnum="50">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>starved cells</text>
  </TERM>
  <TERM end="452" id="V809308" paragraph="paragraph10" rule="-SIMPLE-REF" start="419" uttnum="51">
    <type>ONT::GENE-PROTEIN</type>
    <name>RAS-ASPP-2</name>
    <text>The RAS–ASPP2 complex was mainly</text>
  </TERM>
  <TERM end="441" id="V809043" paragraph="paragraph10" rule="-SIMPLE-REF" start="433" uttnum="51">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM end="506" id="V809154" paragraph="paragraph10" rule="-INEVENT2,-SIMPLE-REF" start="464" uttnum="51">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V809142"/>
        <event id="V809182"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>EGF-treated cells that express active RAS</text>
  </TERM>
  <EVENT end="506" id="V809142" paragraph="paragraph10" rule="-RULE10_AGENT_AFFECTED" start="464" uttnum="51">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="506" id="V809142" start="464">
      <type>ONT::MODULATE</type>
      <text>EGF-treated cells that express active RAS</text>
    </predicate>
    <arg1 id="V809134" role=":AGENT"/>
    <arg2 id="V809154" role=":AFFECTED"/>
    <text>EGF-treated cells that express active RAS</text>
  </EVENT>
  <EVENT end="506" id="V809182" paragraph="paragraph10" rule="-RULE50_AGENT_AFFECTED-RESULT" start="464" uttnum="51">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="506" id="V809182" start="464">
      <type>ONT::EXPRESS</type>
      <text>EGF-treated cells that express active RAS</text>
    </predicate>
    <arg2 id="V809197" role=":AFFECTED-RESULT"/>
    <text>EGF-treated cells that express active RAS</text>
    <location mod="IN-LOC" id="V809154"/>
  </EVENT>
  <TERM dbid="UP:P01133" end="476" id="V809134" paragraph="paragraph10" rule="-SIMPLE-REF" start="464" uttnum="51">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF-treated</text>
  </TERM>
  <TERM end="506" id="V809197" paragraph="paragraph10" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="495" uttnum="51">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM end="567" id="V809216" paragraph="paragraph10" rule="-SIMPLE-REF" start="513" uttnum="51">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure 1c, compare lanes 7 and 8)</text>
  </TERM>
  <TERM end="566" id="V809280" paragraph="paragraph10" rule="-SIMPLE-REF" start="553" uttnum="51">
    <type>ONT::LANE</type>
    <name>LANE</name>
    <text>lanes 7 and 8</text>
  </TERM>
  <EVENT end="637" id="V822956" paragraph="paragraph10" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="598" uttnum="52">
    <type>ONT::EXPRESS</type>
    <predicate end="637" id="V822956" start="598">
      <type>ONT::EXPRESS</type>
      <text>the expression levels of RAS and ASPP2</text>
    </predicate>
    <site end="637" id="V822964" start="598">
      <type>ONT::LEVEL</type>
      <text normalization="LEVEL">the expression levels of RAS and ASPP2</text>
    </site>
    <text>the expression levels of RAS and ASPP2</text>
  </EVENT>
  <TERM end="637" id="V822990" paragraph="paragraph10" rule="-LOGICALOP-REF" start="623" uttnum="52">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V822986"/>
      <member id="V823006"/>
    </aggregate>
    <text normalization="">RAS and ASPP2</text>
  </TERM>
  <TERM end="627" id="V822986" paragraph="paragraph10" rule="-SIMPLE-REF" start="623" uttnum="52">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="637" id="V823006" paragraph="paragraph10" rule="-SIMPLE-REF" start="631" uttnum="52">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="658" id="V823082" paragraph="paragraph10" rule="-SIMPLE-REF" start="649" uttnum="52">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>in cells</text>
  </TERM>
  <EVENT end="687" id="V823122" paragraph="paragraph10" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="674" uttnum="52">
    <type>ONT::MODULATE</type>
    <predicate end="687" id="V823122" start="674">
      <type>ONT::MODULATE</type>
      <text>EGF treatment</text>
    </predicate>
    <arg2 id="V823119" role=":AFFECTED"/>
    <text>EGF treatment</text>
  </EVENT>
  <TERM dbid="UP:P01133" end="678" id="V823119" paragraph="paragraph10" rule="-SIMPLE-REF" start="674" uttnum="52">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <EPI end="757" id="V839046" paragraph="paragraph10" rule="-RULE50_0_AGENT_NEUTRAL-NEUTRAL" start="699" uttnum="53">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V839013" role=":NEUTRAL"/>
    <text>an interaction was also observed between endogenous ASPP2</text>
  </EPI>
  <EVENT end="757" id="V839013" paragraph="paragraph10" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE20C_AFFECTED_AFFECTED1-NONE" start="699" uttnum="53">
    <type>ONT::BIND</type>
    <epistemic-modality id="V839046"/>
    <predicate end="757" id="V839013" start="699">
      <type>ONT::BIND</type>
      <text>an interaction was also observed between endogenous ASPP2</text>
    </predicate>
    <text>an interaction was also observed between endogenous ASPP2</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="757" id="V839075" paragraph="paragraph10" rule="-SIMPLE-REF" start="740" uttnum="53">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>endogenous ASPP2</text>
  </TERM>
  <TERM dbid="BTO:0000797" end="803" id="V839275" paragraph="paragraph10" rule="-SIMPLE-REF" start="772" uttnum="53">
    <type>ONT::CELL-LINE</type>
    <name>COLON-CANCER-CELL-LINE</name>
    <text>a human colon cancer cell line</text>
  </TERM>
  <TERM dbid="CVCL:9796" end="808" id="V839332" paragraph="paragraph10" rule="-SIMPLE-REF" start="803" uttnum="53">
    <type>ONT::CELL-LINE</type>
    <name>HKE-3</name>
    <text>HKe3</text>
  </TERM>
  <TERM end="824" id="V839364" paragraph="paragraph10" rule="-SIMPLE-REF" start="811" uttnum="53">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>HRASV12 cells</text>
  </TERM>
  <EVENT end="909" id="V848517" paragraph="paragraph10" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="866" uttnum="53">
    <type>ONT::INCREASE</type>
    <predicate end="909" id="V848517" start="866">
      <type>ONT::INCREASE</type>
      <text>the addition of 4-hydroxytamoxifen (4-OHT)</text>
    </predicate>
    <arg2 id="V848540" role=":AFFECTED"/>
    <text>the addition of 4-hydroxytamoxifen (4-OHT)</text>
  </EVENT>
  <TERM dbid="MESH:C016601" end="909" id="V848540" paragraph="paragraph10" rule="-SIMPLE-REF" start="879" uttnum="53">
    <type>ONT::PHARMACOLOGIC-SUBSTANCE</type>
    <name>4-HYDROXYTAMOXIFEN</name>
    <text>of 4-hydroxytamoxifen (4-OHT)</text>
  </TERM>
  <TERM dbid="CHEBI:44616" end="907" id="V848560" paragraph="paragraph10" rule="-SIMPLE-REF" start="902" uttnum="53">
    <type>ONT::MOLECULE</type>
    <name>4-OHT</name>
    <text>4-OHT</text>
  </TERM>
  <TERM end="839" id="V848470" paragraph="paragraph10" rule="-SIMPLE-REF" start="835" uttnum="53">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="923" id="V848573" paragraph="paragraph10" rule="-SIMPLE-REF" start="916" uttnum="53">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1010" id="V864824" paragraph="paragraph10" rule="-SIMPLE-REF" start="990" uttnum="53">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of endogenous ASPP2</text>
  </TERM>
  <EVENT end="1045" id="V864854" paragraph="paragraph10" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1013" uttnum="53">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1045" id="V864854" start="1013">
      <type>ONT::BIND</type>
      <text>bind with endogenous active RAS</text>
    </predicate>
    <arg2 id="V864884" role=":AFFECTED"/>
    <text>bind with endogenous active RAS</text>
  </EVENT>
  <TERM end="1045" id="V864884" paragraph="paragraph10" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="1018" uttnum="53">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">with endogenous active RAS</text>
  </TERM>
  <TERM dbid="CO:2000042" end="1102" id="V864999" paragraph="paragraph10" rule="-SIMPLE-REF" start="1067" uttnum="53">
    <type>ONT::CELL</type>
    <name>EMBRYONIC-FIBROBLASTS</name>
    <text>mouse embryonic fibroblasts (MEFs)</text>
  </TERM>
  <TERM end="1102" id="V864970" paragraph="paragraph10" rule="-SIMPLE-REF" start="1067" uttnum="53">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>MOUSE</name>
    <text>mouse embryonic fibroblasts (MEFs)</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="1100" id="V865023" paragraph="paragraph10" rule="-SIMPLE-REF" start="1096" uttnum="53">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1145" id="V865127" paragraph="paragraph10" rule="-SIMPLE-REF" start="1135" uttnum="53">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1125" id="V865052" paragraph="paragraph10" rule="-SIMPLE-REF" start="1115" uttnum="53">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 wild</text>
  </TERM>
  <TERM dbid="BTO:0001233|BTO:0000379" end="1166" id="V865216" paragraph="paragraph10" rule="-SIMPLE-REF" start="1159" uttnum="53">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>EMBRYOS</name>
    <text>embryos</text>
  </TERM>
  <TERM end="1206" id="V878895" paragraph="paragraph10" rule="-LOGICALOP-REF" start="1168" uttnum="54">
    <type>ONT::PROTEIN</type>
    <aggregate operator="OR">
      <member id="V878892"/>
      <member id="V878904"/>
    </aggregate>
    <text normalization="">Growth factors such as EGF or insulin</text>
  </TERM>
  <TERM dbid="UP:P01133" end="1195" id="V878892" paragraph="paragraph10" rule="-SIMPLE-REF" start="1168" uttnum="54">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>Growth factors such as EGF</text>
  </TERM>
  <TERM dbid="UP:P01308" end="1206" id="V878904" paragraph="paragraph10" rule="-SIMPLE-REF" start="1198" uttnum="54">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM dbid="GO:0008083" end="1191" id="V878841" paragraph="paragraph10" rule="-SIMPLE-REF" start="1168" uttnum="54">
    <type>ONT::PROTEIN</type>
    <name>GROWTH-FACTORS</name>
    <text>Growth factors such as</text>
  </TERM>
  <EVENT end="1253" id="V878972" paragraph="paragraph10" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="1219" uttnum="54">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1253" id="V878972" start="1219">
      <type>ONT::STIMULATE</type>
      <text>stimulate serum-starved ASPP2</text>
    </predicate>
    <arg2 id="V879008" role=":AFFECTED"/>
    <text>stimulate serum-starved ASPP2</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1253" id="V879008" paragraph="paragraph10" rule="-SIMPLE-REF" start="1229" uttnum="54">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>serum-starved ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1279" id="V879043" paragraph="paragraph10" rule="-SIMPLE-REF" start="1269" uttnum="54">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="1308" id="V879099" paragraph="paragraph10" rule="-INEVENT2B,-SIMPLE-REF" start="1293" uttnum="54">
    <type>ONT::GENE</type>
    <features>
      <inevent>
        <event id="V879129"/>
      </inevent>
    </features>
    <name>MEFS</name>
    <text>MEFs to induce</text>
  </TERM>
  <EVENT end="1308" id="V879129" paragraph="paragraph10" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1293" uttnum="54">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="1308" id="V879129" start="1293">
      <type>ONT::PRODUCE</type>
      <text>MEFs to induce</text>
    </predicate>
    <arg2 id="V879099" role=":AFFECTED"/>
    <text>MEFs to induce</text>
  </EVENT>
  <EVENT end="1322" id="V879139" paragraph="paragraph10" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1308" uttnum="54">
    <type>ONT::ACTIVATE</type>
    <predicate end="1322" id="V879139" start="1308">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V879135" role=":AFFECTED"/>
    <arg id="R000207" role=":RESULT"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="1312" id="V879135" paragraph="paragraph10" rule="-SIMPLE-REF" start="1308" uttnum="54">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1349" id="V895442" paragraph="paragraph10" rule="-LOGICALOP-REF" start="1324" uttnum="55">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V895438"/>
      <member id="V895453"/>
    </aggregate>
    <text normalization="">Endogenous ASPP2 and RAS</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1402" id="V895552" paragraph="paragraph10" rule="-INEVENT2B,-SIMPLE-REF" start="1354" uttnum="55">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODY</name>
    <text>co-immunoprecipitated with an anti-RAS antibody</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1341" id="V895438" paragraph="paragraph10" rule="-SIMPLE-REF" start="1324" uttnum="55">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>Endogenous ASPP2</text>
  </TERM>
  <TERM end="1349" id="V895453" paragraph="paragraph10" rule="-SIMPLE-REF" start="1345" uttnum="55">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <EVENT end="1388" id="V895490" paragraph="paragraph10" rule="-RULE20_AGENT_AFFECTED-NONE" start="1354" uttnum="55">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="1388" id="V895490" start="1354">
      <type>ONT::PPEXPT</type>
      <text>co-immunoprecipitated with an anti</text>
    </predicate>
    <text>co-immunoprecipitated with an anti</text>
  </EVENT>
  <TERM end="1393" id="V895535" paragraph="paragraph10" rule="-SIMPLE-REF" start="1389" uttnum="55">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1415" id="V895615" paragraph="paragraph10" rule="-SIMPLE-REF" start="1405" uttnum="55">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="1431" id="V895651" paragraph="paragraph10" rule="-SIMPLE-REF" start="1427" uttnum="55">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="1512" id="V911460" paragraph="paragraph10" rule="-SIMPLE-REF" start="1484" uttnum="56">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>ASPP2(Δ3/Δ3) MEFs</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1508" id="V911404" paragraph="paragraph10" rule="-SIMPLE-REF" start="1484" uttnum="56">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2(Δ3/Δ3)</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1587" id="V928427" paragraph="paragraph10" rule="-INEVENT2B,-SIMPLE-REF" start="1557" uttnum="56">
    <type>ONT::GENE</type>
    <features>
      <inevent>
        <event id="V928404"/>
      </inevent>
    </features>
    <name>ASPP-2</name>
    <text>of N-terminal-truncated ASPP2</text>
  </TERM>
  <EVENT end="1581" id="V928404" paragraph="paragraph10" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="1560" uttnum="56">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1581" id="V928404" start="1560">
      <type>ONT::TRANSFORM</type>
      <text>N-terminal-truncated</text>
    </predicate>
    <arg1 id="V928363" role=":AGENT"/>
    <arg2 id="V928427" role=":FORMAL"/>
    <text>N-terminal-truncated</text>
  </EVENT>
  <TERM end="1581" id="V928363" paragraph="paragraph10" rule="-SIMPLE-REF" start="1560" uttnum="56">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINAL</name>
    <text>N-terminal-truncated</text>
  </TERM>
  <TERM end="1601" id="V928437" paragraph="paragraph10" rule="-SIMPLE-REF" start="1594" uttnum="56">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="1610" id="V928464" paragraph="paragraph10" rule="-SIMPLE-REF" start="1601" uttnum="56">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>1d</text>
  </TERM>
  <EPI end="1692" id="V942273" paragraph="paragraph10" rule="-RULE50_0_NEUTRAL_FORMAL" start="1613" uttnum="57">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V942262" role=":NEUTRAL"/>
    <arg2 id="V942315" role=":FORMAL"/>
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
  </EPI>
  <TERM end="1624" id="V942262" paragraph="paragraph10" rule="-SIMPLE-REF" start="1613" uttnum="57">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>These data</text>
  </TERM>
  <EVENT end="1692" id="V942315" paragraph="paragraph10" rule="-RULE50_0_NEUTRAL_FORMAL-EVENT,-RULE20C_AGENT_AFFECTED" start="1613" uttnum="57">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V942273"/>
    <predicate end="1692" id="V942315" start="1613">
      <type>ONT::BIND</type>
      <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    </predicate>
    <arg1 id="V942303" role=":AGENT"/>
    <arg2 id="V942324" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000139"/>
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1647" id="V942303" paragraph="paragraph10" rule="-SIMPLE-REF" start="1641" uttnum="57">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <not-features>
      <bound-to id="V942324" event="V942315"/>
    </not-features>
  </TERM>
  <TERM end="1672" id="V942324" paragraph="paragraph10" rule="-SIMPLE-REF" start="1668" uttnum="57">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <not-features>
      <bound-to event="V942315" id="V942303"/>
    </not-features>
  </TERM>
  <EVENT end="1692" id="V942366" paragraph="paragraph10" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1677" uttnum="57">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1692" id="V942366" start="1677">
      <type>ONT::ACTIVATE</type>
      <text>it is activated</text>
    </predicate>
    <arg2 id="V942340" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000212"/>
    <text>it is activated</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1680" id="V942340" paragraph="paragraph10" rule="-SIMPLE-REF" start="1677" uttnum="57">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>it</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="89" id="V957365" paragraph="paragraph11" rule="-RULE20C_AGENT_AFFECTED" start="3" uttnum="58">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="89" id="V957365" start="3">
      <type>ONT::BIND</type>
      <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    </predicate>
    <arg1 id="V957333" role=":AGENT"/>
    <arg2 id="V957398" role=":AFFECTED"/>
    <arg id="R000148" role=":RESULT"/>
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
  </EVENT>
  <TERM end="52" id="V957333" paragraph="paragraph11" rule="-LOGICALOP-REF" start="36" uttnum="58">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V957329"/>
      <member id="V957349"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <not-features>
      <bound-to id="V957398" event="V957365"/>
    </not-features>
  </TERM>
  <TERM end="89" id="V957398" paragraph="paragraph11" rule="-SIMPLE-REF" start="76" uttnum="58">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">with RAS–GTP,</text>
    <not-features>
      <bound-to event="V957365" id="V957333"/>
    </not-features>
  </TERM>
  <TERM end="36" id="V957313" paragraph="paragraph11" rule="-ROBUSTPRO" start="31" uttnum="58">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <TERM end="31" id="V957305" paragraph="paragraph11" rule="-SIMPLE-REF" start="14" uttnum="58">
    <type>ONT::INFORMATION</type>
    <name>EVIDENCE</name>
    <text>further evidence</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="42" id="V957329" paragraph="paragraph11" rule="-SIMPLE-REF" start="36" uttnum="58">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="52" id="V957349" paragraph="paragraph11" rule="-SIMPLE-REF" start="46" uttnum="58">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="BTO:0000407" end="124" id="V966511" paragraph="paragraph11" rule="-SIMPLE-REF" start="90" uttnum="58">
    <type>ONT::CELL-LINE</type>
    <name>OSTEOSARCOMA-CELL-LINE</name>
    <text>a p53-null osteosarcoma cell line</text>
  </TERM>
  <TERM dbid="CVCL:0548" end="130" id="V966525" paragraph="paragraph11" rule="-SIMPLE-REF" start="124" uttnum="58">
    <type>ONT::CELL-LINE</type>
    <name>SAOS-2</name>
    <text>Saos2</text>
  </TERM>
  <TERM end="180" id="V966595" paragraph="paragraph11" rule="-SIMPLE-REF" start="149" uttnum="58">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>h and then stimulated with 20%</text>
  </TERM>
  <TERM dbid="UP:P01133" end="211" id="V966709" paragraph="paragraph11" rule="-SIMPLE-REF" start="208" uttnum="58">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <EPI end="277" id="V978879" paragraph="paragraph11" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="213" uttnum="59">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V978856" role=":FORMAL"/>
    <text>More RAS was detected in the ASPP1 and ASPP2 immunoprecipitates</text>
  </EPI>
  <TERM end="222" id="V978856" paragraph="paragraph11" rule="-SIMPLE-REF" start="213" uttnum="59">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">More RAS</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="248" id="V978949" paragraph="paragraph11" rule="-SIMPLE-REF" start="238" uttnum="59">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>the ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="258" id="V978969" paragraph="paragraph11" rule="-SIMPLE-REF" start="252" uttnum="59">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="295" id="V979013" paragraph="paragraph11" rule="-SIMPLE-REF" start="290" uttnum="59">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM end="329" id="V979057" paragraph="paragraph11" rule="-SIMPLE-REF" start="301" uttnum="59">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CELL</name>
    <text>EGF-stimulated cell lysates</text>
  </TERM>
  <TERM dbid="UP:P01133" end="316" id="V979036" paragraph="paragraph11" rule="-SIMPLE-REF" start="301" uttnum="59">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF-stimulated</text>
  </TERM>
  <TERM end="380" id="V979181" paragraph="paragraph11" rule="-SIMPLE-REF" start="364" uttnum="59">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>Figure 1e</text>
  </TERM>
  <TERM end="380" id="V979164" paragraph="paragraph11" rule="-SIMPLE-REF" start="364" uttnum="59">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1e</text>
  </TERM>
  <TERM end="396" id="V979207" paragraph="paragraph11" rule="-SIMPLE-REF" start="390" uttnum="59">
    <type>ONT::LANE</type>
    <name>LANE</name>
    <text>lanes</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="410" id="V979243" paragraph="paragraph11" rule="-SIMPLE-REF" start="404" uttnum="59">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="427" id="V979289" paragraph="paragraph11" rule="-SIMPLE-REF" start="422" uttnum="59">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM end="509" id="V991829" paragraph="paragraph11" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="499" uttnum="60">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM end="472" id="V991750" paragraph="paragraph11" rule="-SIMPLE-REF" start="453" uttnum="60">
    <type>ONT::GOAL</type>
    <name>TERMINI</name>
    <text>N-termini of ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="482" id="V991801" paragraph="paragraph11" rule="-SIMPLE-REF" start="476" uttnum="60">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="472" id="V991736" paragraph="paragraph11" rule="-SIMPLE-REF" start="453" uttnum="60">
    <type>ONT::SUBSTANCE</type>
    <name>N</name>
    <text>N-termini of ASPP1</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="472" id="V991781" paragraph="paragraph11" rule="-SIMPLE-REF" start="463" uttnum="60">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <TERM end="548" id="V1005570" paragraph="paragraph11" rule="-LOGICALOP-REF" start="529" uttnum="61">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V1005566"/>
      <member id="V1005586"/>
    </aggregate>
    <text normalization="">of ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="538" id="V1005566" paragraph="paragraph11" rule="-SIMPLE-REF" start="532" uttnum="61">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="548" id="V1005586" paragraph="paragraph11" rule="-SIMPLE-REF" start="542" uttnum="61">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="570" id="V1005656" paragraph="paragraph11" rule="-SIMPLE-REF" start="563" uttnum="61">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <EVENT end="588" id="V1005700" paragraph="paragraph11" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="578" uttnum="61">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="588" id="V1005700" start="578">
      <type>ONT::BIND</type>
      <text>p53 binds</text>
    </predicate>
    <arg1 id="V1005694" role=":AGENT"/>
    <text>p53 binds</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="582" id="V1005694" paragraph="paragraph11" rule="-SIMPLE-REF" start="578" uttnum="61">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="BTO:0000971" end="631" id="V1005843" paragraph="paragraph11" rule="-SIMPLE-REF" start="619" uttnum="61">
    <type>ONT::CELL-LINE</type>
    <name>SAOS-2-CELLS</name>
    <text>Saos2 cells</text>
  </TERM>
  <TERM dbid="FA:00278" end="615" id="V1005807" paragraph="paragraph11" rule="-SIMPLE-REF" start="602" uttnum="61">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPPS</name>
    <text normalization="">of the ASPPs</text>
  </TERM>
  <TERM dbid="UP:P04637" end="643" id="V1005891" paragraph="paragraph11" rule="-SIMPLE-REF" start="635" uttnum="61">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-null</text>
  </TERM>
  <TERM end="17" id="V1020805" paragraph="paragraph12" rule="-INEVENT2B,-SIMPLE-REF" start="3" uttnum="62">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">Activated RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="56" id="V1020835" paragraph="paragraph12" rule="-RULE20C_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-NONE" start="20" uttnum="62">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="56" id="V1020835" start="20">
      <type>ONT::BIND</type>
      <text>mainly located at cellular membranes</text>
    </predicate>
    <location end="56" id="V1020870" mod="null" start="38">
      <type>ONT::CELL-PART</type>
      <text normalization="">cellular membranes</text>
    </location>
    <text>mainly located at cellular membranes</text>
  </EVENT>
  <EVENT end="17" id="V1020798" paragraph="paragraph12" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="3" uttnum="62">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="17" id="V1020798" start="3">
      <type>ONT::ACTIVATE</type>
      <text>Activated RAS</text>
    </predicate>
    <arg2 id="V1020805" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000046"/>
    <text>Activated RAS</text>
  </EVENT>
  <TERM dbid="GO:0005886" end="56" id="V1020870" paragraph="paragraph12" rule="-SIMPLE-REF" start="38" uttnum="62">
    <type>ONT::CELL-PART</type>
    <name>CELLULAR-MEMBRANES</name>
    <text>cellular membranes</text>
  </TERM>
  <TERM end="117" id="V1026068" paragraph="paragraph12" rule="-EXPLICIT-REF-SEQ0B" start="108" uttnum="63">
    <type>ONT::PROTEIN-FAMILY</type>
    <components>
      <component id="V1025913"/>
      <component id="V1025921"/>
    </components>
    <text normalization="">RAS–ASPP</text>
  </TERM>
  <TERM end="117" id="V1025913" paragraph="paragraph12" rule="-EXPLICIT-REF-SEQ0B-TERM" start="108" uttnum="63">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS–ASPP</text>
  </TERM>
  <TERM dbid="FA:00278" end="117" id="V1025921" paragraph="paragraph12" rule="-SIMPLE-REF" start="112" uttnum="63">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPP</name>
    <text normalization="">ASPP</text>
  </TERM>
  <TERM end="134" id="V1028350" paragraph="paragraph12" rule="-ROBUSTPRO" start="131" uttnum="63">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="GO:0051641" end="175" id="V1028388" paragraph="paragraph12" rule="-SIMPLE-REF" start="149" uttnum="63">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELLULAR-LOCALISATION</name>
    <text>the cellular localisation</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="221" id="V1028466" paragraph="paragraph12" rule="-SIMPLE-REF" start="214" uttnum="63">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2,</text>
  </TERM>
  <TERM dbid="UP:SL-0039|GO:0005886" end="276" id="V1028589" paragraph="paragraph12" rule="-SIMPLE-REF" start="255" uttnum="63">
    <type>ONT::CELL-PART</type>
    <name>CELL-MEMBRANE</name>
    <text>to the cell membrane</text>
  </TERM>
  <TERM dbid="BTO:0001938" end="290" id="V1028697" paragraph="paragraph12" rule="-SIMPLE-REF" start="279" uttnum="63">
    <type>ONT::CELL-LINE</type>
    <name>U-2-OS-CELLS</name>
    <text>U2OS cells</text>
  </TERM>
  <TERM end="304" id="V1028707" paragraph="paragraph12" rule="-SIMPLE-REF" start="297" uttnum="63">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM dbid="HGNC:3443|XFAM:PF00104|XFAM:PF12743|XFAM:PF02159|XFAM:PF00105|UP:P03372|UP:P19785|XFAM:PF01133.14|UP:O14944|HGNC:3467" end="326" id="V1043047" paragraph="paragraph12" rule="-SIMPLE-REF" start="319" uttnum="64">
    <type>ONT::GENE-PROTEIN</type>
    <name>ER</name>
    <text>HK-e3ER</text>
  </TERM>
  <TERM dbid="CVCL:9796" end="324" id="V1043037" paragraph="paragraph12" rule="-SIMPLE-REF" start="319" uttnum="64">
    <type>ONT::CELL-LINE</type>
    <name>HK-E-3</name>
    <text>HK-e3</text>
  </TERM>
  <TERM end="340" id="V1043101" paragraph="paragraph12" rule="-SIMPLE-REF" start="332" uttnum="64">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>12 cells</text>
  </TERM>
  <EVENT end="392" id="V1043155" paragraph="paragraph12" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="342" uttnum="64">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <mods>
      <frequency>
        <type>ONT::FREQUENCY</type>
        <value>NORMALLY</value>
      </frequency>
    </mods>
    <predicate end="392" id="V1043155" start="342">
      <type>ONT::EXPRESS</type>
      <text>ASPP2 is normally expressed at cell/cell junctions</text>
    </predicate>
    <arg2 id="V1043117" role=":AFFECTED-RESULT"/>
    <text>ASPP2 is normally expressed at cell/cell junctions</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="348" id="V1043117" paragraph="paragraph12" rule="-SIMPLE-REF" start="342" uttnum="64">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="392" id="V1043180" paragraph="paragraph12" rule="-SIMPLE-REF" start="373" uttnum="64">
    <type>ONT::DEVICE-COMPONENT</type>
    <name>JUNCTION</name>
    <text>cell/cell junctions</text>
  </TERM>
  <TERM end="383" id="V1043544" paragraph="paragraph12" rule="-EXPLICIT-REF-SEQ0B" start="373" uttnum="64">
    <type>ONT::CELL</type>
    <components>
      <component id="V1042715"/>
      <component id="V1042729"/>
    </components>
    <text normalization="CELL">cell/cell</text>
  </TERM>
  <TERM end="383" id="V1042715" paragraph="paragraph12" rule="-EXPLICIT-REF-SEQ0B-TERM" start="373" uttnum="64">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell/cell</text>
  </TERM>
  <TERM end="383" id="V1042729" paragraph="paragraph12" rule="-SIMPLE-REF" start="378" uttnum="64">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell</text>
  </TERM>
  <EVENT end="535" id="V1043295" paragraph="paragraph12" rule="-RULE40A_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-ROBUST-AFFECTED" start="420" uttnum="64">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="535" id="V1043295" start="420">
      <type>ONT::PRODUCE</type>
      <text>One hour after RAS induction, endogenous ASPP2 colocalised with induced HRASV12 at the cell membrane in HKe3 cells</text>
    </predicate>
    <arg1 id="V1043254" role=":AGENT"/>
    <arg2 id="V1043309" role=":AFFECTED"/>
    <location end="521" id="V1043364" mod="null" start="503">
      <type>ONT::CELL-PART</type>
      <text normalization="">the cell membrane</text>
    </location>
    <text>One hour after RAS induction, endogenous ASPP2 colocalised with induced HRASV12 at the cell membrane in HKe3 cells</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="484" id="V1043254" paragraph="paragraph12" rule="-SIMPLE-REF" start="450" uttnum="64">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>endogenous ASPP2 colocalised with</text>
  </TERM>
  <TERM end="535" id="V1043309" paragraph="paragraph12" rule="-RULE40A_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-ROBUST-AFFECTED-TERM" start="420" uttnum="64">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>HRASV-12</name>
    <text>One hour after RAS induction, endogenous ASPP2 colocalised with induced HRASV12 at the cell membrane in HKe3 cells</text>
  </TERM>
  <EVENT end="450" id="V1043234" paragraph="paragraph12" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="435" uttnum="64">
    <type>ONT::PRODUCE</type>
    <predicate end="450" id="V1043234" start="435">
      <type>ONT::PRODUCE</type>
      <text>RAS induction,</text>
    </predicate>
    <arg2 id="V1043229" role=":AFFECTED"/>
    <text>RAS induction,</text>
  </EVENT>
  <TERM end="439" id="V1043229" paragraph="paragraph12" rule="-SIMPLE-REF" start="435" uttnum="64">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:SL-0039|GO:0005886" end="521" id="V1043364" paragraph="paragraph12" rule="-SIMPLE-REF" start="503" uttnum="64">
    <type>ONT::CELL-PART</type>
    <name>CELL-MEMBRANE</name>
    <text>the cell membrane</text>
  </TERM>
  <TERM dbid="BTO:0003469" end="535" id="V1043484" paragraph="paragraph12" rule="-SIMPLE-REF" start="524" uttnum="64">
    <type>ONT::CELL</type>
    <name>HKE-3-CELLS</name>
    <text>HKe3 cells</text>
  </TERM>
  <TERM end="550" id="V1043494" paragraph="paragraph12" rule="-SIMPLE-REF" start="542" uttnum="64">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2</text>
  </TERM>
  <TERM end="558" id="V1043516" paragraph="paragraph12" rule="-SIMPLE-REF" start="550" uttnum="64">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>B</name>
    <text>b</text>
  </TERM>
  <EVENT end="617" id="V1057335" paragraph="paragraph12" rule="-RULE5_AGENT_AFFECTED" start="574" uttnum="65">
    <type>ONT::TRANSFORM</type>
    <predicate end="617" id="V1057335" start="574">
      <type>ONT::TRANSFORM</type>
      <text>ASPP2 depletion by RNA interference (RNAi)</text>
    </predicate>
    <arg1 id="V1057379" role=":AGENT"/>
    <arg2 id="V1057326" role=":AFFECTED"/>
    <text>ASPP2 depletion by RNA interference (RNAi)</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="580" id="V1057326" paragraph="paragraph12" rule="-SIMPLE-REF" start="574" uttnum="65">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0016246" end="617" id="V1057379" paragraph="paragraph12" rule="-SIMPLE-REF" start="590" uttnum="65">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>RNA-INTERFERENCE</name>
    <text>by RNA interference (RNAi)</text>
  </TERM>
  <TERM dbid="GO:0016246" end="615" id="V1057434" paragraph="paragraph12" rule="-SIMPLE-REF" start="611" uttnum="65">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>RNAI</name>
    <text>RNAi</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="648" id="V1057457" paragraph="paragraph12" rule="-SIMPLE-REF" start="635" uttnum="65">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane</text>
  </TERM>
  <EVENT end="707" id="V1057505" paragraph="paragraph12" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="678" uttnum="65">
    <type>ONT::PRODUCE</type>
    <predicate end="707" id="V1057505" start="678">
      <type>ONT::PRODUCE</type>
      <text>RAS induction in these cells</text>
    </predicate>
    <arg2 id="V1057500" role=":AFFECTED"/>
    <text>RAS induction in these cells</text>
  </EVENT>
  <TERM end="682" id="V1057500" paragraph="paragraph12" rule="-SIMPLE-REF" start="678" uttnum="65">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="707" id="V1057568" paragraph="paragraph12" rule="-SIMPLE-REF" start="695" uttnum="65">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells</text>
  </TERM>
  <TERM end="735" id="V1057590" paragraph="paragraph12" rule="-SIMPLE-REF" start="714" uttnum="65">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure</text>
  </TERM>
  <TERM end="35" id="V1069467" paragraph="paragraph13" rule="-SIMPLE-REF" start="3" uttnum="66">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>The ability of endogenous ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="35" id="V1069506" paragraph="paragraph13" rule="-SIMPLE-REF" start="15" uttnum="66">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of endogenous ASPP2</text>
  </TERM>
  <TERM end="85" id="V1069597" paragraph="paragraph13" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="58" uttnum="66">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">with endogenous active RAS</text>
  </TERM>
  <TERM end="122" id="V1069722" paragraph="paragraph13" rule="-SIMPLE-REF" start="99" uttnum="66">
    <type>ONT::SETTING</type>
    <name>SETTING</name>
    <text>a physiological setting</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="137" id="V1085467" paragraph="paragraph13" rule="-SIMPLE-REF" start="127" uttnum="67">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="224" id="V1085544" paragraph="paragraph13" rule="-LOCATION1,-LOGICALOP-REF" start="149" uttnum="67">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1085560"/>
      <member id="V1085503"/>
      <member id="V1085540"/>
    </aggregate>
    <features>
      <location id="V1085639"/>
    </features>
    <text normalization="">MEFs, insulin-induced active RAS and ASPP2 colocalised at the cell membrane</text>
  </TERM>
  <TERM dbid="UP:SL-0039|GO:0005886" end="224" id="V1085639" paragraph="paragraph13" rule="-SIMPLE-REF" start="204" uttnum="67">
    <type>ONT::CELL-PART</type>
    <name>CELL-MEMBRANE</name>
    <text>at the cell membrane</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="153" id="V1085503" paragraph="paragraph13" rule="-SIMPLE-REF" start="149" uttnum="67">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <TERM end="182" id="V1085540" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="155" uttnum="67">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">insulin-induced active RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="192" id="V1085560" paragraph="paragraph13" rule="-SIMPLE-REF" start="186" uttnum="67">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <CC end="171" id="V1085519" paragraph="paragraph13" rule="-RULE5B_AGENT_RESULT-AGENT" start="155" uttnum="67">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1085511" role=":FACTOR"/>
    <text>insulin-induced</text>
  </CC>
  <TERM dbid="UP:P01308" end="171" id="V1085511" paragraph="paragraph13" rule="-SIMPLE-REF" start="155" uttnum="67">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin-induced</text>
  </TERM>
  <TERM end="289" id="V1100270" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="239" uttnum="68">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V1100282"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>of the cells expressing membrane-associated ASPP2</text>
  </TERM>
  <EVENT end="289" id="V1100282" paragraph="paragraph13" rule="-RULE50_AGENT_AFFECTED-RESULT" start="239" uttnum="68">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="289" id="V1100282" start="239">
      <type>ONT::EXPRESS</type>
      <text>of the cells expressing membrane-associated ASPP2</text>
    </predicate>
    <arg2 id="V1100318" role=":AFFECTED-RESULT"/>
    <text>of the cells expressing membrane-associated ASPP2</text>
    <location mod="IN-LOC" id="V1100270"/>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="289" id="V1100318" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="263" uttnum="68">
    <type>ONT::GENE</type>
    <features>
      <inevent>
        <event id="V1100299"/>
      </inevent>
    </features>
    <name>ASPP-2</name>
    <text>membrane-associated ASPP2</text>
  </TERM>
  <EVENT end="289" id="V1100299" paragraph="paragraph13" rule="-RULE20C_AGENT_AFFECTED" start="263" uttnum="68">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="289" id="V1100299" start="263">
      <type>ONT::BIND</type>
      <text>membrane-associated ASPP2</text>
    </predicate>
    <arg1 id="V1100291" role=":AGENT"/>
    <arg2 id="V1100318" role=":AFFECTED"/>
    <text>membrane-associated ASPP2</text>
  </EVENT>
  <TERM dbid="GO:0016020|UP:SL-0162" end="283" id="V1100291" paragraph="paragraph13" rule="-SIMPLE-REF" start="263" uttnum="68">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane-associated</text>
  </TERM>
  <TERM end="321" id="V1100372" paragraph="paragraph13" rule="-SIMPLE-REF" start="298" uttnum="68">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">membrane-localised RAS</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="317" id="V1100347" paragraph="paragraph13" rule="-SIMPLE-REF" start="298" uttnum="68">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane-localised</text>
  </TERM>
  <TERM end="368" id="V1100417" paragraph="paragraph13" rule="-SIMPLE-REF" start="360" uttnum="68">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2</text>
  </TERM>
  <TERM end="389" id="V1100499" paragraph="paragraph13" rule="-SIMPLE-REF" start="383" uttnum="68">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel</text>
  </TERM>
  <TERM end="400" id="V1100513" paragraph="paragraph13" rule="-SIMPLE-REF" start="394" uttnum="68">
    <type>ONT::ICON</type>
    <name>ARROW</name>
    <text>arrows</text>
  </TERM>
  <EPI end="472" id="V1115318" paragraph="paragraph13" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="403" uttnum="69">
    <type>ONT::OBSERVE</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <arg2 id="V1115280" role=":FORMAL"/>
    <text>RAS was not detected at the cell membrane in ASPP2(Δ3/Δ3)</text>
  </EPI>
  <TERM end="407" id="V1115280" paragraph="paragraph13" rule="-SIMPLE-REF" start="403" uttnum="69">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:SL-0039|GO:0005886" end="445" id="V1115374" paragraph="paragraph13" rule="-SIMPLE-REF" start="427" uttnum="69">
    <type>ONT::CELL-PART</type>
    <name>CELL-MEMBRANE</name>
    <text>the cell membrane</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="472" id="V1115437" paragraph="paragraph13" rule="-SIMPLE-REF" start="448" uttnum="69">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2(Δ3/Δ3)</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="502" id="V1115493" paragraph="paragraph13" rule="-SIMPLE-REF" start="472" uttnum="69">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs (Figure 2c)</text>
  </TERM>
  <TERM end="500" id="V1115503" paragraph="paragraph13" rule="-SIMPLE-REF" start="484" uttnum="69">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2c</text>
  </TERM>
  <TERM end="557" id="V1115610" paragraph="paragraph13" rule="-SIMPLE-REF" start="540" uttnum="69">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>with the results</text>
  </TERM>
  <TERM dbid="BTO:0003469" end="571" id="V1115732" paragraph="paragraph13" rule="-SIMPLE-REF" start="560" uttnum="69">
    <type>ONT::CELL</type>
    <name>HKE-3-CELLS</name>
    <text>HKe3 cells</text>
  </TERM>
  <TERM end="599" id="V1115751" paragraph="paragraph13" rule="-SIMPLE-REF" start="578" uttnum="69">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure</text>
  </TERM>
  <EPI end="672" id="V1127362" paragraph="paragraph13" rule="-RULE50_0_AGENT_FORMAL-NONE" start="610" uttnum="70">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1127334" role=":NEUTRAL"/>
    <text>Similar results were observed in HRASV12-expressing ASPP2</text>
  </EPI>
  <TERM end="626" id="V1127334" paragraph="paragraph13" rule="-SIMPLE-REF" start="610" uttnum="70">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Similar results</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="672" id="V1127464" paragraph="paragraph13" rule="-SIMPLE-REF" start="643" uttnum="70">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>HRASV12-expressing ASPP2</text>
  </TERM>
  <TERM end="753" id="V1127632" paragraph="paragraph13" rule="-SIMPLE-REF" start="688" uttnum="70">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>ASPP2(Δ3/Δ3) MEFs (Figure 2c, right panel</text>
  </TERM>
  <TERM end="753" id="V1127623" paragraph="paragraph13" rule="-SIMPLE-REF" start="688" uttnum="70">
    <type>ONT::RIGHT-LOC</type>
    <name>RIGHT</name>
    <text>ASPP2(Δ3/Δ3) MEFs (Figure 2c, right panel</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="712" id="V1127499" paragraph="paragraph13" rule="-SIMPLE-REF" start="688" uttnum="70">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2(Δ3/Δ3)</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="742" id="V1127555" paragraph="paragraph13" rule="-SIMPLE-REF" start="712" uttnum="70">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs (Figure 2c,</text>
  </TERM>
  <TERM end="740" id="V1127565" paragraph="paragraph13" rule="-SIMPLE-REF" start="724" uttnum="70">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2c</text>
  </TERM>
  <TERM end="777" id="V1141203" paragraph="paragraph13" rule="-SIMPLE-REF" start="766" uttnum="71">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>these data</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="796" id="V1141240" paragraph="paragraph13" rule="-SIMPLE-REF" start="790" uttnum="71">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="817" id="V1141276" paragraph="paragraph13" rule="-SIMPLE-REF" start="808" uttnum="71">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with RAS</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="846" id="V1141325" paragraph="paragraph13" rule="-SIMPLE-REF" start="833" uttnum="71">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane</text>
  </TERM>
  <TERM end="866" id="V1141344" paragraph="paragraph13" rule="-SIMPLE-REF" start="859" uttnum="71">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">of RAS</text>
  </TERM>
  <TERM end="888" id="V1141418" paragraph="paragraph13" rule="-SIMPLE-REF" start="875" uttnum="71">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="44" id="V1157986" paragraph="paragraph14" rule="-SIMPLE-REF" start="3" uttnum="72">
    <type>ONT::MENTAL-OBJECT</type>
    <name>IMPLICATIONS</name>
    <text>The biological implications of ASPP2–RAS</text>
  </TERM>
  <TERM end="44" id="V1158283" paragraph="paragraph14" rule="-EXPLICIT-REF-SEQ0B" start="34" uttnum="72">
    <type>ONT::GENE-PROTEIN</type>
    <components>
      <component id="V1157897"/>
      <component id="V1157905"/>
    </components>
    <text normalization="">ASPP2–RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="44" id="V1157897" paragraph="paragraph14" rule="-EXPLICIT-REF-SEQ0B-TERM" start="34" uttnum="72">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2–RAS</text>
  </TERM>
  <TERM end="44" id="V1157905" paragraph="paragraph14" rule="-SIMPLE-REF" start="40" uttnum="72">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="52" id="V1158014" paragraph="paragraph14" rule="-SIMPLE-REF" start="44" uttnum="72">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BINDING</name>
    <text>binding</text>
  </TERM>
  <EPI end="142" id="V1158096" paragraph="paragraph14" rule="-RULE50_0_AGENT_FORMAL-NONE" start="92" uttnum="72">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1158116" role=":NEUTRAL"/>
    <text>examining the RAS signalling cascade in ASPP2</text>
  </EPI>
  <TERM end="142" id="V1158116" paragraph="paragraph14" rule="-SIMPLE-REF" start="102" uttnum="72">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>CASCADE</name>
    <text>the RAS signalling cascade in ASPP2</text>
  </TERM>
  <TERM dbid="GO:0023052" end="142" id="V1158113" paragraph="paragraph14" rule="-SIMPLE-REF" start="102" uttnum="72">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>the RAS signalling cascade in ASPP2</text>
  </TERM>
  <TERM end="110" id="V1158108" paragraph="paragraph14" rule="-SIMPLE-REF" start="106" uttnum="72">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="142" id="V1158183" paragraph="paragraph14" rule="-SIMPLE-REF" start="132" uttnum="72">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="168" id="V1158218" paragraph="paragraph14" rule="-SIMPLE-REF" start="158" uttnum="72">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="186" id="V1158274" paragraph="paragraph14" rule="-SIMPLE-REF" start="182" uttnum="72">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <EVENT end="240" id="V1172125" paragraph="paragraph14" rule="-RULE60_AGENT_AFFECTED-LOC5-GD-NONE" start="188" uttnum="73">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="240" id="V1172125" start="188">
      <type>ONT::PHOSPHORYLATION</type>
      <text>The basal phosphorylation level of ERK in ASPP2</text>
    </predicate>
    <site end="240" id="V1172128" start="188">
      <type>ONT::LEVEL</type>
      <text normalization="LEVEL">The basal phosphorylation level of ERK in ASPP2</text>
    </site>
    <text>The basal phosphorylation level of ERK in ASPP2</text>
  </EVENT>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="240" id="V1172140" paragraph="paragraph14" rule="-SIMPLE-REF" start="223" uttnum="73">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>ERK in ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="240" id="V1172203" paragraph="paragraph14" rule="-SIMPLE-REF" start="230" uttnum="73">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="257" id="V1172223" paragraph="paragraph14" rule="-SIMPLE-REF" start="252" uttnum="73">
    <type>ONT::GENE</type>
    <name>MEF</name>
    <text>MEFs</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="372" id="V1172395" paragraph="paragraph14" rule="-SIMPLE-REF" start="281" uttnum="73">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>ASPP2(Δ3/Δ3) MEFs (Figure 3a; Supplementary Figure 3a)</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="305" id="V1172339" paragraph="paragraph14" rule="-SIMPLE-REF" start="281" uttnum="73">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2(Δ3/Δ3)</text>
  </TERM>
  <TERM end="371" id="V1172478" paragraph="paragraph14" rule="-SIMPLE-REF" start="317" uttnum="73">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3a; Supplementary Figure 3a</text>
  </TERM>
  <TERM end="371" id="V1172405" paragraph="paragraph14" rule="-SIMPLE-REF" start="317" uttnum="73">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3a; Supplementary Figure 3a</text>
  </TERM>
  <TERM end="390" id="V1183352" paragraph="paragraph14" rule="-SIMPLE-REF" start="374" uttnum="74">
    <type>ONT::COMPARISON</type>
    <name>DIFFERENCE</name>
    <text>This difference</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="439" id="V1183479" paragraph="paragraph14" rule="-SIMPLE-REF" start="410" uttnum="74">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>HRASV12-expressing ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="483" id="V1183559" paragraph="paragraph14" rule="-SIMPLE-REF" start="459" uttnum="74">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2(Δ3/Δ3)</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="550" id="V1183615" paragraph="paragraph14" rule="-SIMPLE-REF" start="483" uttnum="74">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs (Figure 3b; Supplementary Figure 3b)</text>
  </TERM>
  <TERM end="549" id="V1183699" paragraph="paragraph14" rule="-SIMPLE-REF" start="495" uttnum="74">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>Figure 3b; Supplementary Figure 3b</text>
  </TERM>
  <TERM end="549" id="V1183625" paragraph="paragraph14" rule="-SIMPLE-REF" start="495" uttnum="74">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3b; Supplementary Figure 3b</text>
  </TERM>
  <TERM end="541" id="V1183675" paragraph="paragraph14" rule="-SIMPLE-REF" start="533" uttnum="74">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3</text>
  </TERM>
  <TERM end="511" id="V1183634" paragraph="paragraph14" rule="-SIMPLE-REF" start="502" uttnum="74">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>3b</text>
  </TERM>
  <EVENT end="574" id="V1196266" paragraph="paragraph14" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="557" uttnum="75">
    <type>ONT::MODULATE</type>
    <predicate end="574" id="V1196266" start="557">
      <type>ONT::MODULATE</type>
      <text>insulin treatment</text>
    </predicate>
    <arg2 id="V1196263" role=":AFFECTED"/>
    <text>insulin treatment</text>
  </EVENT>
  <TERM dbid="UP:P01308" end="565" id="V1196263" paragraph="paragraph14" rule="-SIMPLE-REF" start="557" uttnum="75">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="622" id="V1196408" paragraph="paragraph14" rule="-SIMPLE-REF" start="612" uttnum="75">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="658" id="V1196457" paragraph="paragraph14" rule="-SIMPLE-REF" start="643" uttnum="75">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>with ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="676" id="V1196515" paragraph="paragraph14" rule="-SIMPLE-REF" start="672" uttnum="75">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <EVENT end="737" id="V1196584" paragraph="paragraph14" rule="-RULE60_AGENT_AFFECTED-LOC5-GD-NONE" start="691" uttnum="75">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="737" id="V1196584" start="691">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the phosphorylation level of both ERK and AKT</text>
    </predicate>
    <site end="737" id="V1196588" start="691">
      <type>ONT::LEVEL</type>
      <text normalization="LEVEL">the phosphorylation level of both ERK and AKT</text>
    </site>
    <text>the phosphorylation level of both ERK and AKT</text>
  </EVENT>
  <TERM end="737" id="V1196600" paragraph="paragraph14" rule="-LOGICALOP-REF" start="720" uttnum="75">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="BOTH">
      <member id="V1196608"/>
      <member id="V1196623"/>
    </aggregate>
    <text normalization="">both ERK and AKT</text>
  </TERM>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="729" id="V1196608" paragraph="paragraph14" rule="-SIMPLE-REF" start="725" uttnum="75">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>ERK</text>
  </TERM>
  <TERM end="737" id="V1196623" paragraph="paragraph14" rule="-SIMPLE-REF" start="733" uttnum="75">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="755" id="V1196632" paragraph="paragraph14" rule="-SIMPLE-REF" start="744" uttnum="75">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures 3a</text>
  </TERM>
  <TERM end="767" id="V1196712" paragraph="paragraph14" rule="-SIMPLE-REF" start="759" uttnum="75">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>b</text>
  </TERM>
  <TERM end="797" id="V1196732" paragraph="paragraph14" rule="-SIMPLE-REF" start="775" uttnum="75">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figures</text>
  </TERM>
  <TERM end="812" id="V1196812" paragraph="paragraph14" rule="-SIMPLE-REF" start="804" uttnum="75">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>b</text>
  </TERM>
  <TERM end="826" id="V1212342" paragraph="paragraph14" rule="-SIMPLE-REF" start="821" uttnum="76">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>data</text>
  </TERM>
  <TERM end="886" id="V1212477" paragraph="paragraph14" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="870" uttnum="76">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">with active RAS</text>
  </TERM>
  <TERM dbid="UP:SL-0039|GO:0005886" end="906" id="V1212532" paragraph="paragraph14" rule="-SIMPLE-REF" start="889" uttnum="76">
    <type>ONT::CELL-PART</type>
    <name>CELL-MEMBRANE</name>
    <text>the cell membrane</text>
  </TERM>
  <EVENT end="940" id="V1223944" paragraph="paragraph14" rule="-RULE20_AGENT_AFFECTED" start="908" uttnum="76">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="940" id="V1223944" start="908">
      <type>ONT::INCREASE</type>
      <text>ASPP2 potentiates RAS signalling</text>
    </predicate>
    <arg1 id="V1223940" role=":AGENT"/>
    <arg2 id="V1223963" role=":AFFECTED"/>
    <text>ASPP2 potentiates RAS signalling</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="914" id="V1223940" paragraph="paragraph14" rule="-SIMPLE-REF" start="908" uttnum="76">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0023052" end="940" id="V1223963" paragraph="paragraph14" rule="-SIMPLE-REF" start="926" uttnum="76">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="940" id="V1223958" paragraph="paragraph14" rule="-SIMPLE-REF" start="926" uttnum="76">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="24" id="V1224367" paragraph="paragraph15" rule="-SIMPLE-REF" start="18" uttnum="77">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0023052" end="42" id="V1224404" paragraph="paragraph15" rule="-SIMPLE-REF" start="27" uttnum="77">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="42" id="V1224399" paragraph="paragraph15" rule="-SIMPLE-REF" start="27" uttnum="77">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM end="89" id="V1224476" paragraph="paragraph15" rule="-SIMPLE-REF" start="84" uttnum="77">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P28482" type="ONT::PROTEIN"/>
      <member dbid="UP:P27361" type="ONT::PROTEIN"/>
    </members>
    <name>MAPK</name>
    <text normalization="">MAPK</text>
  </TERM>
  <TERM end="165" id="V1237854" paragraph="paragraph15" rule="-SIMPLE-REF" start="155" uttnum="78">
    <type>ONT::PERSON</type>
    <name>EFFECTORS</name>
    <text>effectors</text>
  </TERM>
  <TERM end="172" id="V1237868" paragraph="paragraph15" rule="-SIMPLE-REF" start="168" uttnum="78">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <EVENT end="231" id="V1237939" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="216" uttnum="78">
    <type>ONT::ACTIVATE</type>
    <predicate end="231" id="V1237939" start="216">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V1237935" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000217"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="220" id="V1237935" paragraph="paragraph15" rule="-SIMPLE-REF" start="216" uttnum="78">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P03372" end="241" id="V1238053" paragraph="paragraph15" rule="-SIMPLE-REF" start="234" uttnum="78">
    <type>ONT::PROTEIN</type>
    <name>ER</name>
    <text>HKe3 ER</text>
  </TERM>
  <TERM dbid="CVCL:9796" end="239" id="V1238043" paragraph="paragraph15" rule="-SIMPLE-REF" start="234" uttnum="78">
    <type>ONT::CELL-LINE</type>
    <name>HKE-3</name>
    <text>HKe3</text>
  </TERM>
  <TERM end="255" id="V1238075" paragraph="paragraph15" rule="-SIMPLE-REF" start="250" uttnum="78">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <EVENT end="344" id="V1251901" paragraph="paragraph15" rule="-RULE10_AGENT_AFFECTED" start="257" uttnum="79">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="344" id="V1251901" start="257">
      <type>ONT::MODULATE</type>
      <text>ASPP2 knockdown dampened the RAS-induced activation of some effectors such as MSK2, p38</text>
    </predicate>
    <arg1 id="V1251896" role=":AGENT"/>
    <arg2 id="V1251947" role=":AFFECTED"/>
    <text>ASPP2 knockdown dampened the RAS-induced activation of some effectors such as MSK2, p38</text>
  </EVENT>
  <EVENT end="273" id="V1251896" paragraph="paragraph15" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="257" uttnum="79">
    <type>ONT::TRANSFORM</type>
    <predicate end="273" id="V1251896" start="257">
      <type>ONT::TRANSFORM</type>
      <text>ASPP2 knockdown</text>
    </predicate>
    <arg2 id="V1251890" role=":AFFECTED"/>
    <text>ASPP2 knockdown</text>
  </EVENT>
  <EVENT end="344" id="V1251947" paragraph="paragraph15" rule="-INEVENT2B,-RULE40A_AGENT_AFFECTED-LOC5-GD-NONE" start="282" uttnum="79">
    <type>ONT::ACTIVATE</type>
    <predicate end="344" id="V1251947" start="282">
      <type>ONT::ACTIVATE</type>
      <text>the RAS-induced activation of some effectors such as MSK2, p38</text>
    </predicate>
    <site end="344" id="V1251947" start="282">
      <type>ONT::ACTIVATE</type>
      <text normalization="">the RAS-induced activation of some effectors such as MSK2, p38</text>
    </site>
    <text>the RAS-induced activation of some effectors such as MSK2, p38</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="263" id="V1251890" paragraph="paragraph15" rule="-SIMPLE-REF" start="257" uttnum="79">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="298" id="V1251926" paragraph="paragraph15" rule="-SIMPLE-REF" start="286" uttnum="79">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="UP:Q16539|UP:O95433|XFAM:PF09229|XFAM:PF08327|HGNC:20609|XFAM:PF07653|UP:O75791|HGNC:1189|HGNC:4563|UP:Q64010|XFAM:PF00018|XFAM:PF00017|GO:0004707|UP:Q13155|HGNC:6876" end="344" id="V1252072" paragraph="paragraph15" rule="-SIMPLE-REF" start="312" uttnum="79">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-38</name>
    <text>some effectors such as MSK2, p38</text>
  </TERM>
  <TERM dbid="UP:O75676|HGNC:10433" end="341" id="V1252038" paragraph="paragraph15" rule="-SIMPLE-REF" start="335" uttnum="79">
    <type>ONT::GENE</type>
    <name>MSK-2</name>
    <text>MSK2,</text>
  </TERM>
  <TERM end="335" id="V1251973" paragraph="paragraph15" rule="-SIMPLE-REF" start="312" uttnum="79">
    <type>ONT::PERSON</type>
    <name>EFFECTORS</name>
    <text>some effectors such as</text>
  </TERM>
  <TERM dbid="XFAM:PF03957.10|GO:0004705|HGNC:6881|UP:P45983" end="355" id="V1252119" paragraph="paragraph15" rule="-SIMPLE-REF" start="350" uttnum="79">
    <type>ONT::GENE-PROTEIN</type>
    <name>JNKS</name>
    <text>JNKs</text>
  </TERM>
  <TERM end="384" id="V1252138" paragraph="paragraph15" rule="-SIMPLE-REF" start="376" uttnum="79">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3</text>
  </TERM>
  <TERM end="392" id="V1252165" paragraph="paragraph15" rule="-SIMPLE-REF" start="384" uttnum="79">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>d</text>
  </TERM>
  <EVENT end="490" id="V1266359" paragraph="paragraph15" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="395" uttnum="80">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="490" id="V1266359" start="395">
      <type>ONT::MODULATE</type>
      <text>Consistent with this, RAS-induced phosphorylation of ERK and AKT is compromised in these cells</text>
    </predicate>
    <arg2 id="V1266308" role=":AFFECTED"/>
    <text>Consistent with this, RAS-induced phosphorylation of ERK and AKT is compromised in these cells</text>
  </EVENT>
  <EVENT end="460" id="V1266308" paragraph="paragraph15" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-AFFECTED" start="417" uttnum="80">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="460" id="V1266308" start="417">
      <type>ONT::PHOSPHORYLATION</type>
      <text>RAS-induced phosphorylation of ERK and AKT</text>
    </predicate>
    <arg2 id="V1266324" role=":AFFECTED"/>
    <arg id="R000182" role=":RESULT"/>
    <text>RAS-induced phosphorylation of ERK and AKT</text>
  </EVENT>
  <TERM end="415" id="V1266278" paragraph="paragraph15" rule="-SIMPLE-REF" start="406" uttnum="80">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>with this</text>
  </TERM>
  <CC end="460" id="V1266296" paragraph="paragraph15" rule="-RULE5B_AGENT_AFFECTED" start="417" uttnum="80">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1266287" role=":FACTOR"/>
    <arg id="V1266308" role=":OUTCOME"/>
    <text>RAS-induced phosphorylation of ERK and AKT</text>
  </CC>
  <TERM end="460" id="V1266324" paragraph="paragraph15" rule="-LOGICALOP-REF" start="445" uttnum="80">
    <type>ONT::PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1266320"/>
      <member id="V1266335"/>
    </aggregate>
    <text normalization="">of ERK and AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1266308"/>
    </not-features>
  </TERM>
  <TERM end="429" id="V1266287" paragraph="paragraph15" rule="-SIMPLE-REF" start="417" uttnum="80">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="452" id="V1266320" paragraph="paragraph15" rule="-SIMPLE-REF" start="448" uttnum="80">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>ERK</text>
  </TERM>
  <TERM end="460" id="V1266335" paragraph="paragraph15" rule="-SIMPLE-REF" start="456" uttnum="80">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="490" id="V1266428" paragraph="paragraph15" rule="-SIMPLE-REF" start="478" uttnum="80">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells</text>
  </TERM>
  <EVENT end="511" id="V1266455" paragraph="paragraph15" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="495" uttnum="80">
    <type>ONT::TRANSFORM</type>
    <predicate end="511" id="V1266455" start="495">
      <type>ONT::TRANSFORM</type>
      <text>ASPP2 depletion</text>
    </predicate>
    <arg2 id="V1266446" role=":AFFECTED"/>
    <text>ASPP2 depletion</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="501" id="V1266446" paragraph="paragraph15" rule="-SIMPLE-REF" start="495" uttnum="80">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="525" id="V1266468" paragraph="paragraph15" rule="-SIMPLE-REF" start="518" uttnum="80">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="563" id="V1266532" paragraph="paragraph15" rule="-SIMPLE-REF" start="556" uttnum="80">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM dbid="HGNC:10446|UP:P55042" end="66" id="V1282935" paragraph="paragraph16" rule="-SIMPLE-REF" start="31" uttnum="81">
    <type>ONT::GENE</type>
    <name>RAD</name>
    <text>the RAD in the N-terminus of ASPP2</text>
  </TERM>
  <TERM end="66" id="V1283000" paragraph="paragraph16" rule="-SIMPLE-REF" start="42" uttnum="81">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>the N-terminus of ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="66" id="V1283043" paragraph="paragraph16" rule="-SIMPLE-REF" start="60" uttnum="81">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:10446|UP:P55042" end="116" id="V1283094" paragraph="paragraph16" rule="-SIMPLE-REF" start="78" uttnum="81">
    <type>ONT::GENE</type>
    <name>RAD</name>
    <text>for its potentiation of RAS signalling</text>
  </TERM>
  <TERM dbid="GO:0023052" end="116" id="V1283115" paragraph="paragraph16" rule="-SIMPLE-REF" start="102" uttnum="81">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="116" id="V1283110" paragraph="paragraph16" rule="-SIMPLE-REF" start="102" uttnum="81">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <EVENT end="150" id="V1296673" paragraph="paragraph16" rule="-RULE40_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="118" uttnum="81">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="150" id="V1296673" start="118">
      <type>ONT::PRODUCE</type>
      <text>two ASPP2 mutants were generated</text>
    </predicate>
    <arg2 id="V1296651" role=":AFFECTED-RESULT"/>
    <text>two ASPP2 mutants were generated</text>
  </EVENT>
  <TERM end="188" id="V1296696" paragraph="paragraph16" rule="-LOGICALOP-REF" start="152" uttnum="81">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V1296686"/>
      <member id="V1296712"/>
    </aggregate>
    <text normalization="ASPP-2">ASPP2 (1–360) and ASPP2 (123–1128),</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="136" id="V1296651" paragraph="paragraph16" rule="-EXPLICIT-REF4" start="118" uttnum="81">
    <type>ONT::GENE</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>ASPP-2</name>
    <text>two ASPP2 mutants</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="166" id="V1296686" paragraph="paragraph16" rule="-SIMPLE-REF" start="152" uttnum="81">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 (1–360)</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="188" id="V1296712" paragraph="paragraph16" rule="-SIMPLE-REF" start="170" uttnum="81">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 (123–1128),</text>
  </TERM>
  <TERM end="243" id="V1296797" paragraph="paragraph16" rule="-SIMPLE-REF" start="201" uttnum="81">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>SPLICE</name>
    <text>a naturally occurring ASPP2 splice variant</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="229" id="V1296790" paragraph="paragraph16" rule="-SIMPLE-REF" start="223" uttnum="81">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="326" id="V1296825" paragraph="paragraph16" rule="-INEVENT2B,-RULE50_AGENT_AFFECTED-RESULT-ROBUST-AGENT-TERM" start="271" uttnum="81">
    <type>ONT::REFERENTIAL-SEM</type>
    <features>
      <inevent>
        <event id="V1296834"/>
      </inevent>
    </features>
    <name>RETROVIRUSES</name>
    <text>Retroviruses expressing full-length or truncated ASPP2</text>
  </TERM>
  <EVENT end="326" id="V1296834" paragraph="paragraph16" rule="-RULE50_AGENT_AFFECTED-RESULT-ROBUST-AGENT" start="271" uttnum="81">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="326" id="V1296834" start="271">
      <type>ONT::EXPRESS</type>
      <text>Retroviruses expressing full-length or truncated ASPP2</text>
    </predicate>
    <arg1 id="V1296825" role=":AGENT"/>
    <arg2 id="V1296895" role=":AFFECTED-RESULT"/>
    <text>Retroviruses expressing full-length or truncated ASPP2</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="326" id="V1296895" paragraph="paragraph16" rule="-SIMPLE-REF" start="295" uttnum="81">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>full-length or truncated ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="392" id="V1297029" paragraph="paragraph16" rule="-SIMPLE-REF" start="345" uttnum="81">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>HRASV12-expressing ASPP2(Δ3/Δ3) MEFs</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="388" id="V1296973" paragraph="paragraph16" rule="-SIMPLE-REF" start="364" uttnum="81">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2(Δ3/Δ3)</text>
  </TERM>
  <TERM dbid="GO:0023052" end="470" id="V1309892" paragraph="paragraph16" rule="-SIMPLE-REF" start="419" uttnum="82">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS–AKT signalling in HRASV12-expressing ASPP2</text>
  </TERM>
  <TERM end="415" id="V1310260" paragraph="paragraph16" rule="-EXPLICIT-REF-SEQ0B" start="407" uttnum="82">
    <type>ONT::GENE-PROTEIN</type>
    <components>
      <component id="V1309797"/>
      <component id="V1309805"/>
    </components>
    <text normalization="">RAS–ERK</text>
  </TERM>
  <TERM end="470" id="V1310255" paragraph="paragraph16" rule="-SIMPLE-REF" start="419" uttnum="82">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>RAS-AKT</name>
    <text normalization="">RAS–AKT signalling in HRASV12-expressing ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="470" id="V1309996" paragraph="paragraph16" rule="-SIMPLE-REF" start="441" uttnum="82">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>HRASV12-expressing ASPP2</text>
  </TERM>
  <TERM end="415" id="V1309797" paragraph="paragraph16" rule="-EXPLICIT-REF-SEQ0B-TERM" start="407" uttnum="82">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS–ERK</text>
  </TERM>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="415" id="V1309805" paragraph="paragraph16" rule="-SIMPLE-REF" start="411" uttnum="82">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>ERK</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="489" id="V1310052" paragraph="paragraph16" rule="-SIMPLE-REF" start="484" uttnum="82">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <EVENT end="573" id="V1310077" paragraph="paragraph16" rule="-RULE5_AGENT_AFFECTED-AGENT" start="501" uttnum="82">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="573" id="V1310077" start="501">
      <type>ONT::TRANSFORM</type>
      <text>rescued by the expression of full-length ASPP2 (Figure 3d,</text>
    </predicate>
    <arg1 id="V1310114" role=":AGENT"/>
    <text>rescued by the expression of full-length ASPP2 (Figure 3d,</text>
  </EVENT>
  <EVENT end="573" id="V1310114" paragraph="paragraph16" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="509" uttnum="82">
    <type>ONT::EXPRESS</type>
    <predicate end="573" id="V1310114" start="509">
      <type>ONT::EXPRESS</type>
      <text>by the expression of full-length ASPP2 (Figure 3d,</text>
    </predicate>
    <arg2 id="V1310171" role=":AFFECTED-RESULT"/>
    <text>by the expression of full-length ASPP2 (Figure 3d,</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="573" id="V1310171" paragraph="paragraph16" rule="-SIMPLE-REF" start="527" uttnum="82">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of full-length ASPP2 (Figure 3d,</text>
  </TERM>
  <TERM end="571" id="V1310208" paragraph="paragraph16" rule="-SIMPLE-REF" start="555" uttnum="82">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 3d</text>
  </TERM>
  <TERM end="571" id="V1310181" paragraph="paragraph16" rule="-SIMPLE-REF" start="555" uttnum="82">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3d</text>
  </TERM>
  <TERM end="584" id="V1310232" paragraph="paragraph16" rule="-SIMPLE-REF" start="573" uttnum="82">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>lower panel</text>
  </TERM>
  <TERM end="592" id="V1310238" paragraph="paragraph16" rule="-SIMPLE-REF" start="586" uttnum="82">
    <type>ONT::LANE</type>
    <name>LANE</name>
    <text>lanes</text>
  </TERM>
  <EVENT end="630" id="V1322020" paragraph="paragraph16" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="598" uttnum="83">
    <type>ONT::EXPRESS</type>
    <predicate end="630" id="V1322020" start="598">
      <type>ONT::EXPRESS</type>
      <text>The expression of ASPP2 (1–360)</text>
    </predicate>
    <arg2 id="V1322042" role=":AFFECTED-RESULT"/>
    <text>The expression of ASPP2 (1–360)</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="622" id="V1322042" paragraph="paragraph16" rule="-SIMPLE-REF" start="613" uttnum="83">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2</text>
  </TERM>
  <TERM end="684" id="V1322097" paragraph="paragraph16" rule="-LOGICALOP-REF" start="672" uttnum="83">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1322093"/>
      <member id="V1322108"/>
    </aggregate>
    <text normalization="">ERK and AKT</text>
  </TERM>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="676" id="V1322093" paragraph="paragraph16" rule="-SIMPLE-REF" start="672" uttnum="83">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>ERK</text>
  </TERM>
  <TERM end="684" id="V1322108" paragraph="paragraph16" rule="-SIMPLE-REF" start="680" uttnum="83">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="722" id="V1322145" paragraph="paragraph16" rule="-SIMPLE-REF" start="691" uttnum="83">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 3d, lower panel,</text>
  </TERM>
  <TERM end="722" id="V1322118" paragraph="paragraph16" rule="-SIMPLE-REF" start="691" uttnum="83">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3d, lower panel,</text>
  </TERM>
  <TERM end="720" id="V1322169" paragraph="paragraph16" rule="-SIMPLE-REF" start="709" uttnum="83">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>lower panel</text>
  </TERM>
  <TERM end="728" id="V1322175" paragraph="paragraph16" rule="-SIMPLE-REF" start="722" uttnum="83">
    <type>ONT::LANE</type>
    <name>LANE</name>
    <text>lanes</text>
  </TERM>
  <EVENT end="801" id="V1334486" paragraph="paragraph16" rule="-INEVENT2B,-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="761" uttnum="84">
    <type>ONT::EXPRESS</type>
    <predicate end="801" id="V1334486" start="761">
      <type>ONT::EXPRESS</type>
      <text>the reduced expression of ASPP2 (1–360)</text>
    </predicate>
    <arg2 id="V1334508" role=":AFFECTED-RESULT"/>
    <text>the reduced expression of ASPP2 (1–360)</text>
  </EVENT>
  <EVENT end="801" id="V1334478" paragraph="paragraph16" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="761" uttnum="84">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="801" id="V1334478" start="761">
      <type>ONT::DECREASE</type>
      <text>the reduced expression of ASPP2 (1–360)</text>
    </predicate>
    <arg2 id="V1334486" role=":AFFECTED"/>
    <text>the reduced expression of ASPP2 (1–360)</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="801" id="V1334508" paragraph="paragraph16" rule="-SIMPLE-REF" start="784" uttnum="84">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2 (1–360)</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="855" id="V1334586" paragraph="paragraph16" rule="-SIMPLE-REF" start="813" uttnum="84">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>full-length ASPP2 (Figure 3e)</text>
  </TERM>
  <TERM end="854" id="V1334613" paragraph="paragraph16" rule="-SIMPLE-REF" start="838" uttnum="84">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>Figure 3e</text>
  </TERM>
  <TERM end="854" id="V1334596" paragraph="paragraph16" rule="-SIMPLE-REF" start="838" uttnum="84">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3e</text>
  </TERM>
  <EVENT end="892" id="V1347097" paragraph="paragraph16" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="857" uttnum="85">
    <type>ONT::EXPRESS</type>
    <predicate end="892" id="V1347097" start="857">
      <type>ONT::EXPRESS</type>
      <text>The expression of ASPP2 (123–1128)</text>
    </predicate>
    <arg2 id="V1347119" role=":AFFECTED-RESULT"/>
    <text>The expression of ASPP2 (123–1128)</text>
  </EVENT>
  <EVENT end="933" id="V1347170" paragraph="paragraph16" rule="-RULE30_AGENT_AFFECTED" start="857" uttnum="85">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="933" id="V1347170" start="857">
      <type>ONT::STIMULATE</type>
      <text>The expression of ASPP2 (123–1128) failed to stimulate ERK and AKT pathways,</text>
    </predicate>
    <arg1 id="V1347097" role=":AGENT"/>
    <arg2 id="V1347194" role=":AFFECTED"/>
    <text>The expression of ASPP2 (123–1128) failed to stimulate ERK and AKT pathways,</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="881" id="V1347119" paragraph="paragraph16" rule="-SIMPLE-REF" start="872" uttnum="85">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2</text>
  </TERM>
  <TERM end="933" id="V1347194" paragraph="paragraph16" rule="-SIMPLE-REF" start="912" uttnum="85">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>ERK and AKT pathways,</text>
  </TERM>
  <TERM end="924" id="V1347180" paragraph="paragraph16" rule="-LOGICALOP-REF" start="912" uttnum="85">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1347176"/>
      <member id="V1347191"/>
    </aggregate>
    <text normalization="">ERK and AKT</text>
  </TERM>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="916" id="V1347176" paragraph="paragraph16" rule="-SIMPLE-REF" start="912" uttnum="85">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>ERK</text>
  </TERM>
  <TERM end="924" id="V1347191" paragraph="paragraph16" rule="-SIMPLE-REF" start="920" uttnum="85">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="965" id="V1355591" paragraph="paragraph16" rule="-SIMPLE-REF" start="954" uttnum="85">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>of protein</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1003" id="V1355688" paragraph="paragraph16" rule="-SIMPLE-REF" start="988" uttnum="85">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 (1–1128)</text>
  </TERM>
  <TERM end="1081" id="V1355731" paragraph="paragraph16" rule="-SIMPLE-REF" start="1010" uttnum="85">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 3d (lower panel, lanes 13–15) and Figure 3e)</text>
  </TERM>
  <TERM end="1081" id="V1355704" paragraph="paragraph16" rule="-SIMPLE-REF" start="1010" uttnum="85">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3d (lower panel, lanes 13–15) and Figure 3e)</text>
  </TERM>
  <TERM end="1095" id="V1367286" paragraph="paragraph16" rule="-SIMPLE-REF" start="1083" uttnum="86">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>This result</text>
  </TERM>
  <TERM end="1144" id="V1367348" paragraph="paragraph16" rule="-SIMPLE-REF" start="1112" uttnum="86">
    <type>ONT::TERMINUS</type>
    <name>TERMINUS</name>
    <text>the N-terminus of ASPP2 (1–123)</text>
  </TERM>
  <TERM end="1144" id="V1367336" paragraph="paragraph16" rule="-SIMPLE-REF" start="1112" uttnum="86">
    <type>ONT::SUBSTANCE</type>
    <name>N</name>
    <text>the N-terminus of ASPP2 (1–123)</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1136" id="V1367372" paragraph="paragraph16" rule="-SIMPLE-REF" start="1130" uttnum="86">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="1186" id="V1367428" paragraph="paragraph16" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1158" uttnum="86">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="1186" id="V1367428" start="1158">
      <type>ONT::INCREASE</type>
      <text>to potentiate RAS signalling</text>
    </predicate>
    <arg2 id="V1367447" role=":AFFECTED"/>
    <text>to potentiate RAS signalling</text>
  </EVENT>
  <TERM dbid="GO:0023052" end="1186" id="V1367447" paragraph="paragraph16" rule="-SIMPLE-REF" start="1172" uttnum="86">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="1186" id="V1367442" paragraph="paragraph16" rule="-SIMPLE-REF" start="1172" uttnum="86">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM end="6" id="V1382235" paragraph="paragraph17" rule="-ROBUSTPRO" start="3" uttnum="87">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="29" id="V1382266" paragraph="paragraph17" rule="-ROBUSTPRO" start="24" uttnum="87">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <TERM end="62" id="V1382293" paragraph="paragraph17" rule="-SIMPLE-REF" start="29" uttnum="87">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>N</name>
    <text>the N-termini of ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="62" id="V1382339" paragraph="paragraph17" rule="-LOGICALOP-REF" start="43" uttnum="87">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V1382335"/>
      <member id="V1382355"/>
    </aggregate>
    <text normalization="">of ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="52" id="V1382335" paragraph="paragraph17" rule="-SIMPLE-REF" start="46" uttnum="87">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="62" id="V1382355" paragraph="paragraph17" rule="-SIMPLE-REF" start="56" uttnum="87">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="111" id="V1382455" paragraph="paragraph17" rule="-ACTIVITY1" start="99" uttnum="87">
    <type>ONT::ACTIVITY</type>
    <predicate end="111" id="V1382455" start="99">
      <type>ONT::ACTIVITY</type>
      <text>p53 activity</text>
    </predicate>
    <arg1 id="V1382452" role=":AGENT"/>
    <text>p53 activity</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="103" id="V1382452" paragraph="paragraph17" rule="-SIMPLE-REF" start="99" uttnum="87">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="142" id="V1382467" paragraph="paragraph17" rule="-ROBUSTPRO" start="139" uttnum="87">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="178" id="V1382499" paragraph="paragraph17" rule="-LOGICALOP-REF" start="162" uttnum="87">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V1382495"/>
      <member id="V1382515"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="197" id="V1382536" paragraph="paragraph17" rule="-SIMPLE-REF" start="188" uttnum="87">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with RAS</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="168" id="V1382495" paragraph="paragraph17" rule="-SIMPLE-REF" start="162" uttnum="87">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="178" id="V1382515" paragraph="paragraph17" rule="-SIMPLE-REF" start="172" uttnum="87">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="239" id="V1382629" paragraph="paragraph17" rule="-SIMPLE-REF" start="233" uttnum="87">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <EVENT end="321" id="V1396061" paragraph="paragraph17" rule="-RULE5_AFFECTED_AFFECTED1-ROBUST-AFFECTED" start="252" uttnum="88">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="321" id="V1396061" start="252">
      <type>ONT::TRANSFORM</type>
      <text>KRASV12 was co-transfected with ASPP1, ASPP2 and p53 into Saos2 cells</text>
    </predicate>
    <arg1 id="V1396029" role=":AFFECTED"/>
    <arg2 id="V1396104" role=":AFFECTED1"/>
    <text>KRASV12 was co-transfected with ASPP1, ASPP2 and p53 into Saos2 cells</text>
  </EVENT>
  <TERM end="321" id="V1396029" paragraph="paragraph17" rule="-RULE5_AFFECTED_AFFECTED1-ROBUST-AFFECTED-TERM" start="252" uttnum="88">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>KRASV-12</name>
    <text>KRASV12 was co-transfected with ASPP1, ASPP2 and p53 into Saos2 cells</text>
  </TERM>
  <TERM end="305" id="V1396104" paragraph="paragraph17" rule="-LOGICALOP-REF" start="279" uttnum="88">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1396141"/>
      <member id="V1396087"/>
      <member id="V1396100"/>
    </aggregate>
    <text normalization="">with ASPP1, ASPP2 and p53</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="289" id="V1396087" paragraph="paragraph17" rule="-SIMPLE-REF" start="284" uttnum="88">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="297" id="V1396100" paragraph="paragraph17" rule="-SIMPLE-REF" start="291" uttnum="88">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="305" id="V1396141" paragraph="paragraph17" rule="-SIMPLE-REF" start="301" uttnum="88">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="BTO:0000971" end="321" id="V1396176" paragraph="paragraph17" rule="-SIMPLE-REF" start="310" uttnum="88">
    <type>ONT::CELL-LINE</type>
    <name>SAOS-2-CELLS</name>
    <text>Saos2 cells</text>
  </TERM>
  <TERM end="335" id="V1410352" paragraph="paragraph17" rule="-SIMPLE-REF" start="323" uttnum="89">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>The results</text>
  </TERM>
  <TERM end="357" id="V1410430" paragraph="paragraph17" rule="-SIMPLE-REF" start="350" uttnum="89">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <EVENT end="459" id="V1410622" paragraph="paragraph17" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="412" uttnum="89">
    <type>ONT::MODULATE</type>
    <predicate end="459" id="V1410622" start="412">
      <type>ONT::MODULATE</type>
      <text>a small stimulatory effect on p53 transactivity</text>
    </predicate>
    <arg2 id="V1410697" role=":AFFECTED"/>
    <text>a small stimulatory effect on p53 transactivity</text>
  </EVENT>
  <EVENT end="459" id="V1410697" paragraph="paragraph17" rule="-ACTIVITY1" start="439" uttnum="89">
    <type>ONT::ACTIVITY</type>
    <predicate end="459" id="V1410697" start="439">
      <type>ONT::ACTIVITY</type>
      <text>on p53 transactivity</text>
    </predicate>
    <arg1 id="V1410686" role=":AGENT"/>
    <text>on p53 transactivity</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="446" id="V1410686" paragraph="paragraph17" rule="-SIMPLE-REF" start="442" uttnum="89">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EVENT end="496" id="V1422828" paragraph="paragraph17" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="474" uttnum="90">
    <type>ONT::EXPRESS</type>
    <predicate end="496" id="V1422828" start="474">
      <type>ONT::EXPRESS</type>
      <text>coexpression of ASPP1</text>
    </predicate>
    <arg2 id="V1422855" role=":AFFECTED-RESULT"/>
    <text>coexpression of ASPP1</text>
  </EVENT>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="496" id="V1422855" paragraph="paragraph17" rule="-SIMPLE-REF" start="487" uttnum="90">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <EVENT end="599" id="V1422919" paragraph="paragraph17" rule="-RULE30_AGENT_AFFECTED" start="499" uttnum="90">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="599" id="V1422919" start="499">
      <type>ONT::STIMULATE</type>
      <text>ASPP2 with p53 enhanced the transcriptional activity of p53 on the Bax promoter–luciferase reporter</text>
    </predicate>
    <arg1 id="V1422872" role=":AGENT"/>
    <arg2 id="V1422934" role=":AFFECTED"/>
    <text>ASPP2 with p53 enhanced the transcriptional activity of p53 on the Bax promoter–luciferase reporter</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="505" id="V1422872" paragraph="paragraph17" rule="-SIMPLE-REF" start="499" uttnum="90">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="559" id="V1422934" paragraph="paragraph17" rule="-ACTIVITY1" start="523" uttnum="90">
    <type>ONT::ACTIVITY</type>
    <predicate end="559" id="V1422934" start="523">
      <type>ONT::ACTIVITY</type>
      <text>the transcriptional activity of p53</text>
    </predicate>
    <arg1 id="V1422974" role=":AGENT"/>
    <text>the transcriptional activity of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="514" id="V1422914" paragraph="paragraph17" rule="-SIMPLE-REF" start="510" uttnum="90">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="UP:P04637" end="559" id="V1422974" paragraph="paragraph17" rule="-SIMPLE-REF" start="552" uttnum="90">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="599" id="V1423016" paragraph="paragraph17" rule="-SIMPLE-REF" start="562" uttnum="90">
    <type>ONT::PROFESSIONAL</type>
    <name>REPORTER</name>
    <text>the Bax promoter–luciferase reporter</text>
  </TERM>
  <TERM dbid="HGNC:959|UP:Q07812" end="599" id="V1423013" paragraph="paragraph17" rule="-SIMPLE-REF" start="562" uttnum="90">
    <type>ONT::GENE</type>
    <name>BAX</name>
    <text>the Bax promoter–luciferase reporter</text>
  </TERM>
  <TERM end="590" id="V1423084" paragraph="paragraph17" rule="-EXPLICIT-REF-SEQ0B" start="570" uttnum="90">
    <type>ONT::MOLECULAR-PART</type>
    <components>
      <component id="V1422690"/>
      <component id="V1422701"/>
    </components>
    <text normalization="">promoter–luciferase</text>
  </TERM>
  <TERM end="590" id="V1422690" paragraph="paragraph17" rule="-EXPLICIT-REF-SEQ0B-TERM" start="570" uttnum="90">
    <type>ONT::PROMOTER</type>
    <name>PROMOTER</name>
    <text>promoter–luciferase</text>
  </TERM>
  <TERM dbid="XFAM:PF10285.6|XFAM:PF10284.6|XFAM:PF05295.8|XFAM:PF00296.17" end="590" id="V1422701" paragraph="paragraph17" rule="-SIMPLE-REF" start="579" uttnum="90">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>LUCIFERASE</name>
    <text>luciferase</text>
  </TERM>
  <EVENT end="680" id="V1436788" paragraph="paragraph17" rule="-RULE50_AGENT_AFFECTED-RESULT-ROBUST-AFFECTED-RESULT" start="651" uttnum="91">
    <type>ONT::EXPRESS</type>
    <predicate end="680" id="V1436788" start="651">
      <type>ONT::EXPRESS</type>
      <text>ASPP1, expression of HRASV12</text>
    </predicate>
    <arg1 id="V1436779" role=":AGENT"/>
    <arg2 id="V1436813" role=":AFFECTED-RESULT"/>
    <text>ASPP1, expression of HRASV12</text>
  </EVENT>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="658" id="V1436779" paragraph="paragraph17" rule="-SIMPLE-REF" start="651" uttnum="91">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1,</text>
  </TERM>
  <TERM end="680" id="V1436813" paragraph="paragraph17" rule="-RULE50_AGENT_AFFECTED-RESULT-ROBUST-AFFECTED-RESULT-TERM" start="651" uttnum="91">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>HRASV-12</name>
    <text>ASPP1, expression of HRASV12</text>
  </TERM>
  <TERM dbid="UP:P04637" end="738" id="V1436914" paragraph="paragraph17" rule="-SIMPLE-REF" start="731" uttnum="91">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="764" id="V1436986" paragraph="paragraph17" rule="-SIMPLE-REF" start="757" uttnum="91">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="813" id="V1450386" paragraph="paragraph17" rule="-SIMPLE-REF" start="807" uttnum="92">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="883" id="V1450451" paragraph="paragraph17" rule="-ACTIVITY1" start="847" uttnum="92">
    <type>ONT::ACTIVITY</type>
    <predicate end="883" id="V1450451" start="847">
      <type>ONT::ACTIVITY</type>
      <text>the transcriptional activity of p53</text>
    </predicate>
    <arg1 id="V1450491" role=":AGENT"/>
    <text>the transcriptional activity of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="883" id="V1450491" paragraph="paragraph17" rule="-SIMPLE-REF" start="876" uttnum="92">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM dbid="UP:P04637" end="947" id="V1464019" paragraph="paragraph17" rule="-SIMPLE-REF" start="941" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="961" id="V1464036" paragraph="paragraph17" rule="-LOGICALOP-REF" start="948" uttnum="93">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1464032"/>
      <member id="V1464073"/>
    </aggregate>
    <text normalization="">ASPP1 and p53</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="954" id="V1464032" paragraph="paragraph17" rule="-SIMPLE-REF" start="948" uttnum="93">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:P04637" end="961" id="V1464073" paragraph="paragraph17" rule="-SIMPLE-REF" start="958" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="968" id="V1464086" paragraph="paragraph17" rule="-SIMPLE-REF" start="962" uttnum="93">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="986" id="V1467977" paragraph="paragraph17" rule="-ROBUSTPRO" start="983" uttnum="93">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1000" id="V1467996" paragraph="paragraph17" rule="-SIMPLE-REF" start="995" uttnum="93">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>that</text>
  </TERM>
  <EVENT end="1136" id="V1468101" paragraph="paragraph17" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="1046" uttnum="93">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1136" id="V1468101" start="1046">
      <type>ONT::STIMULATE</type>
      <text>enhance the transcriptional activity of p53 by around three-folds (Figure 4b)</text>
    </predicate>
    <arg2 id="V1468116" role=":AFFECTED"/>
    <text>enhance the transcriptional activity of p53 by around three-folds (Figure 4b)</text>
  </EVENT>
  <EVENT end="1090" id="V1468116" paragraph="paragraph17" rule="-ACTIVITY1" start="1054" uttnum="93">
    <type>ONT::ACTIVITY</type>
    <predicate end="1090" id="V1468116" start="1054">
      <type>ONT::ACTIVITY</type>
      <text>the transcriptional activity of p53</text>
    </predicate>
    <arg1 id="V1468156" role=":AGENT"/>
    <text>the transcriptional activity of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="1090" id="V1468156" paragraph="paragraph17" rule="-SIMPLE-REF" start="1083" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="1135" id="V1468223" paragraph="paragraph17" rule="-SIMPLE-REF" start="1119" uttnum="93">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>B</name>
    <text>Figure 4b</text>
  </TERM>
  <TERM end="1135" id="V1468201" paragraph="paragraph17" rule="-SIMPLE-REF" start="1119" uttnum="93">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4b</text>
  </TERM>
  <EPI end="123" id="V1483313" paragraph="paragraph18" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="3" uttnum="94">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1483377" role=":FORMAL"/>
    <text>To demonstrate further that RAS activation is required to enhance the transcriptional activity of p53 via ASPP1 or ASPP2</text>
  </EPI>
  <CC end="123" id="V1483377" paragraph="paragraph18" rule="-NECESSARY3" start="26" uttnum="94">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V1483351" role=":FACTOR"/>
    <arg id="V1483406" role=":OUTCOME"/>
    <text>that RAS activation is required to enhance the transcriptional activity of p53 via ASPP1 or ASPP2</text>
  </CC>
  <EVENT end="46" id="V1483351" paragraph="paragraph18" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="31" uttnum="94">
    <type>ONT::ACTIVATE</type>
    <predicate end="46" id="V1483351" start="31">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V1483348" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000222"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="35" id="V1483348" paragraph="paragraph18" rule="-SIMPLE-REF" start="31" uttnum="94">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="123" id="V1483406" paragraph="paragraph18" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="61" uttnum="94">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="123" id="V1483406" start="61">
      <type>ONT::STIMULATE</type>
      <text>enhance the transcriptional activity of p53 via ASPP1 or ASPP2</text>
    </predicate>
    <arg2 id="V1483422" role=":AFFECTED"/>
    <text>enhance the transcriptional activity of p53 via ASPP1 or ASPP2</text>
  </EVENT>
  <EVENT end="105" id="V1483422" paragraph="paragraph18" rule="-ACTIVITY1" start="69" uttnum="94">
    <type>ONT::ACTIVITY</type>
    <predicate end="105" id="V1483422" start="69">
      <type>ONT::ACTIVITY</type>
      <text>the transcriptional activity of p53</text>
    </predicate>
    <arg1 id="V1483461" role=":AGENT"/>
    <text>the transcriptional activity of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="105" id="V1483461" paragraph="paragraph18" rule="-SIMPLE-REF" start="98" uttnum="94">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="123" id="V1483481" paragraph="paragraph18" rule="-LOGICALOP-REF" start="109" uttnum="94">
    <type>ONT::GENE</type>
    <aggregate operator="OR">
      <member id="V1483478"/>
      <member id="V1483495"/>
    </aggregate>
    <text normalization="">ASPP1 or ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="115" id="V1483478" paragraph="paragraph18" rule="-SIMPLE-REF" start="109" uttnum="94">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="123" id="V1483495" paragraph="paragraph18" rule="-SIMPLE-REF" start="118" uttnum="94">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="239" id="V1498427" paragraph="paragraph18" rule="-RULE5_AFFECTED_AFFECTED1" start="125" uttnum="94">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="239" id="V1498427" start="125">
      <type>ONT::TRANSFORM</type>
      <text>a wild-type RAS or a dominant negative form of HRAS–HRASN17 was co-transfected with ASPP2 and p53 into Saos2 cells</text>
    </predicate>
    <arg1 id="V1498249" role=":AFFECTED"/>
    <arg2 id="V1498457" role=":AFFECTED1"/>
    <text>a wild-type RAS or a dominant negative form of HRAS–HRASN17 was co-transfected with ASPP2 and p53 into Saos2 cells</text>
  </EVENT>
  <TERM end="223" id="V1498457" paragraph="paragraph18" rule="-LOGICALOP-REF" start="204" uttnum="94">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1498453"/>
      <member id="V1498494"/>
    </aggregate>
    <text normalization="">with ASPP2 and p53</text>
  </TERM>
  <TERM end="185" id="V1498249" paragraph="paragraph18" rule="-SIMPLE-REF-MUTATION7" start="125" uttnum="94">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILD-TYPE</name>
    <text>a wild-type RAS or a dominant negative form of HRAS–HRASN17</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="215" id="V1498453" paragraph="paragraph18" rule="-SIMPLE-REF" start="209" uttnum="94">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="223" id="V1498494" paragraph="paragraph18" rule="-SIMPLE-REF" start="219" uttnum="94">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="BTO:0000971" end="239" id="V1498529" paragraph="paragraph18" rule="-SIMPLE-REF" start="228" uttnum="94">
    <type>ONT::CELL-LINE</type>
    <name>SAOS-2-CELLS</name>
    <text>Saos2 cells</text>
  </TERM>
  <TERM end="141" id="V1498305" paragraph="paragraph18" rule="-SIMPLE-REF" start="137" uttnum="94">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="185" id="V1498373" paragraph="paragraph18" rule="-SIMPLE-REF" start="144" uttnum="94">
    <type>ONT::SHAPE</type>
    <name>FORM</name>
    <text>a dominant negative form of HRAS–HRASN17</text>
  </TERM>
  <TERM dbid="UP:P01112" end="176" id="V1497962" paragraph="paragraph18" rule="-SIMPLE-REF" start="172" uttnum="94">
    <type>ONT::PROTEIN</type>
    <name>HRAS</name>
    <text>HRAS</text>
  </TERM>
  <TERM end="253" id="V1513147" paragraph="paragraph18" rule="-SIMPLE-REF" start="241" uttnum="95">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>The results</text>
  </TERM>
  <TERM end="276" id="V1513225" paragraph="paragraph18" rule="-SIMPLE-REF" start="268" uttnum="95">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4</text>
  </TERM>
  <TERM end="301" id="V1513293" paragraph="paragraph18" rule="-SIMPLE-REF" start="296" uttnum="95">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>that</text>
  </TERM>
  <TERM dbid="UP:P04637" end="384" id="V1513495" paragraph="paragraph18" rule="-SIMPLE-REF" start="378" uttnum="95">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="412" id="V1525785" paragraph="paragraph18" rule="-SIMPLE-REF" start="405" uttnum="96">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2,</text>
  </TERM>
  <TERM dbid="UP:P04637" end="476" id="V1525888" paragraph="paragraph18" rule="-SIMPLE-REF" start="469" uttnum="96">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <EVENT end="552" id="V1539553" paragraph="paragraph18" rule="-RULE5_AFFECTED_AFFECTED1-ROBUST-AFFECTED" start="501" uttnum="97">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="552" id="V1539553" start="501">
      <type>ONT::TRANSFORM</type>
      <text>When HRASN17 was co-transfected with ASPP2 and p53,</text>
    </predicate>
    <arg1 id="V1539521" role=":AFFECTED"/>
    <arg2 id="V1539583" role=":AFFECTED1"/>
    <text>When HRASN17 was co-transfected with ASPP2 and p53,</text>
  </EVENT>
  <TERM end="552" id="V1539521" paragraph="paragraph18" rule="-RULE5_AFFECTED_AFFECTED1-ROBUST-AFFECTED-TERM" start="501" uttnum="97">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>HRASN-17</name>
    <text>When HRASN17 was co-transfected with ASPP2 and p53,</text>
  </TERM>
  <TERM end="552" id="V1539583" paragraph="paragraph18" rule="-LOGICALOP-REF" start="533" uttnum="97">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1539579"/>
      <member id="V1539620"/>
    </aggregate>
    <text normalization="">with ASPP2 and p53,</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="544" id="V1539579" paragraph="paragraph18" rule="-SIMPLE-REF" start="538" uttnum="97">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="552" id="V1539620" paragraph="paragraph18" rule="-SIMPLE-REF" start="548" uttnum="97">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53,</text>
  </TERM>
  <TERM dbid="UP:P04637" end="589" id="V1553632" paragraph="paragraph18" rule="-SIMPLE-REF" start="582" uttnum="97">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="633" id="V1553946" paragraph="paragraph18" rule="-SIMPLE-REF" start="628" uttnum="98">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="672" id="V1555242" paragraph="paragraph18" rule="-SIMPLE-REF" start="668" uttnum="98">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="UP:P04637" end="740" id="V1555410" paragraph="paragraph18" rule="-SIMPLE-REF" start="736" uttnum="98">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EVENT end="769" id="V1555434" paragraph="paragraph18" rule="-ACTIVITY1" start="744" uttnum="98">
    <type>ONT::ACTIVITY</type>
    <predicate end="769" id="V1555434" start="744">
      <type>ONT::ACTIVITY</type>
      <text>ASPP2 activity more than</text>
    </predicate>
    <arg1 id="V1555430" role=":AGENT"/>
    <text>ASPP2 activity more than</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="750" id="V1555430" paragraph="paragraph18" rule="-SIMPLE-REF" start="744" uttnum="98">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="802" id="V1571884" paragraph="paragraph18" rule="-SIMPLE-REF" start="798" uttnum="98">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="FA:00278" end="822" id="V1571901" paragraph="paragraph18" rule="-SIMPLE-REF" start="806" uttnum="98">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPP</name>
    <text normalization="">endogenous ASPP</text>
  </TERM>
  <TERM end="865" id="V1587213" paragraph="paragraph18" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="851" uttnum="99">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>RAS</name>
    <text normalization="">wild-type RAS</text>
  </TERM>
  <EVENT end="926" id="V1587247" paragraph="paragraph18" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="869" uttnum="99">
    <type>ONT::MODULATE</type>
    <predicate end="926" id="V1587247" start="869">
      <type>ONT::MODULATE</type>
      <text>very little effect on the transactivation function of p53</text>
    </predicate>
    <arg2 id="V1587297" role=":AFFECTED"/>
    <text>very little effect on the transactivation function of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="926" id="V1587354" paragraph="paragraph18" rule="-SIMPLE-REF" start="920" uttnum="99">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <EVENT end="911" id="V1587297" paragraph="paragraph18" rule="-RULE40A_AGENT_AFFECTED-MODA1_1-NONE" start="888" uttnum="99">
    <type>ONT::ACTIVATE</type>
    <mods>
      <mod>
        <type>ONT::ACROSS</type>
        <value>TRANS-</value>
      </mod>
    </mods>
    <predicate end="911" id="V1587297" start="888">
      <type>ONT::ACTIVATE</type>
      <text>on the transactivation</text>
    </predicate>
    <text>on the transactivation</text>
  </EVENT>
  <TERM end="981" id="V1600520" paragraph="paragraph18" rule="-INEVENT2B,-SIMPLE-REF" start="962" uttnum="100">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <inevent>
        <event id="V1600513"/>
      </inevent>
    </features>
    <name>RAS</name>
    <text normalization="">that increased RAS</text>
  </TERM>
  <EVENT end="981" id="V1600513" paragraph="paragraph18" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="962" uttnum="100">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="981" id="V1600513" start="962">
      <type>ONT::INCREASE</type>
      <text>that increased RAS</text>
    </predicate>
    <arg2 id="V1600520" role=":AFFECTED"/>
    <text>that increased RAS</text>
  </EVENT>
  <TERM end="1057" id="V1600647" paragraph="paragraph18" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="1041" uttnum="100">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V1600703"/>
    </features>
    <name>RAS-GTP</name>
    <text normalization="">RAS–GTP in cells</text>
  </TERM>
  <TERM end="1057" id="V1600703" paragraph="paragraph18" rule="-SIMPLE-REF" start="1052" uttnum="100">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <EPI end="13" id="V1615301" paragraph="paragraph19" rule="-RULE50_0_AGENT_NEUTRAL-AGENT" start="3" uttnum="101">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg1 id="V1615296" role=":AGENT"/>
    <text>We tested</text>
  </EPI>
  <TERM end="6" id="V1615296" paragraph="paragraph19" rule="-ROBUSTPRO" start="3" uttnum="101">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="75" id="V1615362" paragraph="paragraph19" rule="-SIMPLE-REF" start="42" uttnum="101">
    <type>ONT::GENE</type>
    <name>ONCOGENE</name>
    <text>of RAS oncogene</text>
  </TERM>
  <TERM end="66" id="V1615358" paragraph="paragraph19" rule="-SIMPLE-REF" start="53" uttnum="101">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="99" id="V1615412" paragraph="paragraph19" rule="-SIMPLE-REF" start="88" uttnum="101">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>with ASPP2</text>
  </TERM>
  <EVENT end="139" id="V1615441" paragraph="paragraph19" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="102" uttnum="101">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="139" id="V1615441" start="102">
      <type>ONT::STIMULATE</type>
      <text>enhance p53 transcriptional activity</text>
    </predicate>
    <arg2 id="V1615481" role=":AFFECTED"/>
    <text>enhance p53 transcriptional activity</text>
  </EVENT>
  <EVENT end="139" id="V1615481" paragraph="paragraph19" rule="-ACTIVITY1" start="110" uttnum="101">
    <type>ONT::ACTIVITY</type>
    <predicate end="139" id="V1615481" start="110">
      <type>ONT::ACTIVITY</type>
      <text>p53 transcriptional activity</text>
    </predicate>
    <arg1 id="V1615472" role=":AGENT"/>
    <text>p53 transcriptional activity</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="114" id="V1615472" paragraph="paragraph19" rule="-SIMPLE-REF" start="110" uttnum="101">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="159" id="V1615504" paragraph="paragraph19" rule="-SIMPLE-REF" start="142" uttnum="101">
    <type>ONT::PROMOTER</type>
    <name>PROMOTER</name>
    <text>promoter-specific</text>
  </TERM>
  <TERM dbid="UP:P04637" end="171" id="V1630792" paragraph="paragraph19" rule="-SIMPLE-REF" start="161" uttnum="102">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>Three p53</text>
  </TERM>
  <TERM end="191" id="V1630809" paragraph="paragraph19" rule="-SIMPLE-REF" start="178" uttnum="102">
    <type>ONT::PROMOTER</type>
    <name>PROMOTER</name>
    <text>gene promoter</text>
  </TERM>
  <TERM end="212" id="V1630825" paragraph="paragraph19" rule="-SIMPLE-REF" start="192" uttnum="102">
    <type>ONT::PROFESSIONAL</type>
    <name>REPORTER</name>
    <text>containing reporters</text>
  </TERM>
  <TERM dbid="HGNC:14492|HGNC:19373|UP:Q53FA7|UP:Q8IXM3" end="248" id="V1630857" paragraph="paragraph19" rule="-SIMPLE-REF" start="214" uttnum="102">
    <type>ONT::GENE</type>
    <name>PIG-3</name>
    <text>PIG3-, Bax- and Mdm2-luciferases,</text>
  </TERM>
  <TERM end="191" id="V1630804" paragraph="paragraph19" rule="-SIMPLE-REF" start="178" uttnum="102">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>gene promoter</text>
  </TERM>
  <TERM end="246" id="V1630877" paragraph="paragraph19" rule="-LOGICALOP-REF" start="221" uttnum="102">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1630873"/>
      <member id="V1630903"/>
    </aggregate>
    <text normalization="">Bax- and Mdm2-luciferases</text>
  </TERM>
  <TERM dbid="HGNC:959|UP:Q07812" end="226" id="V1630873" paragraph="paragraph19" rule="-SIMPLE-REF" start="221" uttnum="102">
    <type>ONT::GENE</type>
    <name>BAX</name>
    <text>Bax-</text>
  </TERM>
  <TERM dbid="GO:0047077|GO:0050397|GO:0047712|GO:0045289|GO:0050248" end="246" id="V1630903" paragraph="paragraph19" rule="-SIMPLE-REF" start="230" uttnum="102">
    <type>ONT::PROTEIN</type>
    <name>LUCIFERASES</name>
    <text>Mdm2-luciferases</text>
  </TERM>
  <TERM dbid="UP:Q00987|HGNC:6973" end="246" id="V1630893" paragraph="paragraph19" rule="-SIMPLE-REF" start="230" uttnum="102">
    <type>ONT::GENE</type>
    <name>MDM-2</name>
    <text>Mdm2-luciferases</text>
  </TERM>
  <TERM end="262" id="V1642947" paragraph="paragraph19" rule="-ROBUSTPRO" start="259" uttnum="103">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="360" id="V1643025" paragraph="paragraph19" rule="-RULE10_AGENT_AFFECTED" start="288" uttnum="103">
    <type>ONT::MODULATE</type>
    <predicate end="360" id="V1643025" start="288">
      <type>ONT::MODULATE</type>
      <text>the most profound effect on the transcriptional activity of p53 on PIG3</text>
    </predicate>
    <arg1 id="V1643160" role=":AGENT"/>
    <text>the most profound effect on the transcriptional activity of p53 on PIG3</text>
  </EVENT>
  <TERM dbid="HGNC:14492|HGNC:19373|UP:Q53FA7|UP:Q8IXM3" end="360" id="V1643160" paragraph="paragraph19" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="345" uttnum="103">
    <type>ONT::GENE</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>PIG-3</name>
    <text>of p53 on PIG3</text>
  </TERM>
  <TERM dbid="UP:P04637" end="352" id="V1643113" paragraph="paragraph19" rule="-SIMPLE-REF" start="348" uttnum="103">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="HGNC:959|UP:Q07812" end="368" id="V1643175" paragraph="paragraph19" rule="-SIMPLE-REF" start="364" uttnum="103">
    <type>ONT::GENE</type>
    <name>BAX</name>
    <text>BAX</text>
  </TERM>
  <TERM end="377" id="V1643178" paragraph="paragraph19" rule="-SIMPLE-REF" start="368" uttnum="103">
    <type>ONT::PROMOTER</type>
    <name>PROMOTER</name>
    <text>promoters</text>
  </TERM>
  <EPI end="461" id="V1652777" paragraph="paragraph19" rule="-RULE50_0_AGENT_NEUTRAL-NEUTRAL" start="379" uttnum="104">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1652750" role=":NEUTRAL"/>
    <text>Under the same conditions, a reduced stimulatory effect was seen on Mdm2 promoter</text>
  </EPI>
  <EVENT end="461" id="V1652750" paragraph="paragraph19" rule="-INEVENT2B,-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE10_AGENT_AFFECTED-NONE" start="379" uttnum="104">
    <type>ONT::MODULATE</type>
    <epistemic-modality id="V1652777"/>
    <predicate end="461" id="V1652750" start="379">
      <type>ONT::MODULATE</type>
      <text>Under the same conditions, a reduced stimulatory effect was seen on Mdm2 promoter</text>
    </predicate>
    <text>Under the same conditions, a reduced stimulatory effect was seen on Mdm2 promoter</text>
  </EVENT>
  <EVENT end="435" id="V1652739" paragraph="paragraph19" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="406" uttnum="104">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="435" id="V1652739" start="406">
      <type>ONT::DECREASE</type>
      <text>a reduced stimulatory effect</text>
    </predicate>
    <arg2 id="V1652750" role=":AFFECTED"/>
    <text>a reduced stimulatory effect</text>
  </EVENT>
  <TERM dbid="UP:Q00987|HGNC:6973" end="461" id="V1652831" paragraph="paragraph19" rule="-EXPLICIT-REF1" start="447" uttnum="104">
    <type>ONT::PROMOTER</type>
    <name>MDM-2</name>
    <assoc-with id="V1652828"/>
    <text>Mdm2 promoter</text>
  </TERM>
  <TERM dbid="UP:Q00987|HGNC:6973" end="452" id="V1652828" paragraph="paragraph19" rule="-SIMPLE-REF" start="447" uttnum="104">
    <type>ONT::GENE</type>
    <name>MDM-2</name>
    <text>Mdm2</text>
  </TERM>
  <TERM end="484" id="V1652868" paragraph="paragraph19" rule="-SIMPLE-REF" start="468" uttnum="104">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 4d</text>
  </TERM>
  <TERM end="484" id="V1652841" paragraph="paragraph19" rule="-SIMPLE-REF" start="468" uttnum="104">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4d</text>
  </TERM>
  <TERM end="540" id="V1670236" paragraph="paragraph19" rule="-SIMPLE-REF" start="499" uttnum="105">
    <type>ONT::CLINICAL-FINDING</type>
    <name>FINDING</name>
    <text>with our previous finding that ASPP2 has</text>
  </TERM>
  <TERM end="540" id="V1670230" paragraph="paragraph19" rule="-ROBUSTPRO" start="499" uttnum="105">
    <type>ONT::PERSON</type>
    <text>with our previous finding that ASPP2 has</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="536" id="V1670274" paragraph="paragraph19" rule="-SIMPLE-REF" start="530" uttnum="105">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="631" id="V1670297" paragraph="paragraph19" rule="-RULE10_AGENT_AFFECTED" start="540" uttnum="105">
    <type>ONT::MODULATE</type>
    <predicate end="631" id="V1670297" start="540">
      <type>ONT::MODULATE</type>
      <text>minimal impact on the transcriptional activity of p53 on the promoters of Mdm2 and p21</text>
    </predicate>
    <arg1 id="V1670383" role=":AGENT"/>
    <text>minimal impact on the transcriptional activity of p53 on the promoters of Mdm2 and p21</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="631" id="V1670383" paragraph="paragraph19" rule="-SIMPLE-REF" start="587" uttnum="105">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53 on the promoters of Mdm2 and p21</text>
  </TERM>
  <TERM end="611" id="V1670420" paragraph="paragraph19" rule="-SIMPLE-REF" start="597" uttnum="105">
    <type>ONT::PROMOTER</type>
    <name>PROMOTER</name>
    <text>the promoters</text>
  </TERM>
  <TERM end="631" id="V1670441" paragraph="paragraph19" rule="-LOGICALOP-REF" start="614" uttnum="105">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1670437"/>
      <member id="V1670478"/>
    </aggregate>
    <text normalization="">Mdm2 and p21</text>
  </TERM>
  <TERM dbid="UP:Q00987|HGNC:6973" end="619" id="V1670437" paragraph="paragraph19" rule="-SIMPLE-REF" start="614" uttnum="105">
    <type>ONT::GENE</type>
    <name>MDM-2</name>
    <text>Mdm2</text>
  </TERM>
  <TERM dbid="UP:Q15170|XFAM:PF02234|UP:Q62092|HGNC:11616|UP:P38936|XFAM:PF06387|UP:P63028|HGNC:1784|UP:P39689|XFAM:PF00838" end="631" id="V1670478" paragraph="paragraph19" rule="-SIMPLE-REF" start="623" uttnum="105">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-21</name>
    <text>p21</text>
  </TERM>
  <TERM dbid="UP:P38936|HGNC:1784" end="641" id="V1670488" paragraph="paragraph19" rule="-SIMPLE-REF" start="631" uttnum="105">
    <type>ONT::GENE</type>
    <name>WAF-1</name>
    <text>waf1</text>
  </TERM>
  <TERM dbid="UP:P38936|HGNC:1784" end="690" id="V1670518" paragraph="paragraph19" rule="-SIMPLE-REF" start="680" uttnum="105">
    <type>ONT::GENE</type>
    <name>WAF-1</name>
    <text>with this,</text>
  </TERM>
  <TERM end="694" id="V1680751" paragraph="paragraph19" rule="-ROBUSTPRO" start="691" uttnum="105">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="UP:Q15170|XFAM:PF02234|UP:Q62092|HGNC:11616|UP:P38936|XFAM:PF06387|UP:P63028|HGNC:1784|UP:P39689|XFAM:PF00838" end="721" id="V1680812" paragraph="paragraph19" rule="-SIMPLE-REF" start="708" uttnum="105">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-21</name>
    <text>that p21</text>
  </TERM>
  <TERM dbid="UP:P38936|HGNC:1784" end="732" id="V1680822" paragraph="paragraph19" rule="-SIMPLE-REF" start="721" uttnum="105">
    <type>ONT::GENE</type>
    <name>WAF-1</name>
    <text>waf1</text>
  </TERM>
  <TERM dbid="CHEBI:33699" end="805" id="V1680858" paragraph="paragraph19" rule="-SIMPLE-REF" start="732" uttnum="105">
    <type>ONT::MRNA</type>
    <name>MRNA</name>
    <text>mRNA expression induced by activated RAS in HKe3 cells is independent of</text>
  </TERM>
  <EVENT end="787" id="V1680864" paragraph="paragraph19" rule="-INEVENT2B,-RULE50_AGENT_AFFECTED-RESULT-NONE" start="737" uttnum="105">
    <type>ONT::EXPRESS</type>
    <predicate end="787" id="V1680864" start="737">
      <type>ONT::EXPRESS</type>
      <text>expression induced by activated RAS in HKe3 cells</text>
    </predicate>
    <text>expression induced by activated RAS in HKe3 cells</text>
  </EVENT>
  <CC end="805" id="V1681053" paragraph="paragraph19" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="732" uttnum="105">
    <type>ONT::INDEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V1680858" role=":FACTOR"/>
    <arg id="V1680864" role=":OUTCOME"/>
    <text>mRNA expression induced by activated RAS in HKe3 cells is independent of</text>
  </CC>
  <CC end="787" id="V1680875" paragraph="paragraph19" rule="-RULE5B_AGENT_AFFECTED" start="737" uttnum="105">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1680912" role=":FACTOR"/>
    <arg id="V1680864" role=":OUTCOME"/>
    <text>expression induced by activated RAS in HKe3 cells</text>
  </CC>
  <TERM end="787" id="V1680912" paragraph="paragraph19" rule="-INEVENT2B,-SIMPLE-REF" start="756" uttnum="105">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">by activated RAS in HKe3 cells</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="787" id="V1680906" paragraph="paragraph19" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="756" uttnum="105">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="787" id="V1680906" start="756">
      <type>ONT::ACTIVATE</type>
      <text>by activated RAS in HKe3 cells</text>
    </predicate>
    <arg2 id="V1680912" role=":RESULT"/>
    <arg id="R000051" role=":AFFECTED"/>
    <text>by activated RAS in HKe3 cells</text>
  </EVENT>
  <TERM dbid="BTO:0003469" end="787" id="V1681031" paragraph="paragraph19" rule="-SIMPLE-REF" start="776" uttnum="105">
    <type>ONT::CELL</type>
    <name>HKE-3-CELLS</name>
    <text>HKe3 cells</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="811" id="V1681080" paragraph="paragraph19" rule="-SIMPLE-REF" start="805" uttnum="105">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="817" id="V1681089" paragraph="paragraph19" rule="-SIMPLE-REF" start="811" uttnum="105">
    <type>ONT::NONESSENTIAL-CONTRACT</type>
    <name>STATUS</name>
    <text>status</text>
  </TERM>
  <EVENT end="897" id="V1692647" paragraph="paragraph19" rule="-RULE10_AGENT_AFFECTED" start="819" uttnum="105">
    <type>ONT::MODULATE</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <modality>ONT::DO</modality>
    <predicate end="897" id="V1692647" start="819">
      <type>ONT::MODULATE</type>
      <text>as ASPP2 knockdown in these cells did not alter p21waf1 expression</text>
    </predicate>
    <arg1 id="V1692608" role=":AGENT"/>
    <arg2 id="V1692696" role=":AFFECTED"/>
    <text>as ASPP2 knockdown in these cells did not alter p21waf1 expression</text>
  </EVENT>
  <TERM end="853" id="V1692608" paragraph="paragraph19" rule="-SIMPLE-REF" start="847" uttnum="105">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <EVENT end="897" id="V1692696" paragraph="paragraph19" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="867" uttnum="105">
    <type>ONT::EXPRESS</type>
    <predicate end="897" id="V1692696" start="867">
      <type>ONT::EXPRESS</type>
      <text>p21waf1 expression</text>
    </predicate>
    <arg2 id="V1692690" role=":AFFECTED-RESULT"/>
    <text>p21waf1 expression</text>
  </EVENT>
  <EVENT end="838" id="V1692546" paragraph="paragraph19" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="822" uttnum="105">
    <type>ONT::TRANSFORM</type>
    <predicate end="838" id="V1692546" start="822">
      <type>ONT::TRANSFORM</type>
      <text>ASPP2 knockdown</text>
    </predicate>
    <arg2 id="V1692540" role=":AFFECTED"/>
    <text>ASPP2 knockdown</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="828" id="V1692540" paragraph="paragraph19" rule="-SIMPLE-REF" start="822" uttnum="105">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="847" id="V1692603" paragraph="paragraph19" rule="-ROBUSTPRO" start="841" uttnum="105">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>these</text>
  </TERM>
  <TERM dbid="UP:P38936|HGNC:1784" end="886" id="V1692690" paragraph="paragraph19" rule="-SIMPLE-REF" start="867" uttnum="105">
    <type>ONT::GENE</type>
    <name>WAF-1</name>
    <text>p21waf1</text>
  </TERM>
  <TERM dbid="UP:Q15170|XFAM:PF02234|UP:Q62092|HGNC:11616|UP:P38936|XFAM:PF06387|UP:P63028|HGNC:1784|UP:P39689|XFAM:PF00838" end="886" id="V1692680" paragraph="paragraph19" rule="-SIMPLE-REF" start="867" uttnum="105">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-21</name>
    <text>p21waf1</text>
  </TERM>
  <MODALITY end="897" id="X1708940" paragraph="paragraph19" rule="-MODALITY" start="819" uttnum="105">
    <type>ONT::DO</type>
    <arg2 id="V1692647" role=":EVENT"/>
    <text>as ASPP2 knockdown in these cells did not alter p21waf1 expression</text>
  </MODALITY>
  <TERM end="925" id="V1692720" paragraph="paragraph19" rule="-SIMPLE-REF" start="904" uttnum="105">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure</text>
  </TERM>
  <TERM end="37" id="V1708988" paragraph="paragraph20" rule="-SIMPLE-REF" start="22" uttnum="106">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">endogenous RAS</text>
  </TERM>
  <EVENT end="86" id="V1709017" paragraph="paragraph20" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="40" uttnum="106">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="86" id="V1709017" start="40">
      <type>ONT::STIMULATE</type>
      <text>stimulate the transcriptional activity of p53</text>
    </predicate>
    <arg2 id="V1709034" role=":AFFECTED"/>
    <text>stimulate the transcriptional activity of p53</text>
  </EVENT>
  <EVENT end="86" id="V1709034" paragraph="paragraph20" rule="-ACTIVITY1" start="50" uttnum="106">
    <type>ONT::ACTIVITY</type>
    <predicate end="86" id="V1709034" start="50">
      <type>ONT::ACTIVITY</type>
      <text>the transcriptional activity of p53</text>
    </predicate>
    <arg1 id="V1709074" role=":AGENT"/>
    <text>the transcriptional activity of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="86" id="V1709074" paragraph="paragraph20" rule="-SIMPLE-REF" start="79" uttnum="106">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="96" id="V1709091" paragraph="paragraph20" rule="-SIMPLE-REF" start="90" uttnum="106">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="139" id="V1709154" paragraph="paragraph20" rule="-LOGICALOP-REF" start="127" uttnum="106">
    <type>ONT::PROTEIN</type>
    <aggregate operator="OR">
      <member id="V1709151"/>
      <member id="V1709163"/>
    </aggregate>
    <text normalization="">HRAS or KRAS</text>
  </TERM>
  <TERM dbid="UP:P01112" end="132" id="V1709151" paragraph="paragraph20" rule="-SIMPLE-REF" start="127" uttnum="106">
    <type>ONT::PROTEIN</type>
    <name>HRAS</name>
    <text>HRAS</text>
  </TERM>
  <TERM dbid="UP:P01116" end="139" id="V1709163" paragraph="paragraph20" rule="-SIMPLE-REF" start="135" uttnum="106">
    <type>ONT::PROTEIN</type>
    <name>KRAS</name>
    <text>KRAS</text>
  </TERM>
  <TERM end="158" id="V1725186" paragraph="paragraph20" rule="-SIMPLE-REF" start="141" uttnum="107">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>Their ability to</text>
  </TERM>
  <TERM end="158" id="V1725174" paragraph="paragraph20" rule="-ROBUSTPRO" start="141" uttnum="107">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>Their ability to</text>
  </TERM>
  <EVENT end="215" id="V1725247" paragraph="paragraph20" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="178" uttnum="107">
    <type>ONT::EXPRESS</type>
    <predicate end="215" id="V1725247" start="178">
      <type>ONT::EXPRESS</type>
      <text>the expression level of HRAS or KRAS</text>
    </predicate>
    <site end="199" id="V1725254" start="178">
      <type>ONT::LEVEL</type>
      <text normalization="LEVEL">the expression level</text>
    </site>
    <text>the expression level of HRAS or KRAS</text>
  </EVENT>
  <TERM end="215" id="V1725279" paragraph="paragraph20" rule="-LOGICALOP-REF" start="202" uttnum="107">
    <type>ONT::PROTEIN</type>
    <aggregate operator="OR">
      <member id="V1725276"/>
      <member id="V1725288"/>
    </aggregate>
    <text normalization="">HRAS or KRAS</text>
  </TERM>
  <TERM dbid="UP:P01112" end="207" id="V1725276" paragraph="paragraph20" rule="-SIMPLE-REF" start="202" uttnum="107">
    <type>ONT::PROTEIN</type>
    <name>HRAS</name>
    <text>HRAS</text>
  </TERM>
  <TERM dbid="UP:P01116" end="215" id="V1725288" paragraph="paragraph20" rule="-SIMPLE-REF" start="210" uttnum="107">
    <type>ONT::PROTEIN</type>
    <name>KRAS</name>
    <text>KRAS</text>
  </TERM>
  <TERM end="266" id="V1725361" paragraph="paragraph20" rule="-SIMPLE-REF" start="236" uttnum="107">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>B</name>
    <text>Supplementary Figure 4b</text>
  </TERM>
  <TERM end="266" id="V1725339" paragraph="paragraph20" rule="-SIMPLE-REF" start="236" uttnum="107">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure 4b</text>
  </TERM>
  <TERM end="272" id="V1739395" paragraph="paragraph20" rule="-ROBUSTPRO" start="269" uttnum="108">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="GO:0016246" end="288" id="V1739482" paragraph="paragraph20" rule="-SIMPLE-REF" start="283" uttnum="108">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>RNAI</name>
    <text>RNAi</text>
  </TERM>
  <TERM end="309" id="V1739497" paragraph="paragraph20" rule="-LOGICALOP-REF" start="296" uttnum="108">
    <type>ONT::PROTEIN</type>
    <aggregate operator="OR">
      <member id="V1739494"/>
      <member id="V1739506"/>
    </aggregate>
    <text normalization="">HRAS or KRAS</text>
  </TERM>
  <TERM dbid="UP:P01112" end="301" id="V1739494" paragraph="paragraph20" rule="-SIMPLE-REF" start="296" uttnum="108">
    <type>ONT::PROTEIN</type>
    <name>HRAS</name>
    <text>HRAS</text>
  </TERM>
  <TERM dbid="UP:P01116" end="309" id="V1739506" paragraph="paragraph20" rule="-SIMPLE-REF" start="304" uttnum="108">
    <type>ONT::PROTEIN</type>
    <name>KRAS</name>
    <text>KRAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="339" id="V1739568" paragraph="paragraph20" rule="-SIMPLE-REF" start="330" uttnum="108">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2</text>
  </TERM>
  <EVENT end="372" id="V1739597" paragraph="paragraph20" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="342" uttnum="108">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="372" id="V1739597" start="342">
      <type>ONT::STIMULATE</type>
      <text>stimulate the transactivation</text>
    </predicate>
    <arg2 id="V1739617" role=":AFFECTED"/>
    <text>stimulate the transactivation</text>
  </EVENT>
  <EVENT end="372" id="V1739617" paragraph="paragraph20" rule="-RULE40A_AGENT_AFFECTED-MODA1_1-NONE" start="352" uttnum="108">
    <type>ONT::ACTIVATE</type>
    <mods>
      <mod>
        <type>ONT::ACROSS</type>
        <value>TRANS-</value>
      </mod>
    </mods>
    <predicate end="372" id="V1739617" start="352">
      <type>ONT::ACTIVATE</type>
      <text>the transactivation</text>
    </predicate>
    <text>the transactivation</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="405" id="V1739673" paragraph="paragraph20" rule="-SIMPLE-REF" start="384" uttnum="108">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53 on the promoters</text>
  </TERM>
  <TERM end="405" id="V1739710" paragraph="paragraph20" rule="-SIMPLE-REF" start="391" uttnum="108">
    <type>ONT::PROMOTER</type>
    <name>PROMOTER</name>
    <text>the promoters</text>
  </TERM>
  <TERM end="439" id="V1739745" paragraph="paragraph20" rule="-SIMPLE-REF" start="426" uttnum="108">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>gene</text>
  </TERM>
  <TERM dbid="HGNC:959|UP:Q07812" end="452" id="V1739752" paragraph="paragraph20" rule="-SIMPLE-REF" start="439" uttnum="108">
    <type>ONT::GENE</type>
    <name>BAX</name>
    <text>Bax</text>
  </TERM>
  <TERM end="466" id="V1739762" paragraph="paragraph20" rule="-SIMPLE-REF" start="459" uttnum="108">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="475" id="V1739779" paragraph="paragraph20" rule="-SIMPLE-REF" start="467" uttnum="108">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>e</text>
  </TERM>
  <TERM end="531" id="V1739838" paragraph="paragraph20" rule="-SIMPLE-REF" start="524" uttnum="108">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="593" id="V1753824" paragraph="paragraph20" rule="-LOGICALOP-REF" start="572" uttnum="109">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V1753820"/>
      <member id="V1753840"/>
    </aggregate>
    <text normalization="">that ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="612" id="V1753861" paragraph="paragraph20" rule="-SIMPLE-REF" start="603" uttnum="109">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with RAS</text>
  </TERM>
  <TERM end="572" id="V1753796" paragraph="paragraph20" rule="-SIMPLE-REF" start="561" uttnum="109">
    <type>ONT::MENTAL-OBJECT</type>
    <name>NOTION</name>
    <text>the notion</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="583" id="V1753820" paragraph="paragraph20" rule="-SIMPLE-REF" start="572" uttnum="109">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>that ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="593" id="V1753840" paragraph="paragraph20" rule="-SIMPLE-REF" start="587" uttnum="109">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="678" id="V1753890" paragraph="paragraph20" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="615" uttnum="109">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="678" id="V1753890" start="615">
      <type>ONT::STIMULATE</type>
      <text>enhance the transcriptional activity of p53 for apoptotic genes</text>
    </predicate>
    <arg2 id="V1753905" role=":AFFECTED"/>
    <text>enhance the transcriptional activity of p53 for apoptotic genes</text>
  </EVENT>
  <EVENT end="659" id="V1753905" paragraph="paragraph20" rule="-ACTIVITY1" start="623" uttnum="109">
    <type>ONT::ACTIVITY</type>
    <predicate end="659" id="V1753905" start="623">
      <type>ONT::ACTIVITY</type>
      <text>the transcriptional activity of p53</text>
    </predicate>
    <arg1 id="V1753945" role=":AGENT"/>
    <text>the transcriptional activity of p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="659" id="V1753945" paragraph="paragraph20" rule="-SIMPLE-REF" start="652" uttnum="109">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM end="678" id="V1753979" paragraph="paragraph20" rule="-SIMPLE-REF" start="663" uttnum="109">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>apoptotic genes</text>
  </TERM>
  <TERM end="685" id="V1766714" paragraph="paragraph20" rule="-SIMPLE-REF" start="680" uttnum="110">
    <type>ONT::MENTAL-OBJECT</type>
    <name>NOTION</name>
    <text>This</text>
  </TERM>
  <EVENT end="792" id="V1766836" paragraph="paragraph20" rule="-RULE20C_AFFECTED_AFFECTED1-LOC5-GD-NONE" start="740" uttnum="110">
    <type>ONT::BIND</type>
    <predicate end="792" id="V1766836" start="740">
      <type>ONT::BIND</type>
      <text>interaction between active RAS and RAD of the ASPPs,</text>
    </predicate>
    <site end="792" id="V1766836" start="740">
      <type>ONT::BIND</type>
      <text normalization="">interaction between active RAS and RAD of the ASPPs,</text>
    </site>
    <text>interaction between active RAS and RAD of the ASPPs,</text>
  </EVENT>
  <TERM end="771" id="V1766861" paragraph="paragraph20" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="760" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM dbid="FA:00278" end="792" id="V1766915" paragraph="paragraph20" rule="-SIMPLE-REF" start="782" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPPS</name>
    <text normalization="">the ASPPs,</text>
  </TERM>
  <TERM dbid="HGNC:10446|UP:P55042" end="838" id="V1779296" paragraph="paragraph20" rule="-SIMPLE-REF" start="817" uttnum="110">
    <type>ONT::GENE</type>
    <name>RAD</name>
    <text>the RAD of the ASPPs</text>
  </TERM>
  <TERM dbid="FA:00278" end="838" id="V1779329" paragraph="paragraph20" rule="-SIMPLE-REF" start="828" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPPS</name>
    <text normalization="">the ASPPs</text>
  </TERM>
  <EVENT end="921" id="V1779446" paragraph="paragraph20" rule="-ACTIVITY1" start="886" uttnum="110">
    <type>ONT::ACTIVITY</type>
    <predicate end="921" id="V1779446" start="886">
      <type>ONT::ACTIVITY</type>
      <text>the transcriptional activity of p53</text>
    </predicate>
    <arg1 id="V1779485" role=":AGENT"/>
    <text>the transcriptional activity of p53</text>
  </EVENT>
  <TERM dbid="FA:00278" end="875" id="V1779382" paragraph="paragraph20" rule="-SIMPLE-REF" start="854" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPPS</name>
    <text normalization="">their full potential</text>
  </TERM>
  <TERM dbid="UP:P04637" end="921" id="V1779485" paragraph="paragraph20" rule="-SIMPLE-REF" start="915" uttnum="110">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <EVENT end="37" id="V1794273" paragraph="paragraph21" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="22" uttnum="111">
    <type>ONT::ACTIVATE</type>
    <predicate end="37" id="V1794273" start="22">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V1794269" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000227"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="26" id="V1794269" paragraph="paragraph21" rule="-SIMPLE-REF" start="22" uttnum="111">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="87" id="V1794372" paragraph="paragraph21" rule="-SIMPLE-REF" start="81" uttnum="111">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <EPI end="164" id="V1794414" paragraph="paragraph21" rule="-RULE50_0_AGENT_FORMAL-NONE" start="91" uttnum="111">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1794392" role=":NEUTRAL"/>
    <text>ASPP2 was tested in two human cancer cell lines with wild-type p53: MCF7</text>
  </EPI>
  <TERM dbid="UP:Q13625|HGNC:12000" end="97" id="V1794392" paragraph="paragraph21" rule="-SIMPLE-REF" start="91" uttnum="111">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="EFO:0001639" end="157" id="V1794521" paragraph="paragraph21" rule="-SIMPLE-REF" start="111" uttnum="111">
    <type>ONT::CELL-LINE</type>
    <name>CANCER-CELL-LINES</name>
    <text>two human cancer cell lines with wild-type p53</text>
  </TERM>
  <TERM dbid="EFO:0001203|CVCL:0031" end="164" id="V1794661" paragraph="paragraph21" rule="-SIMPLE-REF" start="159" uttnum="111">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7</name>
    <text>MCF7</text>
  </TERM>
  <TERM end="121" id="V1794472" paragraph="paragraph21" rule="-SIMPLE-REF" start="111" uttnum="111">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>two human</text>
  </TERM>
  <TERM dbid="UP:P04637" end="157" id="V1794628" paragraph="paragraph21" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="144" uttnum="111">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>P-53</name>
    <text>wild-type p53</text>
  </TERM>
  <TERM dbid="EFO:0002869|CVCL:0042" end="172" id="V1794711" paragraph="paragraph21" rule="-SIMPLE-REF" start="168" uttnum="111">
    <type>ONT::CELL-LINE</type>
    <name>U-2-OS</name>
    <text>U2OS</text>
  </TERM>
  <CC end="287" id="V1806983" paragraph="paragraph21" rule="-RULE5B_AGENT_AFFECTED" start="187" uttnum="112">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1806940" role=":FACTOR"/>
    <arg id="V1807044" role=":OUTCOME"/>
    <text>previously, increased expression of ASPP1 or ASPP2 induces p53-mediated apoptosis in both cell lines</text>
  </CC>
  <EVENT end="238" id="V1806940" paragraph="paragraph21" rule="-INEVENT2B,-RULE50_AGENT_AFFECTED-AFFECTED" start="199" uttnum="112">
    <type>ONT::EXPRESS</type>
    <predicate end="238" id="V1806940" start="199">
      <type>ONT::EXPRESS</type>
      <text>increased expression of ASPP1 or ASPP2</text>
    </predicate>
    <arg2 id="V1806964" role=":AFFECTED"/>
    <text>increased expression of ASPP1 or ASPP2</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="269" id="V1807044" paragraph="paragraph21" rule="-INEVENT2B,-SIMPLE-REF" start="246" uttnum="112">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V1807023"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>p53-mediated apoptosis</text>
  </TERM>
  <EVENT end="238" id="V1806931" paragraph="paragraph21" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="199" uttnum="112">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="238" id="V1806931" start="199">
      <type>ONT::INCREASE</type>
      <text>increased expression of ASPP1 or ASPP2</text>
    </predicate>
    <arg2 id="V1806940" role=":AFFECTED"/>
    <text>increased expression of ASPP1 or ASPP2</text>
  </EVENT>
  <TERM end="238" id="V1806964" paragraph="paragraph21" rule="-LOGICALOP-REF" start="220" uttnum="112">
    <type>ONT::GENE</type>
    <aggregate operator="OR">
      <member id="V1806961"/>
      <member id="V1806978"/>
    </aggregate>
    <text normalization="">of ASPP1 or ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="229" id="V1806961" paragraph="paragraph21" rule="-SIMPLE-REF" start="223" uttnum="112">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="238" id="V1806978" paragraph="paragraph21" rule="-SIMPLE-REF" start="232" uttnum="112">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="269" id="V1807023" paragraph="paragraph21" rule="-RULE10_AGENT_AFFECTED" start="246" uttnum="112">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="269" id="V1807023" start="246">
      <type>ONT::MODULATE</type>
      <text>p53-mediated apoptosis</text>
    </predicate>
    <arg1 id="V1807015" role=":AGENT"/>
    <arg2 id="V1807044" role=":AFFECTED"/>
    <text>p53-mediated apoptosis</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="259" id="V1807015" paragraph="paragraph21" rule="-SIMPLE-REF" start="246" uttnum="112">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-mediated</text>
  </TERM>
  <TERM dbid="EFO:0000322" end="287" id="V1807132" paragraph="paragraph21" rule="-SIMPLE-REF" start="272" uttnum="112">
    <type>ONT::CELL-LINE</type>
    <name>CELL-LINE</name>
    <text>both cell lines</text>
  </TERM>
  <EVENT end="379" id="V1807216" paragraph="paragraph21" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="331" uttnum="112">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="379" id="V1807216" start="331">
      <type>ONT::DECREASE</type>
      <text>reduce the expression of endogenous HRAS or KRAS</text>
    </predicate>
    <arg2 id="V1807233" role=":AFFECTED"/>
    <text>reduce the expression of endogenous HRAS or KRAS</text>
  </EVENT>
  <EVENT end="379" id="V1807233" paragraph="paragraph21" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="338" uttnum="112">
    <type>ONT::EXPRESS</type>
    <predicate end="379" id="V1807233" start="338">
      <type>ONT::EXPRESS</type>
      <text>the expression of endogenous HRAS or KRAS</text>
    </predicate>
    <arg2 id="V1807258" role=":AFFECTED-RESULT"/>
    <text>the expression of endogenous HRAS or KRAS</text>
  </EVENT>
  <TERM end="379" id="V1807258" paragraph="paragraph21" rule="-LOGICALOP-REF" start="353" uttnum="112">
    <type>ONT::PROTEIN</type>
    <aggregate operator="OR">
      <member id="V1807255"/>
      <member id="V1807267"/>
    </aggregate>
    <text normalization="">of endogenous HRAS or KRAS</text>
  </TERM>
  <TERM dbid="UP:P01112" end="372" id="V1807255" paragraph="paragraph21" rule="-SIMPLE-REF" start="356" uttnum="112">
    <type>ONT::PROTEIN</type>
    <name>HRAS</name>
    <text>endogenous HRAS</text>
  </TERM>
  <TERM dbid="UP:P01116" end="379" id="V1807267" paragraph="paragraph21" rule="-SIMPLE-REF" start="375" uttnum="112">
    <type>ONT::PROTEIN</type>
    <name>KRAS</name>
    <text>KRAS</text>
  </TERM>
  <EPI end="486" id="V1821096" paragraph="paragraph21" rule="-RULE50_0_AGENT_NEUTRAL" start="381" uttnum="112">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg1 id="V1821091" role=":AGENT"/>
    <arg2 id="V1821147" role=":NEUTRAL"/>
    <text>we observed a reduction in the percentage of apoptosis in cells induced by ASPP1 or ASPP2 overexpression</text>
  </EPI>
  <TERM end="384" id="V1821091" paragraph="paragraph21" rule="-ROBUSTPRO" start="381" uttnum="112">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="486" id="V1821147" paragraph="paragraph21" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE20_AGENT_AFFECTED-NONE" start="381" uttnum="112">
    <type>ONT::DECREASE</type>
    <epistemic-modality id="V1821096"/>
    <predicate end="486" id="V1821147" start="381">
      <type>ONT::DECREASE</type>
      <text>we observed a reduction in the percentage of apoptosis in cells induced by ASPP1 or ASPP2 overexpression</text>
    </predicate>
    <text>we observed a reduction in the percentage of apoptosis in cells induced by ASPP1 or ASPP2 overexpression</text>
  </EVENT>
  <TERM end="445" id="V1821282" paragraph="paragraph21" rule="-SIMPLE-REF" start="439" uttnum="112">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="462" id="V1821326" paragraph="paragraph21" rule="-SIMPLE-REF" start="456" uttnum="112">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <EVENT end="486" id="V1821357" paragraph="paragraph21" rule="-RULE50_AGENT_AFFECTED-AFFECTED" start="465" uttnum="112">
    <type>ONT::EXPRESS</type>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>OVER-</value>
      </degree>
    </mods>
    <predicate end="486" id="V1821357" start="465">
      <type>ONT::EXPRESS</type>
      <text>ASPP2 overexpression</text>
    </predicate>
    <arg2 id="V1821343" role=":AFFECTED"/>
    <text>ASPP2 overexpression</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="471" id="V1821343" paragraph="paragraph21" rule="-SIMPLE-REF" start="465" uttnum="112">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="436" id="V1821226" paragraph="paragraph21" rule="-SIMPLE-REF" start="423" uttnum="112">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>of apoptosis</text>
  </TERM>
  <TERM end="500" id="V1821376" paragraph="paragraph21" rule="-SIMPLE-REF" start="493" uttnum="112">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="527" id="V1836415" paragraph="paragraph21" rule="-SIMPLE-REF" start="512" uttnum="113">
    <type>ONT::CLINICAL-FINDING</type>
    <name>FINDING</name>
    <text>These findings</text>
  </TERM>
  <TERM end="565" id="V1836454" paragraph="paragraph21" rule="-LOGICALOP-REF" start="540" uttnum="113">
    <type>ONT::PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1836450"/>
      <member id="V1836465"/>
    </aggregate>
    <text normalization="">endogenous HRAS and KRAS</text>
  </TERM>
  <TERM dbid="UP:P01112" end="556" id="V1836450" paragraph="paragraph21" rule="-SIMPLE-REF" start="540" uttnum="113">
    <type>ONT::PROTEIN</type>
    <name>HRAS</name>
    <text>endogenous HRAS</text>
  </TERM>
  <TERM dbid="UP:P01116" end="565" id="V1836465" paragraph="paragraph21" rule="-SIMPLE-REF" start="560" uttnum="113">
    <type>ONT::PROTEIN</type>
    <name>KRAS</name>
    <text>KRAS</text>
  </TERM>
  <TERM end="620" id="V1836562" paragraph="paragraph21" rule="-LOGICALOP-REF" start="602" uttnum="113">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V1836558"/>
      <member id="V1836578"/>
    </aggregate>
    <text normalization="">of ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="611" id="V1836558" paragraph="paragraph21" rule="-SIMPLE-REF" start="605" uttnum="113">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="620" id="V1836578" paragraph="paragraph21" rule="-SIMPLE-REF" start="615" uttnum="113">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="31" id="V1849240" paragraph="paragraph22" rule="-ROBUSTPRO" start="28" uttnum="114">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="CVCL:9796" end="41" id="V1849301" paragraph="paragraph22" rule="-SIMPLE-REF" start="36" uttnum="114">
    <type>ONT::CELL-LINE</type>
    <name>HKE-3</name>
    <text>HKe3</text>
  </TERM>
  <TERM end="57" id="V1849332" paragraph="paragraph22" rule="-SIMPLE-REF" start="44" uttnum="114">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>HRASV12 cells</text>
  </TERM>
  <EVENT end="83" id="V1860796" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="68" uttnum="114">
    <type>ONT::ACTIVATE</type>
    <predicate end="83" id="V1860796" start="68">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V1860793" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000232"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="72" id="V1860793" paragraph="paragraph22" rule="-SIMPLE-REF" start="68" uttnum="114">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="120" id="V1860839" paragraph="paragraph22" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="99" uttnum="114">
    <type>ONT::INCREASE</type>
    <predicate end="120" id="V1860839" start="99">
      <type>ONT::INCREASE</type>
      <text>the addition of 4-OHT</text>
    </predicate>
    <arg2 id="V1860863" role=":AFFECTED"/>
    <text>the addition of 4-OHT</text>
  </EVENT>
  <TERM dbid="CHEBI:44616" end="120" id="V1860863" paragraph="paragraph22" rule="-SIMPLE-REF" start="112" uttnum="114">
    <type>ONT::MOLECULE</type>
    <name>4-OHT</name>
    <text>of 4-OHT</text>
  </TERM>
  <CC end="222" id="V1875641" paragraph="paragraph22" rule="-RULE5B_AGENT_AFFECTED" start="122" uttnum="115">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1875633" role=":FACTOR"/>
    <arg id="V1875647" role=":OUTCOME"/>
    <text>Importantly, oncogenic RAS activation induced apoptosis in these cells indicated by the presence of</text>
  </CC>
  <EVENT end="160" id="V1875633" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="135" uttnum="115">
    <type>ONT::ACTIVATE</type>
    <predicate end="160" id="V1875633" start="135">
      <type>ONT::ACTIVATE</type>
      <text>oncogenic RAS activation</text>
    </predicate>
    <arg2 id="V1875630" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000237"/>
    <text>oncogenic RAS activation</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="178" id="V1875647" paragraph="paragraph22" rule="-SIMPLE-REF" start="168" uttnum="115">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="149" id="V1875630" paragraph="paragraph22" rule="-SIMPLE-REF" start="145" uttnum="115">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="222" id="V1875708" paragraph="paragraph22" rule="-SIMPLE-REF" start="181" uttnum="115">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells indicated by the presence of</text>
  </TERM>
  <TERM dbid="CHEBI:62913" end="235" id="V1875792" paragraph="paragraph22" rule="-SIMPLE-REF" start="230" uttnum="115">
    <type>ONT::CHEMICAL</type>
    <name>PARP</name>
    <text>PARP</text>
  </TERM>
  <TERM end="258" id="V1875808" paragraph="paragraph22" rule="-SIMPLE-REF" start="242" uttnum="115">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 5c</text>
  </TERM>
  <TERM dbid="UP:P04637" end="281" id="V1891456" paragraph="paragraph22" rule="-SIMPLE-REF" start="277" uttnum="116">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="340" id="V1891618" paragraph="paragraph22" rule="-INEVENT2B,-SIMPLE-REF" start="318" uttnum="116">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V1891604"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>RAS-induced apoptosis</text>
  </TERM>
  <CC end="340" id="V1891604" paragraph="paragraph22" rule="-RULE5B_AGENT_AFFECTED" start="318" uttnum="116">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1891595" role=":FACTOR"/>
    <arg id="V1891618" role=":OUTCOME"/>
    <text>RAS-induced apoptosis</text>
  </CC>
  <TERM end="330" id="V1891595" paragraph="paragraph22" rule="-SIMPLE-REF" start="318" uttnum="116">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="GO:0016246" end="372" id="V1891792" paragraph="paragraph22" rule="-SIMPLE-REF" start="355" uttnum="116">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>RNAI</name>
    <text>RNAi against p53</text>
  </TERM>
  <TERM dbid="BTO:0003469" end="353" id="V1891737" paragraph="paragraph22" rule="-SIMPLE-REF" start="343" uttnum="116">
    <type>ONT::CELL</type>
    <name>HKE-3-CELLS</name>
    <text>HKe3 cells</text>
  </TERM>
  <TERM dbid="UP:P04637" end="372" id="V1891830" paragraph="paragraph22" rule="-SIMPLE-REF" start="368" uttnum="116">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="431" id="V1907280" paragraph="paragraph22" rule="-INEVENT2B,-SIMPLE-REF" start="409" uttnum="117">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>RAS-induced apoptosis</text>
  </TERM>
  <TERM dbid="UP:P04637" end="399" id="V1907247" paragraph="paragraph22" rule="-SIMPLE-REF" start="392" uttnum="117">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <CC end="421" id="V1907265" paragraph="paragraph22" rule="-RULE5B_AGENT_RESULT-AGENT" start="409" uttnum="117">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1907257" role=":FACTOR"/>
    <text>RAS-induced</text>
  </CC>
  <TERM end="421" id="V1907257" paragraph="paragraph22" rule="-SIMPLE-REF" start="409" uttnum="117">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM end="445" id="V1907341" paragraph="paragraph22" rule="-SIMPLE-REF" start="434" uttnum="117">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells</text>
  </TERM>
  <TERM dbid="BTO:0003469" end="452" id="V1908258" paragraph="paragraph22" rule="-SIMPLE-REF" start="447" uttnum="118">
    <type>ONT::CELL</type>
    <name>HKE-3-CELLS</name>
    <text>This</text>
  </TERM>
  <TERM dbid="HGNC:270|UP:P09874|XFAM:PF00644.17" end="483" id="V1908352" paragraph="paragraph22" rule="-SIMPLE-REF" start="478" uttnum="118">
    <type>ONT::GENE-PROTEIN</type>
    <name>PARP</name>
    <text>PARP</text>
  </TERM>
  <TERM end="531" id="V1908426" paragraph="paragraph22" rule="-SIMPLE-REF" start="495" uttnum="118">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells (Figure 5d)</text>
  </TERM>
  <TERM end="530" id="V1908466" paragraph="paragraph22" rule="-SIMPLE-REF" start="514" uttnum="118">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 5d</text>
  </TERM>
  <TERM end="530" id="V1908439" paragraph="paragraph22" rule="-SIMPLE-REF" start="514" uttnum="118">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 5d</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="27" id="V1920480" paragraph="paragraph23" rule="-SIMPLE-REF" start="21" uttnum="119">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="UP:P04637" end="47" id="V1920526" paragraph="paragraph23" rule="-SIMPLE-REF" start="38" uttnum="119">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>with p53</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="67" id="V1920562" paragraph="paragraph23" rule="-SIMPLE-REF" start="57" uttnum="119">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="82" id="V1920629" paragraph="paragraph23" rule="-SIMPLE-REF" start="70" uttnum="119">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="87" id="V1934590" paragraph="paragraph23" rule="-ROBUSTPRO" start="84" uttnum="119">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="GO:0051641" end="131" id="V1934619" paragraph="paragraph23" rule="-SIMPLE-REF" start="96" uttnum="119">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELLULAR-LOCALISATION</name>
    <text>the cellular localisation of ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="131" id="V1934636" paragraph="paragraph23" rule="-SIMPLE-REF" start="125" uttnum="119">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="CVCL:9796" end="139" id="V1934739" paragraph="paragraph23" rule="-SIMPLE-REF" start="134" uttnum="119">
    <type>ONT::CELL-LINE</type>
    <name>HKE-3</name>
    <text>HKe3</text>
  </TERM>
  <TERM end="174" id="V1934770" paragraph="paragraph23" rule="-SIMPLE-REF" start="147" uttnum="119">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>12 cells upon RAS induction</text>
  </TERM>
  <EVENT end="174" id="V1934788" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="161" uttnum="119">
    <type>ONT::PRODUCE</type>
    <predicate end="174" id="V1934788" start="161">
      <type>ONT::PRODUCE</type>
      <text>RAS induction</text>
    </predicate>
    <arg2 id="V1934783" role=":AFFECTED"/>
    <text>RAS induction</text>
  </EVENT>
  <TERM end="165" id="V1934783" paragraph="paragraph23" rule="-SIMPLE-REF" start="161" uttnum="119">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="179" id="V1947568" paragraph="paragraph23" rule="-ROBUSTPRO" start="176" uttnum="120">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="296" id="V1947612" paragraph="paragraph23" rule="-RULE10C_AGENT_AFFECTED" start="204" uttnum="120">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="296" id="V1947612" start="204">
      <type>ONT::TRANSLOCATE</type>
      <text>ASPP2 translocates from cell/cell junctions to the cytosol/nucleus following RAS activation</text>
    </predicate>
    <arg1 id="V1947608" role=":AGENT"/>
    <arg2 id="V1947673" role=":AFFECTED"/>
    <text>ASPP2 translocates from cell/cell junctions to the cytosol/nucleus following RAS activation</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="210" id="V1947608" paragraph="paragraph23" rule="-SIMPLE-REF" start="204" uttnum="120">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="296" id="V1947673" paragraph="paragraph23" rule="-RULE10C_AGENT_AFFECTED-CELL_LOC3-GD-TO-NONE" start="223" uttnum="120">
    <type>ONT::TRANSLOCATE</type>
    <predicate end="296" id="V1947673" start="223">
      <type>ONT::TRANSLOCATE</type>
      <text>from cell/cell junctions to the cytosol/nucleus following RAS activation</text>
    </predicate>
    <arg2 id="V1947684" role=":NEUTRAL"/>
    <to-location end="271" id="V1947762" start="255">
      <type>ONT::CELL-PART</type>
      <text normalization="">cytosol/nucleus</text>
    </to-location>
    <text>from cell/cell junctions to the cytosol/nucleus following RAS activation</text>
  </EVENT>
  <EVENT end="296" id="V1947684" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="281" uttnum="120">
    <type>ONT::ACTIVATE</type>
    <predicate end="296" id="V1947684" start="281">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V1947681" role=":AFFECTED"/>
    <arg id="R000242" role=":RESULT"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="248" id="V1947626" paragraph="paragraph23" rule="-SIMPLE-REF" start="228" uttnum="120">
    <type>ONT::DEVICE-COMPONENT</type>
    <name>JUNCTION</name>
    <text>cell/cell junctions</text>
  </TERM>
  <TERM end="238" id="V1947774" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B" start="228" uttnum="120">
    <type>ONT::CELL</type>
    <components>
      <component id="V1947467"/>
      <component id="V1947481"/>
    </components>
    <text normalization="CELL">cell/cell</text>
  </TERM>
  <TERM end="238" id="V1947467" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B-TERM" start="228" uttnum="120">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell/cell</text>
  </TERM>
  <TERM end="238" id="V1947481" paragraph="paragraph23" rule="-SIMPLE-REF" start="233" uttnum="120">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell</text>
  </TERM>
  <TERM end="271" id="V1947762" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B" start="255" uttnum="120">
    <type>ONT::CELL-PART</type>
    <components>
      <component id="V1947421"/>
      <component id="V1947429"/>
    </components>
    <text normalization="">cytosol/nucleus</text>
  </TERM>
  <TERM dbid="UP:SL-0091|GO:0005829" end="271" id="V1947421" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B-TERM" start="255" uttnum="120">
    <type>ONT::CELL-PART</type>
    <name>CYTOSOL</name>
    <text>cytosol/nucleus</text>
  </TERM>
  <TERM dbid="UP:SL-0191|GO:0005634" end="271" id="V1947429" paragraph="paragraph23" rule="-SIMPLE-REF" start="263" uttnum="120">
    <type>ONT::CELL-PART</type>
    <name>NUCLEUS</name>
    <text>nucleus</text>
  </TERM>
  <TERM end="285" id="V1947681" paragraph="paragraph23" rule="-SIMPLE-REF" start="281" uttnum="120">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="310" id="V1947696" paragraph="paragraph23" rule="-SIMPLE-REF" start="303" uttnum="120">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="467" id="V1961885" paragraph="paragraph23" rule="-SIMPLE-REF" start="345" uttnum="121">
    <type>ONT::MENTAL-OBJECT</type>
    <name>DETECTION</name>
    <text>by the detection of an increase in the expression levels of ASPP2 in the nuclear and cytoplasmic fractions in these cells</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="467" id="V1962021" paragraph="paragraph23" rule="-SIMPLE-REF" start="405" uttnum="121">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 in the nuclear and cytoplasmic fractions in these cells</text>
  </TERM>
  <TERM end="467" id="V1962167" paragraph="paragraph23" rule="-SIMPLE-REF" start="455" uttnum="121">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells</text>
  </TERM>
  <EVENT end="488" id="V1962183" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="472" uttnum="121">
    <type>ONT::ACTIVATE</type>
    <predicate end="488" id="V1962183" start="472">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation,</text>
    </predicate>
    <arg2 id="V1962180" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000247"/>
    <text>RAS activation,</text>
  </EVENT>
  <TERM end="476" id="V1962180" paragraph="paragraph23" rule="-SIMPLE-REF" start="472" uttnum="121">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="570" id="V1962320" paragraph="paragraph23" rule="-SIMPLE-REF" start="541" uttnum="121">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>nuclear and cytoplasmic ASPP2</text>
  </TERM>
  <TERM end="600" id="V1962336" paragraph="paragraph23" rule="-SIMPLE-REF" start="592" uttnum="121">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6</text>
  </TERM>
  <TERM end="608" id="V1962358" paragraph="paragraph23" rule="-SIMPLE-REF" start="600" uttnum="121">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>B</name>
    <text>b</text>
  </TERM>
  <EPI end="725" id="V1973703" paragraph="paragraph23" rule="-RULE50_0_AGENT_FORMAL" start="621" uttnum="122">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg1 id="V1973692" role=":AGENT"/>
    <arg2 id="V1973710" role=":FORMAL"/>
    <text>we also detected an increase in the amount of p53–ASPP2 complex in these cells following RAS activation</text>
  </EPI>
  <TERM end="624" id="V1973692" paragraph="paragraph23" rule="-ROBUSTPRO" start="621" uttnum="122">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="725" id="V1973710" paragraph="paragraph23" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE20_AGENT_AFFECTED-NONE" start="621" uttnum="122">
    <type>ONT::INCREASE</type>
    <epistemic-modality id="V1973703"/>
    <predicate end="725" id="V1973710" start="621">
      <type>ONT::INCREASE</type>
      <text>we also detected an increase in the amount of p53–ASPP2 complex in these cells following RAS activation</text>
    </predicate>
    <text>we also detected an increase in the amount of p53–ASPP2 complex in these cells following RAS activation</text>
  </EVENT>
  <EVENT end="725" id="V1973871" paragraph="paragraph23" rule="-RULE10C_AGENT_AFFECTED-CELL_LOC1-GD-OTHERS-NONE" start="650" uttnum="122">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="725" id="V1973871" start="650">
      <type>ONT::TRANSLOCATE</type>
      <text>in the amount of p53–ASPP2 complex in these cells following RAS activation</text>
    </predicate>
    <arg2 id="V1973883" role=":NEUTRAL"/>
    <location end="700" id="V1973863" mod="null" start="688">
      <type>ONT::CELL</type>
      <text normalization="">these cells</text>
    </location>
    <text>in the amount of p53–ASPP2 complex in these cells following RAS activation</text>
  </EVENT>
  <EVENT end="725" id="V1973883" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="710" uttnum="122">
    <type>ONT::ACTIVATE</type>
    <predicate end="725" id="V1973883" start="710">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V1973879" role=":AFFECTED"/>
    <arg id="R000252" role=":RESULT"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="685" id="V1973797" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0" start="664" uttnum="122">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <components>
      <component id="V1973963"/>
    </components>
    <text normalization="">of p53–ASPP2 complex</text>
  </TERM>
  <TERM end="685" id="V1973963" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0-TERM" start="664" uttnum="122">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-53-ASPP-2</name>
    <text>of p53–ASPP2 complex</text>
  </TERM>
  <TERM end="700" id="V1973863" paragraph="paragraph23" rule="-SIMPLE-REF" start="688" uttnum="122">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells</text>
  </TERM>
  <TERM end="714" id="V1973879" paragraph="paragraph23" rule="-SIMPLE-REF" start="710" uttnum="122">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="739" id="V1973894" paragraph="paragraph23" rule="-SIMPLE-REF" start="732" uttnum="122">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <EVENT end="793" id="V1987472" paragraph="paragraph23" rule="-RULE10_AGENT_AFFECTED-AGENT" start="767" uttnum="123">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="793" id="V1987472" start="767">
      <type>ONT::MODULATE</type>
      <text>endogenous ASPP2 mediates</text>
    </predicate>
    <arg1 id="V1987468" role=":AGENT"/>
    <text>endogenous ASPP2 mediates</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="784" id="V1987468" paragraph="paragraph23" rule="-SIMPLE-REF" start="767" uttnum="123">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>endogenous ASPP2</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="828" id="V1987518" paragraph="paragraph23" rule="-INEVENT2B,-SIMPLE-REF" start="806" uttnum="123">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V1987504"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>RAS-induced apoptosis</text>
  </TERM>
  <CC end="828" id="V1987504" paragraph="paragraph23" rule="-RULE5B_AGENT_AFFECTED" start="806" uttnum="123">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1987495" role=":FACTOR"/>
    <arg id="V1987518" role=":OUTCOME"/>
    <text>RAS-induced apoptosis</text>
  </CC>
  <TERM end="818" id="V1987495" paragraph="paragraph23" rule="-SIMPLE-REF" start="806" uttnum="123">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="854" id="V1987651" paragraph="paragraph23" rule="-SIMPLE-REF" start="843" uttnum="123">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 RNAi</text>
  </TERM>
  <TERM dbid="BTO:0003469" end="841" id="V1987638" paragraph="paragraph23" rule="-SIMPLE-REF" start="831" uttnum="123">
    <type>ONT::CELL</type>
    <name>HKE-3-CELLS</name>
    <text>HKe3 cells</text>
  </TERM>
  <TERM dbid="GO:0016246" end="854" id="V1987703" paragraph="paragraph23" rule="-SIMPLE-REF" start="849" uttnum="123">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>RNAI</name>
    <text>RNAi</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="912" id="V2000873" paragraph="paragraph23" rule="-INEVENT2,-SIMPLE-REF" start="864" uttnum="124">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V2000859"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>ASPP2 knockdown abolished RAS-induced apoptosis</text>
  </TERM>
  <EVENT end="890" id="V2000845" paragraph="paragraph23" rule="-RULE30_AGENT_FORMAL-AGENT" start="864" uttnum="124">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="890" id="V2000845" start="864">
      <type>ONT::INHIBIT</type>
      <text>ASPP2 knockdown abolished</text>
    </predicate>
    <arg1 id="V2000839" role=":AGENT"/>
    <text>ASPP2 knockdown abolished</text>
  </EVENT>
  <CC end="912" id="V2000859" paragraph="paragraph23" rule="-RULE5B_AGENT_AFFECTED" start="864" uttnum="124">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2000850" role=":FACTOR"/>
    <arg id="V2000873" role=":OUTCOME"/>
    <text>ASPP2 knockdown abolished RAS-induced apoptosis</text>
  </CC>
  <EVENT end="890" id="V2000839" paragraph="paragraph23" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="864" uttnum="124">
    <type>ONT::TRANSFORM</type>
    <predicate end="890" id="V2000839" start="864">
      <type>ONT::TRANSFORM</type>
      <text>ASPP2 knockdown abolished</text>
    </predicate>
    <text>ASPP2 knockdown abolished</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="890" id="V2000833" paragraph="paragraph23" rule="-SIMPLE-REF" start="864" uttnum="124">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 knockdown abolished</text>
  </TERM>
  <TERM end="902" id="V2000850" paragraph="paragraph23" rule="-SIMPLE-REF" start="890" uttnum="124">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="HGNC:270|UP:P09874|XFAM:PF00644.17" end="940" id="V2000964" paragraph="paragraph23" rule="-SIMPLE-REF" start="935" uttnum="124">
    <type>ONT::GENE-PROTEIN</type>
    <name>PARP</name>
    <text>PARP</text>
  </TERM>
  <TERM end="972" id="V2001014" paragraph="paragraph23" rule="-SIMPLE-REF" start="956" uttnum="124">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 6d</text>
  </TERM>
  <TERM end="972" id="V2000987" paragraph="paragraph23" rule="-SIMPLE-REF" start="956" uttnum="124">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6d</text>
  </TERM>
  <TERM end="986" id="V2012306" paragraph="paragraph23" rule="-SIMPLE-REF" start="975" uttnum="125">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>These data</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1001" id="V2012328" paragraph="paragraph23" rule="-SIMPLE-REF" start="995" uttnum="125">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="1060" id="V2012368" paragraph="paragraph23" rule="-SIMPLE-REF" start="1004" uttnum="125">
    <type>ONT::COMMUNICATION-PARTY</type>
    <name>MEDIATOR</name>
    <text>an important mediator of oncogenic RAS-induced apoptosis</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="1060" id="V2012410" paragraph="paragraph23" rule="-INEVENT2B,-SIMPLE-REF" start="1026" uttnum="125">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>of oncogenic RAS-induced apoptosis</text>
  </TERM>
  <CC end="1051" id="V2012395" paragraph="paragraph23" rule="-RULE5B_AGENT_RESULT-AGENT" start="1029" uttnum="125">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2012387" role=":FACTOR"/>
    <text>oncogenic RAS-induced</text>
  </CC>
  <TERM end="1051" id="V2012387" paragraph="paragraph23" rule="-SIMPLE-REF" start="1029" uttnum="125">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">oncogenic RAS-induced</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1067" id="V2025835" paragraph="paragraph23" rule="-SIMPLE-REF" start="1062" uttnum="126">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>This</text>
  </TERM>
  <TERM end="1117" id="V2025929" paragraph="paragraph23" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="1099" uttnum="126">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">of the active RAS</text>
  </TERM>
  <EVENT end="1162" id="V2025975" paragraph="paragraph23" rule="-RULE10C_AGENT_AFFECTED-AFFECTED" start="1127" uttnum="126">
    <type>ONT::TRANSLOCATE</type>
    <predicate end="1162" id="V2025975" start="1127">
      <type>ONT::TRANSLOCATE</type>
      <text>the cellular translocation of ASPP2</text>
    </predicate>
    <arg2 id="V2025992" role=":AFFECTED"/>
    <text>the cellular translocation of ASPP2</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1162" id="V2025992" paragraph="paragraph23" rule="-SIMPLE-REF" start="1154" uttnum="126">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2</text>
  </TERM>
  <TERM end="1197" id="V2039376" paragraph="paragraph23" rule="-SIMPLE-REF" start="1176" uttnum="126">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>the ability of ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1197" id="V2039402" paragraph="paragraph23" rule="-SIMPLE-REF" start="1191" uttnum="126">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="1209" id="V2039431" paragraph="paragraph23" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1200" uttnum="126">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1209" id="V2039431" start="1200">
      <type>ONT::BIND</type>
      <text>bind p53</text>
    </predicate>
    <arg2 id="V2039466" role=":AFFECTED"/>
    <text>bind p53</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="1209" id="V2039466" paragraph="paragraph23" rule="-SIMPLE-REF" start="1205" uttnum="126">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="1236" id="V2039508" paragraph="paragraph23" rule="-SIMPLE-REF" start="1224" uttnum="126">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>its activity</text>
  </TERM>
  <TERM end="39" id="V2054316" paragraph="paragraph24" rule="-SIMPLE-REF" start="22" uttnum="127">
    <type>ONT::CONTAINER</type>
    <name>WELL</name>
    <text>well-established</text>
  </TERM>
  <TERM end="85" id="V2054417" paragraph="paragraph24" rule="-SIMPLE-REF" start="76" uttnum="127">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">that RAS</text>
  </TERM>
  <TERM end="141" id="V2054500" paragraph="paragraph24" rule="-SIMPLE-REF" start="126" uttnum="127">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>its ability to</text>
  </TERM>
  <TERM end="141" id="V2054488" paragraph="paragraph24" rule="-SIMPLE-REF" start="126" uttnum="127">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>its ability to</text>
  </TERM>
  <EVENT end="211" id="V2054539" paragraph="paragraph24" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="141" uttnum="127">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="211" id="V2054539" start="141">
      <type>ONT::PRODUCE</type>
      <text>induce senescence in primary fibroblasts and apoptosis in cancer cells</text>
    </predicate>
    <arg2 id="V2054545" role=":AFFECTED"/>
    <text>induce senescence in primary fibroblasts and apoptosis in cancer cells</text>
  </EVENT>
  <TERM dbid="XFAM:PF06911.9" end="159" id="V2054545" paragraph="paragraph24" rule="-SIMPLE-REF" start="148" uttnum="127">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SENESCENCE</name>
    <text normalization="">senescence</text>
  </TERM>
  <TERM dbid="CO:0000057" end="182" id="V2054613" paragraph="paragraph24" rule="-SIMPLE-REF" start="162" uttnum="127">
    <type>ONT::CELL</type>
    <name>FIBROBLASTS</name>
    <text>primary fibroblasts</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="196" id="V2054628" paragraph="paragraph24" rule="-SIMPLE-REF" start="186" uttnum="127">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="211" id="V2054695" paragraph="paragraph24" rule="-SIMPLE-REF" start="199" uttnum="127">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="226" id="V2066386" paragraph="paragraph24" rule="-ROBUSTPRO" start="223" uttnum="128">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="244" id="V2066428" paragraph="paragraph24" rule="-SIMPLE-REF" start="238" uttnum="128">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="290" id="V2066495" paragraph="paragraph24" rule="-SIMPLE-REF" start="247" uttnum="128">
    <type>ONT::COMMUNICATION-PARTY</type>
    <name>MEDIATOR</name>
    <text>a potent mediator of RAS-induced senescence</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="290" id="V2066532" paragraph="paragraph24" rule="-INEVENT2B,-SIMPLE-REF" start="265" uttnum="128">
    <type>ONT::PROTEIN-FAMILY</type>
    <features>
      <inevent>
        <event id="V2066518"/>
      </inevent>
    </features>
    <name>SENESCENCE</name>
    <text normalization="">of RAS-induced senescence</text>
  </TERM>
  <EVENT end="290" id="V2066518" paragraph="paragraph24" rule="-RULE40A_AGENT_AFFECTED" start="265" uttnum="128">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="290" id="V2066518" start="265">
      <type>ONT::PRODUCE</type>
      <text>of RAS-induced senescence</text>
    </predicate>
    <arg1 id="V2066509" role=":AGENT"/>
    <arg2 id="V2066532" role=":AFFECTED"/>
    <text>of RAS-induced senescence</text>
  </EVENT>
  <TERM end="280" id="V2066509" paragraph="paragraph24" rule="-SIMPLE-REF" start="268" uttnum="128">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="UP:P04637" end="324" id="V2067949" paragraph="paragraph24" rule="-SIMPLE-REF" start="309" uttnum="129">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-independent</text>
  </TERM>
  <TERM dbid="GO:0006914" end="445" id="V2068228" paragraph="paragraph24" rule="-SIMPLE-REF" start="436" uttnum="129">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>AUTOPHAGY</name>
    <text>autophagy</text>
  </TERM>
  <TERM end="396" id="V2068073" paragraph="paragraph24" rule="-SIMPLE-REF" start="369" uttnum="129">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>of the N-terminus of ASPP2</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="396" id="V2068116" paragraph="paragraph24" rule="-SIMPLE-REF" start="390" uttnum="129">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="409" id="V2068145" paragraph="paragraph24" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="399" uttnum="129">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="409" id="V2068145" start="399">
      <type>ONT::BIND</type>
      <text>bind ATG5</text>
    </predicate>
    <arg2 id="V2068159" role=":AFFECTED"/>
    <text>bind ATG5</text>
  </EVENT>
  <TERM dbid="HGNC:589|FA:00292|UP:Q9H1Y0" end="409" id="V2068159" paragraph="paragraph24" rule="-SIMPLE-REF" start="404" uttnum="129">
    <type>ONT::GENE-PROTEIN</type>
    <name>ATG-5</name>
    <text>ATG5</text>
  </TERM>
  <EVENT end="427" id="V2068198" paragraph="paragraph24" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="416" uttnum="129">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="427" id="V2068198" start="416">
      <type>ONT::INHIBIT</type>
      <text>inhibit RAS</text>
    </predicate>
    <arg2 id="V2068205" role=":AFFECTED"/>
    <text>inhibit RAS</text>
  </EVENT>
  <TERM end="427" id="V2068205" paragraph="paragraph24" rule="-SIMPLE-REF" start="424" uttnum="129">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <EVENT end="534" id="V2082750" paragraph="paragraph24" rule="-RULE10C_AGENT_AFFECTED" start="447" uttnum="129">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="534" id="V2082750" start="447">
      <type>ONT::TRANSLOCATE</type>
      <text>as elevated autophagy activity bypasses oncogenic RAS-induced senescence in fibroblasts</text>
    </predicate>
    <arg2 id="V2082783" role=":AFFECTED"/>
    <text>as elevated autophagy activity bypasses oncogenic RAS-induced senescence in fibroblasts</text>
  </EVENT>
  <TERM dbid="XFAM:PF06911.9" end="534" id="V2082783" paragraph="paragraph24" rule="-INEVENT2B,-SIMPLE-REF" start="487" uttnum="129">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SENESCENCE</name>
    <text normalization="">oncogenic RAS-induced senescence in fibroblasts</text>
  </TERM>
  <TERM dbid="GO:0006914" end="469" id="V2082741" paragraph="paragraph24" rule="-INEVENT2B,-SIMPLE-REF" start="450" uttnum="129">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V2082733"/>
      </inevent>
    </features>
    <name>AUTOPHAGY</name>
    <text>elevated autophagy</text>
  </TERM>
  <EVENT end="469" id="V2082733" paragraph="paragraph24" rule="-RULE10C_AGENT_AFFECTED-AFFECTED" start="450" uttnum="129">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="469" id="V2082733" start="450">
      <type>ONT::TRANSLOCATE</type>
      <text>elevated autophagy</text>
    </predicate>
    <arg2 id="V2082741" role=":AFFECTED"/>
    <text>elevated autophagy</text>
  </EVENT>
  <CC end="509" id="V2082768" paragraph="paragraph24" rule="-RULE5B_AGENT_RESULT-AGENT" start="487" uttnum="129">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2082760" role=":FACTOR"/>
    <text>oncogenic RAS-induced</text>
  </CC>
  <TERM end="509" id="V2082760" paragraph="paragraph24" rule="-SIMPLE-REF" start="487" uttnum="129">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">oncogenic RAS-induced</text>
  </TERM>
  <TERM dbid="CO:0000057" end="534" id="V2082846" paragraph="paragraph24" rule="-SIMPLE-REF" start="523" uttnum="129">
    <type>ONT::CELL</type>
    <name>FIBROBLASTS</name>
    <text>fibroblasts</text>
  </TERM>
  <EPI end="72" id="V2097888" paragraph="paragraph25" rule="-RULE50_0_AGENT_FORMAL" start="3" uttnum="130">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V2097877" role=":AGENT"/>
    <arg2 id="V2097954" role=":FORMAL"/>
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
  </EPI>
  <TERM end="6" id="V2097877" paragraph="paragraph25" rule="-ROBUSTPRO" start="3" uttnum="130">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="72" id="V2097954" paragraph="paragraph25" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE20C_AGENT_AFFECTED" start="3" uttnum="130">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V2097888"/>
    <predicate end="72" id="V2097954" start="3">
      <type>ONT::BIND</type>
      <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    </predicate>
    <arg1 id="V2097933" role=":AGENT"/>
    <arg2 id="V2097969" role=":AFFECTED"/>
    <arg id="R000157" role=":RESULT"/>
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
  </EVENT>
  <TERM end="37" id="V2097933" paragraph="paragraph25" rule="-LOGICALOP-REF" start="21" uttnum="130">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V2097929"/>
      <member id="V2097949"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <not-features>
      <bound-to event="V2097954" id="V2097969"/>
    </not-features>
  </TERM>
  <TERM end="53" id="V2097969" paragraph="paragraph25" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="42" uttnum="130">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
    <not-features>
      <bound-to id="V2097933" event="V2097954"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="27" id="V2097929" paragraph="paragraph25" rule="-SIMPLE-REF" start="21" uttnum="130">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="37" id="V2097949" paragraph="paragraph25" rule="-SIMPLE-REF" start="31" uttnum="130">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="72" id="V2097979" paragraph="paragraph25" rule="-ROBUSTPRO" start="57" uttnum="130">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>their N-termini</text>
  </TERM>
  <EVENT end="107" id="V2100466" paragraph="paragraph25" rule="-RULE20_AGENT_AFFECTED" start="74" uttnum="131">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="107" id="V2100466" start="74">
      <type>ONT::INCREASE</type>
      <text>ASPP2 potentiates RAS signalling</text>
    </predicate>
    <arg1 id="V2100458" role=":AGENT"/>
    <arg2 id="V2100481" role=":AFFECTED"/>
    <text>ASPP2 potentiates RAS signalling</text>
  </EVENT>
  <EVENT end="149" id="V2100495" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS" start="74" uttnum="131">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="149" id="V2100495" start="74">
      <type>ONT::ACTIVATE</type>
      <text>ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane</text>
    </predicate>
    <arg1 id="V2100458" role=":AGENT"/>
    <arg2 id="V2100502" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000257"/>
    <location end="149" id="V2100542" mod="null" start="128">
      <type>ONT::CELL-PART</type>
      <text normalization="">the cellular membrane</text>
    </location>
    <text>ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="80" id="V2100458" paragraph="paragraph25" rule="-SIMPLE-REF" start="74" uttnum="131">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="GO:0023052" end="107" id="V2100481" paragraph="paragraph25" rule="-SIMPLE-REF" start="92" uttnum="131">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="107" id="V2100476" paragraph="paragraph25" rule="-SIMPLE-REF" start="92" uttnum="131">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM end="125" id="V2100502" paragraph="paragraph25" rule="-SIMPLE-REF" start="121" uttnum="131">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="GO:0005886" end="149" id="V2100542" paragraph="paragraph25" rule="-SIMPLE-REF" start="128" uttnum="131">
    <type>ONT::CELL-PART</type>
    <name>CELLULAR-MEMBRANE</name>
    <text>the cellular membrane</text>
  </TERM>
  <TERM end="183" id="V2101542" paragraph="paragraph25" rule="-EXPLICIT-REF-SEQ0B" start="174" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <components>
      <component id="V2101282"/>
      <component id="V2101290"/>
    </components>
    <text normalization="">RAS–ASPP</text>
  </TERM>
  <TERM end="183" id="V2101282" paragraph="paragraph25" rule="-EXPLICIT-REF-SEQ0B-TERM" start="174" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS–ASPP</text>
  </TERM>
  <TERM dbid="FA:00278" end="183" id="V2101290" paragraph="paragraph25" rule="-SIMPLE-REF" start="178" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>ASPP</name>
    <text normalization="">ASPP</text>
  </TERM>
  <EVENT end="267" id="V2101397" paragraph="paragraph25" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="204" uttnum="132">
    <type>ONT::TRANSCRIBE</type>
    <predicate end="267" id="V2101397" start="204">
      <type>ONT::TRANSCRIBE</type>
      <text>the transcription and apoptotic function of p53 in cancer cells</text>
    </predicate>
    <site end="245" id="V2101405" start="204">
      <type>ONT::REFERENTIAL-SEM</type>
      <text normalization="">the transcription and apoptotic function</text>
    </site>
    <text>the transcription and apoptotic function of p53 in cancer cells</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="267" id="V2101466" paragraph="paragraph25" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="248" uttnum="132">
    <type>ONT::PROTEIN</type>
    <features>
      <location id="V2101533"/>
    </features>
    <name>P-53</name>
    <text>p53 in cancer cells</text>
  </TERM>
  <TERM end="267" id="V2101533" paragraph="paragraph25" rule="-SIMPLE-REF" start="255" uttnum="132">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <EVENT end="350" id="V2116042" paragraph="paragraph25" rule="-RULE10_AGENT_AFFECTED" start="269" uttnum="133">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="350" id="V2116042" start="269">
      <type>ONT::MODULATE</type>
      <text>In primary fibroblasts, ASPP2 mediates RAS-induced senescence independent of p53,</text>
    </predicate>
    <arg1 id="V2116038" role=":AGENT"/>
    <arg2 id="V2116070" role=":AFFECTED"/>
    <text>In primary fibroblasts, ASPP2 mediates RAS-induced senescence independent of p53,</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="299" id="V2116038" paragraph="paragraph25" rule="-SIMPLE-REF" start="293" uttnum="133">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="XFAM:PF06911.9" end="350" id="V2116070" paragraph="paragraph25" rule="-INEVENT2,-SIMPLE-REF" start="308" uttnum="133">
    <type>ONT::PROTEIN-FAMILY</type>
    <features>
      <inevent>
        <event id="V2116073"/>
      </inevent>
    </features>
    <name>SENESCENCE</name>
    <text normalization="">RAS-induced senescence independent of p53,</text>
  </TERM>
  <TERM dbid="CO:0000057" end="291" id="V2116025" paragraph="paragraph25" rule="-SIMPLE-REF" start="272" uttnum="133">
    <type>ONT::CELL</type>
    <name>FIBROBLASTS</name>
    <text>primary fibroblasts</text>
  </TERM>
  <CC end="320" id="V2116055" paragraph="paragraph25" rule="-RULE5B_AGENT_RESULT-AGENT" start="308" uttnum="133">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2116047" role=":FACTOR"/>
    <text>RAS-induced</text>
  </CC>
  <CC end="350" id="V2116073" paragraph="paragraph25" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="308" uttnum="133">
    <type>ONT::INDEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V2116121" role=":FACTOR"/>
    <arg id="V2116070" role=":OUTCOME"/>
    <text>RAS-induced senescence independent of p53,</text>
  </CC>
  <TERM end="320" id="V2116047" paragraph="paragraph25" rule="-SIMPLE-REF" start="308" uttnum="133">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM dbid="UP:P04637" end="350" id="V2116121" paragraph="paragraph25" rule="-SIMPLE-REF" start="343" uttnum="133">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53,</text>
  </TERM>
  <EVENT end="435" id="V2117542" paragraph="paragraph25" rule="-RULE10_AGENT_AFFECTED" start="359" uttnum="133">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="435" id="V2117542" start="359">
      <type>ONT::MODULATE</type>
      <text>in cancer cells, ASPP1 and ASPP2 mediate RAS-induced p53-dependent apoptosis</text>
    </predicate>
    <arg1 id="V2117521" role=":AGENT"/>
    <arg2 id="V2117624" role=":AFFECTED"/>
    <text>in cancer cells, ASPP1 and ASPP2 mediate RAS-induced p53-dependent apoptosis</text>
  </EVENT>
  <TERM end="392" id="V2117521" paragraph="paragraph25" rule="-LOGICALOP-REF" start="376" uttnum="133">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V2117517"/>
      <member id="V2117537"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="435" id="V2117624" paragraph="paragraph25" rule="-INEVENT2B,-SIMPLE-REF" start="400" uttnum="133">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V2117602"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>RAS-induced p53-dependent apoptosis</text>
  </TERM>
  <TERM end="374" id="V2117504" paragraph="paragraph25" rule="-SIMPLE-REF" start="362" uttnum="133">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="382" id="V2117517" paragraph="paragraph25" rule="-SIMPLE-REF" start="376" uttnum="133">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="392" id="V2117537" paragraph="paragraph25" rule="-SIMPLE-REF" start="386" uttnum="133">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <CC end="435" id="V2117602" paragraph="paragraph25" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="400" uttnum="133">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V2117596" role=":FACTOR"/>
    <arg id="V2117624" role=":OUTCOME"/>
    <text>RAS-induced p53-dependent apoptosis</text>
  </CC>
  <TERM dbid="UP:P04637" end="426" id="V2117596" paragraph="paragraph25" rule="-INEVENT2B,-SIMPLE-REF" start="400" uttnum="133">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V2117556"/>
      </inevent>
    </features>
    <name>P-53</name>
    <text>RAS-induced p53-dependent</text>
  </TERM>
  <EVENT end="426" id="V2117556" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED" start="400" uttnum="133">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="426" id="V2117556" start="400">
      <type>ONT::PRODUCE</type>
      <text>RAS-induced p53-dependent</text>
    </predicate>
    <arg1 id="V2117547" role=":AGENT"/>
    <arg2 id="V2117596" role=":AFFECTED"/>
    <text>RAS-induced p53-dependent</text>
  </EVENT>
  <TERM end="412" id="V2117547" paragraph="paragraph25" rule="-SIMPLE-REF" start="400" uttnum="133">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <TERM end="464" id="V2133098" paragraph="paragraph25" rule="-LOGICALOP-REF" start="448" uttnum="134">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V2133094"/>
      <member id="V2133114"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="536" id="V2133150" paragraph="paragraph25" rule="-SIMPLE-REF" start="468" uttnum="134">
    <type>ONT::COMMUNICATION-PARTY</type>
    <name>MEDIATORS</name>
    <text>the key mediators of RAS signalling in both primary and cancer cells</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="454" id="V2133094" paragraph="paragraph25" rule="-SIMPLE-REF" start="448" uttnum="134">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="464" id="V2133114" paragraph="paragraph25" rule="-SIMPLE-REF" start="458" uttnum="134">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="536" id="V2133141" paragraph="paragraph25" rule="-SIMPLE-REF" start="468" uttnum="134">
    <type>ONT::IDENTIFICATION</type>
    <name>KEY</name>
    <text>the key mediators of RAS signalling in both primary and cancer cells</text>
  </TERM>
  <TERM dbid="GO:0023052" end="536" id="V2133169" paragraph="paragraph25" rule="-SIMPLE-REF" start="486" uttnum="134">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>of RAS signalling in both primary and cancer cells</text>
  </TERM>
  <TERM end="536" id="V2133164" paragraph="paragraph25" rule="-SIMPLE-REF" start="486" uttnum="134">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">of RAS signalling in both primary and cancer cells</text>
  </TERM>
  <TERM end="536" id="V2133258" paragraph="paragraph25" rule="-SIMPLE-REF" start="524" uttnum="134">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="568" id="V2147815" paragraph="paragraph25" rule="-SIMPLE-REF" start="562" uttnum="135">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="558" id="V2147795" paragraph="paragraph25" rule="-SIMPLE-REF" start="549" uttnum="135">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <TERM dbid="GO:0023052" end="629" id="V2147887" paragraph="paragraph25" rule="-SIMPLE-REF" start="615" uttnum="135">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="629" id="V2147882" paragraph="paragraph25" rule="-SIMPLE-REF" start="615" uttnum="135">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="663" id="V2163247" paragraph="paragraph25" rule="-SIMPLE-REF" start="654" uttnum="136">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2</text>
  </TERM>
  <EVENT end="743" id="V2163292" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-NONE" start="663" uttnum="136">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="743" id="V2163292" start="663">
      <type>ONT::BIND</type>
      <text>to be located at cell junctions to bind and colocalise with RAS on the one hand,</text>
    </predicate>
    <location end="695" id="V2163339" mod="null" start="680">
      <type>ONT::CELL-PART</type>
      <text normalization="">cell junctions</text>
    </location>
    <text>to be located at cell junctions to bind and colocalise with RAS on the one hand,</text>
  </EVENT>
  <TERM dbid="UP:SL-0038|GO:0030054" end="695" id="V2163339" paragraph="paragraph25" rule="-SIMPLE-REF" start="680" uttnum="136">
    <type>ONT::CELL-PART</type>
    <name>CELL-JUNCTIONS</name>
    <text>cell junctions</text>
  </TERM>
  <TERM end="727" id="V2163419" paragraph="paragraph25" rule="-SIMPLE-REF" start="718" uttnum="136">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with RAS</text>
  </TERM>
  <TERM end="743" id="V2163469" paragraph="paragraph25" rule="-SIMPLE-REF" start="730" uttnum="136">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>HAND</name>
    <text>the one hand,</text>
  </TERM>
  <TERM dbid="GO:0005737|UP:SL-0086" end="773" id="V2176029" paragraph="paragraph25" rule="-SIMPLE-REF" start="759" uttnum="136">
    <type>ONT::CELL-PART</type>
    <name>CYTOPLASM</name>
    <text>the cytoplasm</text>
  </TERM>
  <TERM dbid="UP:P04637" end="786" id="V2176079" paragraph="paragraph25" rule="-SIMPLE-REF" start="782" uttnum="136">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EVENT end="806" id="V2176093" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="791" uttnum="136">
    <type>ONT::ACTIVATE</type>
    <predicate end="806" id="V2176093" start="791">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V2176089" role=":AFFECTED"/>
    <arg id="R000262" role=":RESULT"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="795" id="V2176089" paragraph="paragraph25" rule="-SIMPLE-REF" start="791" uttnum="136">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="854" id="V2176152" paragraph="paragraph25" rule="-SIMPLE-REF" start="827" uttnum="136">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2 in an ideal position</text>
  </TERM>
  <TERM end="854" id="V2176220" paragraph="paragraph25" rule="-SIMPLE-REF" start="836" uttnum="136">
    <type>ONT::MOLECULAR-SITE</type>
    <name>POSITION</name>
    <text>an ideal position</text>
  </TERM>
  <TERM dbid="GO:0023052" end="896" id="V2176283" paragraph="paragraph25" rule="-SIMPLE-REF" start="878" uttnum="136">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>of RAS signalling</text>
  </TERM>
  <TERM end="896" id="V2176278" paragraph="paragraph25" rule="-SIMPLE-REF" start="878" uttnum="136">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">of RAS signalling</text>
  </TERM>
  <TERM end="1018" id="V2190391" paragraph="paragraph25" rule="-SIMPLE-REF" start="1013" uttnum="137">
    <type>ONT::MOLECULAR-SITE</type>
    <name>POSITION</name>
    <text>that,</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1010" id="V2190364" paragraph="paragraph25" rule="-SIMPLE-REF" start="1004" uttnum="137">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="1062" id="V2193324" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED" start="1042" uttnum="137">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1062" id="V2193324" start="1042">
      <type>ONT::BIND</type>
      <text>it binds active RAS</text>
    </predicate>
    <arg1 id="V2193318" role=":AGENT"/>
    <arg2 id="V2193339" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000166"/>
    <text>it binds active RAS</text>
  </EVENT>
  <EVENT end="1040" id="V2193310" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1024" uttnum="137">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1040" id="V2193310" start="1024">
      <type>ONT::ACTIVATE</type>
      <text>RAS is activated</text>
    </predicate>
    <arg2 id="V2193286" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000267"/>
    <text>RAS is activated</text>
  </EVENT>
  <TERM end="1028" id="V2193286" paragraph="paragraph25" rule="-SIMPLE-REF" start="1024" uttnum="137">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1045" id="V2193318" paragraph="paragraph25" rule="-SIMPLE-REF" start="1042" uttnum="137">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">it</text>
    <not-features>
      <bound-to event="V2193324" id="V2193339"/>
    </not-features>
  </TERM>
  <TERM end="1062" id="V2193339" paragraph="paragraph25" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="1051" uttnum="137">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
    <not-features>
      <bound-to event="V2193324" id="V2193318"/>
    </not-features>
  </TERM>
  <TERM end="1100" id="V2193384" paragraph="paragraph25" rule="-SIMPLE-REF" start="1092" uttnum="137">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">the RAS</text>
  </TERM>
  <EVENT end="1160" id="V2210565" paragraph="paragraph25" rule="-RULE10C_AGENT_AFFECTED-AFFECTED" start="1108" uttnum="138">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1160" id="V2210565" start="1108">
      <type>ONT::TRANSLOCATE</type>
      <text>When RAS signalling is elevated to a certain level,</text>
    </predicate>
    <arg2 id="V2210541" role=":AFFECTED"/>
    <text>When RAS signalling is elevated to a certain level,</text>
  </EVENT>
  <TERM dbid="GO:0023052" end="1128" id="V2210541" paragraph="paragraph25" rule="-SIMPLE-REF" start="1113" uttnum="138">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="1128" id="V2210536" paragraph="paragraph25" rule="-SIMPLE-REF" start="1113" uttnum="138">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <EVENT end="1215" id="V2210696" paragraph="paragraph25" rule="-RULE30_AGENT_FORMAL-NONE" start="1172" uttnum="138">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="1215" id="V2210696" start="1172">
      <type>ONT::INHIBIT</type>
      <text>to disrupt cell/cell junctions for example,</text>
    </predicate>
    <arg2 id="V2210699" role=":AFFECTED"/>
    <text>to disrupt cell/cell junctions for example,</text>
  </EVENT>
  <TERM end="1203" id="V2210699" paragraph="paragraph25" rule="-SIMPLE-REF" start="1183" uttnum="138">
    <type>ONT::DEVICE-COMPONENT</type>
    <name>JUNCTION</name>
    <text>cell/cell junctions</text>
  </TERM>
  <TERM end="1193" id="V2210772" paragraph="paragraph25" rule="-EXPLICIT-REF-SEQ0B" start="1183" uttnum="138">
    <type>ONT::CELL</type>
    <components>
      <component id="V2210385"/>
      <component id="V2210399"/>
    </components>
    <text normalization="CELL">cell/cell</text>
  </TERM>
  <TERM end="1193" id="V2210385" paragraph="paragraph25" rule="-EXPLICIT-REF-SEQ0B-TERM" start="1183" uttnum="138">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell/cell</text>
  </TERM>
  <TERM end="1193" id="V2210399" paragraph="paragraph25" rule="-SIMPLE-REF" start="1188" uttnum="138">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1243" id="V2223571" paragraph="paragraph25" rule="-SIMPLE-REF" start="1237" uttnum="138">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="1267" id="V2223585" paragraph="paragraph25" rule="-SIMPLE-REF" start="1248" uttnum="138">
    <type>ONT::DEVICE-COMPONENT</type>
    <name>JUNCTION</name>
    <text>cell/cell junctions</text>
  </TERM>
  <TERM end="1258" id="V2223612" paragraph="paragraph25" rule="-EXPLICIT-REF-SEQ0B" start="1248" uttnum="138">
    <type>ONT::CELL</type>
    <components>
      <component id="V2223392"/>
      <component id="V2223406"/>
    </components>
    <text normalization="CELL">cell/cell</text>
  </TERM>
  <TERM end="1258" id="V2223392" paragraph="paragraph25" rule="-EXPLICIT-REF-SEQ0B-TERM" start="1248" uttnum="138">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell/cell</text>
  </TERM>
  <TERM end="1258" id="V2223406" paragraph="paragraph25" rule="-SIMPLE-REF" start="1253" uttnum="138">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell</text>
  </TERM>
  <EVENT end="1342" id="V2241175" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1316" uttnum="139">
    <type>ONT::BIND</type>
    <predicate end="1342" id="V2241175" start="1316">
      <type>ONT::BIND</type>
      <text>the interaction with ATG5</text>
    </predicate>
    <arg2 id="V2241200" role=":AFFECTED"/>
    <text>the interaction with ATG5</text>
  </EVENT>
  <EVENT end="1363" id="V2241229" paragraph="paragraph25" rule="-RULE30_AGENT_AFFECTED" start="1316" uttnum="139">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="1363" id="V2241229" start="1316">
      <type>ONT::INHIBIT</type>
      <text>the interaction with ATG5 to inhibit autophagy</text>
    </predicate>
    <arg1 id="V2241175" role=":AGENT"/>
    <arg2 id="V2241236" role=":AFFECTED"/>
    <text>the interaction with ATG5 to inhibit autophagy</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1298" id="V2241141" paragraph="paragraph25" rule="-SIMPLE-REF" start="1289" uttnum="139">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>of ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:589|FA:00292|UP:Q9H1Y0" end="1342" id="V2241200" paragraph="paragraph25" rule="-SIMPLE-REF" start="1332" uttnum="139">
    <type>ONT::GENE-PROTEIN</type>
    <name>ATG-5</name>
    <text>with ATG5</text>
  </TERM>
  <TERM dbid="GO:0006914" end="1363" id="V2241236" paragraph="paragraph25" rule="-SIMPLE-REF" start="1353" uttnum="139">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>AUTOPHAGY</name>
    <text>autophagy</text>
  </TERM>
  <EVENT end="1390" id="V2241289" paragraph="paragraph25" rule="-RULE40_AGENT_AFFECTED-RESULT-AGENT" start="1378" uttnum="139">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="1390" id="V2241289" start="1378">
      <type>ONT::PRODUCE</type>
      <text>RAS-induced</text>
    </predicate>
    <arg1 id="V2241280" role=":AGENT"/>
    <text>RAS-induced</text>
  </EVENT>
  <TERM end="1390" id="V2241280" paragraph="paragraph25" rule="-SIMPLE-REF" start="1378" uttnum="139">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-induced</text>
  </TERM>
  <EVENT end="1419" id="V2241339" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1404" uttnum="139">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1419" id="V2241339" start="1404">
      <type>ONT::BIND</type>
      <text>to bind p53 to</text>
    </predicate>
    <arg2 id="V2241374" role=":AFFECTED"/>
    <text>to bind p53 to</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="1416" id="V2241374" paragraph="paragraph25" rule="-SIMPLE-REF" start="1412" uttnum="139">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="1451" id="V2241420" paragraph="paragraph25" rule="-SIMPLE-REF" start="1444" uttnum="139">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="1460" id="V2241437" paragraph="paragraph25" rule="-SIMPLE-REF" start="1452" uttnum="139">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>e</text>
  </TERM>
  <EVENT end="1589" id="V2259069" paragraph="paragraph25" rule="-INEVENT2B,-RULE40A_AGENT_AFFECTED-AFFECTED" start="1480" uttnum="140">
    <type>ONT::ACTIVATE</type>
    <predicate end="1589" id="V2259069" start="1480">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions</text>
    </predicate>
    <arg2 id="V2259066" role=":AFFECTED"/>
    <arg id="R000272" role=":RESULT"/>
    <text>RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions</text>
  </EVENT>
  <TERM end="1484" id="V2259066" paragraph="paragraph25" rule="-SIMPLE-REF" start="1480" uttnum="140">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <CC end="1589" id="V2259077" paragraph="paragraph25" rule="-RULE5B_AGENT_AFFECTED" start="1480" uttnum="140">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2259174" role=":FACTOR"/>
    <arg id="V2259069" role=":OUTCOME"/>
    <text>RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions</text>
  </CC>
  <TERM end="1589" id="V2259174" paragraph="paragraph25" rule="-LOGICALOP-REF" start="1503" uttnum="140">
    <type>ONT::PROTEIN</type>
    <aggregate operator="OR">
      <member id="V2259171"/>
      <member id="V2259183"/>
    </aggregate>
    <text normalization="">by growth factors such as EGF or insulin in primary cells in normal growth conditions</text>
  </TERM>
  <TERM dbid="UP:P01133" end="1533" id="V2259171" paragraph="paragraph25" rule="-SIMPLE-REF" start="1506" uttnum="140">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>growth factors such as EGF</text>
  </TERM>
  <TERM dbid="UP:P01308" end="1589" id="V2259183" paragraph="paragraph25" rule="-SIMPLE-REF" start="1536" uttnum="140">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin in primary cells in normal growth conditions</text>
  </TERM>
  <TERM dbid="GO:0008083" end="1529" id="V2259116" paragraph="paragraph25" rule="-SIMPLE-REF" start="1506" uttnum="140">
    <type>ONT::PROTEIN</type>
    <name>GROWTH-FACTORS</name>
    <text>growth factors such as</text>
  </TERM>
  <TERM dbid="BTO:0001413" end="1589" id="V2259306" paragraph="paragraph25" rule="-SIMPLE-REF" start="1547" uttnum="140">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>PRIMARY-CELLS</name>
    <text>primary cells in normal growth conditions</text>
  </TERM>
  <TERM dbid="GO:0040007" end="1578" id="V2259367" paragraph="paragraph25" rule="-SIMPLE-REF" start="1571" uttnum="140">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH</name>
    <text>growth</text>
  </TERM>
  <TERM dbid="GO:0040007" end="1608" id="V2259413" paragraph="paragraph25" rule="-SIMPLE-REF" start="1598" uttnum="140">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH</name>
    <text>than that</text>
  </TERM>
  <EVENT end="1710" id="V2259491" paragraph="paragraph25" rule="-RULE40_AGENT_AFFECTED-RESULT-CELL_LOC2-GD-OTHERS-AGENT" start="1608" uttnum="140">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="1710" id="V2259491" start="1608">
      <type>ONT::PRODUCE</type>
      <text>in cancer cells caused by mutation or amplifications of RAS or EGFR</text>
    </predicate>
    <location end="1624" id="V2259486" mod="null" start="1611">
      <type>ONT::CELL</type>
      <text normalization="">cancer cells</text>
    </location>
    <text>in cancer cells caused by mutation or amplifications of RAS or EGFR</text>
  </EVENT>
  <TERM end="1624" id="V2259486" paragraph="paragraph25" rule="-SIMPLE-REF" start="1611" uttnum="140">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <EVENT end="1710" id="V2259537" paragraph="paragraph25" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1646" uttnum="140">
    <type>ONT::TRANSFORM</type>
    <predicate end="1710" id="V2259537" start="1646">
      <type>ONT::TRANSFORM</type>
      <text>amplifications of RAS or EGFR</text>
    </predicate>
    <arg2 id="V2259554" role=":AFFECTED"/>
    <text>amplifications of RAS or EGFR</text>
  </EVENT>
  <TERM end="1710" id="V2259554" paragraph="paragraph25" rule="-LOGICALOP-REF" start="1661" uttnum="140">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="OR">
      <member id="V2259551"/>
      <member id="V2259563"/>
    </aggregate>
    <text normalization="">of RAS or EGFR</text>
  </TERM>
  <TERM end="1685" id="V2259551" paragraph="paragraph25" rule="-SIMPLE-REF" start="1672" uttnum="140">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:P00533" end="1710" id="V2259563" paragraph="paragraph25" rule="-SIMPLE-REF" start="1696" uttnum="140">
    <type>ONT::PROTEIN</type>
    <name>EGFR</name>
    <text>EGFR</text>
  </TERM>
  <TERM end="1715" id="V2259566" paragraph="paragraph25" rule="-SIMPLE-REF" start="1710" uttnum="140">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>genes</text>
  </TERM>
  <TERM end="1722" id="V2269241" paragraph="paragraph25" rule="-LOGICALOP-REF" start="1717" uttnum="140">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="OR">
      <member id="V2259551"/>
      <member id="V2259563"/>
    </aggregate>
    <text normalization="">this</text>
  </TERM>
  <TERM dbid="GO:0051641" end="1778" id="V2269259" paragraph="paragraph25" rule="-SIMPLE-REF" start="1722" uttnum="140">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELLULAR-LOCALISATION</name>
    <text>cellular localisation of ASPP2 and its binding partners</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1753" id="V2269276" paragraph="paragraph25" rule="-SIMPLE-REF" start="1747" uttnum="140">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="1827" id="V2269419" paragraph="paragraph25" rule="-LOGICALOP-REF" start="1797" uttnum="140">
    <type>ONT::INTERNAL-BODY-PART</type>
    <aggregate operator="AND">
      <member id="V2269414"/>
      <member id="V2269440"/>
    </aggregate>
    <text normalization="">primary cells and cancer cells</text>
  </TERM>
  <TERM dbid="BTO:0001413" end="1811" id="V2269414" paragraph="paragraph25" rule="-SIMPLE-REF" start="1797" uttnum="140">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>PRIMARY-CELLS</name>
    <text>primary cells</text>
  </TERM>
  <TERM end="1827" id="V2269440" paragraph="paragraph25" rule="-SIMPLE-REF" start="1815" uttnum="140">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM end="1844" id="V2285250" paragraph="paragraph25" rule="-SIMPLE-REF" start="1829" uttnum="141">
    <type>ONT::MENTAL-OBJECT</type>
    <name>STUDIES</name>
    <text>Future studies</text>
  </TERM>
  <TERM dbid="GO:0051641" end="1912" id="V2285352" paragraph="paragraph25" rule="-SIMPLE-REF" start="1871" uttnum="141">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELLULAR-LOCALISATION</name>
    <text>cellular localisation of ASPP1 and ASPP2,</text>
  </TERM>
  <TERM end="1912" id="V2285373" paragraph="paragraph25" rule="-LOGICALOP-REF" start="1896" uttnum="141">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V2285369"/>
      <member id="V2285389"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2,</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="1902" id="V2285369" paragraph="paragraph25" rule="-SIMPLE-REF" start="1896" uttnum="141">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1912" id="V2285389" paragraph="paragraph25" rule="-SIMPLE-REF" start="1906" uttnum="141">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2,</text>
  </TERM>
  <TERM end="1931" id="V2295517" paragraph="paragraph25" rule="-SIMPLE-REF" start="1917" uttnum="141">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>their ability</text>
  </TERM>
  <TERM end="1931" id="V2295513" paragraph="paragraph25" rule="-SIMPLE-REF" start="1917" uttnum="141">
    <type>ONT::MENTAL-OBJECT</type>
    <name>STUDIES</name>
    <text>their ability</text>
  </TERM>
  <TERM end="1991" id="V2295692" paragraph="paragraph25" rule="-SIMPLE-REF" start="1967" uttnum="141">
    <type>ONT::MOTIVE</type>
    <name>REASON</name>
    <text>an underline reason for</text>
  </TERM>
  <EVENT end="1960" id="V2295566" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1934" uttnum="141">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1960" id="V2295566" start="1934">
      <type>ONT::BIND</type>
      <text>interact with ATG5 or p53</text>
    </predicate>
    <arg2 id="V2295594" role=":AFFECTED"/>
    <text>interact with ATG5 or p53</text>
  </EVENT>
  <TERM end="1960" id="V2295594" paragraph="paragraph25" rule="-LOGICALOP-REF" start="1943" uttnum="141">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="OR">
      <member id="V2295591"/>
      <member id="V2295629"/>
    </aggregate>
    <text normalization="">with ATG5 or p53</text>
  </TERM>
  <TERM dbid="HGNC:589|FA:00292|UP:Q9H1Y0" end="1953" id="V2295591" paragraph="paragraph25" rule="-SIMPLE-REF" start="1948" uttnum="141">
    <type>ONT::GENE-PROTEIN</type>
    <name>ATG-5</name>
    <text>ATG5</text>
  </TERM>
  <TERM dbid="UP:P04637" end="1960" id="V2295629" paragraph="paragraph25" rule="-SIMPLE-REF" start="1956" uttnum="141">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="1991" id="V2295661" paragraph="paragraph25" rule="-SIMPLE-REF" start="1967" uttnum="141">
    <type>ONT::FONT</type>
    <name>UNDERLINE</name>
    <text>an underline reason for</text>
  </TERM>
  <TERM end="1999" id="V2295727" paragraph="paragraph25" rule="-SIMPLE-REF" start="1995" uttnum="141">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <EVENT end="2067" id="V2295783" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED" start="2002" uttnum="141">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="2067" id="V2295783" start="2002">
      <type>ONT::PRODUCE</type>
      <text>p53 activation predominately induces senescence in primary cells</text>
    </predicate>
    <arg1 id="V2295769" role=":AGENT"/>
    <arg2 id="V2295789" role=":AFFECTED"/>
    <text>p53 activation predominately induces senescence in primary cells</text>
  </EVENT>
  <EVENT end="2017" id="V2295769" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="2002" uttnum="141">
    <type>ONT::ACTIVATE</type>
    <predicate end="2017" id="V2295769" start="2002">
      <type>ONT::ACTIVATE</type>
      <text>p53 activation</text>
    </predicate>
    <arg2 id="V2295765" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000277"/>
    <text>p53 activation</text>
  </EVENT>
  <TERM dbid="XFAM:PF06911.9" end="2050" id="V2295789" paragraph="paragraph25" rule="-SIMPLE-REF" start="2039" uttnum="141">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>SENESCENCE</name>
    <text normalization="">senescence</text>
  </TERM>
  <TERM dbid="UP:P04637" end="2006" id="V2295765" paragraph="paragraph25" rule="-SIMPLE-REF" start="2002" uttnum="141">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="BTO:0001413" end="2067" id="V2295912" paragraph="paragraph25" rule="-SIMPLE-REF" start="2053" uttnum="141">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>PRIMARY-CELLS</name>
    <text>primary cells</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="2096" id="V2295926" paragraph="paragraph25" rule="-SIMPLE-REF" start="2071" uttnum="141">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis in cancer cells</text>
  </TERM>
  <TERM end="2096" id="V2295993" paragraph="paragraph25" rule="-SIMPLE-REF" start="2084" uttnum="141">
    <type>ONT::CELL</type>
    <name>CANCER-CELLS</name>
    <text>cancer cells</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="18" id="V2310877" paragraph="paragraph26" rule="-SIMPLE-REF" start="12" uttnum="142">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="28" id="V2310897" paragraph="paragraph26" rule="-SIMPLE-REF" start="22" uttnum="142">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="54" id="V2310917" paragraph="paragraph26" rule="-SIMPLE-REF" start="43" uttnum="142">
    <type>ONT::COMPARISON</type>
    <name>SIMILARITY</name>
    <text>similarity</text>
  </TERM>
  <EVENT end="158" id="V2311075" paragraph="paragraph26" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="117" uttnum="142">
    <type>ONT::INCREASE</type>
    <predicate end="158" id="V2311075" start="117">
      <type>ONT::INCREASE</type>
      <text>including the interaction with active RAS</text>
    </predicate>
    <arg2 id="V2311090" role=":AFFECTED"/>
    <text>including the interaction with active RAS</text>
  </EVENT>
  <EVENT end="143" id="V2311090" paragraph="paragraph26" rule="-RULE20C_AFFECTED_AFFECTED1-NONE" start="127" uttnum="142">
    <type>ONT::BIND</type>
    <predicate end="143" id="V2311090" start="127">
      <type>ONT::BIND</type>
      <text>the interaction</text>
    </predicate>
    <text>the interaction</text>
  </EVENT>
  <TERM end="158" id="V2311115" paragraph="paragraph26" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="143" uttnum="142">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>RAS</name>
    <text normalization="">with active RAS</text>
  </TERM>
  <EVENT end="243" id="V2324245" paragraph="paragraph26" rule="-RULE20C_AGENT_AFFECTED" start="226" uttnum="143">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="243" id="V2324245" start="226">
      <type>ONT::BIND</type>
      <text>ASPP2 binds PAR3</text>
    </predicate>
    <arg1 id="V2324241" role=":AGENT"/>
    <arg2 id="V2324263" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000175"/>
    <text>ASPP2 binds PAR3</text>
  </EVENT>
  <EVENT end="306" id="V2324277" paragraph="paragraph26" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="226" uttnum="143">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="306" id="V2324277" start="226">
      <type>ONT::BIND</type>
      <text>ASPP2 binds PAR3 and locates at cell/cell junctions,21,</text>
    </predicate>
    <arg1 id="V2324241" role=":AGENT"/>
    <text>ASPP2 binds PAR3 and locates at cell/cell junctions,21,</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="232" id="V2324241" paragraph="paragraph26" rule="-SIMPLE-REF" start="226" uttnum="143">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <not-features>
      <bound-to id="V2324263" event="V2324245"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:O08675|UP:Q99NH2|XFAM:PF00001|XFAM:PF00595|UP:Q8TEW0|HGNC:16051|HGNC:3539|UP:O00254|FA:02653|XFAM:PF12053" end="243" id="V2324263" paragraph="paragraph26" rule="-SIMPLE-REF" start="238" uttnum="143">
    <type>ONT::GENE-PROTEIN</type>
    <name>PAR-3</name>
    <text>PAR3</text>
    <not-features>
      <bound-to id="V2324241" event="V2324245"/>
    </not-features>
  </TERM>
  <TERM end="306" id="V2324298" paragraph="paragraph26" rule="-SIMPLE-REF" start="258" uttnum="143">
    <type>ONT::DEVICE-COMPONENT</type>
    <name>JUNCTION</name>
    <text>cell/cell junctions,21,</text>
  </TERM>
  <TERM end="268" id="V2324618" paragraph="paragraph26" rule="-EXPLICIT-REF-SEQ0B" start="258" uttnum="143">
    <type>ONT::CELL</type>
    <components>
      <component id="V2324133"/>
      <component id="V2324147"/>
    </components>
    <text normalization="CELL">cell/cell</text>
  </TERM>
  <TERM end="268" id="V2324133" paragraph="paragraph26" rule="-EXPLICIT-REF-SEQ0B-TERM" start="258" uttnum="143">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell/cell</text>
  </TERM>
  <TERM end="268" id="V2324147" paragraph="paragraph26" rule="-SIMPLE-REF" start="263" uttnum="143">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell</text>
  </TERM>
  <EVENT end="368" id="V2324365" paragraph="paragraph26" rule="-RULE20C_AGENT_AFFECTED-CELL_LOC3-GD-OTHERS-AGENT" start="330" uttnum="143">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="368" id="V2324365" start="330">
      <type>ONT::BIND</type>
      <text>ASPP1 binds YAP and locates in cytosol</text>
    </predicate>
    <arg1 id="V2324334" role=":AGENT"/>
    <location end="368" id="V2324422" mod="null" start="361">
      <type>ONT::CELL-PART</type>
      <text normalization="">cytosol</text>
    </location>
    <text>ASPP1 binds YAP and locates in cytosol</text>
  </EVENT>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="336" id="V2324334" paragraph="paragraph26" rule="-SIMPLE-REF" start="330" uttnum="143">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="CVCL:8467" end="346" id="V2324347" paragraph="paragraph26" rule="-SIMPLE-REF" start="342" uttnum="143">
    <type>ONT::CELL-LINE</type>
    <name>YAP</name>
    <text>YAP</text>
  </TERM>
  <TERM dbid="UP:SL-0091|GO:0005829" end="368" id="V2324422" paragraph="paragraph26" rule="-SIMPLE-REF" start="361" uttnum="143">
    <type>ONT::CELL-PART</type>
    <name>CYTOSOL</name>
    <text>cytosol</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="419" id="V2324445" paragraph="paragraph26" rule="-SIMPLE-REF" start="413" uttnum="143">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="438" id="V2324507" paragraph="paragraph26" rule="-SIMPLE-REF" start="433" uttnum="143">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice</text>
  </TERM>
  <TERM end="474" id="V2324594" paragraph="paragraph26" rule="-SIMPLE-REF" start="468" uttnum="143">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>MOUSE</name>
    <text>mouse</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="560" id="V2340077" paragraph="paragraph26" rule="-SIMPLE-REF" start="555" uttnum="143">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>This</text>
  </TERM>
  <TERM end="513" id="V2340056" paragraph="paragraph26" rule="-SIMPLE-REF" start="496" uttnum="143">
    <type>ONT::BODY-PART</type>
    <name>LYMPHATIC-VESSEL</name>
    <text>lymphatic vessel</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="594" id="V2340125" paragraph="paragraph26" rule="-SIMPLE-REF" start="573" uttnum="143">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>ASPP2-deficient mice,</text>
  </TERM>
  <TERM end="675" id="V2341385" paragraph="paragraph26" rule="-SIMPLE-REF" start="629" uttnum="143">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PROLIFERATION</name>
    <text>excessive proliferation of neural progenitors</text>
  </TERM>
  <TERM end="625" id="V2341357" paragraph="paragraph26" rule="-SIMPLE-REF" start="608" uttnum="143">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>of cell polarity</text>
  </TERM>
  <TERM end="675" id="V2341407" paragraph="paragraph26" rule="-SIMPLE-REF" start="653" uttnum="143">
    <type>ONT::FAMILY-RELATION</type>
    <name>PROGENITORS</name>
    <text>of neural progenitors</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="715" id="V2352702" paragraph="paragraph26" rule="-SIMPLE-REF" start="709" uttnum="144">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="774" id="V2352762" paragraph="paragraph26" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="744" uttnum="144">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="774" id="V2352762" start="744">
      <type>ONT::PRODUCE</type>
      <text>to predispose mice to develop</text>
    </predicate>
    <arg2 id="V2352775" role=":AFFECTED"/>
    <text>to predispose mice to develop</text>
  </EVENT>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="763" id="V2352775" paragraph="paragraph26" rule="-SIMPLE-REF" start="758" uttnum="144">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice</text>
  </TERM>
  <EVENT end="844" id="V2352833" paragraph="paragraph26" rule="-RULE40_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="826" uttnum="144">
    <type>ONT::PRODUCE</type>
    <predicate end="844" id="V2352833" start="826">
      <type>ONT::PRODUCE</type>
      <text>establishing ASPP2</text>
    </predicate>
    <arg2 id="V2352849" role=":AFFECTED-RESULT"/>
    <text>establishing ASPP2</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="844" id="V2352849" paragraph="paragraph26" rule="-SIMPLE-REF" start="839" uttnum="144">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="926" id="V2367047" paragraph="paragraph26" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="910" uttnum="145">
    <type>ONT::TRANSFORM</type>
    <predicate end="926" id="V2367047" start="910">
      <type>ONT::TRANSFORM</type>
      <text>ASPP2 depletion</text>
    </predicate>
    <arg2 id="V2367038" role=":AFFECTED"/>
    <text>ASPP2 depletion</text>
  </EVENT>
  <TERM dbid="UP:Q13625|HGNC:12000" end="916" id="V2367038" paragraph="paragraph26" rule="-SIMPLE-REF" start="910" uttnum="145">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="970" id="V2367106" paragraph="paragraph26" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="946" uttnum="145">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="970" id="V2367106" start="946">
      <type>ONT::MODULATE</type>
      <text>to affect RAS signalling</text>
    </predicate>
    <arg2 id="V2367116" role=":AFFECTED"/>
    <text>to affect RAS signalling</text>
  </EVENT>
  <TERM dbid="GO:0023052" end="970" id="V2367116" paragraph="paragraph26" rule="-SIMPLE-REF" start="956" uttnum="145">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>RAS signalling</text>
  </TERM>
  <TERM end="970" id="V2367111" paragraph="paragraph26" rule="-SIMPLE-REF" start="956" uttnum="145">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS signalling</text>
  </TERM>
  <TERM end="987" id="V2368323" paragraph="paragraph26" rule="-SIMPLE-REF" start="972" uttnum="146">
    <type>ONT::MENTAL-OBJECT</type>
    <name>STUDIES</name>
    <text>Future studies</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="1078" id="V2368563" paragraph="paragraph26" rule="-SIMPLE-REF" start="1069" uttnum="146">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <EVENT end="1132" id="V2368632" paragraph="paragraph26" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="1111" uttnum="146">
    <type>ONT::BIND</type>
    <predicate end="1132" id="V2368632" start="1111">
      <type>ONT::BIND</type>
      <text>ASPP1–RAS interaction</text>
    </predicate>
    <arg1 id="V2368645" role=":AGENT"/>
    <text>ASPP1–RAS interaction</text>
  </EVENT>
  <TERM end="1121" id="V2368645" paragraph="paragraph26" rule="-EXPLICIT-REF-SEQ0B" start="1111" uttnum="146">
    <type>ONT::GENE-PROTEIN</type>
    <components>
      <component id="V2368230"/>
      <component id="V2368238"/>
    </components>
    <text normalization="">ASPP1–RAS</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="1121" id="V2368230" paragraph="paragraph26" rule="-EXPLICIT-REF-SEQ0B-TERM" start="1111" uttnum="146">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1–RAS</text>
  </TERM>
  <TERM end="1121" id="V2368238" paragraph="paragraph26" rule="-SIMPLE-REF" start="1117" uttnum="146">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM end="106" id="V2384562" paragraph="paragraph27" rule="-SIMPLE-REF" start="19" uttnum="147">
    <type>ONT::DOCUMENT</type>
    <name>REPORT</name>
    <text>many reports demonstrating that RAS activation inhibits apoptosis and promotes survival</text>
  </TERM>
  <EVENT end="106" id="V2384608" paragraph="paragraph27" rule="-RULE30_AGENT_AFFECTED" start="46" uttnum="147">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="106" id="V2384608" start="46">
      <type>ONT::INHIBIT</type>
      <text>that RAS activation inhibits apoptosis and promotes survival</text>
    </predicate>
    <arg1 id="V2384602" role=":AGENT"/>
    <arg2 id="V2384615" role=":AFFECTED"/>
    <text>that RAS activation inhibits apoptosis and promotes survival</text>
  </EVENT>
  <EVENT end="66" id="V2384602" paragraph="paragraph27" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="51" uttnum="147">
    <type>ONT::ACTIVATE</type>
    <predicate end="66" id="V2384602" start="51">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V2384599" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000282"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM end="55" id="V2384599" paragraph="paragraph27" rule="-SIMPLE-REF" start="51" uttnum="147">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="85" id="V2384615" paragraph="paragraph27" rule="-SIMPLE-REF" start="75" uttnum="147">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <CC end="206" id="V2388009" paragraph="paragraph27" rule="-RULE5B_AGENT_AFFECTED" start="169" uttnum="148">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2388002" role=":FACTOR"/>
    <arg id="V2388015" role=":OUTCOME"/>
    <text>that RAS activation induces apoptosis</text>
  </CC>
  <EVENT end="189" id="V2388002" paragraph="paragraph27" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="174" uttnum="148">
    <type>ONT::ACTIVATE</type>
    <predicate end="189" id="V2388002" start="174">
      <type>ONT::ACTIVATE</type>
      <text>RAS activation</text>
    </predicate>
    <arg2 id="V2387999" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000287"/>
    <text>RAS activation</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="206" id="V2388015" paragraph="paragraph27" rule="-SIMPLE-REF" start="197" uttnum="148">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="178" id="V2387999" paragraph="paragraph27" rule="-SIMPLE-REF" start="174" uttnum="148">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="226" id="V2394891" paragraph="paragraph27" rule="-SIMPLE-REF" start="219" uttnum="149">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">of RAS</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="272" id="V2394935" paragraph="paragraph27" rule="-SIMPLE-REF" start="262" uttnum="149">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM dbid="EFO:0000324" end="302" id="V2395011" paragraph="paragraph27" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="280" uttnum="149">
    <type>ONT::CELL</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>CELL-TYPES</name>
    <text>largely on cell types</text>
  </TERM>
  <EVENT end="356" id="V2395028" paragraph="paragraph27" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="306" uttnum="149">
    <type>ONT::ACTIVATE</type>
    <predicate end="356" id="V2395028" start="306">
      <type>ONT::ACTIVATE</type>
      <text>concurrent activation of other signalling pathways</text>
    </predicate>
    <arg2 id="V2395048" role=":AFFECTED"/>
    <text>concurrent activation of other signalling pathways</text>
  </EVENT>
  <TERM end="356" id="V2395048" paragraph="paragraph27" rule="-SIMPLE-REF" start="328" uttnum="149">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>of other signalling pathways</text>
  </TERM>
  <TERM dbid="GO:0023052" end="348" id="V2395045" paragraph="paragraph27" rule="-SIMPLE-REF" start="337" uttnum="149">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>signalling</text>
  </TERM>
  <TERM end="420" id="V2406004" paragraph="paragraph27" rule="-SIMPLE-REF" start="358" uttnum="150">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>The most prominent pathway involved in RAS-mediated apoptosis</text>
  </TERM>
  <TERM end="442" id="V2406118" paragraph="paragraph27" rule="-EXPLICIT-REF-SEQ0A" start="423" uttnum="150">
    <type>ONT::SIGNALING-PATHWAY</type>
    <components>
      <component id="V2405807"/>
      <component id="V2405815"/>
    </components>
    <text normalization="">the Raf–ERK pathway</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="420" id="V2406089" paragraph="paragraph27" rule="-INEVENT2B,-SIMPLE-REF" start="394" uttnum="150">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V2406076"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>in RAS-mediated apoptosis</text>
  </TERM>
  <EVENT end="420" id="V2406076" paragraph="paragraph27" rule="-RULE10_AGENT_AFFECTED" start="394" uttnum="150">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="420" id="V2406076" start="394">
      <type>ONT::MODULATE</type>
      <text>in RAS-mediated apoptosis</text>
    </predicate>
    <arg1 id="V2406068" role=":AGENT"/>
    <arg2 id="V2406089" role=":AFFECTED"/>
    <text>in RAS-mediated apoptosis</text>
  </EVENT>
  <TERM end="410" id="V2406068" paragraph="paragraph27" rule="-SIMPLE-REF" start="397" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-mediated</text>
  </TERM>
  <TERM end="442" id="V2405807" paragraph="paragraph27" rule="-EXPLICIT-REF-SEQ0A-TERM" start="423" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10398" type="ONT::PROTEIN"/>
      <member dbid="UP:P04049" type="ONT::PROTEIN"/>
      <member dbid="UP:P15056" type="ONT::PROTEIN"/>
    </members>
    <name>RAF</name>
    <text normalization="">the Raf–ERK pathway</text>
  </TERM>
  <TERM dbid="UP:P29323|HGNC:3393|UP:P28482|HGNC:6871" end="435" id="V2405815" paragraph="paragraph27" rule="-SIMPLE-REF" start="431" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <name>ERK</name>
    <text>ERK</text>
  </TERM>
  <TERM dbid="UP:P04637" end="508" id="V2406168" paragraph="paragraph27" rule="-SIMPLE-REF" start="504" uttnum="150">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="564" id="V2406335" paragraph="paragraph27" rule="-INEVENT2B,-SIMPLE-REF" start="539" uttnum="150">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V2406322"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>in RAS-mediated apoptosis</text>
  </TERM>
  <EVENT end="564" id="V2406322" paragraph="paragraph27" rule="-RULE10_AGENT_AFFECTED" start="539" uttnum="150">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="564" id="V2406322" start="539">
      <type>ONT::MODULATE</type>
      <text>in RAS-mediated apoptosis</text>
    </predicate>
    <arg1 id="V2406314" role=":AGENT"/>
    <arg2 id="V2406335" role=":AFFECTED"/>
    <text>in RAS-mediated apoptosis</text>
  </EVENT>
  <TERM end="555" id="V2406314" paragraph="paragraph27" rule="-SIMPLE-REF" start="542" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS-mediated</text>
  </TERM>
  <TERM end="573" id="V2420677" paragraph="paragraph27" rule="-SIMPLE-REF" start="569" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="625" id="V2420819" paragraph="paragraph27" rule="-SIMPLE-REF" start="621" uttnum="150">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EPI end="766" id="V2420872" paragraph="paragraph27" rule="-RULE50_0_EXPERIENCER_FORMAL-FORMAL" start="691" uttnum="150">
    <type>ONT::KNOW</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2420915" role=":FORMAL"/>
    <text>RAS is known to stimulate p53 activity through the induction of Arf and PML</text>
  </EPI>
  <TERM end="695" id="V2420846" paragraph="paragraph27" rule="-SIMPLE-REF" start="691" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <EVENT end="766" id="V2420915" paragraph="paragraph27" rule="-RULE50_0_EXPERIENCER_FORMAL-EVENT,-RULE30_AGENT_AFFECTED-MODA1_1" start="691" uttnum="150">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V2420872"/>
    <mods>
      <mod>
        <type>ONT::VIA</type>
        <value>THROUGH</value>
      </mod>
    </mods>
    <predicate end="766" id="V2420915" start="691">
      <type>ONT::STIMULATE</type>
      <text>RAS is known to stimulate p53 activity through the induction of Arf and PML</text>
    </predicate>
    <arg1 id="V2420846" role=":AGENT"/>
    <arg2 id="V2420950" role=":AFFECTED"/>
    <text>RAS is known to stimulate p53 activity through the induction of Arf and PML</text>
  </EVENT>
  <EVENT end="730" id="V2420950" paragraph="paragraph27" rule="-ACTIVITY1" start="717" uttnum="150">
    <type>ONT::ACTIVITY</type>
    <predicate end="730" id="V2420950" start="717">
      <type>ONT::ACTIVITY</type>
      <text>p53 activity</text>
    </predicate>
    <arg1 id="V2420947" role=":AGENT"/>
    <text>p53 activity</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="721" id="V2420947" paragraph="paragraph27" rule="-SIMPLE-REF" start="717" uttnum="150">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EVENT end="766" id="V2420977" paragraph="paragraph27" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="738" uttnum="150">
    <type>ONT::PRODUCE</type>
    <predicate end="766" id="V2420977" start="738">
      <type>ONT::PRODUCE</type>
      <text>the induction of Arf and PML</text>
    </predicate>
    <arg2 id="V2421003" role=":AFFECTED"/>
    <text>the induction of Arf and PML</text>
  </EVENT>
  <TERM end="766" id="V2421003" paragraph="paragraph27" rule="-LOGICALOP-REF" start="752" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V2420991"/>
      <member id="V2421014"/>
    </aggregate>
    <text normalization="">of Arf and PML</text>
  </TERM>
  <TERM dbid="UP:Q8N726|XFAM:PF07392|FA:03659|UP:P42771|UP:Q64364|HGNC:1787" end="759" id="V2420991" paragraph="paragraph27" rule="-SIMPLE-REF" start="755" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <name>ARF</name>
    <text>Arf</text>
  </TERM>
  <TERM dbid="HGNC:9113|UP:P29590" end="766" id="V2421014" paragraph="paragraph27" rule="-SIMPLE-REF" start="763" uttnum="150">
    <type>ONT::GENE</type>
    <name>PML</name>
    <text>PML</text>
  </TERM>
  <TERM end="885" id="V2421167" paragraph="paragraph27" rule="-SIMPLE-REF" start="881" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="936" id="V2421284" paragraph="paragraph27" rule="-SIMPLE-REF" start="929" uttnum="150">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>of p53</text>
  </TERM>
  <TERM dbid="UP:Q8N726|XFAM:PF07392|FA:03659|UP:P42771|UP:Q64364|HGNC:1787" end="956" id="V2421309" paragraph="paragraph27" rule="-SIMPLE-REF" start="953" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <name>ARF</name>
    <text>Arf</text>
  </TERM>
  <TERM dbid="UP:Q8N726|XFAM:PF07392|FA:03659|UP:P42771|UP:Q64364|HGNC:1787" end="999" id="V2435367" paragraph="paragraph27" rule="-SIMPLE-REF" start="996" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <name>ARF</name>
    <text>Arf</text>
  </TERM>
  <TERM end="966" id="V2435279" paragraph="paragraph27" rule="-SIMPLE-REF" start="963" uttnum="150">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2S</text>
  </TERM>
  <TERM dbid="EFO:0001203|BTO:0000093" end="981" id="V2435316" paragraph="paragraph27" rule="-SIMPLE-REF" start="970" uttnum="150">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7-CELLS</name>
    <text>MCF7 cells</text>
  </TERM>
  <EVENT end="1069" id="V2435395" paragraph="paragraph27" rule="-RULE10_AGENT_AFFECTED" start="1027" uttnum="150">
    <type>ONT::MODULATE</type>
    <predicate end="1069" id="V2435395" start="1027">
      <type>ONT::MODULATE</type>
      <text>The overall effect of RAS on p53 activity</text>
    </predicate>
    <arg1 id="V2435413" role=":AGENT"/>
    <arg2 id="V2435474" role=":AFFECTED"/>
    <text>The overall effect of RAS on p53 activity</text>
  </EVENT>
  <TERM end="1053" id="V2435413" paragraph="paragraph27" rule="-SIMPLE-REF" start="1046" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">of RAS</text>
  </TERM>
  <EVENT end="1069" id="V2435474" paragraph="paragraph27" rule="-ACTIVITY1" start="1053" uttnum="150">
    <type>ONT::ACTIVITY</type>
    <predicate end="1069" id="V2435474" start="1053">
      <type>ONT::ACTIVITY</type>
      <text>on p53 activity</text>
    </predicate>
    <arg1 id="V2435471" role=":AGENT"/>
    <text>on p53 activity</text>
  </EVENT>
  <TERM dbid="UP:P04637" end="1060" id="V2435471" paragraph="paragraph27" rule="-SIMPLE-REF" start="1056" uttnum="150">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM end="1154" id="V2435609" paragraph="paragraph27" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="1107" uttnum="150">
    <type>ONT::SIGNALING-PATHWAY</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>DIFFERENT</value>
      </mod>
    </mods>
    <name>PATHWAY</name>
    <text>the different pathways linking the two proteins</text>
  </TERM>
  <TERM end="1154" id="V2435630" paragraph="paragraph27" rule="-SIMPLE-REF" start="1138" uttnum="150">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>the two proteins</text>
  </TERM>
  <TERM end="88" id="V2451549" paragraph="paragraph28" rule="-SIMPLE-REF" start="79" uttnum="151">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the cell</text>
  </TERM>
  <TERM end="28" id="V2451425" paragraph="paragraph28" rule="-SIMPLE-REF" start="15" uttnum="151">
    <type>ONT::GENE</type>
    <name>ONCOGENES</name>
    <text>of oncogenes</text>
  </TERM>
  <EVENT end="72" id="V2451454" paragraph="paragraph28" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="31" uttnum="151">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="72" id="V2451454" start="31">
      <type>ONT::STIMULATE</type>
      <text>stimulate cell cycle arrest or apoptosis</text>
    </predicate>
    <arg2 id="V2451519" role=":AFFECTED"/>
    <text>stimulate cell cycle arrest or apoptosis</text>
  </EVENT>
  <TERM end="72" id="V2451519" paragraph="paragraph28" rule="-LOGICALOP-REF" start="41" uttnum="151">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <aggregate operator="OR">
      <member id="V2451516"/>
      <member id="V2451528"/>
    </aggregate>
    <text normalization="">cell cycle arrest or apoptosis</text>
  </TERM>
  <TERM dbid="GO:0007050" end="59" id="V2451516" paragraph="paragraph28" rule="-SIMPLE-REF" start="41" uttnum="151">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-CYCLE-ARREST</name>
    <text>cell cycle arrest</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="72" id="V2451528" paragraph="paragraph28" rule="-SIMPLE-REF" start="62" uttnum="151">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="115" id="V2451704" paragraph="paragraph28" rule="-SIMPLE-REF" start="109" uttnum="151">
    <type>ONT::AGENT</type>
    <name>SYSTEM</name>
    <text>system</text>
  </TERM>
  <EVENT end="137" id="V2451717" paragraph="paragraph28" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="117" uttnum="151">
    <type>ONT::ACTIVATE</type>
    <predicate end="137" id="V2451717" start="117">
      <type>ONT::ACTIVATE</type>
      <text>oncogene activation</text>
    </predicate>
    <arg2 id="V2451713" role=":AFFECTED"/>
    <arg id="R000292" role=":RESULT"/>
    <text>oncogene activation</text>
  </EVENT>
  <TERM end="126" id="V2451713" paragraph="paragraph28" rule="-SIMPLE-REF" start="117" uttnum="151">
    <type>ONT::GENE</type>
    <name>ONCOGENE</name>
    <text>oncogene</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="214" id="V2468530" paragraph="paragraph28" rule="-RULE40_AGENT_AFFECTED-RESULT-NONE" start="155" uttnum="151">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="214" id="V2468530" start="155">
      <type>ONT::PRODUCE</type>
      <text>inducing the cell to proliferate in an uncontrolled manner,</text>
    </predicate>
    <arg2 id="V2468545" role=":AFFECTED"/>
    <text>inducing the cell to proliferate in an uncontrolled manner,</text>
  </EVENT>
  <TERM end="214" id="V2468545" paragraph="paragraph28" rule="-SIMPLE-REF" start="164" uttnum="151">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>the cell to proliferate in an uncontrolled manner,</text>
  </TERM>
  <TERM end="213" id="V2468653" paragraph="paragraph28" rule="-SIMPLE-REF" start="191" uttnum="151">
    <type>ONT::METHOD</type>
    <name>MANNER</name>
    <text>an uncontrolled manner</text>
  </TERM>
  <TERM end="251" id="V2480460" paragraph="paragraph28" rule="-SIMPLE-REF" start="224" uttnum="151">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>tumour-suppressor proteins,</text>
  </TERM>
  <TERM end="242" id="V2480389" paragraph="paragraph28" rule="-SIMPLE-REF" start="231" uttnum="151">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>suppressor</text>
  </TERM>
  <TERM end="280" id="V2480649" paragraph="paragraph28" rule="-SIMPLE-REF" start="271" uttnum="151">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the cell</text>
  </TERM>
  <TERM end="307" id="V2480677" paragraph="paragraph28" rule="-SIMPLE-REF" start="297" uttnum="151">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>its damage</text>
  </TERM>
  <TERM end="350" id="V2482159" paragraph="paragraph28" rule="-LOGICALOP-REF" start="318" uttnum="152">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <aggregate operator="AND">
      <member id="V2482155"/>
      <member id="V2482170"/>
    </aggregate>
    <text normalization="">cell cycle arrest and apoptosis</text>
  </TERM>
  <TERM end="374" id="V2482203" paragraph="paragraph28" rule="-SIMPLE-REF" start="354" uttnum="152">
    <type>ONT::METHOD</type>
    <name>WAY</name>
    <text>both efficient ways</text>
  </TERM>
  <TERM dbid="GO:0007050" end="336" id="V2482155" paragraph="paragraph28" rule="-SIMPLE-REF" start="318" uttnum="152">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-CYCLE-ARREST</name>
    <text>cell cycle arrest</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="350" id="V2482170" paragraph="paragraph28" rule="-SIMPLE-REF" start="340" uttnum="152">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <EVENT end="422" id="V2482272" paragraph="paragraph28" rule="-RULE30_AGENT_AFFECTED" start="378" uttnum="152">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="422" id="V2482272" start="378">
      <type>ONT::INHIBIT</type>
      <text>cells to prevent propagation of their damage</text>
    </predicate>
    <arg1 id="V2482240" role=":AGENT"/>
    <text>cells to prevent propagation of their damage</text>
  </EVENT>
  <TERM end="384" id="V2482240" paragraph="paragraph28" rule="-SIMPLE-REF" start="378" uttnum="152">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <TERM end="422" id="V2482306" paragraph="paragraph28" rule="-SIMPLE-REF" start="407" uttnum="152">
    <type>ONT::METHOD</type>
    <name>WAY</name>
    <text>of their damage</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="434" id="V2497696" paragraph="paragraph28" rule="-SIMPLE-REF" start="424" uttnum="152">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="499" id="V2498074" paragraph="paragraph28" rule="-SIMPLE-REF" start="480" uttnum="153">
    <type>ONT::SYMBOLIC-REPRESENTATION</type>
    <name>IDENTIFICATION</name>
    <text>The identification</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="508" id="V2498091" paragraph="paragraph28" rule="-SIMPLE-REF" start="499" uttnum="153">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>of ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="518" id="V2498111" paragraph="paragraph28" rule="-SIMPLE-REF" start="512" uttnum="153">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <TERM end="546" id="V2498145" paragraph="paragraph28" rule="-SIMPLE-REF" start="521" uttnum="153">
    <type>ONT::COMMUNICATION-PARTY</type>
    <name>MEDIATORS</name>
    <text>mediators of RAS and p53</text>
  </TERM>
  <TERM end="546" id="V2498163" paragraph="paragraph28" rule="-LOGICALOP-REF" start="531" uttnum="153">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V2498159"/>
      <member id="V2498200"/>
    </aggregate>
    <text normalization="">of RAS and p53</text>
  </TERM>
  <TERM end="538" id="V2498159" paragraph="paragraph28" rule="-SIMPLE-REF" start="534" uttnum="153">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="546" id="V2498200" paragraph="paragraph28" rule="-SIMPLE-REF" start="542" uttnum="153">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EVENT end="570" id="V2498256" paragraph="paragraph28" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="549" uttnum="153">
    <type>ONT::MODULATE</type>
    <predicate end="570" id="V2498256" start="549">
      <type>ONT::MODULATE</type>
      <text>regulating apoptosis</text>
    </predicate>
    <arg2 id="V2498261" role=":AFFECTED"/>
    <text>regulating apoptosis</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="570" id="V2498261" paragraph="paragraph28" rule="-SIMPLE-REF" start="560" uttnum="153">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="598" id="V2498295" paragraph="paragraph28" rule="-SIMPLE-REF" start="584" uttnum="153">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">oncogenic RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="624" id="V2498418" paragraph="paragraph28" rule="-SIMPLE-REF" start="620" uttnum="153">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <TERM dbid="GO:0006915|GO:0097194" end="643" id="V2498454" paragraph="paragraph28" rule="-SIMPLE-REF" start="634" uttnum="153">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>APOPTOSIS</name>
    <text>apoptosis</text>
  </TERM>
  <TERM end="691" id="V2512547" paragraph="paragraph28" rule="-LOGICALOP-REF" start="670" uttnum="154">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V2512543"/>
      <member id="V2512563"/>
    </aggregate>
    <text normalization="">that ASPP1 and ASPP2</text>
  </TERM>
  <TERM end="710" id="V2512584" paragraph="paragraph28" rule="-SIMPLE-REF" start="701" uttnum="154">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with RAS</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="681" id="V2512543" paragraph="paragraph28" rule="-SIMPLE-REF" start="670" uttnum="154">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>that ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="691" id="V2512563" paragraph="paragraph28" rule="-SIMPLE-REF" start="685" uttnum="154">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="743" id="V2512613" paragraph="paragraph28" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="713" uttnum="154">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="743" id="V2512613" start="713">
      <type>ONT::STIMULATE</type>
      <text>enhance p53-induced apoptosis</text>
    </predicate>
    <arg2 id="V2512675" role=":AFFECTED"/>
    <text>enhance p53-induced apoptosis</text>
  </EVENT>
  <TERM dbid="GO:0006915|GO:0097194" end="743" id="V2512675" paragraph="paragraph28" rule="-INEVENT2B,-SIMPLE-REF" start="721" uttnum="154">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <features>
      <inevent>
        <event id="V2512653"/>
      </inevent>
    </features>
    <name>APOPTOSIS</name>
    <text>p53-induced apoptosis</text>
  </TERM>
  <CC end="743" id="V2512653" paragraph="paragraph28" rule="-RULE5B_AGENT_AFFECTED" start="721" uttnum="154">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2512644" role=":FACTOR"/>
    <arg id="V2512675" role=":OUTCOME"/>
    <text>p53-induced apoptosis</text>
  </CC>
  <TERM dbid="UP:P04637" end="733" id="V2512644" paragraph="paragraph28" rule="-SIMPLE-REF" start="721" uttnum="154">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53-induced</text>
  </TERM>
  <TERM end="757" id="V2512693" paragraph="paragraph28" rule="-LOGICALOP-REF" start="752" uttnum="154">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V2512543"/>
      <member id="V2512563"/>
    </aggregate>
    <text normalization="">that</text>
  </TERM>
  <TERM end="780" id="V2512722" paragraph="paragraph28" rule="-LOGICALOP-REF" start="762" uttnum="154">
    <type>ONT::GENE</type>
    <aggregate operator="OR">
      <member id="V2512719"/>
      <member id="V2512736"/>
    </aggregate>
    <text normalization="">of ASPP1 or ASPP2</text>
  </TERM>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="771" id="V2512719" paragraph="paragraph28" rule="-SIMPLE-REF" start="765" uttnum="154">
    <type>ONT::GENE</type>
    <name>ASPP-1</name>
    <text>ASPP1</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="780" id="V2512736" paragraph="paragraph28" rule="-SIMPLE-REF" start="774" uttnum="154">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
  </TERM>
  <EVENT end="847" id="V2512742" paragraph="paragraph28" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="780" uttnum="154">
    <type>ONT::EXPRESS</type>
    <predicate end="847" id="V2512742" start="780">
      <type>ONT::EXPRESS</type>
      <text>expression may be a frequent event in human cancers with mutant RAS</text>
    </predicate>
    <site end="847" id="V2512882" start="818">
      <type>ONT::CANCER</type>
      <text normalization="CANCER">human cancers with mutant RAS</text>
    </site>
    <text>expression may be a frequent event in human cancers with mutant RAS</text>
  </EVENT>
  <TERM end="847" id="V2512903" paragraph="paragraph28" rule="-SIMPLE-REF-MUTATION5,-SIMPLE-REF" start="837" uttnum="154">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>RAS</name>
    <text normalization="">mutant RAS</text>
  </TERM>
  <TERM end="862" id="V2526958" paragraph="paragraph28" rule="-SIMPLE-REF" start="849" uttnum="155">
    <type>ONT::CLINICAL-FINDING</type>
    <name>FINDING</name>
    <text>This finding</text>
  </TERM>
  <TERM end="934" id="V2527126" paragraph="paragraph28" rule="-SIMPLE-REF-MUTATION8" start="912" uttnum="155">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>RAS and p53 mutations</text>
  </TERM>
  <TERM end="924" id="V2527083" paragraph="paragraph28" rule="-LOGICALOP-REF" start="912" uttnum="155">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V2527079"/>
      <member id="V2527120"/>
    </aggregate>
    <text normalization="">RAS and p53</text>
  </TERM>
  <TERM end="916" id="V2527079" paragraph="paragraph28" rule="-SIMPLE-REF" start="912" uttnum="155">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
  </TERM>
  <TERM dbid="UP:P04637" end="924" id="V2527120" paragraph="paragraph28" rule="-SIMPLE-REF" start="920" uttnum="155">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
  </TERM>
  <EVENT paragraph="paragraph1" refid="V121190" end="875" uttnum="8" id="R000001" start="847" rule="EKR:LocateTerm">
    <type>ONT::LOCALIZATION</type>
    <text>ASPP2 in human cancer cells </text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V121190"/>
    <location id="V121264"/>
  </EVENT>
  <EVENT uttnum="23" id="R000002" start="427" rule="EKR:LocateTerm" paragraph="paragraph5" end="454" refid="V363290">
    <type>ONT::LOCALIZATION</type>
    <text>primary fibroblasts, ASPP2 </text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V363290"/>
    <location id="V363277"/>
  </EVENT>
  <EVENT refid="V399290" end="214" paragraph="paragraph6" rule="EKR:LocateTerm" start="185" id="R000003" uttnum="25">
    <type>ONT::LOCALIZATION</type>
    <text>senescence in primary cells, </text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V399290"/>
    <location id="V399413"/>
  </EVENT>
  <EVENT start="218" rule="EKR:LocateTerm" uttnum="25" id="R000004" refid="V399430" end="243" paragraph="paragraph6">
    <type>ONT::LOCALIZATION</type>
    <text>apoptosis in cancer cells</text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V399430"/>
    <location id="V399497"/>
  </EVENT>
  <EVENT paragraph="paragraph10" end="417" refid="V796317" uttnum="50" id="R000005" start="395" rule="EKR:LocateTerm">
    <type>ONT::LOCALIZATION</type>
    <text>ASPP2 in starved cells</text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V796317" role=":NEUTRAL"/>
    <location id="V796384"/>
  </EVENT>
  <EVENT paragraph="paragraph13" end="224" refid="V1085544" uttnum="67" id="R000006" start="149" rule="EKR:LocateTerm">
    <type>ONT::LOCALIZATION</type>
    <text>MEFs, insulin-induced active RAS and ASPP2 colocalised at the cell membrane</text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V1085544"/>
    <location id="V1085639"/>
  </EVENT>
  <EVENT rule="EKR:LocateTerm" start="1041" id="R000007" uttnum="100" end="1057" refid="V1600647" paragraph="paragraph18">
    <type>ONT::LOCALIZATION</type>
    <text>RAS–GTP in cells</text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V1600647" role=":NEUTRAL"/>
    <location id="V1600703"/>
  </EVENT>
  <EVENT id="R000008" uttnum="132" rule="EKR:LocateTerm" start="248" paragraph="paragraph25" refid="V2101466" end="267">
    <type>ONT::LOCALIZATION</type>
    <text>p53 in cancer cells</text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V2101466" role=":NEUTRAL"/>
    <location id="V2101533"/>
  </EVENT>
  <TERM end="552" paragraph="paragraph2" start="519" uttnum="11" id="R000009" refid="V167917" rule="EKR:InEventBind">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS that constitutively binds GTP</text>
    <not-features>
      <bound-to event="V167943" id="V167952"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:15996|CHEBI:37565" end="552" paragraph="paragraph2" start="549" uttnum="11" id="R000010" refid="V167952" rule="EKR:InEventBind">
    <type>ONT::MOLECULE</type>
    <name>GTP</name>
    <text>GTP</text>
    <features>
      <bound-to id="V167917" event="V167943"/>
    </features>
  </TERM>
  <TERM rule="EKR:InEventBind" start="519" id="R000011" uttnum="11" refid="V167943,V167917,R000010" end="552" paragraph="paragraph2">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>RAS that constitutively binds GTP</text>
    <name>RAS/GTP</name>
    <components>
      <component id="V167917"/>
      <component id="R000010"/>
    </components>
  </TERM>
  <EVENT uttnum="11" id="R000012" start="519" rule="EKR:InEventBind" paragraph="paragraph2" end="552" refid="V167943">
    <text>RAS that constitutively binds GTP</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000011"/>
  </EVENT>
  <CC start="519" rule="EKR:InEventBind" uttnum="11" id="R000013" end="552" refid="V167943" paragraph="paragraph2">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS that constitutively binds GTP</text>
    <arg role=":FACTOR" id="V167943"/>
    <arg id="R000012" role=":OUTCOME"/>
  </CC>
  <EVENT end="552" refid="V167943" paragraph="paragraph2" rule="EKR:InEventBind" start="519" id="R000014" uttnum="11">
    <type>ONT::DECREASE</type>
    <text>RAS that constitutively binds GTP</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000009" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph2" refid="V167943" end="552" uttnum="11" id="R000015" start="519" rule="EKR:InEventBind">
    <text>RAS that constitutively binds GTP</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V167943" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000014"/>
  </CC>
  <EVENT paragraph="paragraph2" refid="V167943" end="552" id="R000016" uttnum="11" rule="EKR:InEventBind" start="519">
    <type>ONT::DECREASE</type>
    <text>RAS that constitutively binds GTP</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V167952"/>
  </EVENT>
  <CC id="R000017" uttnum="11" rule="EKR:InEventBind" start="519" paragraph="paragraph2" refid="V167943" end="552">
    <text>RAS that constitutively binds GTP</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V167943" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000016"/>
  </CC>
  <TERM end="92" paragraph="paragraph9" start="56" uttnum="41" id="R000018" refid="V671571" rule="EKR:InEventBind">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">the RAS-binding domain (RBD) of Raf1</text>
    <not-features>
      <bound-to event="V671578" id="V671596"/>
    </not-features>
  </TERM>
  <TERM end="85" paragraph="paragraph9" start="72" uttnum="41" id="R000019" refid="V671596" rule="EKR:InEventBind">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>domain (RBD)</text>
    <features>
      <bound-to event="V671578" id="V671571"/>
    </features>
  </TERM>
  <TERM uttnum="41" id="R000020" start="56" rule="EKR:InEventBind" paragraph="paragraph9" refid="V671578,V671571,R000019" end="92">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>the RAS-binding domain (RBD) of Raf1</text>
    <name>RAS/DOMAIN</name>
    <components>
      <component id="V671571"/>
      <component id="R000019"/>
    </components>
  </TERM>
  <EVENT end="92" refid="V671578" paragraph="paragraph9" start="56" rule="EKR:InEventBind" uttnum="41" id="R000021">
    <text>the RAS-binding domain (RBD) of Raf1</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000020" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph9" refid="V671578" end="92" uttnum="41" id="R000022" start="56" rule="EKR:InEventBind">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the RAS-binding domain (RBD) of Raf1</text>
    <arg role=":FACTOR" id="V671578"/>
    <arg role=":OUTCOME" id="R000021"/>
  </CC>
  <EVENT end="92" refid="V671578" paragraph="paragraph9" rule="EKR:InEventBind" start="56" id="R000023" uttnum="41">
    <type>ONT::DECREASE</type>
    <text>the RAS-binding domain (RBD) of Raf1</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000018"/>
  </EVENT>
  <CC start="56" rule="EKR:InEventBind" uttnum="41" id="R000024" end="92" refid="V671578" paragraph="paragraph9">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the RAS-binding domain (RBD) of Raf1</text>
    <arg id="V671578" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000023"/>
  </CC>
  <EVENT end="92" refid="V671578" paragraph="paragraph9" start="56" rule="EKR:InEventBind" uttnum="41" id="R000025">
    <text>the RAS-binding domain (RBD) of Raf1</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V671596" role=":AFFECTED"/>
  </EVENT>
  <CC start="56" rule="EKR:InEventBind" uttnum="41" id="R000026" refid="V671578" end="92" paragraph="paragraph9">
    <text>the RAS-binding domain (RBD) of Raf1</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V671578"/>
    <arg role=":OUTCOME" id="R000025"/>
  </CC>
  <TERM end="188" paragraph="paragraph9" start="156" uttnum="42" id="R000027" refid="V687636" rule="EKR:InEventBind">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>proteins associated with RAS–GTP</text>
    <not-features>
      <bound-to event="V687641" id="V687674"/>
    </not-features>
  </TERM>
  <TERM end="188" paragraph="paragraph9" start="176" uttnum="42" id="R000028" refid="V687674" rule="EKR:InEventBind">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">with RAS–GTP</text>
    <features>
      <bound-to id="V687636" event="V687641"/>
    </features>
  </TERM>
  <TERM paragraph="paragraph9" refid="V687641,V687636,R000028" end="188" uttnum="42" id="R000029" start="156" rule="EKR:InEventBind">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>proteins associated with RAS–GTP</text>
    <name>PROTEIN/RAS-GTP</name>
    <components>
      <component id="V687636"/>
      <component id="R000028"/>
    </components>
  </TERM>
  <EVENT id="R000030" uttnum="42" rule="EKR:InEventBind" start="156" paragraph="paragraph9" end="188" refid="V687641">
    <type>ONT::INCREASE</type>
    <text>proteins associated with RAS–GTP</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000029" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:InEventBind" start="156" id="R000031" uttnum="42" end="188" refid="V687641" paragraph="paragraph9">
    <type>ONT::CAUSE-EFFECT</type>
    <text>proteins associated with RAS–GTP</text>
    <arg role=":FACTOR" id="V687641"/>
    <arg id="R000030" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V687641" end="188" paragraph="paragraph9" start="156" rule="EKR:InEventBind" uttnum="42" id="R000032">
    <type>ONT::DECREASE</type>
    <text>proteins associated with RAS–GTP</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000027" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V687641" end="188" paragraph="paragraph9" rule="EKR:InEventBind" start="156" id="R000033" uttnum="42">
    <text>proteins associated with RAS–GTP</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V687641"/>
    <arg id="R000032" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:InEventBind" start="156" id="R000034" uttnum="42" refid="V687641" end="188" paragraph="paragraph9">
    <text>proteins associated with RAS–GTP</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V687674"/>
  </EVENT>
  <CC paragraph="paragraph9" end="188" refid="V687641" uttnum="42" id="R000035" start="156" rule="EKR:InEventBind">
    <type>ONT::CAUSE-EFFECT</type>
    <text>proteins associated with RAS–GTP</text>
    <arg role=":FACTOR" id="V687641"/>
    <arg role=":OUTCOME" id="R000034"/>
  </CC>
  <TERM end="79" paragraph="paragraph1" start="54" uttnum="2" id="R000036" refid="V45976" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">activated RAS signalling</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT refid="V45969" end="79" paragraph="paragraph1" start="54" rule="EKR:IneventActivate" uttnum="2" id="R000037">
    <text>activated RAS signalling </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V45976" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="54" id="R000038" uttnum="2" end="79" refid="V45969" paragraph="paragraph1">
    <text>activated RAS signalling </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V45969"/>
    <arg id="R000037" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="2" id="R000039" start="54" rule="EKR:IneventActivate" paragraph="paragraph1" refid="V45969" end="79">
    <type>ONT::DECREASE</type>
    <text>activated RAS signalling </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000036" role=":AFFECTED"/>
  </EVENT>
  <CC end="79" refid="V45969" paragraph="paragraph1" rule="EKR:IneventActivate" start="54" id="R000040" uttnum="2">
    <text>activated RAS signalling </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V45969"/>
    <arg id="R000039" role=":OUTCOME"/>
  </CC>
  <TERM end="17" paragraph="paragraph9" start="3" uttnum="41" id="R000041" refid="V671475" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">Activated RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph9" end="17" refid="V671469" uttnum="41" id="R000042" start="3" rule="EKR:IneventActivate">
    <text>Activated RAS </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V671475" role=":AFFECTED"/>
  </EVENT>
  <CC end="17" refid="V671469" paragraph="paragraph9" start="3" rule="EKR:IneventActivate" uttnum="41" id="R000043">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated RAS </text>
    <arg role=":FACTOR" id="V671469"/>
    <arg id="R000042" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:IneventActivate" start="3" id="R000044" uttnum="41" refid="V671469" end="17" paragraph="paragraph9">
    <text>Activated RAS </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000041"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="3" id="R000045" uttnum="41" refid="V671469" end="17" paragraph="paragraph9">
    <text>Activated RAS </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V671469" role=":FACTOR"/>
    <arg id="R000044" role=":OUTCOME"/>
  </CC>
  <TERM end="17" paragraph="paragraph12" start="3" uttnum="62" id="R000046" refid="V1020805" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">Activated RAS</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT refid="V1020798" end="17" paragraph="paragraph12" rule="EKR:IneventActivate" start="3" id="R000047" uttnum="62">
    <type>ONT::INCREASE</type>
    <text>Activated RAS </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1020805"/>
  </EVENT>
  <CC paragraph="paragraph12" end="17" refid="V1020798" uttnum="62" id="R000048" start="3" rule="EKR:IneventActivate">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated RAS </text>
    <arg role=":FACTOR" id="V1020798"/>
    <arg id="R000047" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph12" end="17" refid="V1020798" uttnum="62" id="R000049" start="3" rule="EKR:IneventActivate">
    <type>ONT::DECREASE</type>
    <text>Activated RAS </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000046" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="3" id="R000050" uttnum="62" end="17" refid="V1020798" paragraph="paragraph12">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated RAS </text>
    <arg role=":FACTOR" id="V1020798"/>
    <arg id="R000049" role=":OUTCOME"/>
  </CC>
  <TERM end="787" paragraph="paragraph19" start="756" uttnum="105" id="R000051" refid="V1680912" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">by activated RAS in HKe3 cells</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="787" refid="V1680906" paragraph="paragraph19" start="756" rule="EKR:IneventActivate" uttnum="105" id="R000052">
    <type>ONT::INCREASE</type>
    <text>by activated RAS in HKe3 cells </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V1680912" role=":AFFECTED"/>
  </EVENT>
  <CC start="756" rule="EKR:IneventActivate" uttnum="105" id="R000053" end="787" refid="V1680906" paragraph="paragraph19">
    <type>ONT::CAUSE-EFFECT</type>
    <text>by activated RAS in HKe3 cells </text>
    <arg id="V1680906" role=":FACTOR"/>
    <arg id="R000052" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph19" refid="V1680906" end="787" id="R000054" uttnum="105" rule="EKR:IneventActivate" start="756">
    <type>ONT::DECREASE</type>
    <text>by activated RAS in HKe3 cells </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000051" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="756" id="R000055" uttnum="105" refid="V1680906" end="787" paragraph="paragraph19">
    <text>by activated RAS in HKe3 cells </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1680906"/>
    <arg role=":OUTCOME" id="R000054"/>
  </CC>
  <TERM end="717" paragraph="paragraph5" start="693" uttnum="23" id="R000056" refid="V386862" rule="EKR:BindXY">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>the N-terminus of ASPP2</text>
    <features>
      <bound-to id="R000057" event="V386909"/>
    </features>
  </TERM>
  <TERM dbid="HGNC:589|FA:00292|UP:Q9H1Y0" end="728" paragraph="paragraph5" start="723" uttnum="23" id="R000057" refid="V386923" rule="EKR:BindXY">
    <type>ONT::GENE-PROTEIN</type>
    <name>ATG-5</name>
    <text>ATG5</text>
    <features>
      <bound-to event="V386909" id="R000056"/>
    </features>
  </TERM>
  <TERM paragraph="paragraph5" refid="V386909,R000056,R000057" end="728" uttnum="23" id="R000058" start="693" rule="EKR:BindXY">
    <text>the N-terminus of ASPP2 binds ATG5 </text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>N-TERMINUS/ATG-5</name>
    <components>
      <component id="R000056"/>
      <component id="R000057"/>
    </components>
  </TERM>
  <EVENT id="R000059" uttnum="23" rule="EKR:BindXY" start="693" paragraph="paragraph5" end="728" refid="V386909">
    <type>ONT::INCREASE</type>
    <text>the N-terminus of ASPP2 binds ATG5 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000058" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="23" id="R000060" start="693" rule="EKR:BindXY" paragraph="paragraph5" end="728" refid="V386909">
    <text>the N-terminus of ASPP2 binds ATG5 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V386909"/>
    <arg id="R000059" role=":OUTCOME"/>
  </CC>
  <EVENT end="728" refid="V386909" paragraph="paragraph5" start="693" rule="EKR:BindXY" uttnum="23" id="R000061">
    <text>the N-terminus of ASPP2 binds ATG5 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V386862"/>
  </EVENT>
  <CC start="693" rule="EKR:BindXY" uttnum="23" id="R000062" refid="V386909" end="728" paragraph="paragraph5">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the N-terminus of ASPP2 binds ATG5 </text>
    <arg id="V386909" role=":FACTOR"/>
    <arg id="R000061" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000063" uttnum="23" rule="EKR:BindXY" start="693" paragraph="paragraph5" refid="V386909" end="728">
    <text>the N-terminus of ASPP2 binds ATG5 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V386923"/>
  </EVENT>
  <CC start="693" rule="EKR:BindXY" uttnum="23" id="R000064" refid="V386909" end="728" paragraph="paragraph5">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the N-terminus of ASPP2 binds ATG5 </text>
    <arg id="V386909" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000063"/>
  </CC>
  <TERM end="644" paragraph="paragraph7" start="628" uttnum="32" id="R000065" refid="V556354" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V556350"/>
      <member id="V556370"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <features>
      <bound-to event="V556375" id="R000066"/>
    </features>
  </TERM>
  <TERM end="659" paragraph="paragraph7" start="649" uttnum="32" id="R000066" refid="V556390" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
      <bound-to id="R000065" event="V556375"/>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM uttnum="32" id="R000067" start="615" rule="EKR:BindXY" paragraph="paragraph7" refid="V556375,R000065,R000066" end="659">
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <components>
      <component id="R000065"/>
      <component id="R000066"/>
    </components>
  </TERM>
  <EVENT paragraph="paragraph7" end="659" refid="V556375" id="R000068" uttnum="32" rule="EKR:BindXY" start="615">
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000067"/>
  </EVENT>
  <CC uttnum="32" id="R000069" start="615" rule="EKR:BindXY" paragraph="paragraph7" end="659" refid="V556375">
    <type>ONT::CAUSE-EFFECT</type>
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    <arg role=":FACTOR" id="V556375"/>
    <arg id="R000068" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph7" refid="V556375" end="659" id="R000070" uttnum="32" rule="EKR:BindXY" start="615">
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V556354" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph7" refid="V556375" end="659" uttnum="32" id="R000071" start="615" rule="EKR:BindXY">
    <type>ONT::CAUSE-EFFECT</type>
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    <arg id="V556375" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000070"/>
  </CC>
  <EVENT paragraph="paragraph7" refid="V556375" end="659" uttnum="32" id="R000072" start="615" rule="EKR:BindXY">
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V556390" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph7" refid="V556375" end="659" uttnum="32" id="R000073" start="615" rule="EKR:BindXY">
    <text>we show that ASPP1 and ASPP2 bind active RAS</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V556375" role=":FACTOR"/>
    <arg id="R000072" role=":OUTCOME"/>
  </CC>
  <TERM end="209" paragraph="paragraph8" start="193" uttnum="35" id="R000074" refid="V592183" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V592179"/>
      <member id="V592199"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <features>
      <bound-to id="R000075" event="V592218"/>
    </features>
  </TERM>
  <TERM end="230" paragraph="paragraph8" start="222" uttnum="35" id="R000075" refid="V592238" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with RAS</text>
    <features>
      <bound-to id="R000074" event="V592218"/>
    </features>
  </TERM>
  <TERM id="R000076" uttnum="35" rule="EKR:BindXY" start="188" paragraph="paragraph8" end="230" refid="V592218,R000074,R000075">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
    <name>COMPLEX</name>
    <components>
      <component id="R000074"/>
      <component id="R000075"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="188" id="R000077" uttnum="35" refid="V592218" end="230" paragraph="paragraph8">
    <type>ONT::INCREASE</type>
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000076" role=":AFFECTED"/>
  </EVENT>
  <CC end="230" refid="V592218" paragraph="paragraph8" rule="EKR:BindXY" start="188" id="R000078" uttnum="35">
    <type>ONT::CAUSE-EFFECT</type>
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
    <arg id="V592218" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000077"/>
  </CC>
  <EVENT end="230" refid="V592218" paragraph="paragraph8" start="188" rule="EKR:BindXY" uttnum="35" id="R000079">
    <type>ONT::DECREASE</type>
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V592183"/>
  </EVENT>
  <CC paragraph="paragraph8" end="230" refid="V592218" id="R000080" uttnum="35" rule="EKR:BindXY" start="188">
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V592218"/>
    <arg id="R000079" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="35" id="R000081" start="188" rule="EKR:BindXY" paragraph="paragraph8" end="230" refid="V592218">
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V592238" role=":AFFECTED"/>
  </EVENT>
  <CC start="188" rule="EKR:BindXY" uttnum="35" id="R000082" refid="V592218" end="230" paragraph="paragraph8">
    <type>ONT::CAUSE-EFFECT</type>
    <text>that ASPP1 and ASPP2 may interact with RAS</text>
    <arg role=":FACTOR" id="V592218"/>
    <arg role=":OUTCOME" id="R000081"/>
  </CC>
  <TERM end="573" paragraph="paragraph8" start="552" uttnum="38" id="R000083" refid="V635876" rule="EKR:BindXY">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINUS</name>
    <text>The ASPP1 N-terminus</text>
    <features>
      <bound-to event="V635915" id="R000084"/>
    </features>
  </TERM>
  <TERM end="587" paragraph="paragraph8" start="579" uttnum="38" id="R000084" refid="V635942" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">RAS–GTP</text>
    <features>
      <bound-to id="R000083" event="V635915"/>
    </features>
  </TERM>
  <TERM start="552" rule="EKR:BindXY" uttnum="38" id="R000085" end="620" refid="V635915,R000083,R000084" paragraph="paragraph8">
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity </text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>N-TERMINUS/RAS-GTP</name>
    <components>
      <component id="R000083"/>
      <component id="R000084"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="552" id="R000086" uttnum="38" refid="V635915" end="620" paragraph="paragraph8">
    <type>ONT::INCREASE</type>
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000085" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph8" refid="V635915" end="620" uttnum="38" id="R000087" start="552" rule="EKR:BindXY">
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V635915" role=":FACTOR"/>
    <arg id="R000086" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="38" id="R000088" start="552" rule="EKR:BindXY" paragraph="paragraph8" refid="V635915" end="620">
    <type>ONT::DECREASE</type>
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V635876" role=":AFFECTED"/>
  </EVENT>
  <CC end="620" refid="V635915" paragraph="paragraph8" rule="EKR:BindXY" start="552" id="R000089" uttnum="38">
    <type>ONT::CAUSE-EFFECT</type>
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity </text>
    <arg id="V635915" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000088"/>
  </CC>
  <EVENT uttnum="38" id="R000090" start="552" rule="EKR:BindXY" paragraph="paragraph8" end="620" refid="V635915">
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V635942"/>
  </EVENT>
  <CC id="R000091" uttnum="38" rule="EKR:BindXY" start="552" paragraph="paragraph8" end="620" refid="V635915">
    <type>ONT::CAUSE-EFFECT</type>
    <text>The ASPP1 N-terminus bound RAS–GTP with a four-fold higher affinity </text>
    <arg id="V635915" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000090"/>
  </CC>
  <TERM dbid="HGNC:14950|UP:Q96KQ4" end="841" paragraph="paragraph8" start="812" uttnum="40" id="R000092" refid="V656323" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <features>
      <mutation>TRUE</mutation>
      <bound-to event="V656346" id="R000093"/>
    </features>
    <name>ASPP-1</name>
    <text>ASPP1 mutants containing RAD</text>
  </TERM>
  <TERM end="871" paragraph="paragraph8" start="851" uttnum="40" id="R000093" refid="V656368" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">with endogenous RAS</text>
    <features>
      <bound-to id="R000092" event="V656346"/>
    </features>
  </TERM>
  <TERM rule="EKR:BindXY" start="798" id="R000094" uttnum="40" end="871" refid="V656346,R000092,R000093" paragraph="paragraph8">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS </text>
    <name>ASPP-1/RAS</name>
    <components>
      <component id="R000092"/>
      <component id="R000093"/>
    </components>
  </TERM>
  <EVENT end="871" refid="V656346" paragraph="paragraph8" start="798" rule="EKR:BindXY" uttnum="40" id="R000095">
    <type>ONT::INCREASE</type>
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000094" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:BindXY" start="798" id="R000096" uttnum="40" end="871" refid="V656346" paragraph="paragraph8">
    <type>ONT::CAUSE-EFFECT</type>
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS </text>
    <arg role=":FACTOR" id="V656346"/>
    <arg role=":OUTCOME" id="R000095"/>
  </CC>
  <EVENT rule="EKR:BindXY" start="798" id="R000097" uttnum="40" refid="V656346" end="871" paragraph="paragraph8">
    <type>ONT::DECREASE</type>
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V656323" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph8" refid="V656346" end="871" id="R000098" uttnum="40" rule="EKR:BindXY" start="798">
    <type>ONT::CAUSE-EFFECT</type>
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS </text>
    <arg role=":FACTOR" id="V656346"/>
    <arg id="R000097" role=":OUTCOME"/>
  </CC>
  <EVENT end="871" refid="V656346" paragraph="paragraph8" rule="EKR:BindXY" start="798" id="R000099" uttnum="40">
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V656368" role=":AFFECTED"/>
  </EVENT>
  <CC end="871" refid="V656346" paragraph="paragraph8" start="798" rule="EKR:BindXY" uttnum="40" id="R000100">
    <text>All truncated ASPP1 mutants containing RAD complexed with endogenous RAS </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V656346"/>
    <arg id="R000099" role=":OUTCOME"/>
  </CC>
  <TERM dbid="UP:Q13625|HGNC:12000" end="374" paragraph="paragraph9" start="368" uttnum="44" id="R000101" refid="V721114" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <features>
      <bound-to event="V721131" id="R000102"/>
    </features>
  </TERM>
  <TERM end="404" paragraph="paragraph9" start="397" uttnum="44" id="R000102" refid="V721153" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">RAS–GTP</text>
    <features>
      <bound-to event="V721131" id="R000101"/>
    </features>
  </TERM>
  <TERM rule="EKR:BindXY" start="368" id="R000103" uttnum="44" refid="V721131,R000101,R000102" end="404" paragraph="paragraph9">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>ASPP2 also selectively binds RAS–GTP</text>
    <name>ASPP-2/RAS-GTP</name>
    <components>
      <component id="R000101"/>
      <component id="R000102"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="368" id="R000104" uttnum="44" end="404" refid="V721131" paragraph="paragraph9">
    <text>ASPP2 also selectively binds RAS–GTP</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000103"/>
  </EVENT>
  <CC start="368" rule="EKR:BindXY" uttnum="44" id="R000105" end="404" refid="V721131" paragraph="paragraph9">
    <type>ONT::CAUSE-EFFECT</type>
    <text>ASPP2 also selectively binds RAS–GTP</text>
    <arg role=":FACTOR" id="V721131"/>
    <arg id="R000104" role=":OUTCOME"/>
  </CC>
  <EVENT end="404" refid="V721131" paragraph="paragraph9" start="368" rule="EKR:BindXY" uttnum="44" id="R000106">
    <type>ONT::DECREASE</type>
    <text>ASPP2 also selectively binds RAS–GTP</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V721114"/>
  </EVENT>
  <CC paragraph="paragraph9" end="404" refid="V721131" uttnum="44" id="R000107" start="368" rule="EKR:BindXY">
    <type>ONT::CAUSE-EFFECT</type>
    <text>ASPP2 also selectively binds RAS–GTP</text>
    <arg id="V721131" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000106"/>
  </CC>
  <EVENT rule="EKR:BindXY" start="368" id="R000108" uttnum="44" refid="V721131" end="404" paragraph="paragraph9">
    <text>ASPP2 also selectively binds RAS–GTP</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V721153"/>
  </EVENT>
  <CC paragraph="paragraph9" end="404" refid="V721131" uttnum="44" id="R000109" start="368" rule="EKR:BindXY">
    <type>ONT::CAUSE-EFFECT</type>
    <text>ASPP2 also selectively binds RAS–GTP</text>
    <arg role=":FACTOR" id="V721131"/>
    <arg id="R000108" role=":OUTCOME"/>
  </CC>
  <TERM dbid="UP:Q13625|HGNC:12000" end="554" paragraph="paragraph9" start="537" uttnum="45" id="R000110" refid="V735235" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>endogenous ASPP2</text>
    <features>
      <bound-to id="R000111" event="V735245"/>
    </features>
  </TERM>
  <TERM end="585" paragraph="paragraph9" start="569" uttnum="45" id="R000111" refid="V735272" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
      <bound-to event="V735245" id="R000110"/>
    </features>
    <name>RAS</name>
    <text normalization="">with active RAS</text>
  </TERM>
  <TERM id="R000112" uttnum="45" rule="EKR:BindXY" start="532" paragraph="paragraph9" refid="V735245,R000110,R000111" end="585">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>that endogenous ASPP2 also complexes with active RAS </text>
    <name>ASPP-2/RAS</name>
    <components>
      <component id="R000110"/>
      <component id="R000111"/>
    </components>
  </TERM>
  <EVENT paragraph="paragraph9" end="585" refid="V735245" uttnum="45" id="R000113" start="532" rule="EKR:BindXY">
    <text>that endogenous ASPP2 also complexes with active RAS </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000112" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000114" uttnum="45" rule="EKR:BindXY" start="532" paragraph="paragraph9" refid="V735245" end="585">
    <text>that endogenous ASPP2 also complexes with active RAS </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V735245" role=":FACTOR"/>
    <arg id="R000113" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph9" refid="V735245" end="585" id="R000115" uttnum="45" rule="EKR:BindXY" start="532">
    <type>ONT::DECREASE</type>
    <text>that endogenous ASPP2 also complexes with active RAS </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V735235"/>
  </EVENT>
  <CC id="R000116" uttnum="45" rule="EKR:BindXY" start="532" paragraph="paragraph9" refid="V735245" end="585">
    <text>that endogenous ASPP2 also complexes with active RAS </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V735245" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000115"/>
  </CC>
  <EVENT paragraph="paragraph9" refid="V735245" end="585" uttnum="45" id="R000117" start="532" rule="EKR:BindXY">
    <type>ONT::DECREASE</type>
    <text>that endogenous ASPP2 also complexes with active RAS </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V735272" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:BindXY" start="532" id="R000118" uttnum="45" end="585" refid="V735245" paragraph="paragraph9">
    <type>ONT::CAUSE-EFFECT</type>
    <text>that endogenous ASPP2 also complexes with active RAS </text>
    <arg id="V735245" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000117"/>
  </CC>
  <TERM end="739" paragraph="paragraph9" start="723" uttnum="47" id="R000119" refid="V754793" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V754789"/>
      <member id="V754809"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <features>
      <bound-to event="V754827" id="R000120"/>
    </features>
  </TERM>
  <TERM end="758" paragraph="paragraph9" start="748" uttnum="47" id="R000120" refid="V754842" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
      <bound-to id="R000119" event="V754827"/>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM paragraph="paragraph9" end="758" refid="V754827,R000119,R000120" uttnum="47" id="R000121" start="718" rule="EKR:BindXY">
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <components>
      <component id="R000119"/>
      <component id="R000120"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="718" id="R000122" uttnum="47" end="758" refid="V754827" paragraph="paragraph9">
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000121" role=":AFFECTED"/>
  </EVENT>
  <CC start="718" rule="EKR:BindXY" uttnum="47" id="R000123" end="758" refid="V754827" paragraph="paragraph9">
    <type>ONT::CAUSE-EFFECT</type>
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
    <arg id="V754827" role=":FACTOR"/>
    <arg id="R000122" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000124" uttnum="47" rule="EKR:BindXY" start="718" paragraph="paragraph9" end="758" refid="V754827">
    <type>ONT::DECREASE</type>
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V754793" role=":AFFECTED"/>
  </EVENT>
  <CC start="718" rule="EKR:BindXY" uttnum="47" id="R000125" refid="V754827" end="758" paragraph="paragraph9">
    <type>ONT::CAUSE-EFFECT</type>
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
    <arg id="V754827" role=":FACTOR"/>
    <arg id="R000124" role=":OUTCOME"/>
  </CC>
  <EVENT start="718" rule="EKR:BindXY" uttnum="47" id="R000126" refid="V754827" end="758" paragraph="paragraph9">
    <type>ONT::DECREASE</type>
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V754842" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph9" refid="V754827" end="758" uttnum="47" id="R000127" start="718" rule="EKR:BindXY">
    <text>that ASPP1 and ASPP2 can bind active RAS</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V754827"/>
    <arg role=":OUTCOME" id="R000126"/>
  </CC>
  <TERM end="122" paragraph="paragraph10" start="97" uttnum="48" id="R000128" refid="V772809" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <mutation>FALSE</mutation>
      <bound-to id="R000129" event="V772813"/>
    </features>
    <name>RAS</name>
    <text normalization="">endogenous wild-type RAS</text>
  </TERM>
  <TERM dbid="UP:Q13625|HGNC:12000" end="134" paragraph="paragraph10" start="128" uttnum="48" id="R000129" refid="V772827" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <features>
      <bound-to id="R000128" event="V772813"/>
    </features>
  </TERM>
  <TERM rule="EKR:BindXY" start="97" id="R000130" uttnum="48" refid="V772813,R000128,R000129" end="160" paragraph="paragraph10">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency </text>
    <name>RAS/ASPP-2</name>
    <components>
      <component id="R000128"/>
      <component id="R000129"/>
    </components>
  </TERM>
  <EVENT start="97" rule="EKR:BindXY" uttnum="48" id="R000131" refid="V772813" end="160" paragraph="paragraph10">
    <type>ONT::INCREASE</type>
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000130"/>
  </EVENT>
  <CC start="97" rule="EKR:BindXY" uttnum="48" id="R000132" end="160" refid="V772813" paragraph="paragraph10">
    <type>ONT::CAUSE-EFFECT</type>
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency </text>
    <arg role=":FACTOR" id="V772813"/>
    <arg role=":OUTCOME" id="R000131"/>
  </CC>
  <EVENT end="160" refid="V772813" paragraph="paragraph10" start="97" rule="EKR:BindXY" uttnum="48" id="R000133">
    <type>ONT::DECREASE</type>
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V772809" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph10" refid="V772813" end="160" uttnum="48" id="R000134" start="97" rule="EKR:BindXY">
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V772813"/>
    <arg id="R000133" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph10" refid="V772813" end="160" uttnum="48" id="R000135" start="97" rule="EKR:BindXY">
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V772827"/>
  </EVENT>
  <CC uttnum="48" id="R000136" start="97" rule="EKR:BindXY" paragraph="paragraph10" end="160" refid="V772813">
    <type>ONT::CAUSE-EFFECT</type>
    <text>endogenous wild-type RAS binds ASPP2 with different efficiency </text>
    <arg role=":FACTOR" id="V772813"/>
    <arg id="R000135" role=":OUTCOME"/>
  </CC>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1647" paragraph="paragraph10" start="1641" uttnum="57" id="R000137" refid="V942303" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <features>
      <bound-to id="R000138" event="V942315"/>
    </features>
  </TERM>
  <TERM end="1672" paragraph="paragraph10" start="1668" uttnum="57" id="R000138" refid="V942324" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <bound-to event="V942315" id="R000137"/>
    </features>
  </TERM>
  <TERM uttnum="57" id="R000139" start="1613" rule="EKR:BindXY" paragraph="paragraph10" refid="V942315,R000137,R000138" end="1692">
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ASPP-2/RAS</name>
    <components>
      <component id="R000137"/>
      <component id="R000138"/>
    </components>
  </TERM>
  <EVENT id="R000140" uttnum="57" rule="EKR:BindXY" start="1613" paragraph="paragraph10" end="1692" refid="V942315">
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000139" role=":AFFECTED"/>
  </EVENT>
  <CC end="1692" refid="V942315" paragraph="paragraph10" start="1613" rule="EKR:BindXY" uttnum="57" id="R000141">
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V942315"/>
    <arg role=":OUTCOME" id="R000140"/>
  </CC>
  <EVENT end="1692" refid="V942315" paragraph="paragraph10" start="1613" rule="EKR:BindXY" uttnum="57" id="R000142">
    <type>ONT::DECREASE</type>
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V942303" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph10" end="1692" refid="V942315" id="R000143" uttnum="57" rule="EKR:BindXY" start="1613">
    <type>ONT::CAUSE-EFFECT</type>
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    <arg role=":FACTOR" id="V942315"/>
    <arg id="R000142" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000144" uttnum="57" rule="EKR:BindXY" start="1613" paragraph="paragraph10" end="1692" refid="V942315">
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V942324" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:BindXY" start="1613" id="R000145" uttnum="57" refid="V942315" end="1692" paragraph="paragraph10">
    <text>These data demonstrate that ASPP2 preferentially binds RAS when it is activated</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V942315" role=":FACTOR"/>
    <arg id="R000144" role=":OUTCOME"/>
  </CC>
  <TERM end="52" paragraph="paragraph11" start="36" uttnum="58" id="R000146" refid="V957333" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V957329"/>
      <member id="V957349"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <features>
      <bound-to id="R000147" event="V957365"/>
    </features>
  </TERM>
  <TERM end="89" paragraph="paragraph11" start="76" uttnum="58" id="R000147" refid="V957398" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P10301" type="ONT::PROTEIN"/>
      <member dbid="UP:O14807" type="ONT::PROTEIN"/>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P62070" type="ONT::PROTEIN"/>
    </members>
    <name>RAS-GTP</name>
    <text normalization="">with RAS–GTP,</text>
    <features>
      <bound-to id="R000146" event="V957365"/>
    </features>
  </TERM>
  <TERM start="3" rule="EKR:BindXY" uttnum="58" id="R000148" end="89" refid="V957365,R000146,R000147" paragraph="paragraph11">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    <name>COMPLEX</name>
    <components>
      <component id="R000146"/>
      <component id="R000147"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="3" id="R000149" uttnum="58" end="89" refid="V957365" paragraph="paragraph11">
    <type>ONT::INCREASE</type>
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000148"/>
  </EVENT>
  <CC paragraph="paragraph11" end="89" refid="V957365" uttnum="58" id="R000150" start="3" rule="EKR:BindXY">
    <type>ONT::CAUSE-EFFECT</type>
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    <arg id="V957365" role=":FACTOR"/>
    <arg id="R000149" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V957365" end="89" paragraph="paragraph11" start="3" rule="EKR:BindXY" uttnum="58" id="R000151">
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V957333" role=":AFFECTED"/>
  </EVENT>
  <CC start="3" rule="EKR:BindXY" uttnum="58" id="R000152" end="89" refid="V957365" paragraph="paragraph11">
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V957365"/>
    <arg id="R000151" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="58" id="R000153" start="3" rule="EKR:BindXY" paragraph="paragraph11" refid="V957365" end="89">
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V957398" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph11" end="89" refid="V957365" id="R000154" uttnum="58" rule="EKR:BindXY" start="3">
    <type>ONT::CAUSE-EFFECT</type>
    <text>To provide further evidence that ASPP1 and ASPP2 preferentially interact with RAS–GTP,</text>
    <arg role=":FACTOR" id="V957365"/>
    <arg role=":OUTCOME" id="R000153"/>
  </CC>
  <TERM end="37" paragraph="paragraph25" start="21" uttnum="130" id="R000155" refid="V2097933" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <aggregate operator="AND">
      <member id="V2097929"/>
      <member id="V2097949"/>
    </aggregate>
    <text normalization="">ASPP1 and ASPP2</text>
    <features>
      <bound-to event="V2097954" id="R000156"/>
    </features>
  </TERM>
  <TERM end="53" paragraph="paragraph25" start="42" uttnum="130" id="R000156" refid="V2097969" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
      <bound-to id="R000155" event="V2097954"/>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM id="R000157" uttnum="130" rule="EKR:BindXY" start="3" paragraph="paragraph25" end="72" refid="V2097954,R000155,R000156">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    <name>COMPLEX</name>
    <components>
      <component id="R000155"/>
      <component id="R000156"/>
    </components>
  </TERM>
  <EVENT refid="V2097954" end="72" paragraph="paragraph25" start="3" rule="EKR:BindXY" uttnum="130" id="R000158">
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000157" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:BindXY" start="3" id="R000159" uttnum="130" refid="V2097954" end="72" paragraph="paragraph25">
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2097954" role=":FACTOR"/>
    <arg id="R000158" role=":OUTCOME"/>
  </CC>
  <EVENT start="3" rule="EKR:BindXY" uttnum="130" id="R000160" refid="V2097954" end="72" paragraph="paragraph25">
    <type>ONT::DECREASE</type>
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2097933" role=":AFFECTED"/>
  </EVENT>
  <CC end="72" refid="V2097954" paragraph="paragraph25" start="3" rule="EKR:BindXY" uttnum="130" id="R000161">
    <type>ONT::CAUSE-EFFECT</type>
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    <arg role=":FACTOR" id="V2097954"/>
    <arg id="R000160" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph25" end="72" refid="V2097954" uttnum="130" id="R000162" start="3" rule="EKR:BindXY">
    <type>ONT::DECREASE</type>
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2097969"/>
  </EVENT>
  <CC rule="EKR:BindXY" start="3" id="R000163" uttnum="130" refid="V2097954" end="72" paragraph="paragraph25">
    <type>ONT::CAUSE-EFFECT</type>
    <text>We show here that ASPP1 and ASPP2 bind active RAS via their N-termini</text>
    <arg id="V2097954" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000162"/>
  </CC>
  <TERM end="1045" paragraph="paragraph25" start="1042" uttnum="137" id="R000164" refid="V2193318" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">it</text>
    <features>
      <bound-to id="R000165" event="V2193324"/>
    </features>
  </TERM>
  <TERM end="1062" paragraph="paragraph25" start="1051" uttnum="137" id="R000165" refid="V2193339" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
      <bound-to id="R000164" event="V2193324"/>
    </features>
    <name>RAS</name>
    <text normalization="">active RAS</text>
  </TERM>
  <TERM start="1042" rule="EKR:BindXY" uttnum="137" id="R000166" end="1062" refid="V2193324,R000164,R000165" paragraph="paragraph25">
    <text>it binds active RAS </text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>RAS/RAS</name>
    <components>
      <component id="R000164"/>
      <component id="R000165"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="1042" id="R000167" uttnum="137" end="1062" refid="V2193324" paragraph="paragraph25">
    <text>it binds active RAS </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000166"/>
  </EVENT>
  <CC paragraph="paragraph25" refid="V2193324" end="1062" uttnum="137" id="R000168" start="1042" rule="EKR:BindXY">
    <type>ONT::CAUSE-EFFECT</type>
    <text>it binds active RAS </text>
    <arg role=":FACTOR" id="V2193324"/>
    <arg role=":OUTCOME" id="R000167"/>
  </CC>
  <EVENT refid="V2193324" end="1062" paragraph="paragraph25" start="1042" rule="EKR:BindXY" uttnum="137" id="R000169">
    <type>ONT::DECREASE</type>
    <text>it binds active RAS </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2193318"/>
  </EVENT>
  <CC end="1062" refid="V2193324" paragraph="paragraph25" start="1042" rule="EKR:BindXY" uttnum="137" id="R000170">
    <type>ONT::CAUSE-EFFECT</type>
    <text>it binds active RAS </text>
    <arg role=":FACTOR" id="V2193324"/>
    <arg role=":OUTCOME" id="R000169"/>
  </CC>
  <EVENT paragraph="paragraph25" end="1062" refid="V2193324" id="R000171" uttnum="137" rule="EKR:BindXY" start="1042">
    <text>it binds active RAS </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2193339"/>
  </EVENT>
  <CC refid="V2193324" end="1062" paragraph="paragraph25" start="1042" rule="EKR:BindXY" uttnum="137" id="R000172">
    <text>it binds active RAS </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2193324"/>
    <arg role=":OUTCOME" id="R000171"/>
  </CC>
  <TERM dbid="UP:Q13625|HGNC:12000" end="232" paragraph="paragraph26" start="226" uttnum="143" id="R000173" refid="V2324241" rule="EKR:BindXY">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>ASPP2</text>
    <features>
      <bound-to event="V2324245" id="R000174"/>
    </features>
  </TERM>
  <TERM dbid="UP:O08675|UP:Q99NH2|XFAM:PF00001|XFAM:PF00595|UP:Q8TEW0|HGNC:16051|HGNC:3539|UP:O00254|FA:02653|XFAM:PF12053" end="243" paragraph="paragraph26" start="238" uttnum="143" id="R000174" refid="V2324263" rule="EKR:BindXY">
    <type>ONT::GENE-PROTEIN</type>
    <name>PAR-3</name>
    <text>PAR3</text>
    <features>
      <bound-to event="V2324245" id="R000173"/>
    </features>
  </TERM>
  <TERM paragraph="paragraph26" end="243" refid="V2324245,R000173,R000174" uttnum="143" id="R000175" start="226" rule="EKR:BindXY">
    <text>ASPP2 binds PAR3 </text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ASPP-2/PAR-3</name>
    <components>
      <component id="R000173"/>
      <component id="R000174"/>
    </components>
  </TERM>
  <EVENT refid="V2324245" end="243" paragraph="paragraph26" start="226" rule="EKR:BindXY" uttnum="143" id="R000176">
    <text>ASPP2 binds PAR3 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000175" role=":AFFECTED"/>
  </EVENT>
  <CC start="226" rule="EKR:BindXY" uttnum="143" id="R000177" refid="V2324245" end="243" paragraph="paragraph26">
    <text>ASPP2 binds PAR3 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2324245" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000176"/>
  </CC>
  <EVENT rule="EKR:BindXY" start="226" id="R000178" uttnum="143" refid="V2324245" end="243" paragraph="paragraph26">
    <type>ONT::DECREASE</type>
    <text>ASPP2 binds PAR3 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2324241" role=":AFFECTED"/>
  </EVENT>
  <CC start="226" rule="EKR:BindXY" uttnum="143" id="R000179" refid="V2324245" end="243" paragraph="paragraph26">
    <type>ONT::CAUSE-EFFECT</type>
    <text>ASPP2 binds PAR3 </text>
    <arg role=":FACTOR" id="V2324245"/>
    <arg id="R000178" role=":OUTCOME"/>
  </CC>
  <EVENT end="243" refid="V2324245" paragraph="paragraph26" rule="EKR:BindXY" start="226" id="R000180" uttnum="143">
    <text>ASPP2 binds PAR3 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2324263"/>
  </EVENT>
  <CC paragraph="paragraph26" end="243" refid="V2324245" uttnum="143" id="R000181" start="226" rule="EKR:BindXY">
    <text>ASPP2 binds PAR3 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2324245"/>
    <arg role=":OUTCOME" id="R000180"/>
  </CC>
  <TERM end="460" paragraph="paragraph15" start="445" uttnum="80" id="R000182" refid="V1266324" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1266320"/>
      <member id="V1266335"/>
    </aggregate>
    <text normalization="">of ERK and AKT</text>
    <features>
      <ptm event="V1266308" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT id="R000183" uttnum="80" rule="EKR:PTM" start="417" paragraph="paragraph15" refid="V1266308" end="460">
    <text>RAS-induced phosphorylation of ERK and AKT </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000182"/>
  </EVENT>
  <CC rule="EKR:PTM" start="417" id="R000184" uttnum="80" refid="V1266308" end="460" paragraph="paragraph15">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS-induced phosphorylation of ERK and AKT </text>
    <arg role=":FACTOR" id="V1266308"/>
    <arg role=":OUTCOME" id="R000183"/>
  </CC>
  <EVENT rule="EKR:PTM" start="417" id="R000185" uttnum="80" end="460" refid="V1266308" paragraph="paragraph15">
    <text>RAS-induced phosphorylation of ERK and AKT </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1266324"/>
  </EVENT>
  <CC start="417" rule="EKR:PTM" uttnum="80" id="R000186" end="460" refid="V1266308" paragraph="paragraph15">
    <text>RAS-induced phosphorylation of ERK and AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1266308"/>
    <arg role=":OUTCOME" id="R000185"/>
  </CC>
  <TERM end="337" paragraph="paragraph2" start="333" uttnum="10" id="R000187" refid="V151648" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V151651" end="348" paragraph="paragraph2" rule="EKR:ActivateX" start="333" id="R000188" uttnum="10">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000187"/>
  </EVENT>
  <CC paragraph="paragraph2" end="348" refid="V151651" uttnum="10" id="R000189" start="333" rule="EKR:ActivateX">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V151651" role=":FACTOR"/>
    <arg id="R000188" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="333" id="R000190" uttnum="10" end="348" refid="V151651" paragraph="paragraph2">
    <type>ONT::DECREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V151648"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="333" id="R000191" uttnum="10" end="348" refid="V151651" paragraph="paragraph2">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V151651" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000190"/>
  </CC>
  <TERM end="572" paragraph="paragraph2" start="565" uttnum="12" id="R000192" refid="V179434" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">of RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V179420" end="572" paragraph="paragraph2" start="554" rule="EKR:ActivateX" uttnum="12" id="R000193">
    <type>ONT::INCREASE</type>
    <text>Activation of RAS </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000192" role=":AFFECTED"/>
  </EVENT>
  <CC start="554" rule="EKR:ActivateX" uttnum="12" id="R000194" end="572" refid="V179420" paragraph="paragraph2">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activation of RAS </text>
    <arg id="V179420" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000193"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="554" id="R000195" uttnum="12" refid="V179420" end="572" paragraph="paragraph2">
    <type>ONT::DECREASE</type>
    <text>Activation of RAS </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V179434" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="12" id="R000196" start="554" rule="EKR:ActivateX" paragraph="paragraph2" end="572" refid="V179420">
    <text>Activation of RAS </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V179420"/>
    <arg id="R000195" role=":OUTCOME"/>
  </CC>
  <TERM end="1097" paragraph="paragraph2" start="1093" uttnum="13" id="R000197" refid="V208043" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V208047" end="1107" paragraph="paragraph2" rule="EKR:ActivateX" start="1093" id="R000198" uttnum="13">
    <text>RAS activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000197" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V208047" end="1107" paragraph="paragraph2" rule="EKR:ActivateX" start="1093" id="R000199" uttnum="13">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation</text>
    <arg role=":FACTOR" id="V208047"/>
    <arg id="R000198" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph2" refid="V208047" end="1107" id="R000200" uttnum="13" rule="EKR:ActivateX" start="1093">
    <type>ONT::DECREASE</type>
    <text>RAS activation</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V208043" role=":AFFECTED"/>
  </EVENT>
  <CC end="1107" refid="V208047" paragraph="paragraph2" start="1093" rule="EKR:ActivateX" uttnum="13" id="R000201">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation</text>
    <arg role=":FACTOR" id="V208047"/>
    <arg role=":OUTCOME" id="R000200"/>
  </CC>
  <TERM end="69" paragraph="paragraph6" start="65" uttnum="24" id="R000202" refid="V398387" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V398390" end="80" paragraph="paragraph6" start="65" rule="EKR:ActivateX" uttnum="24" id="R000203">
    <text>RAS activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000202"/>
  </EVENT>
  <CC refid="V398390" end="80" paragraph="paragraph6" rule="EKR:ActivateX" start="65" id="R000204" uttnum="24">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg id="V398390" role=":FACTOR"/>
    <arg id="R000203" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph6" refid="V398390" end="80" uttnum="24" id="R000205" start="65" rule="EKR:ActivateX">
    <text>RAS activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V398387"/>
  </EVENT>
  <CC end="80" refid="V398390" paragraph="paragraph6" rule="EKR:ActivateX" start="65" id="R000206" uttnum="24">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg id="V398390" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000205"/>
  </CC>
  <TERM end="1312" paragraph="paragraph10" start="1308" uttnum="54" id="R000207" refid="V879135" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph10" refid="V879139" end="1322" uttnum="54" id="R000208" start="1308" rule="EKR:ActivateX">
    <text>RAS activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000207" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="1308" id="R000209" uttnum="54" refid="V879139" end="1322" paragraph="paragraph10">
    <text>RAS activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V879139" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000208"/>
  </CC>
  <EVENT paragraph="paragraph10" refid="V879139" end="1322" uttnum="54" id="R000210" start="1308" rule="EKR:ActivateX">
    <text>RAS activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V879135"/>
  </EVENT>
  <CC paragraph="paragraph10" end="1322" refid="V879139" uttnum="54" id="R000211" start="1308" rule="EKR:ActivateX">
    <text>RAS activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V879139" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000210"/>
  </CC>
  <TERM dbid="UP:Q13625|HGNC:12000" end="1680" paragraph="paragraph10" start="1677" uttnum="57" id="R000212" refid="V942340" rule="EKR:ActivateX">
    <type>ONT::GENE</type>
    <name>ASPP-2</name>
    <text>it</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V942366" end="1692" paragraph="paragraph10" start="1677" rule="EKR:ActivateX" uttnum="57" id="R000213">
    <type>ONT::INCREASE</type>
    <text>it is activated</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000212"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="1677" id="R000214" uttnum="57" refid="V942366" end="1692" paragraph="paragraph10">
    <type>ONT::CAUSE-EFFECT</type>
    <text>it is activated</text>
    <arg id="V942366" role=":FACTOR"/>
    <arg id="R000213" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V942366" end="1692" paragraph="paragraph10" start="1677" rule="EKR:ActivateX" uttnum="57" id="R000215">
    <type>ONT::DECREASE</type>
    <text>it is activated</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V942340"/>
  </EVENT>
  <CC id="R000216" uttnum="57" rule="EKR:ActivateX" start="1677" paragraph="paragraph10" refid="V942366" end="1692">
    <type>ONT::CAUSE-EFFECT</type>
    <text>it is activated</text>
    <arg role=":FACTOR" id="V942366"/>
    <arg role=":OUTCOME" id="R000215"/>
  </CC>
  <TERM end="220" paragraph="paragraph15" start="216" uttnum="78" id="R000217" refid="V1237935" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000218" uttnum="78" rule="EKR:ActivateX" start="216" paragraph="paragraph15" end="231" refid="V1237939">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000217"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="216" id="R000219" uttnum="78" end="231" refid="V1237939" paragraph="paragraph15">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg role=":FACTOR" id="V1237939"/>
    <arg id="R000218" role=":OUTCOME"/>
  </CC>
  <EVENT start="216" rule="EKR:ActivateX" uttnum="78" id="R000220" end="231" refid="V1237939" paragraph="paragraph15">
    <type>ONT::DECREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1237935" role=":AFFECTED"/>
  </EVENT>
  <CC start="216" rule="EKR:ActivateX" uttnum="78" id="R000221" end="231" refid="V1237939" paragraph="paragraph15">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1237939"/>
    <arg id="R000220" role=":OUTCOME"/>
  </CC>
  <TERM end="35" paragraph="paragraph18" start="31" uttnum="94" id="R000222" refid="V1483348" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="94" id="R000223" start="31" rule="EKR:ActivateX" paragraph="paragraph18" end="46" refid="V1483351">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000222"/>
  </EVENT>
  <CC paragraph="paragraph18" refid="V1483351" end="46" uttnum="94" id="R000224" start="31" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg id="V1483351" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000223"/>
  </CC>
  <EVENT refid="V1483351" end="46" paragraph="paragraph18" rule="EKR:ActivateX" start="31" id="R000225" uttnum="94">
    <text>RAS activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1483348" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="31" id="R000226" uttnum="94" end="46" refid="V1483351" paragraph="paragraph18">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg id="V1483351" role=":FACTOR"/>
    <arg id="R000225" role=":OUTCOME"/>
  </CC>
  <TERM end="26" paragraph="paragraph21" start="22" uttnum="111" id="R000227" refid="V1794269" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph21" refid="V1794273" end="37" id="R000228" uttnum="111" rule="EKR:ActivateX" start="22">
    <text>RAS activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000227"/>
  </EVENT>
  <CC id="R000229" uttnum="111" rule="EKR:ActivateX" start="22" paragraph="paragraph21" refid="V1794273" end="37">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1794273"/>
    <arg role=":OUTCOME" id="R000228"/>
  </CC>
  <EVENT start="22" rule="EKR:ActivateX" uttnum="111" id="R000230" refid="V1794273" end="37" paragraph="paragraph21">
    <type>ONT::DECREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1794269"/>
  </EVENT>
  <CC paragraph="paragraph21" refid="V1794273" end="37" uttnum="111" id="R000231" start="22" rule="EKR:ActivateX">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1794273"/>
    <arg id="R000230" role=":OUTCOME"/>
  </CC>
  <TERM end="72" paragraph="paragraph22" start="68" uttnum="114" id="R000232" refid="V1860793" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph22" refid="V1860796" end="83" uttnum="114" id="R000233" start="68" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000232"/>
  </EVENT>
  <CC end="83" refid="V1860796" paragraph="paragraph22" start="68" rule="EKR:ActivateX" uttnum="114" id="R000234">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1860796" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000233"/>
  </CC>
  <EVENT uttnum="114" id="R000235" start="68" rule="EKR:ActivateX" paragraph="paragraph22" refid="V1860796" end="83">
    <type>ONT::DECREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1860793"/>
  </EVENT>
  <CC start="68" rule="EKR:ActivateX" uttnum="114" id="R000236" end="83" refid="V1860796" paragraph="paragraph22">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg id="V1860796" role=":FACTOR"/>
    <arg id="R000235" role=":OUTCOME"/>
  </CC>
  <TERM end="149" paragraph="paragraph22" start="145" uttnum="115" id="R000237" refid="V1875630" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph22" refid="V1875633" end="160" id="R000238" uttnum="115" rule="EKR:ActivateX" start="135">
    <text>oncogenic RAS activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000237" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000239" uttnum="115" rule="EKR:ActivateX" start="135" paragraph="paragraph22" end="160" refid="V1875633">
    <text>oncogenic RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1875633"/>
    <arg id="R000238" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000240" uttnum="115" rule="EKR:ActivateX" start="135" paragraph="paragraph22" end="160" refid="V1875633">
    <text>oncogenic RAS activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1875630" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="135" id="R000241" uttnum="115" refid="V1875633" end="160" paragraph="paragraph22">
    <text>oncogenic RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1875633"/>
    <arg id="R000240" role=":OUTCOME"/>
  </CC>
  <TERM end="285" paragraph="paragraph23" start="281" uttnum="120" id="R000242" refid="V1947681" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="281" rule="EKR:ActivateX" uttnum="120" id="R000243" end="296" refid="V1947684" paragraph="paragraph23">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000242"/>
  </EVENT>
  <CC uttnum="120" id="R000244" start="281" rule="EKR:ActivateX" paragraph="paragraph23" end="296" refid="V1947684">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg id="V1947684" role=":FACTOR"/>
    <arg id="R000243" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="281" id="R000245" uttnum="120" end="296" refid="V1947684" paragraph="paragraph23">
    <type>ONT::DECREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1947681"/>
  </EVENT>
  <CC start="281" rule="EKR:ActivateX" uttnum="120" id="R000246" end="296" refid="V1947684" paragraph="paragraph23">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg role=":FACTOR" id="V1947684"/>
    <arg id="R000245" role=":OUTCOME"/>
  </CC>
  <TERM end="476" paragraph="paragraph23" start="472" uttnum="121" id="R000247" refid="V1962180" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="488" refid="V1962183" paragraph="paragraph23" rule="EKR:ActivateX" start="472" id="R000248" uttnum="121">
    <type>ONT::INCREASE</type>
    <text>RAS activation, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000247" role=":AFFECTED"/>
  </EVENT>
  <CC end="488" refid="V1962183" paragraph="paragraph23" rule="EKR:ActivateX" start="472" id="R000249" uttnum="121">
    <text>RAS activation, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1962183"/>
    <arg id="R000248" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph23" end="488" refid="V1962183" uttnum="121" id="R000250" start="472" rule="EKR:ActivateX">
    <text>RAS activation, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1962180" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V1962183" end="488" paragraph="paragraph23" rule="EKR:ActivateX" start="472" id="R000251" uttnum="121">
    <text>RAS activation, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1962183" role=":FACTOR"/>
    <arg id="R000250" role=":OUTCOME"/>
  </CC>
  <TERM end="714" paragraph="paragraph23" start="710" uttnum="122" id="R000252" refid="V1973879" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="710" id="R000253" uttnum="122" end="725" refid="V1973883" paragraph="paragraph23">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000252"/>
  </EVENT>
  <CC paragraph="paragraph23" refid="V1973883" end="725" uttnum="122" id="R000254" start="710" rule="EKR:ActivateX">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1973883"/>
    <arg role=":OUTCOME" id="R000253"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="710" id="R000255" uttnum="122" end="725" refid="V1973883" paragraph="paragraph23">
    <text>RAS activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1973879"/>
  </EVENT>
  <CC id="R000256" uttnum="122" rule="EKR:ActivateX" start="710" paragraph="paragraph23" refid="V1973883" end="725">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1973883"/>
    <arg role=":OUTCOME" id="R000255"/>
  </CC>
  <TERM end="125" paragraph="paragraph25" start="121" uttnum="131" id="R000257" refid="V2100502" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="149" refid="V2100495" paragraph="paragraph25" rule="EKR:ActivateX" start="74" id="R000258" uttnum="131">
    <type>ONT::INCREASE</type>
    <text>ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000257"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="74" id="R000259" uttnum="131" end="149" refid="V2100495" paragraph="paragraph25">
    <text>ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2100495"/>
    <arg role=":OUTCOME" id="R000258"/>
  </CC>
  <EVENT uttnum="131" id="R000260" start="74" rule="EKR:ActivateX" paragraph="paragraph25" refid="V2100495" end="149">
    <type>ONT::DECREASE</type>
    <text>ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2100502" role=":AFFECTED"/>
  </EVENT>
  <CC end="149" refid="V2100495" paragraph="paragraph25" rule="EKR:ActivateX" start="74" id="R000261" uttnum="131">
    <text>ASPP2 potentiates RAS signalling and activates RAS at the cellular membrane</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2100495" role=":FACTOR"/>
    <arg id="R000260" role=":OUTCOME"/>
  </CC>
  <TERM end="795" paragraph="paragraph25" start="791" uttnum="136" id="R000262" refid="V2176089" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph25" end="806" refid="V2176093" uttnum="136" id="R000263" start="791" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000262"/>
  </EVENT>
  <CC paragraph="paragraph25" end="806" refid="V2176093" id="R000264" uttnum="136" rule="EKR:ActivateX" start="791">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2176093"/>
    <arg id="R000263" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000265" uttnum="136" rule="EKR:ActivateX" start="791" paragraph="paragraph25" refid="V2176093" end="806">
    <type>ONT::DECREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2176089"/>
  </EVENT>
  <CC paragraph="paragraph25" refid="V2176093" end="806" id="R000266" uttnum="136" rule="EKR:ActivateX" start="791">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2176093"/>
    <arg id="R000265" role=":OUTCOME"/>
  </CC>
  <TERM end="1028" paragraph="paragraph25" start="1024" uttnum="137" id="R000267" refid="V2193286" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph25" refid="V2193310" end="1040" id="R000268" uttnum="137" rule="EKR:ActivateX" start="1024">
    <text>RAS is activated</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000267" role=":AFFECTED"/>
  </EVENT>
  <CC start="1024" rule="EKR:ActivateX" uttnum="137" id="R000269" refid="V2193310" end="1040" paragraph="paragraph25">
    <text>RAS is activated</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2193310" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000268"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="1024" id="R000270" uttnum="137" end="1040" refid="V2193310" paragraph="paragraph25">
    <text>RAS is activated</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2193286" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="1024" id="R000271" uttnum="137" refid="V2193310" end="1040" paragraph="paragraph25">
    <text>RAS is activated</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2193310" role=":FACTOR"/>
    <arg id="R000270" role=":OUTCOME"/>
  </CC>
  <TERM end="1484" paragraph="paragraph25" start="1480" uttnum="140" id="R000272" refid="V2259066" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000273" uttnum="140" rule="EKR:ActivateX" start="1480" paragraph="paragraph25" end="1589" refid="V2259069">
    <type>ONT::INCREASE</type>
    <text>RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000272" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph25" end="1589" refid="V2259069" uttnum="140" id="R000274" start="1480" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions </text>
    <arg id="V2259069" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000273"/>
  </CC>
  <EVENT uttnum="140" id="R000275" start="1480" rule="EKR:ActivateX" paragraph="paragraph25" refid="V2259069" end="1589">
    <text>RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2259066"/>
  </EVENT>
  <CC paragraph="paragraph25" end="1589" refid="V2259069" uttnum="140" id="R000276" start="1480" rule="EKR:ActivateX">
    <text>RAS activation induced by growth factors such as EGF or insulin in primary cells in normal growth conditions </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2259069" role=":FACTOR"/>
    <arg id="R000275" role=":OUTCOME"/>
  </CC>
  <TERM dbid="UP:P04637" end="2006" paragraph="paragraph25" start="2002" uttnum="141" id="R000277" refid="V2295765" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>P-53</name>
    <text>p53</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V2295769" end="2017" paragraph="paragraph25" rule="EKR:ActivateX" start="2002" id="R000278" uttnum="141">
    <type>ONT::INCREASE</type>
    <text>p53 activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000277" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph25" refid="V2295769" end="2017" id="R000279" uttnum="141" rule="EKR:ActivateX" start="2002">
    <text>p53 activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2295769" role=":FACTOR"/>
    <arg id="R000278" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="141" id="R000280" start="2002" rule="EKR:ActivateX" paragraph="paragraph25" refid="V2295769" end="2017">
    <type>ONT::DECREASE</type>
    <text>p53 activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2295765"/>
  </EVENT>
  <CC start="2002" rule="EKR:ActivateX" uttnum="141" id="R000281" refid="V2295769" end="2017" paragraph="paragraph25">
    <type>ONT::CAUSE-EFFECT</type>
    <text>p53 activation </text>
    <arg id="V2295769" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000280"/>
  </CC>
  <TERM end="55" paragraph="paragraph27" start="51" uttnum="147" id="R000282" refid="V2384599" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph27" end="66" refid="V2384602" id="R000283" uttnum="147" rule="EKR:ActivateX" start="51">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000282"/>
  </EVENT>
  <CC paragraph="paragraph27" end="66" refid="V2384602" id="R000284" uttnum="147" rule="EKR:ActivateX" start="51">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg role=":FACTOR" id="V2384602"/>
    <arg role=":OUTCOME" id="R000283"/>
  </CC>
  <EVENT paragraph="paragraph27" refid="V2384602" end="66" uttnum="147" id="R000285" start="51" rule="EKR:ActivateX">
    <text>RAS activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2384599"/>
  </EVENT>
  <CC end="66" refid="V2384602" paragraph="paragraph27" rule="EKR:ActivateX" start="51" id="R000286" uttnum="147">
    <type>ONT::CAUSE-EFFECT</type>
    <text>RAS activation </text>
    <arg id="V2384602" role=":FACTOR"/>
    <arg id="R000285" role=":OUTCOME"/>
  </CC>
  <TERM end="178" paragraph="paragraph27" start="174" uttnum="148" id="R000287" refid="V2387999" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P01112" type="ONT::PROTEIN"/>
      <member dbid="UP:P01111" type="ONT::PROTEIN"/>
      <member dbid="UP:P01116" type="ONT::PROTEIN"/>
    </members>
    <name>RAS</name>
    <text normalization="">RAS</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="174" id="R000288" uttnum="148" refid="V2388002" end="189" paragraph="paragraph27">
    <type>ONT::INCREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000287"/>
  </EVENT>
  <CC uttnum="148" id="R000289" start="174" rule="EKR:ActivateX" paragraph="paragraph27" refid="V2388002" end="189">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2388002"/>
    <arg role=":OUTCOME" id="R000288"/>
  </CC>
  <EVENT paragraph="paragraph27" end="189" refid="V2388002" id="R000290" uttnum="148" rule="EKR:ActivateX" start="174">
    <type>ONT::DECREASE</type>
    <text>RAS activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2387999" role=":AFFECTED"/>
  </EVENT>
  <CC end="189" refid="V2388002" paragraph="paragraph27" start="174" rule="EKR:ActivateX" uttnum="148" id="R000291">
    <text>RAS activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2388002" role=":FACTOR"/>
    <arg id="R000290" role=":OUTCOME"/>
  </CC>
  <TERM end="126" paragraph="paragraph28" start="117" uttnum="151" id="R000292" refid="V2451713" rule="EKR:ActivateX">
    <type>ONT::GENE</type>
    <name>ONCOGENE</name>
    <text>oncogene</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="117" id="R000293" uttnum="151" refid="V2451717" end="137" paragraph="paragraph28">
    <type>ONT::INCREASE</type>
    <text>oncogene activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000292" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="151" id="R000294" start="117" rule="EKR:ActivateX" paragraph="paragraph28" end="137" refid="V2451717">
    <type>ONT::CAUSE-EFFECT</type>
    <text>oncogene activation </text>
    <arg id="V2451717" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000293"/>
  </CC>
  <EVENT paragraph="paragraph28" refid="V2451717" end="137" uttnum="151" id="R000295" start="117" rule="EKR:ActivateX">
    <type>ONT::DECREASE</type>
    <text>oncogene activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2451713"/>
  </EVENT>
  <CC refid="V2451717" end="137" paragraph="paragraph28" rule="EKR:ActivateX" start="117" id="R000296" uttnum="151">
    <type>ONT::CAUSE-EFFECT</type>
    <text>oncogene activation </text>
    <arg id="V2451717" role=":FACTOR"/>
    <arg id="R000295" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF08934|HGNC:9884|UP:P13405|XFAM:PF01857|UP:P06400|XFAM:PF11934|XFAM:PF01858" end="740" paragraph="paragraph6" start="730" uttnum="27" id="R000297" refid="V461376" rule="EKR:DeactivateX">
    <type>ONT::PROTEIN</type>
    <name>RB</name>
    <text>of the Rb</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:DeactivateX" start="717" id="R000298" uttnum="27" refid="V461356" end="740" paragraph="paragraph6">
    <type>ONT::INCREASE</type>
    <text>inactivation of the Rb </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000297" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000299" uttnum="27" rule="EKR:DeactivateX" start="717" paragraph="paragraph6" refid="V461356" end="740">
    <type>ONT::CAUSE-EFFECT</type>
    <text>inactivation of the Rb </text>
    <arg role=":FACTOR" id="V461356"/>
    <arg role=":OUTCOME" id="R000298"/>
  </CC>
  <EVENT refid="V461356" end="740" paragraph="paragraph6" rule="EKR:DeactivateX" start="717" id="R000300" uttnum="27">
    <text>inactivation of the Rb </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V461376" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="27" id="R000301" start="717" rule="EKR:DeactivateX" paragraph="paragraph6" end="740" refid="V461356">
    <type>ONT::CAUSE-EFFECT</type>
    <text>inactivation of the Rb </text>
    <arg role=":FACTOR" id="V461356"/>
    <arg role=":OUTCOME" id="R000300"/>
  </CC>
</ekb>
